BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 842440 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O2S/c1-12-8-26-20(32-12)16-5-15(6-18(7-16)31-11-14-3-4-14)19(30)29-13(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,13-14H,3-4,11H2,1-2H3,(H,29,30)/t13-/m1/s1 KPIHUQDIFGXEHA-CYBMUJFWSA-N 319834 3-(Cyclopropylmethoxy)-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 1::US10202369, Example 1::US10472354, Example 1 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319834&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397250 384223114 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842441 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O2S/c1-12-8-26-20(32-12)16-5-15(6-18(7-16)31-11-14-3-4-14)19(30)29-13(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,13-14H,3-4,11H2,1-2H3,(H,29,30)/t13-/m1/s1 KPIHUQDIFGXEHA-CYBMUJFWSA-N 319834 3-(Cyclopropylmethoxy)-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 1::US10202369, Example 1::US10472354, Example 1 P2X purinoceptor 2/3 Homo sapiens 76.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319834&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397250 384223114 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842442 Cc1cnc(s1)-c1cc(OCC2CC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C21H22N4O2S/c1-13-3-6-18(25-24-13)11-22-20(26)16-7-17(21-23-10-14(2)28-21)9-19(8-16)27-12-15-4-5-15/h3,6-10,15H,4-5,11-12H2,1-2H3,(H,22,26) LHMIEJIRNSAGER-UHFFFAOYSA-N 319835 3-(Cyclopropylmethoxy)-N-[(6-methylpyridazin-3-yl)methyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 2::US10202369, Example 2::US10472354, Example 2 P2X purinoceptor 3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319835&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397260 384223115 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842443 Cc1cnc(s1)-c1cc(OCC2CC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C21H22N4O2S/c1-13-3-6-18(25-24-13)11-22-20(26)16-7-17(21-23-10-14(2)28-21)9-19(8-16)27-12-15-4-5-15/h3,6-10,15H,4-5,11-12H2,1-2H3,(H,22,26) LHMIEJIRNSAGER-UHFFFAOYSA-N 319835 3-(Cyclopropylmethoxy)-N-[(6-methylpyridazin-3-yl)methyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 2::US10202369, Example 2::US10472354, Example 2 P2X purinoceptor 2/3 Homo sapiens 251 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319835&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397260 384223115 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842444 Cc1cnc(s1)-c1cc(OCC2CC2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C21H22N4O2S/c1-13-8-23-18(10-22-13)11-24-20(26)16-5-17(21-25-9-14(2)28-21)7-19(6-16)27-12-15-3-4-15/h5-10,15H,3-4,11-12H2,1-2H3,(H,24,26) SHCAJJQUYCQWRM-UHFFFAOYSA-N 319836 3-(Cyclopropylmethoxy)-N-[(5-methylpyrazin-2-yl)methyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 3::US10202369, Example 3::US10472354, Example 3 P2X purinoceptor 3 Homo sapiens 26.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319836&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397194 384223116 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842445 Cc1cnc(s1)-c1cc(OCC2CC2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C21H22N4O2S/c1-13-8-23-18(10-22-13)11-24-20(26)16-5-17(21-25-9-14(2)28-21)7-19(6-16)27-12-15-3-4-15/h5-10,15H,3-4,11-12H2,1-2H3,(H,24,26) SHCAJJQUYCQWRM-UHFFFAOYSA-N 319836 3-(Cyclopropylmethoxy)-N-[(5-methylpyrazin-2-yl)methyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 3::US10202369, Example 3::US10472354, Example 3 P2X purinoceptor 2/3 Homo sapiens 1106 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319836&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397194 384223116 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842446 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C22H24N4O2S/c1-13-9-24-20(11-23-13)15(3)26-21(27)17-6-18(22-25-10-14(2)29-22)8-19(7-17)28-12-16-4-5-16/h6-11,15-16H,4-5,12H2,1-3H3,(H,26,27)/t15-/m1/s1 DYWYLXQLERQEEM-OAHLLOKOSA-N 319837 3-(Cyclopropylmethoxy)-N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 4::US10202369, Example 4::US10472354, Example 4 P2X purinoceptor 3 Homo sapiens 9.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319837&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397428 384223117 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842447 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C22H24N4O2S/c1-13-9-24-20(11-23-13)15(3)26-21(27)17-6-18(22-25-10-14(2)29-22)8-19(7-17)28-12-16-4-5-16/h6-11,15-16H,4-5,12H2,1-3H3,(H,26,27)/t15-/m1/s1 DYWYLXQLERQEEM-OAHLLOKOSA-N 319837 3-(Cyclopropylmethoxy)-N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 4::US10202369, Example 4::US10472354, Example 4 P2X purinoceptor 2/3 Homo sapiens 98.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319837&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397428 384223117 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842448 CC(NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C22H21ClFN3O2S/c1-12-9-26-22(30-12)16-5-15(6-18(7-16)29-11-14-3-4-14)21(28)27-13(2)20-19(23)8-17(24)10-25-20/h5-10,13-14H,3-4,11H2,1-2H3,(H,27,28) CGCJNRQFWMKWFU-UHFFFAOYSA-N 319838 N-[1-(3-Chloro-5-fluoropyridin-2-yl)ethyl]-3-(cyclopropylmethoxy)-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 5::US10202369, Example 5::US10472354, Example 5 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319838&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397491 384223118 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842449 CC(NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C22H21ClFN3O2S/c1-12-9-26-22(30-12)16-5-15(6-18(7-16)29-11-14-3-4-14)21(28)27-13(2)20-19(23)8-17(24)10-25-20/h5-10,13-14H,3-4,11H2,1-2H3,(H,27,28) CGCJNRQFWMKWFU-UHFFFAOYSA-N 319838 N-[1-(3-Chloro-5-fluoropyridin-2-yl)ethyl]-3-(cyclopropylmethoxy)-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 5::US10202369, Example 5::US10472354, Example 5 P2X purinoceptor 2/3 Homo sapiens 346 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319838&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397491 384223118 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842450 CC(NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C22H21ClFN3O2S/c1-12-9-26-22(30-12)16-5-15(6-18(7-16)29-11-14-3-4-14)21(28)27-13(2)20-19(24)8-17(23)10-25-20/h5-10,13-14H,3-4,11H2,1-2H3,(H,27,28) YIPUFXDTAKNGSX-UHFFFAOYSA-N 319839 N-[1-(5-Chloro-3-fluoropyridin-2-yl)ethyl]-3-(cyclopropylmethoxy)-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 6::US10202369, Example 6::US10472354, Example 6 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319839&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397488 384223119 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842451 CC(NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C22H21ClFN3O2S/c1-12-9-26-22(30-12)16-5-15(6-18(7-16)29-11-14-3-4-14)21(28)27-13(2)20-19(24)8-17(23)10-25-20/h5-10,13-14H,3-4,11H2,1-2H3,(H,27,28) YIPUFXDTAKNGSX-UHFFFAOYSA-N 319839 N-[1-(5-Chloro-3-fluoropyridin-2-yl)ethyl]-3-(cyclopropylmethoxy)-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 6::US10202369, Example 6::US10472354, Example 6 P2X purinoceptor 2/3 Homo sapiens 38.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319839&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397488 384223119 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842452 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1nnc(C)s1 InChI=1S/C20H22N4O2S2/c1-11-9-21-20(27-11)16-6-15(7-17(8-16)26-10-14-4-5-14)18(25)22-12(2)19-24-23-13(3)28-19/h6-9,12,14H,4-5,10H2,1-3H3,(H,22,25)/t12-/m1/s1 QOCVVHCSVZQPAR-GFCCVEGCSA-N 319840 3-(Cyclopropylmethoxy)-N-[(1R)-1-(5-methyl-1,3,4-thiadiazol-2-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 7::US10202369, Example 7::US10472354, Example 7 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319840&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397154 384223120 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842453 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1nnc(C)s1 InChI=1S/C20H22N4O2S2/c1-11-9-21-20(27-11)16-6-15(7-17(8-16)26-10-14-4-5-14)18(25)22-12(2)19-24-23-13(3)28-19/h6-9,12,14H,4-5,10H2,1-3H3,(H,22,25)/t12-/m1/s1 QOCVVHCSVZQPAR-GFCCVEGCSA-N 319840 3-(Cyclopropylmethoxy)-N-[(1R)-1-(5-methyl-1,3,4-thiadiazol-2-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 7::US10202369, Example 7::US10472354, Example 7 P2X purinoceptor 2/3 Homo sapiens 106 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319840&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397154 384223120 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842454 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C22H24N4O2S/c1-13-4-7-20(26-25-13)15(3)24-21(27)17-8-18(22-23-11-14(2)29-22)10-19(9-17)28-12-16-5-6-16/h4,7-11,15-16H,5-6,12H2,1-3H3,(H,24,27)/t15-/m1/s1 ZZPHBEIBURIANJ-OAHLLOKOSA-N 319841 3-(Cyclopropylmethoxy)-N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 8::US10202369, Example 8::US10472354, Example 8 P2X purinoceptor 3 Homo sapiens 3.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319841&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397204 384223121 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842455 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C22H24N4O2S/c1-13-4-7-20(26-25-13)15(3)24-21(27)17-8-18(22-23-11-14(2)29-22)10-19(9-17)28-12-16-5-6-16/h4,7-11,15-16H,5-6,12H2,1-3H3,(H,24,27)/t15-/m1/s1 ZZPHBEIBURIANJ-OAHLLOKOSA-N 319841 3-(Cyclopropylmethoxy)-N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 8::US10202369, Example 8::US10472354, Example 8 P2X purinoceptor 2/3 Homo sapiens 90.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319841&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397204 384223121 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842456 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C22H21F3N4O2S/c1-12-10-26-21(32-12)16-7-15(8-17(9-16)31-11-14-3-4-14)20(30)27-13(2)18-5-6-19(29-28-18)22(23,24)25/h5-10,13-14H,3-4,11H2,1-2H3,(H,27,30)/t13-/m1/s1 FDEHTNMFMQMRCT-CYBMUJFWSA-N 319842 3-(Cyclopropylmethoxy)-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[6-(trifluoromethyl)pyridazin-3-yl]ethyl}benzamide::US10174016, Example 9::US10202369, Example 9::US10472354, Example 9 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319842&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397573 384223122 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842457 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C22H21F3N4O2S/c1-12-10-26-21(32-12)16-7-15(8-17(9-16)31-11-14-3-4-14)20(30)27-13(2)18-5-6-19(29-28-18)22(23,24)25/h5-10,13-14H,3-4,11H2,1-2H3,(H,27,30)/t13-/m1/s1 FDEHTNMFMQMRCT-CYBMUJFWSA-N 319842 3-(Cyclopropylmethoxy)-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[6-(trifluoromethyl)pyridazin-3-yl]ethyl}benzamide::US10174016, Example 9::US10202369, Example 9::US10472354, Example 9 P2X purinoceptor 2/3 Homo sapiens 145 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319842&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397573 384223122 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842458 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C22H24N4O2S/c1-13-9-25-22(29-13)18-6-17(7-20(8-18)28-12-16-4-5-16)21(27)26-14(2)19-10-23-15(3)24-11-19/h6-11,14,16H,4-5,12H2,1-3H3,(H,26,27)/t14-/m1/s1 HEHYSAYIHLPEGC-CQSZACIVSA-N 319843 3-(Cyclopropylmethoxy)-N-[(1R)-1-(2-methylpyrimidin-5-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 10::US10202369, Example 10::US10472354, Example 10 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319843&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397702 384223123 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842459 C[C@@H](NC(=O)c1cc(OCC2CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C22H24N4O2S/c1-13-9-25-22(29-13)18-6-17(7-20(8-18)28-12-16-4-5-16)21(27)26-14(2)19-10-23-15(3)24-11-19/h6-11,14,16H,4-5,12H2,1-3H3,(H,26,27)/t14-/m1/s1 HEHYSAYIHLPEGC-CQSZACIVSA-N 319843 3-(Cyclopropylmethoxy)-N-[(1R)-1-(2-methylpyrimidin-5-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 10::US10202369, Example 10::US10472354, Example 10 P2X purinoceptor 2/3 Homo sapiens 185 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319843&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397702 384223123 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842460 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-8-26-20(33-12)15-5-14(6-18(7-15)32-17-3-4-31-11-17)19(30)29-13(2)16-9-27-21(28-10-16)22(23,24)25/h5-10,13,17H,3-4,11H2,1-2H3,(H,29,30)/t13-,17-/m1/s1 GTQPEQGDLVSFJO-CXAGYDPISA-N 319844 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 11::US10202369, Example 11::US10472354, Example 291 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319844&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397587 384223124 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842461 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-8-26-20(33-12)15-5-14(6-18(7-15)32-17-3-4-31-11-17)19(30)29-13(2)16-9-27-21(28-10-16)22(23,24)25/h5-10,13,17H,3-4,11H2,1-2H3,(H,29,30)/t13-,17-/m1/s1 GTQPEQGDLVSFJO-CXAGYDPISA-N 319844 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 11::US10202369, Example 11::US10472354, Example 291 P2X purinoceptor 2/3 Homo sapiens 163 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319844&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397587 384223124 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842462 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-13-9-24-20(11-23-13)15(3)26-21(27)16-6-17(22-25-10-14(2)30-22)8-19(7-16)29-18-4-5-28-12-18/h6-11,15,18H,4-5,12H2,1-3H3,(H,26,27)/t15-,18-/m1/s1 GGLGXVJJVCGSBA-CRAIPNDOSA-N 319849 N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 16::US10202369, Example 16::US10472354, Example 16 P2X purinoceptor 3 Homo sapiens 283 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319849&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397267 384223129 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842463 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-13-9-24-20(11-23-13)15(3)26-21(27)16-6-17(22-25-10-14(2)30-22)8-19(7-16)29-18-4-5-28-12-18/h6-11,15,18H,4-5,12H2,1-3H3,(H,26,27)/t15-,18-/m1/s1 GGLGXVJJVCGSBA-CRAIPNDOSA-N 319849 N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 16::US10202369, Example 16::US10472354, Example 16 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319849&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397267 384223129 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842464 CC(NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C22H21ClFN3O3S/c1-12-9-26-22(31-12)15-5-14(6-18(7-15)30-17-3-4-29-11-17)21(28)27-13(2)20-19(23)8-16(24)10-25-20/h5-10,13,17H,3-4,11H2,1-2H3,(H,27,28)/t13?,17-/m1/s1 YETTUNLUNMEXML-LRHAYUFXSA-N 319846 N-[1-(3-chloro-5-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 13::US10202369, Example 13::US10472354, Example 13 P2X purinoceptor 3 Homo sapiens 21.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319846&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397669 384223126 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842465 CC(NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C22H21ClFN3O3S/c1-12-9-26-22(31-12)15-5-14(6-18(7-15)30-17-3-4-29-11-17)21(28)27-13(2)20-19(23)8-16(24)10-25-20/h5-10,13,17H,3-4,11H2,1-2H3,(H,27,28)/t13?,17-/m1/s1 YETTUNLUNMEXML-LRHAYUFXSA-N 319846 N-[1-(3-chloro-5-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 13::US10202369, Example 13::US10472354, Example 13 P2X purinoceptor 2/3 Homo sapiens 1102 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319846&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397669 384223126 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842466 CC(NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C22H21ClFN3O3S/c1-12-9-26-22(31-12)15-5-14(6-18(7-15)30-17-3-4-29-11-17)21(28)27-13(2)20-19(24)8-16(23)10-25-20/h5-10,13,17H,3-4,11H2,1-2H3,(H,27,28)/t13?,17-/m1/s1 DLODQDUFIVUCLQ-LRHAYUFXSA-N 319847 N-[1-(5-chloro-3-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 14::US10202369, Example 14::US10472354, Example 14 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319847&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397583 384223127 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842467 CC(NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C22H21ClFN3O3S/c1-12-9-26-22(31-12)15-5-14(6-18(7-15)30-17-3-4-29-11-17)21(28)27-13(2)20-19(24)8-16(23)10-25-20/h5-10,13,17H,3-4,11H2,1-2H3,(H,27,28)/t13?,17-/m1/s1 DLODQDUFIVUCLQ-LRHAYUFXSA-N 319847 N-[1-(5-chloro-3-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 14::US10202369, Example 14::US10472354, Example 14 P2X purinoceptor 2/3 Homo sapiens 88.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319847&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397583 384223127 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842468 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(Cl)cn1 InChI=1S/C22H22ClN3O3S/c1-13-10-25-22(30-13)16-7-15(8-19(9-16)29-18-5-6-28-12-18)21(27)26-14(2)20-4-3-17(23)11-24-20/h3-4,7-11,14,18H,5-6,12H2,1-2H3,(H,26,27)/t14-,18-/m1/s1 DURBVTDNVKUTOV-RDTXWAMCSA-N 319848 N-[(1R)-1-(5-chloropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 15::US10202369, Example 15::US10472354, Example 15 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319848&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397630 384223128 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842469 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(Cl)cn1 InChI=1S/C22H22ClN3O3S/c1-13-10-25-22(30-13)16-7-15(8-19(9-16)29-18-5-6-28-12-18)21(27)26-14(2)20-4-3-17(23)11-24-20/h3-4,7-11,14,18H,5-6,12H2,1-2H3,(H,26,27)/t14-,18-/m1/s1 DURBVTDNVKUTOV-RDTXWAMCSA-N 319848 N-[(1R)-1-(5-chloropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 15::US10202369, Example 15::US10472354, Example 15 P2X purinoceptor 2/3 Homo sapiens 147 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319848&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397630 384223128 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842470 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-13-9-24-20(11-23-13)15(3)26-21(27)16-6-17(22-25-10-14(2)30-22)8-19(7-16)29-18-4-5-28-12-18/h6-11,15,18H,4-5,12H2,1-3H3,(H,26,27)/t15-,18-/m1/s1 GGLGXVJJVCGSBA-CRAIPNDOSA-N 319849 N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 16::US10202369, Example 16::US10472354, Example 16 P2X purinoceptor 3 Homo sapiens 38.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319849&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397267 384223129 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842471 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-13-9-24-20(11-23-13)15(3)26-21(27)16-6-17(22-25-10-14(2)30-22)8-19(7-16)29-18-4-5-28-12-18/h6-11,15,18H,4-5,12H2,1-3H3,(H,26,27)/t15-,18-/m1/s1 GGLGXVJJVCGSBA-CRAIPNDOSA-N 319849 N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 16::US10202369, Example 16::US10472354, Example 16 P2X purinoceptor 2/3 Homo sapiens 1707 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319849&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397267 384223129 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842472 Cc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C21H22N4O3S/c1-13-3-4-17(25-24-13)11-22-20(26)15-7-16(21-23-10-14(2)29-21)9-19(8-15)28-18-5-6-27-12-18/h3-4,7-10,18H,5-6,11-12H2,1-2H3,(H,22,26)/t18-/m1/s1 VKRRMZCTKMLCQJ-GOSISDBHSA-N 319850 N-[(6-methylpyridazin-3-yl)methyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 17::US10202369, Example 17::US10472354, Example 17 P2X purinoceptor 3 Homo sapiens 35.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319850&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397146 384223130 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842473 Cc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C21H22N4O3S/c1-13-3-4-17(25-24-13)11-22-20(26)15-7-16(21-23-10-14(2)29-21)9-19(8-15)28-18-5-6-27-12-18/h3-4,7-10,18H,5-6,11-12H2,1-2H3,(H,22,26)/t18-/m1/s1 VKRRMZCTKMLCQJ-GOSISDBHSA-N 319850 N-[(6-methylpyridazin-3-yl)methyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 17::US10202369, Example 17::US10472354, Example 17 P2X purinoceptor 2/3 Homo sapiens 1005 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319850&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397146 384223130 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842474 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-13-4-5-20(26-25-13)15(3)24-21(27)16-8-17(22-23-11-14(2)30-22)10-19(9-16)29-18-6-7-28-12-18/h4-5,8-11,15,18H,6-7,12H2,1-3H3,(H,24,27)/t15-,18-/m1/s1 JJXMVDHMQZPOJY-CRAIPNDOSA-N 319851 N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 18::US10202369, Example 18::US10472354, Example 18 P2X purinoceptor 3 Homo sapiens 34.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319851&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397758 384223131 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842475 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-13-4-5-20(26-25-13)15(3)24-21(27)16-8-17(22-23-11-14(2)30-22)10-19(9-16)29-18-6-7-28-12-18/h4-5,8-11,15,18H,6-7,12H2,1-3H3,(H,24,27)/t15-,18-/m1/s1 JJXMVDHMQZPOJY-CRAIPNDOSA-N 319851 N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 18::US10202369, Example 18::US10472354, Example 18 P2X purinoceptor 2/3 Homo sapiens 427 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319851&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397758 384223131 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842476 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-10-26-21(33-12)15-7-14(8-17(9-15)32-16-5-6-31-11-16)20(30)27-13(2)18-3-4-19(29-28-18)22(23,24)25/h3-4,7-10,13,16H,5-6,11H2,1-2H3,(H,27,30)/t13-,16-/m1/s1 DNHMMXLROIMBSA-CZUORRHYSA-N 319852 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[6-(trifluoromethyl)pyridazin-3-yl]ethyl}benzamide::US10174016, Example 19::US10202369, Example 19::US10472354, Example 19 P2X purinoceptor 3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319852&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397747 384223132 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842477 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-10-26-21(33-12)15-7-14(8-17(9-15)32-16-5-6-31-11-16)20(30)27-13(2)18-3-4-19(29-28-18)22(23,24)25/h3-4,7-10,13,16H,5-6,11H2,1-2H3,(H,27,30)/t13-,16-/m1/s1 DNHMMXLROIMBSA-CZUORRHYSA-N 319852 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[6-(trifluoromethyl)pyridazin-3-yl]ethyl}benzamide::US10174016, Example 19::US10202369, Example 19::US10472354, Example 19 P2X purinoceptor 2/3 Homo sapiens 749 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319852&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397747 384223132 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842478 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1nnc(C)s1 InChI=1S/C20H22N4O3S2/c1-11-9-21-20(28-11)15-6-14(7-17(8-15)27-16-4-5-26-10-16)18(25)22-12(2)19-24-23-13(3)29-19/h6-9,12,16H,4-5,10H2,1-3H3,(H,22,25)/t12-,16-/m1/s1 WVNVOAPVSAUSTP-MLGOLLRUSA-N 319853 N-[(1R)-1-(5-methyl-1,3,4-thiadiazol-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 20::US10202369, Example 20::US10472354, Example 20 P2X purinoceptor 3 Homo sapiens 35.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319853&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397835 384223133 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842479 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1nnc(C)s1 InChI=1S/C20H22N4O3S2/c1-11-9-21-20(28-11)15-6-14(7-17(8-15)27-16-4-5-26-10-16)18(25)22-12(2)19-24-23-13(3)29-19/h6-9,12,16H,4-5,10H2,1-3H3,(H,22,25)/t12-,16-/m1/s1 WVNVOAPVSAUSTP-MLGOLLRUSA-N 319853 N-[(1R)-1-(5-methyl-1,3,4-thiadiazol-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 20::US10202369, Example 20::US10472354, Example 20 P2X purinoceptor 2/3 Homo sapiens 486 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319853&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397835 384223133 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842480 Cc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)NCc1ccc(nn1)C(F)(F)F InChI=1S/C21H19F3N4O3S/c1-12-9-26-20(32-12)14-6-13(7-17(8-14)31-16-4-5-30-11-16)19(29)25-10-15-2-3-18(28-27-15)21(22,23)24/h2-3,6-9,16H,4-5,10-11H2,1H3,(H,25,29)/t16-/m1/s1 YZCYRJHHBOIVER-MRXNPFEDSA-N 319854 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{[6-(trifluoromethyl)pyridazin-3-yl]methyl}benzamide::US10174016, Example 21::US10202369, Example 21::US10472354, Example 21 P2X purinoceptor 3 Homo sapiens 71.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319854&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397575 384223134 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842481 Cc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)NCc1ccc(nn1)C(F)(F)F InChI=1S/C21H19F3N4O3S/c1-12-9-26-20(32-12)14-6-13(7-17(8-14)31-16-4-5-30-11-16)19(29)25-10-15-2-3-18(28-27-15)21(22,23)24/h2-3,6-9,16H,4-5,10-11H2,1H3,(H,25,29)/t16-/m1/s1 YZCYRJHHBOIVER-MRXNPFEDSA-N 319854 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{[6-(trifluoromethyl)pyridazin-3-yl]methyl}benzamide::US10174016, Example 21::US10202369, Example 21::US10472354, Example 21 P2X purinoceptor 2/3 Homo sapiens 445 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319854&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397575 384223134 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842482 CC[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-3-19(16-10-28-22(29-11-16)23(24,25)26)30-20(31)14-6-15(21-27-9-13(2)34-21)8-18(7-14)33-17-4-5-32-12-17/h6-11,17,19H,3-5,12H2,1-2H3,(H,30,31)/t17-,19-/m1/s1 VUXDKUAYZMWTBM-IEBWSBKVSA-N 319855 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]propyl}benzamide::US10174016, Example 22::US10202369, Example 22::US10472354, Example 22 P2X purinoceptor 3 Homo sapiens 132 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319855&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397246 384223135 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842483 CC[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-3-19(16-10-28-22(29-11-16)23(24,25)26)30-20(31)14-6-15(21-27-9-13(2)34-21)8-18(7-14)33-17-4-5-32-12-17/h6-11,17,19H,3-5,12H2,1-2H3,(H,30,31)/t17-,19-/m1/s1 VUXDKUAYZMWTBM-IEBWSBKVSA-N 319855 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]propyl}benzamide::US10174016, Example 22::US10202369, Example 22::US10472354, Example 22 P2X purinoceptor 2/3 Homo sapiens 987 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319855&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397246 384223135 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842484 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)C1=[S]C=C(C)N1)c1cnc(C)nc1 InChI=1S/C22H25N4O3S/c1-13-12-30-22(25-13)17-6-16(7-20(8-17)29-19-4-5-28-11-19)21(27)26-14(2)18-9-23-15(3)24-10-18/h6-10,12,14,19,25H,4-5,11H2,1-3H3,(H,26,27)/t14-,19-/m1/s1 XUSIIGAFSFFFBZ-AUUYWEPGSA-N 419937 US10472354, Example 23 P2X purinoceptor 3 Homo sapiens 30.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=419937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=419937&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842485 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)C1=[S]C=C(C)N1)c1cnc(C)nc1 InChI=1S/C22H25N4O3S/c1-13-12-30-22(25-13)17-6-16(7-20(8-17)29-19-4-5-28-11-19)21(27)26-14(2)18-9-23-15(3)24-10-18/h6-10,12,14,19,25H,4-5,11H2,1-3H3,(H,26,27)/t14-,19-/m1/s1 XUSIIGAFSFFFBZ-AUUYWEPGSA-N 419937 US10472354, Example 23 P2X purinoceptor 2/3 Homo sapiens 1106 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=419937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=419937&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842486 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C23H25N3O3S/c1-14-4-5-17(12-24-14)16(3)26-22(27)18-8-19(23-25-11-15(2)30-23)10-21(9-18)29-20-6-7-28-13-20/h4-5,8-12,16,20H,6-7,13H2,1-3H3,(H,26,27)/t16-,20+/m1/s1 KGDPEGCMVCXNPY-UZLBHIALSA-N 319863 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran- 3-yloxy] benzamide::US10174016, Example 30::US10202369, Example 30::US10472354, Example 30 P2X purinoceptor 3 Homo sapiens 36.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319863&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397828 384223143 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842487 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C23H25N3O3S/c1-14-4-5-17(12-24-14)16(3)26-22(27)18-8-19(23-25-11-15(2)30-23)10-21(9-18)29-20-6-7-28-13-20/h4-5,8-12,16,20H,6-7,13H2,1-3H3,(H,26,27)/t16-,20+/m1/s1 KGDPEGCMVCXNPY-UZLBHIALSA-N 319863 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran- 3-yloxy] benzamide::US10174016, Example 30::US10202369, Example 30::US10472354, Example 30 P2X purinoceptor 2/3 Homo sapiens 332 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319863&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397828 384223143 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842488 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-13-4-5-20(26-25-13)15(3)24-21(27)16-8-17(22-23-11-14(2)30-22)10-19(9-16)29-18-6-7-28-12-18/h4-5,8-11,15,18H,6-7,12H2,1-3H3,(H,24,27)/t15-,18+/m1/s1 JJXMVDHMQZPOJY-QAPCUYQASA-N 319858 N-[(1R)-1-(6-Methylpyridazin-3-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 25::US10202369, Example 25::US10472354, Example 25 P2X purinoceptor 3 Homo sapiens 39.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319858&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397569 384223138 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842489 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-13-4-5-20(26-25-13)15(3)24-21(27)16-8-17(22-23-11-14(2)30-22)10-19(9-16)29-18-6-7-28-12-18/h4-5,8-11,15,18H,6-7,12H2,1-3H3,(H,24,27)/t15-,18+/m1/s1 JJXMVDHMQZPOJY-QAPCUYQASA-N 319858 N-[(1R)-1-(6-Methylpyridazin-3-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 25::US10202369, Example 25::US10472354, Example 25 P2X purinoceptor 2/3 Homo sapiens 975 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319858&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397569 384223138 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842490 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-8-26-20(33-12)15-5-14(6-18(7-15)32-17-3-4-31-11-17)19(30)29-13(2)16-9-27-21(28-10-16)22(23,24)25/h5-10,13,17H,3-4,11H2,1-2H3,(H,29,30)/t13-,17+/m1/s1 GTQPEQGDLVSFJO-DYVFJYSZSA-N 319859 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 26::US10202369, Example 26::US10472354, Example 26 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319859&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397418 384223139 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842491 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-8-26-20(33-12)15-5-14(6-18(7-15)32-17-3-4-31-11-17)19(30)29-13(2)16-9-27-21(28-10-16)22(23,24)25/h5-10,13,17H,3-4,11H2,1-2H3,(H,29,30)/t13-,17+/m1/s1 GTQPEQGDLVSFJO-DYVFJYSZSA-N 319859 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 26::US10202369, Example 26::US10472354, Example 26 P2X purinoceptor 2/3 Homo sapiens 297 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319859&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397418 384223139 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842492 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(Cl)cn1 InChI=1S/C22H22ClN3O3S/c1-13-10-25-22(30-13)16-7-15(8-19(9-16)29-18-5-6-28-12-18)21(27)26-14(2)20-4-3-17(23)11-24-20/h3-4,7-11,14,18H,5-6,12H2,1-2H3,(H,26,27)/t14-,18+/m1/s1 DURBVTDNVKUTOV-KDOFPFPSSA-N 319860 N-[(1R)-1-(5-Chloropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 27::US10202369, Example 27::US10472354, Example 27 P2X purinoceptor 3 Homo sapiens 25.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319860&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397158 384223140 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842493 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(Cl)cn1 InChI=1S/C22H22ClN3O3S/c1-13-10-25-22(30-13)16-7-15(8-19(9-16)29-18-5-6-28-12-18)21(27)26-14(2)20-4-3-17(23)11-24-20/h3-4,7-11,14,18H,5-6,12H2,1-2H3,(H,26,27)/t14-,18+/m1/s1 DURBVTDNVKUTOV-KDOFPFPSSA-N 319860 N-[(1R)-1-(5-Chloropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 27::US10202369, Example 27::US10472354, Example 27 P2X purinoceptor 2/3 Homo sapiens 280 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319860&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397158 384223140 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842494 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)cn1 InChI=1S/C23H25N3O3S/c1-14-4-5-21(24-11-14)16(3)26-22(27)17-8-18(23-25-12-15(2)30-23)10-20(9-17)29-19-6-7-28-13-19/h4-5,8-12,16,19H,6-7,13H2,1-3H3,(H,26,27)/t16-,19+/m1/s1 CFTQNAYGOFQJGD-APWZRJJASA-N 319861 N-[(1R)-1-(5-Methylpyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 28::US10202369, Example 28::US10472354, Example 28 P2X purinoceptor 3 Homo sapiens 48.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319861&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397224 384223141 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842495 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)cn1 InChI=1S/C23H25N3O3S/c1-14-4-5-21(24-11-14)16(3)26-22(27)17-8-18(23-25-12-15(2)30-23)10-20(9-17)29-19-6-7-28-13-19/h4-5,8-12,16,19H,6-7,13H2,1-3H3,(H,26,27)/t16-,19+/m1/s1 CFTQNAYGOFQJGD-APWZRJJASA-N 319861 N-[(1R)-1-(5-Methylpyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 28::US10202369, Example 28::US10472354, Example 28 P2X purinoceptor 2/3 Homo sapiens 121 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319861&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397224 384223141 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842496 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-13-9-24-20(11-23-13)15(3)26-21(27)16-6-17(22-25-10-14(2)30-22)8-19(7-16)29-18-4-5-28-12-18/h6-11,15,18H,4-5,12H2,1-3H3,(H,26,27)/t15-,18+/m1/s1 GGLGXVJJVCGSBA-QAPCUYQASA-N 319862 N-[(1R)-1-(5-Methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 29::US10472354, Example 29 P2X purinoceptor 3 Homo sapiens 79.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319862&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397726 384223142 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842497 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-13-9-24-20(11-23-13)15(3)26-21(27)16-6-17(22-25-10-14(2)30-22)8-19(7-16)29-18-4-5-28-12-18/h6-11,15,18H,4-5,12H2,1-3H3,(H,26,27)/t15-,18+/m1/s1 GGLGXVJJVCGSBA-QAPCUYQASA-N 319862 N-[(1R)-1-(5-Methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 29::US10472354, Example 29 P2X purinoceptor 2/3 Homo sapiens 580 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319862&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397726 384223142 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842498 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C23H25N3O3S/c1-14-4-5-17(12-24-14)16(3)26-22(27)18-8-19(23-25-11-15(2)30-23)10-21(9-18)29-20-6-7-28-13-20/h4-5,8-12,16,20H,6-7,13H2,1-3H3,(H,26,27)/t16-,20+/m1/s1 KGDPEGCMVCXNPY-UZLBHIALSA-N 319863 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran- 3-yloxy] benzamide::US10174016, Example 30::US10202369, Example 30::US10472354, Example 30 P2X purinoceptor 3 Homo sapiens 38.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319863&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397828 384223143 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842499 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C23H25N3O3S/c1-14-4-5-17(12-24-14)16(3)26-22(27)18-8-19(23-25-11-15(2)30-23)10-21(9-18)29-20-6-7-28-13-20/h4-5,8-12,16,20H,6-7,13H2,1-3H3,(H,26,27)/t16-,20+/m1/s1 KGDPEGCMVCXNPY-UZLBHIALSA-N 319863 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran- 3-yloxy] benzamide::US10174016, Example 30::US10202369, Example 30::US10472354, Example 30 P2X purinoceptor 2/3 Homo sapiens 485 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319863&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397828 384223143 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842500 Cc1cnc(s1)-c1cc(OCC#C)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C20H18N4O2S/c1-4-7-26-18-9-15(8-16(10-18)20-22-11-14(3)27-20)19(25)21-12-17-6-5-13(2)23-24-17/h1,5-6,8-11H,7,12H2,2-3H3,(H,21,25) JDOBHPRLWOBCFP-UHFFFAOYSA-N 319864 N-[(6- Methylpyridazin- 3-yl)methyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (prop-2-yn-1- yloxy) benzamide::US10174016, Example 31::US10202369, Example 31::US10472354, Example 31 P2X purinoceptor 3 Homo sapiens 173 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319864&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397457 384223144 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842501 Cc1cnc(s1)-c1cc(OCC#C)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C20H18N4O2S/c1-4-7-26-18-9-15(8-16(10-18)20-22-11-14(3)27-20)19(25)21-12-17-6-5-13(2)23-24-17/h1,5-6,8-11H,7,12H2,2-3H3,(H,21,25) JDOBHPRLWOBCFP-UHFFFAOYSA-N 319864 N-[(6- Methylpyridazin- 3-yl)methyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (prop-2-yn-1- yloxy) benzamide::US10174016, Example 31::US10202369, Example 31::US10472354, Example 31 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319864&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397457 384223144 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842502 Cc1cnc(s1)-c1cc(OCC#C)cc(c1)C(=O)NCc1ncc(Cl)cc1F InChI=1S/C20H15ClFN3O2S/c1-3-4-27-16-6-13(5-14(7-16)20-25-9-12(2)28-20)19(26)24-11-18-17(22)8-15(21)10-23-18/h1,5-10H,4,11H2,2H3,(H,24,26) VKJAMZXKIQCHSG-UHFFFAOYSA-N 322220 N-[(5-Chloro-3- fluoropyridin-2- yl)methyl]-3-(5- methyl-1,3- thiazol-2-yl)-5- (prop-2-yn-1- yloxy) benzamide::US10183937, Example 32::US10202369, Example 32::US10472354, Example 32 P2X purinoceptor 3 Homo sapiens 24.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322220&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397185 384225297 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842503 Cc1cnc(s1)-c1cc(OCC#C)cc(c1)C(=O)NCc1ncc(Cl)cc1F InChI=1S/C20H15ClFN3O2S/c1-3-4-27-16-6-13(5-14(7-16)20-25-9-12(2)28-20)19(26)24-11-18-17(22)8-15(21)10-23-18/h1,5-10H,4,11H2,2H3,(H,24,26) VKJAMZXKIQCHSG-UHFFFAOYSA-N 322220 N-[(5-Chloro-3- fluoropyridin-2- yl)methyl]-3-(5- methyl-1,3- thiazol-2-yl)-5- (prop-2-yn-1- yloxy) benzamide::US10183937, Example 32::US10202369, Example 32::US10472354, Example 32 P2X purinoceptor 2/3 Homo sapiens 1781 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322220&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397185 384225297 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842504 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C22H21N3O2S/c1-5-8-27-20-10-18(9-19(11-20)22-24-12-15(3)28-22)21(26)25-16(4)17-7-6-14(2)23-13-17/h1,6-7,9-13,16H,8H2,2-4H3,(H,25,26)/t16-/m1/s1 ZCHZUISZWKOUTB-MRXNPFEDSA-N 319866 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (prop-2-yn-1- yloxy) benzamide::US10174016, Example 33::US10202369, Example 33::US10472354, Example 33 P2X purinoceptor 3 Homo sapiens 29.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319866&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397790 384223146 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842505 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C22H21N3O2S/c1-5-8-27-20-10-18(9-19(11-20)22-24-12-15(3)28-22)21(26)25-16(4)17-7-6-14(2)23-13-17/h1,6-7,9-13,16H,8H2,2-4H3,(H,25,26)/t16-/m1/s1 ZCHZUISZWKOUTB-MRXNPFEDSA-N 319866 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (prop-2-yn-1- yloxy) benzamide::US10174016, Example 33::US10202369, Example 33::US10472354, Example 33 P2X purinoceptor 2/3 Homo sapiens 912 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319866&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397790 384223146 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842506 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C21H20N4O2S/c1-5-6-27-18-8-16(7-17(9-18)21-24-11-14(3)28-21)20(26)25-15(4)19-12-22-13(2)10-23-19/h1,7-12,15H,6H2,2-4H3,(H,25,26)/t15-/m1/s1 UJLVWKMINNYJSM-OAHLLOKOSA-N 319867 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (prop-2-yn-1- yloxy) benzamide::US10174016, Example 34::US10202369, Example 34::US10472354, Example 34 P2X purinoceptor 3 Homo sapiens 111 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319867&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397514 384223147 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842507 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C21H20N4O2S/c1-5-6-27-18-8-16(7-17(9-18)21-24-11-14(3)28-21)20(26)25-15(4)19-12-22-13(2)10-23-19/h1,7-12,15H,6H2,2-4H3,(H,25,26)/t15-/m1/s1 UJLVWKMINNYJSM-OAHLLOKOSA-N 319867 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (prop-2-yn-1- yloxy) benzamide::US10174016, Example 34::US10202369, Example 34::US10472354, Example 34 P2X purinoceptor 2/3 Homo sapiens 2124 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319867&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397514 384223147 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842508 Cc1cnc(s1)-c1cc(OCC#C)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C20H18N4O2S/c1-4-5-26-18-7-15(6-16(8-18)20-24-10-14(3)27-20)19(25)23-12-17-11-21-13(2)9-22-17/h1,6-11H,5,12H2,2-3H3,(H,23,25) HKQDCIZFKBUDQD-UHFFFAOYSA-N 319868 N-[(5- Methylpyrazin- 2-yl)methyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-(prop-2- yn-1- yloxy)benzamide::US10174016, Example 35::US10202369, Example 35::US10472354, Example 35 P2X purinoceptor 3 Homo sapiens 460 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319868&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397704 384223148 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842509 Cc1cnc(s1)-c1cc(OCC#C)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C20H18N4O2S/c1-4-5-26-18-7-15(6-16(8-18)20-24-10-14(3)27-20)19(25)23-12-17-11-21-13(2)9-22-17/h1,6-11H,5,12H2,2-3H3,(H,23,25) HKQDCIZFKBUDQD-UHFFFAOYSA-N 319868 N-[(5- Methylpyrazin- 2-yl)methyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-(prop-2- yn-1- yloxy)benzamide::US10174016, Example 35::US10202369, Example 35::US10472354, Example 35 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319868&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397704 384223148 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842510 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C21H17F3N4O2S/c1-4-5-30-17-7-14(6-15(8-17)19-25-9-12(2)31-19)18(29)28-13(3)16-10-26-20(27-11-16)21(22,23)24/h1,6-11,13H,5H2,2-3H3,(H,28,29)/t13-/m1/s1 BTRSFHCVZJPJKT-CYBMUJFWSA-N 319869 3-(5-Methyl- 1,3-thiazol-2- yl)-5-(prop-2- yn-1-yloxy)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 36::US10202369, Example 36::US10472354, Example 36 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319869&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397309 384223149 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842511 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C21H17F3N4O2S/c1-4-5-30-17-7-14(6-15(8-17)19-25-9-12(2)31-19)18(29)28-13(3)16-10-26-20(27-11-16)21(22,23)24/h1,6-11,13H,5H2,2-3H3,(H,28,29)/t13-/m1/s1 BTRSFHCVZJPJKT-CYBMUJFWSA-N 319869 3-(5-Methyl- 1,3-thiazol-2- yl)-5-(prop-2- yn-1-yloxy)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 36::US10202369, Example 36::US10472354, Example 36 P2X purinoceptor 2/3 Homo sapiens 306 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319869&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397309 384223149 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842512 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C21H20N4O2S/c1-5-8-27-18-10-16(9-17(11-18)21-22-12-14(3)28-21)20(26)23-15(4)19-7-6-13(2)24-25-19/h1,6-7,9-12,15H,8H2,2-4H3,(H,23,26)/t15-/m1/s1 IZIUFNSLLIEWJE-OAHLLOKOSA-N 319870 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-(prop-2- yn-1- yloxy) benzamide::US10174016, Example 37::US10202369, Example 37::US10472354, Example 37 P2X purinoceptor 3 Homo sapiens 55.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319870&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397261 384223150 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842513 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C21H20N4O2S/c1-5-8-27-18-10-16(9-17(11-18)21-22-12-14(3)28-21)20(26)23-15(4)19-7-6-13(2)24-25-19/h1,6-7,9-12,15H,8H2,2-4H3,(H,23,26)/t15-/m1/s1 IZIUFNSLLIEWJE-OAHLLOKOSA-N 319870 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-(prop-2- yn-1- yloxy) benzamide::US10174016, Example 37::US10202369, Example 37::US10472354, Example 37 P2X purinoceptor 2/3 Homo sapiens 1176 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319870&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397261 384223150 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842514 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C21H17F3N4O2S/c1-4-7-30-16-9-14(8-15(10-16)20-25-11-12(2)31-20)19(29)26-13(3)17-5-6-18(28-27-17)21(22,23)24/h1,5-6,8-11,13H,7H2,2-3H3,(H,26,29)/t13-/m1/s1 PNZFOFJAUOCDQW-CYBMUJFWSA-N 319871 3-(5-Methyl- 1,3-thiazol-2- yl)-5-(prop-2- yn-1-yloxy)-N- [(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl] benzamide::US10174016, Example 38::US10202369, Example 38::US10472354, Example 38 P2X purinoceptor 3 Homo sapiens 55.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319871&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397333 384223151 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842515 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C21H17F3N4O2S/c1-4-7-30-16-9-14(8-15(10-16)20-25-11-12(2)31-20)19(29)26-13(3)17-5-6-18(28-27-17)21(22,23)24/h1,5-6,8-11,13H,7H2,2-3H3,(H,26,29)/t13-/m1/s1 PNZFOFJAUOCDQW-CYBMUJFWSA-N 319871 3-(5-Methyl- 1,3-thiazol-2- yl)-5-(prop-2- yn-1-yloxy)-N- [(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl] benzamide::US10174016, Example 38::US10202369, Example 38::US10472354, Example 38 P2X purinoceptor 2/3 Homo sapiens 1145 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319871&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397333 384223151 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842516 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C21H20N4O2S/c1-5-6-27-19-8-16(7-17(9-19)21-24-10-13(2)28-21)20(26)25-14(3)18-11-22-15(4)23-12-18/h1,7-12,14H,6H2,2-4H3,(H,25,26)/t14-/m1/s1 OVENJFXCZONLOP-CQSZACIVSA-N 319872 N-[(1R)-1-(2- Methylpyrimidin- 5-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-(prop-2- yn-1- yloxy) benzamide::US10174016, Example 39::US10202369, Example 39::US10472354, Example 39 P2X purinoceptor 3 Homo sapiens 81.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319872&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397588 384223152 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842517 C[C@@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C21H20N4O2S/c1-5-6-27-19-8-16(7-17(9-19)21-24-10-13(2)28-21)20(26)25-14(3)18-11-22-15(4)23-12-18/h1,7-12,14H,6H2,2-4H3,(H,25,26)/t14-/m1/s1 OVENJFXCZONLOP-CQSZACIVSA-N 319872 N-[(1R)-1-(2- Methylpyrimidin- 5-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-(prop-2- yn-1- yloxy) benzamide::US10174016, Example 39::US10202369, Example 39::US10472354, Example 39 P2X purinoceptor 2/3 Homo sapiens 1646 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319872&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397588 384223152 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842518 CC#CCOc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H19F3N4O2S/c1-4-5-6-31-18-8-15(7-16(9-18)20-26-10-13(2)32-20)19(30)29-14(3)17-11-27-21(28-12-17)22(23,24)25/h7-12,14H,6H2,1-3H3,(H,29,30)/t14-/m1/s1 XSZOYFWYESZINQ-CQSZACIVSA-N 319873 3-(But-2-yn-1- yloxy)-5-(5- methyl-1,3- thiazol-2-yl)- N-[(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl] benzamide::US10174016, Example 40::US10202369, Example 40::US10472354, Example 40 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319873&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397357 384223153 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842519 CC#CCOc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H19F3N4O2S/c1-4-5-6-31-18-8-15(7-16(9-18)20-26-10-13(2)32-20)19(30)29-14(3)17-11-27-21(28-12-17)22(23,24)25/h7-12,14H,6H2,1-3H3,(H,29,30)/t14-/m1/s1 XSZOYFWYESZINQ-CQSZACIVSA-N 319873 3-(But-2-yn-1- yloxy)-5-(5- methyl-1,3- thiazol-2-yl)- N-[(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl] benzamide::US10174016, Example 40::US10202369, Example 40::US10472354, Example 40 P2X purinoceptor 2/3 Homo sapiens 383 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319873&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397357 384223153 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842520 CC#CCOc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1nnc(C)s1 InChI=1S/C20H20N4O2S2/c1-5-6-7-26-17-9-15(8-16(10-17)20-21-11-12(2)27-20)18(25)22-13(3)19-24-23-14(4)28-19/h8-11,13H,7H2,1-4H3,(H,22,25)/t13-/m1/s1 ORWZAOZYNYEGDS-CYBMUJFWSA-N 319874 3-(But-2-yn-1- yloxy)-N-[(1R)- 1-(5-methyl- 1,3,4- thiadiazol-2- yl)ethyl]-5-(5- methyl-1,3- thiazol-2- yl)benzamide::US10174016, Example 41::US10202369, Example 41::US10472354, Example 41 P2X purinoceptor 3 Homo sapiens 130 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319874&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397286 384223154 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842521 CC#CCOc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1nnc(C)s1 InChI=1S/C20H20N4O2S2/c1-5-6-7-26-17-9-15(8-16(10-17)20-21-11-12(2)27-20)18(25)22-13(3)19-24-23-14(4)28-19/h8-11,13H,7H2,1-4H3,(H,22,25)/t13-/m1/s1 ORWZAOZYNYEGDS-CYBMUJFWSA-N 319874 3-(But-2-yn-1- yloxy)-N-[(1R)- 1-(5-methyl- 1,3,4- thiadiazol-2- yl)ethyl]-5-(5- methyl-1,3- thiazol-2- yl)benzamide::US10174016, Example 41::US10202369, Example 41::US10472354, Example 41 P2X purinoceptor 2/3 Homo sapiens 1592 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319874&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397286 384223154 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842522 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C21H22N4O3S/c1-12-7-23-19(9-22-12)14(3)25-20(26)15-4-16(21-24-8-13(2)29-21)6-17(5-15)28-18-10-27-11-18/h4-9,14,18H,10-11H2,1-3H3,(H,25,26)/t14-/m1/s1 AWWAAAATSKEOQH-CQSZACIVSA-N 319875 N-[(1R)-1-(5-Methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 42::US10202369, Example 42::US10472354, Example 42 P2X purinoceptor 3 Homo sapiens 129 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319875&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397394 384223155 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842523 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C21H22N4O3S/c1-12-7-23-19(9-22-12)14(3)25-20(26)15-4-16(21-24-8-13(2)29-21)6-17(5-15)28-18-10-27-11-18/h4-9,14,18H,10-11H2,1-3H3,(H,25,26)/t14-/m1/s1 AWWAAAATSKEOQH-CQSZACIVSA-N 319875 N-[(1R)-1-(5-Methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 42::US10202369, Example 42::US10472354, Example 42 P2X purinoceptor 2/3 Homo sapiens 1565 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319875&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397394 384223155 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842524 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C21H22N4O3S/c1-12-7-24-21(29-12)16-4-15(5-18(6-16)28-19-10-27-11-19)20(26)25-13(2)17-8-22-14(3)23-9-17/h4-9,13,19H,10-11H2,1-3H3,(H,25,26)/t13-/m1/s1 QZYMXYIOESSIBG-CYBMUJFWSA-N 319876 N-[(1R)-1-(2-Methylpyrimidin-5-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 43::US10202369, Example 43::US10472354, Example 43 P2X purinoceptor 3 Homo sapiens 50.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319876&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397750 384223156 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842525 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C21H22N4O3S/c1-12-7-24-21(29-12)16-4-15(5-18(6-16)28-19-10-27-11-19)20(26)25-13(2)17-8-22-14(3)23-9-17/h4-9,13,19H,10-11H2,1-3H3,(H,25,26)/t13-/m1/s1 QZYMXYIOESSIBG-CYBMUJFWSA-N 319876 N-[(1R)-1-(2-Methylpyrimidin-5-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 43::US10202369, Example 43::US10472354, Example 43 P2X purinoceptor 2/3 Homo sapiens 2688 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319876&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397750 384223156 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842526 CC(NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C21H19ClFN3O3S/c1-11-7-25-21(30-11)14-3-13(4-16(5-14)29-17-9-28-10-17)20(27)26-12(2)19-18(23)6-15(22)8-24-19/h3-8,12,17H,9-10H2,1-2H3,(H,26,27) DXVSMJSLGFWBSV-UHFFFAOYSA-N 319877 N-[1-(5-Chloro-3-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 44::US10202369, Example 44::US10472354, Example 44 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319877&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397182 384223157 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842527 CC(NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C21H19ClFN3O3S/c1-11-7-25-21(30-11)14-3-13(4-16(5-14)29-17-9-28-10-17)20(27)26-12(2)19-18(23)6-15(22)8-24-19/h3-8,12,17H,9-10H2,1-2H3,(H,26,27) DXVSMJSLGFWBSV-UHFFFAOYSA-N 319877 N-[1-(5-Chloro-3-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 44::US10202369, Example 44::US10472354, Example 44 P2X purinoceptor 2/3 Homo sapiens 370 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319877&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397182 384223157 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842528 Cc1cnc(s1)-c1cc(OC2COC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C20H20N4O3S/c1-12-3-4-16(24-23-12)9-21-19(25)14-5-15(20-22-8-13(2)28-20)7-17(6-14)27-18-10-26-11-18/h3-8,18H,9-11H2,1-2H3,(H,21,25) AFIPEIBYSBBLBJ-UHFFFAOYSA-N 319878 N-[(6-Methylpyridazin-3-yl)methyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 45::US10202369, Example 45::US10472354, Example 45 P2X purinoceptor 3 Homo sapiens 212 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319878&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397740 384223158 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842529 Cc1cnc(s1)-c1cc(OC2COC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C20H20N4O3S/c1-12-3-4-16(24-23-12)9-21-19(25)14-5-15(20-22-8-13(2)28-20)7-17(6-14)27-18-10-26-11-18/h3-8,18H,9-11H2,1-2H3,(H,21,25) AFIPEIBYSBBLBJ-UHFFFAOYSA-N 319878 N-[(6-Methylpyridazin-3-yl)methyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 45::US10202369, Example 45::US10472354, Example 45 P2X purinoceptor 2/3 Homo sapiens 1510 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319878&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397740 384223158 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842530 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ccc(Cl)cn1 InChI=1S/C21H20ClN3O3S/c1-12-8-24-21(29-12)15-5-14(6-17(7-15)28-18-10-27-11-18)20(26)25-13(2)19-4-3-16(22)9-23-19/h3-9,13,18H,10-11H2,1-2H3,(H,25,26)/t13-/m1/s1 FFCGGIUVAQWIMW-CYBMUJFWSA-N 319879 N-[(1R)-1-(5-Chloropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 46::US10202369, Example 46::US10472354, Example 46 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319879&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397660 384223159 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842531 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ccc(Cl)cn1 InChI=1S/C21H20ClN3O3S/c1-12-8-24-21(29-12)15-5-14(6-17(7-15)28-18-10-27-11-18)20(26)25-13(2)19-4-3-16(22)9-23-19/h3-9,13,18H,10-11H2,1-2H3,(H,25,26)/t13-/m1/s1 FFCGGIUVAQWIMW-CYBMUJFWSA-N 319879 N-[(1R)-1-(5-Chloropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 46::US10202369, Example 46::US10472354, Example 46 P2X purinoceptor 2/3 Homo sapiens 389 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319879&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397660 384223159 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842532 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C21H22N4O3S/c1-12-4-5-19(25-24-12)14(3)23-20(26)15-6-16(21-22-9-13(2)29-21)8-17(7-15)28-18-10-27-11-18/h4-9,14,18H,10-11H2,1-3H3,(H,23,26)/t14-/m1/s1 HFDOVXXFUCEVBK-CQSZACIVSA-N 319880 N-[(1R)-1-(6-Methylpyridazin-3-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 47::US10202369, Example 47::US10472354, Example 47 P2X purinoceptor 3 Homo sapiens 82.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319880&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397352 384223160 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842533 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C21H22N4O3S/c1-12-4-5-19(25-24-12)14(3)23-20(26)15-6-16(21-22-9-13(2)29-21)8-17(7-15)28-18-10-27-11-18/h4-9,14,18H,10-11H2,1-3H3,(H,23,26)/t14-/m1/s1 HFDOVXXFUCEVBK-CQSZACIVSA-N 319880 N-[(1R)-1-(6-Methylpyridazin-3-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 47::US10202369, Example 47::US10472354, Example 47 P2X purinoceptor 2/3 Homo sapiens 621 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319880&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397352 384223160 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842534 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C21H19F3N4O3S/c1-11-6-25-19(32-11)14-3-13(4-16(5-14)31-17-9-30-10-17)18(29)28-12(2)15-7-26-20(27-8-15)21(22,23)24/h3-8,12,17H,9-10H2,1-2H3,(H,28,29)/t12-/m1/s1 HXNSKECKPLVRIH-GFCCVEGCSA-N 319881 3-(5-Methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 48::US10202369, Example 48::US10472354, Example 48 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319881&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397291 384223161 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842535 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C21H19F3N4O3S/c1-11-6-25-19(32-11)14-3-13(4-16(5-14)31-17-9-30-10-17)18(29)28-12(2)15-7-26-20(27-8-15)21(22,23)24/h3-8,12,17H,9-10H2,1-2H3,(H,28,29)/t12-/m1/s1 HXNSKECKPLVRIH-GFCCVEGCSA-N 319881 3-(5-Methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 48::US10202369, Example 48::US10472354, Example 48 P2X purinoceptor 2/3 Homo sapiens 451 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319881&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397291 384223161 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842536 CC(NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C21H19ClFN3O3S/c1-11-7-25-21(30-11)14-3-13(4-16(5-14)29-17-9-28-10-17)20(27)26-12(2)19-18(22)6-15(23)8-24-19/h3-8,12,17H,9-10H2,1-2H3,(H,26,27) FNMVOFQACWEVTO-UHFFFAOYSA-N 319882 N-[1-(3-Chloro-5-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 49::US10202369, Example 49::US10472354, Example 49 P2X purinoceptor 3 Homo sapiens 132 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319882&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397320 384223162 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842537 CC(NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C21H19ClFN3O3S/c1-11-7-25-21(30-11)14-3-13(4-16(5-14)29-17-9-28-10-17)20(27)26-12(2)19-18(22)6-15(23)8-24-19/h3-8,12,17H,9-10H2,1-2H3,(H,26,27) FNMVOFQACWEVTO-UHFFFAOYSA-N 319882 N-[1-(3-Chloro-5-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)benzamide::US10174016, Example 49::US10202369, Example 49::US10472354, Example 49 P2X purinoceptor 2/3 Homo sapiens 1525 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319882&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397320 384223162 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842538 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)C1=[S]C=C(C)N1)c1nnc(C)s1 InChI=1S/C19H21N4O3S2/c1-10-9-27-19(20-10)14-4-13(5-15(6-14)26-16-7-25-8-16)17(24)21-11(2)18-23-22-12(3)28-18/h4-6,9,11,16,20H,7-8H2,1-3H3,(H,21,24)/t11-/m1/s1 VNOLWUXOQFRHOP-LLVKDONJSA-N 419970 US10472354, Example 50 P2X purinoceptor 3 Homo sapiens 77.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=419970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=419970&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842539 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)C1=[S]C=C(C)N1)c1nnc(C)s1 InChI=1S/C19H21N4O3S2/c1-10-9-27-19(20-10)14-4-13(5-15(6-14)26-16-7-25-8-16)17(24)21-11(2)18-23-22-12(3)28-18/h4-6,9,11,16,20H,7-8H2,1-3H3,(H,21,24)/t11-/m1/s1 VNOLWUXOQFRHOP-LLVKDONJSA-N 419970 US10472354, Example 50 P2X purinoceptor 2/3 Homo sapiens 982 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=419970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=419970&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842540 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)C1=[S]C(C)=CN1)c1ccc(C)nc1 InChI=1S/C22H24N3O3S/c1-13-4-5-16(10-23-13)15(3)25-21(26)17-6-18(22-24-9-14(2)29-22)8-19(7-17)28-20-11-27-12-20/h4-10,15,20,24H,11-12H2,1-3H3,(H,25,26)/t15-/m1/s1 GAVXGHHYABXHOQ-OAHLLOKOSA-N 419971 US10472354, Example 51 P2X purinoceptor 3 Homo sapiens 74.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=419971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=419971&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842541 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)C1=[S]C(C)=CN1)c1ccc(C)nc1 InChI=1S/C22H24N3O3S/c1-13-4-5-16(10-23-13)15(3)25-21(26)17-6-18(22-24-9-14(2)29-22)8-19(7-17)28-20-11-27-12-20/h4-10,15,20,24H,11-12H2,1-3H3,(H,25,26)/t15-/m1/s1 GAVXGHHYABXHOQ-OAHLLOKOSA-N 419971 US10472354, Example 51 P2X purinoceptor 2/3 Homo sapiens 1389 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=419971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=419971&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842542 Cc1cnc(s1)-c1cc(OC2COC2)cc(c1)C(=O)NCc1ccc(nn1)C(F)(F)F InChI=1S/C20H17F3N4O3S/c1-11-7-25-19(31-11)13-4-12(5-15(6-13)30-16-9-29-10-16)18(28)24-8-14-2-3-17(27-26-14)20(21,22)23/h2-7,16H,8-10H2,1H3,(H,24,28) KTKYNBLLOZOZPY-UHFFFAOYSA-N 319885 3-(5-Methyl- 1,3-thiazol-2- yl)-5-(oxetan- 3-yloxy)-N-{[6- (trifluoromethyl) pyridazin-3- yl]methyl} benzamide::US10174016, Example 52::US10202369, Example 52::US10472354, Example 52 P2X purinoceptor 3 Homo sapiens 194 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319885&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397650 384223165 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842543 Cc1cnc(s1)-c1cc(OC2COC2)cc(c1)C(=O)NCc1ccc(nn1)C(F)(F)F InChI=1S/C20H17F3N4O3S/c1-11-7-25-19(31-11)13-4-12(5-15(6-13)30-16-9-29-10-16)18(28)24-8-14-2-3-17(27-26-14)20(21,22)23/h2-7,16H,8-10H2,1H3,(H,24,28) KTKYNBLLOZOZPY-UHFFFAOYSA-N 319885 3-(5-Methyl- 1,3-thiazol-2- yl)-5-(oxetan- 3-yloxy)-N-{[6- (trifluoromethyl) pyridazin-3- yl]methyl} benzamide::US10174016, Example 52::US10202369, Example 52::US10472354, Example 52 P2X purinoceptor 2/3 Homo sapiens 564 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319885&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397650 384223165 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842544 CC[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-3-18(15-8-27-21(28-9-15)22(23,24)25)29-19(30)13-4-14(20-26-7-12(2)33-20)6-16(5-13)32-17-10-31-11-17/h4-9,17-18H,3,10-11H2,1-2H3,(H,29,30)/t18-/m1/s1 PHCWFMJDVHAVQT-GOSISDBHSA-N 319886 3-(5-Methyl- 1,3-thiazol-2- yl)-5-(oxetan- 3-yloxy)-N- [(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]propyl] benzamide::US10174016, Example 53::US10202369, Example 53::US10472354, Example 53 P2X purinoceptor 3 Homo sapiens 318 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319886&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397526 384223166 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842545 CC[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-3-18(15-8-27-21(28-9-15)22(23,24)25)29-19(30)13-4-14(20-26-7-12(2)33-20)6-16(5-13)32-17-10-31-11-17/h4-9,17-18H,3,10-11H2,1-2H3,(H,29,30)/t18-/m1/s1 PHCWFMJDVHAVQT-GOSISDBHSA-N 319886 3-(5-Methyl- 1,3-thiazol-2- yl)-5-(oxetan- 3-yloxy)-N- [(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]propyl] benzamide::US10174016, Example 53::US10202369, Example 53::US10472354, Example 53 P2X purinoceptor 2/3 Homo sapiens 2740 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319886&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397526 384223166 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842546 Cc1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-14-5-6-18(26-25-14)12-23-21(27)16-8-17(22-24-11-15(2)30-22)10-20(9-16)29-13-19-4-3-7-28-19/h5-6,8-11,19H,3-4,7,12-13H2,1-2H3,(H,23,27)/t19-/m0/s1 IFCRFQDQDLUKDL-IBGZPJMESA-N 319887 N-[(6-Methylpyridazin-3-yl)methyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 54::US10202369, Example 54::US10472354, Example 54 P2X purinoceptor 3 Homo sapiens 66.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319887&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397485 384223167 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842547 Cc1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-14-5-6-18(26-25-14)12-23-21(27)16-8-17(22-24-11-15(2)30-22)10-20(9-16)29-13-19-4-3-7-28-19/h5-6,8-11,19H,3-4,7,12-13H2,1-2H3,(H,23,27)/t19-/m0/s1 IFCRFQDQDLUKDL-IBGZPJMESA-N 319887 N-[(6-Methylpyridazin-3-yl)methyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 54::US10202369, Example 54::US10472354, Example 54 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319887&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397485 384223167 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842548 CC1=CNC(=[S]1)c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)NCc1ncc(Cl)cc1F InChI=1S/C22H22ClFN3O3S/c1-13-9-27-22(31-13)15-5-14(6-18(7-15)30-12-17-3-2-4-29-17)21(28)26-11-20-19(24)8-16(23)10-25-20/h5-10,17,27H,2-4,11-12H2,1H3,(H,26,28)/t17-/m0/s1 ALVAUYIPIZELRY-KRWDZBQOSA-N 419975 US10472354, Example 55 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=419975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=419975&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842549 CC1=CNC(=[S]1)c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)NCc1ncc(Cl)cc1F InChI=1S/C22H22ClFN3O3S/c1-13-9-27-22(31-13)15-5-14(6-18(7-15)30-12-17-3-2-4-29-17)21(28)26-11-20-19(24)8-16(23)10-25-20/h5-10,17,27H,2-4,11-12H2,1H3,(H,26,28)/t17-/m0/s1 ALVAUYIPIZELRY-KRWDZBQOSA-N 419975 US10472354, Example 55 P2X purinoceptor 2/3 Homo sapiens 325 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=419975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=419975&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842550 CC1=CNC(=[S]1)c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C22H25N4O3S/c1-14-9-24-18(11-23-14)12-25-21(27)16-6-17(22-26-10-15(2)30-22)8-20(7-16)29-13-19-4-3-5-28-19/h6-11,19,26H,3-5,12-13H2,1-2H3,(H,25,27)/t19-/m0/s1 UAHUKPQUPXOADJ-IBGZPJMESA-N 419976 US10472354, Example 56 P2X purinoceptor 3 Homo sapiens 148 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=419976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=419976&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842551 CC1=CNC(=[S]1)c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C22H25N4O3S/c1-14-9-24-18(11-23-14)12-25-21(27)16-6-17(22-26-10-15(2)30-22)8-20(7-16)29-13-19-4-3-5-28-19/h6-11,19,26H,3-5,12-13H2,1-2H3,(H,25,27)/t19-/m0/s1 UAHUKPQUPXOADJ-IBGZPJMESA-N 419976 US10472354, Example 56 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=419976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=419976&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842552 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-14-10-25-21(12-24-14)16(3)27-22(28)17-7-18(23-26-11-15(2)31-23)9-20(8-17)30-13-19-5-4-6-29-19/h7-12,16,19H,4-6,13H2,1-3H3,(H,27,28)/t16-,19+/m1/s1 MANPQCKCYFRFOG-APWZRJJASA-N 319890 N-[(1R)-1-(5-Methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 57::US10202369, Example 57::US10472354, Example 57 P2X purinoceptor 3 Homo sapiens 25.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319890&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397390 384223170 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842553 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-14-10-25-21(12-24-14)16(3)27-22(28)17-7-18(23-26-11-15(2)31-23)9-20(8-17)30-13-19-5-4-6-29-19/h7-12,16,19H,4-6,13H2,1-3H3,(H,27,28)/t16-,19+/m1/s1 MANPQCKCYFRFOG-APWZRJJASA-N 319890 N-[(1R)-1-(5-Methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 57::US10202369, Example 57::US10472354, Example 57 P2X purinoceptor 2/3 Homo sapiens 2840 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319890&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397390 384223170 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842554 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-9-27-21(34-13)16-6-15(7-19(8-16)33-12-18-4-3-5-32-18)20(31)30-14(2)17-10-28-22(29-11-17)23(24,25)26/h6-11,14,18H,3-5,12H2,1-2H3,(H,30,31)/t14-,18+/m1/s1 MXZPUDRHAAYJOR-KDOFPFPSSA-N 319891 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(2S)-tetrahydrofuran-2-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 58::US10202369, Example 58::US10472354, Example 58 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319891&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397134 384223171 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842555 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-9-27-21(34-13)16-6-15(7-19(8-16)33-12-18-4-3-5-32-18)20(31)30-14(2)17-10-28-22(29-11-17)23(24,25)26/h6-11,14,18H,3-5,12H2,1-2H3,(H,30,31)/t14-,18+/m1/s1 MXZPUDRHAAYJOR-KDOFPFPSSA-N 319891 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(2S)-tetrahydrofuran-2-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 58::US10202369, Example 58::US10472354, Example 58 P2X purinoceptor 2/3 Homo sapiens 461 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319891&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397134 384223171 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842556 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-14-6-7-21(27-26-14)16(3)25-22(28)17-9-18(23-24-12-15(2)31-23)11-20(10-17)30-13-19-5-4-8-29-19/h6-7,9-12,16,19H,4-5,8,13H2,1-3H3,(H,25,28)/t16-,19+/m1/s1 JHPJVAOLQKHAFN-APWZRJJASA-N 319892 N-[(1R)-1-(6-Methylpyridazin-3-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 59::US10202369, Example 59::US10472354, Example 59 P2X purinoceptor 3 Homo sapiens 13.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319892&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397721 384223172 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842557 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-14-6-7-21(27-26-14)16(3)25-22(28)17-9-18(23-24-12-15(2)31-23)11-20(10-17)30-13-19-5-4-8-29-19/h6-7,9-12,16,19H,4-5,8,13H2,1-3H3,(H,25,28)/t16-,19+/m1/s1 JHPJVAOLQKHAFN-APWZRJJASA-N 319892 N-[(1R)-1-(6-Methylpyridazin-3-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2S)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 59::US10202369, Example 59::US10472354, Example 59 P2X purinoceptor 2/3 Homo sapiens 507 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319892&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397721 384223172 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842558 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-11-27-22(34-13)16-8-15(9-18(10-16)33-12-17-4-3-7-32-17)21(31)28-14(2)19-5-6-20(30-29-19)23(24,25)26/h5-6,8-11,14,17H,3-4,7,12H2,1-2H3,(H,28,31)/t14-,17+/m1/s1 KNJYTDFISMIFTK-PBHICJAKSA-N 319893 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(2S)-tetrahydrofuran-2-ylmethoxy]-N-{(1R)-1-[6-(trifluoromethyl)pyridazin-3-yl]ethyl}benzamide::US10174016, Example 60::US10202369, Example 60::US10472354, Example 60 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319893&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397124 384223173 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842559 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-11-27-22(34-13)16-8-15(9-18(10-16)33-12-17-4-3-7-32-17)21(31)28-14(2)19-5-6-20(30-29-19)23(24,25)26/h5-6,8-11,14,17H,3-4,7,12H2,1-2H3,(H,28,31)/t14-,17+/m1/s1 KNJYTDFISMIFTK-PBHICJAKSA-N 319893 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(2S)-tetrahydrofuran-2-ylmethoxy]-N-{(1R)-1-[6-(trifluoromethyl)pyridazin-3-yl]ethyl}benzamide::US10174016, Example 60::US10202369, Example 60::US10472354, Example 60 P2X purinoceptor 2/3 Homo sapiens 578 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319893&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397124 384223173 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842560 C[C@@H](NC(=O)c1cc(OC[C@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-14-6-7-21(27-26-14)16(3)25-22(28)17-9-18(23-24-12-15(2)31-23)11-20(10-17)30-13-19-5-4-8-29-19/h6-7,9-12,16,19H,4-5,8,13H2,1-3H3,(H,25,28)/t16-,19-/m1/s1 JHPJVAOLQKHAFN-VQIMIIECSA-N 319894 N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2R)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 61::US10202369, Example 61::US10472354, Example 61 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319894&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397475 384223174 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842561 C[C@@H](NC(=O)c1cc(OC[C@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-14-6-7-21(27-26-14)16(3)25-22(28)17-9-18(23-24-12-15(2)31-23)11-20(10-17)30-13-19-5-4-8-29-19/h6-7,9-12,16,19H,4-5,8,13H2,1-3H3,(H,25,28)/t16-,19-/m1/s1 JHPJVAOLQKHAFN-VQIMIIECSA-N 319894 N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2R)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 61::US10202369, Example 61::US10472354, Example 61 P2X purinoceptor 2/3 Homo sapiens 428 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319894&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397475 384223174 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842562 Cc1cnc(s1)-c1cc(OC[C@H]2CCCO2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-14-5-6-18(26-25-14)12-23-21(27)16-8-17(22-24-11-15(2)30-22)10-20(9-16)29-13-19-4-3-7-28-19/h5-6,8-11,19H,3-4,7,12-13H2,1-2H3,(H,23,27)/t19-/m1/s1 IFCRFQDQDLUKDL-LJQANCHMSA-N 319895 N-[(6-Methylpyridazin-3-yl)methyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2R)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 62::US10202369, Example 62::US10472354, Example 62 P2X purinoceptor 3 Homo sapiens 85.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319895&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397725 384223175 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842563 Cc1cnc(s1)-c1cc(OC[C@H]2CCCO2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-14-5-6-18(26-25-14)12-23-21(27)16-8-17(22-24-11-15(2)30-22)10-20(9-16)29-13-19-4-3-7-28-19/h5-6,8-11,19H,3-4,7,12-13H2,1-2H3,(H,23,27)/t19-/m1/s1 IFCRFQDQDLUKDL-LJQANCHMSA-N 319895 N-[(6-Methylpyridazin-3-yl)methyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2R)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 62::US10202369, Example 62::US10472354, Example 62 P2X purinoceptor 2/3 Homo sapiens 1436 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319895&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397725 384223175 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842564 C[C@@H](NC(=O)c1cc(OC[C@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-9-27-21(34-13)16-6-15(7-19(8-16)33-12-18-4-3-5-32-18)20(31)30-14(2)17-10-28-22(29-11-17)23(24,25)26/h6-11,14,18H,3-5,12H2,1-2H3,(H,30,31)/t14-,18-/m1/s1 MXZPUDRHAAYJOR-RDTXWAMCSA-N 319896 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(2R)-tetrahydrofuran-2-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 63::US10202369, Example 63::US10472354, Example 63 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319896&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397292 384223176 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842565 C[C@@H](NC(=O)c1cc(OC[C@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-9-27-21(34-13)16-6-15(7-19(8-16)33-12-18-4-3-5-32-18)20(31)30-14(2)17-10-28-22(29-11-17)23(24,25)26/h6-11,14,18H,3-5,12H2,1-2H3,(H,30,31)/t14-,18-/m1/s1 MXZPUDRHAAYJOR-RDTXWAMCSA-N 319896 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(2R)-tetrahydrofuran-2-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 63::US10202369, Example 63::US10472354, Example 63 P2X purinoceptor 2/3 Homo sapiens 118 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319896&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397292 384223176 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842566 C[C@@H](NC(=O)c1cc(OC[C@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-14-10-25-21(12-24-14)16(3)27-22(28)17-7-18(23-26-11-15(2)31-23)9-20(8-17)30-13-19-5-4-6-29-19/h7-12,16,19H,4-6,13H2,1-3H3,(H,27,28)/t16-,19-/m1/s1 MANPQCKCYFRFOG-VQIMIIECSA-N 319897 N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2R)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 64::US10202369, Example 64::US10472354, Example 64 P2X purinoceptor 3 Homo sapiens 53.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319897&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397244 384223177 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842567 C[C@@H](NC(=O)c1cc(OC[C@H]2CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-14-10-25-21(12-24-14)16(3)27-22(28)17-7-18(23-26-11-15(2)31-23)9-20(8-17)30-13-19-5-4-6-29-19/h7-12,16,19H,4-6,13H2,1-3H3,(H,27,28)/t16-,19-/m1/s1 MANPQCKCYFRFOG-VQIMIIECSA-N 319897 N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(2R)-tetrahydrofuran-2-ylmethoxy]benzamide::US10174016, Example 64::US10202369, Example 64::US10472354, Example 64 P2X purinoceptor 2/3 Homo sapiens 984 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319897&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397244 384223177 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842568 CC(NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C23H23ClFN3O3S/c1-13-9-27-23(32-13)17-5-16(6-19(7-17)31-12-15-3-4-30-11-15)22(29)28-14(2)21-20(25)8-18(24)10-26-21/h5-10,14-15H,3-4,11-12H2,1-2H3,(H,28,29)/t14?,15-/m0/s1 NHGFOVVSFOISFI-LOACHALJSA-N 319898 N-[1-(5- Chloro-3- fluoropyridin- 2-yl)ethyl]-3- (5-methyL- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 65::US10202369, Example 65::US10472354, Example 65 P2X purinoceptor 3 Homo sapiens 3.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319898&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397187 384223178 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842569 CC(NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C23H23ClFN3O3S/c1-13-9-27-23(32-13)17-5-16(6-19(7-17)31-12-15-3-4-30-11-15)22(29)28-14(2)21-20(25)8-18(24)10-26-21/h5-10,14-15H,3-4,11-12H2,1-2H3,(H,28,29)/t14?,15-/m0/s1 NHGFOVVSFOISFI-LOACHALJSA-N 319898 N-[1-(5- Chloro-3- fluoropyridin- 2-yl)ethyl]-3- (5-methyL- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 65::US10202369, Example 65::US10472354, Example 65 P2X purinoceptor 2/3 Homo sapiens 54.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319898&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397187 384223178 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842570 Cc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-14-3-4-19(26-25-14)11-23-21(27)17-7-18(22-24-10-15(2)30-22)9-20(8-17)29-13-16-5-6-28-12-16/h3-4,7-10,16H,5-6,11-13H2,1-2H3,(H,23,27)/t16-/m0/s1 SKNHRCMFBDROGE-INIZCTEOSA-N 319899 N-[(6- Methylpyridazin- 3-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 66::US10202369, Example 66::US10472354, Example 66 P2X purinoceptor 3 Homo sapiens 35.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319899&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397153 384223179 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842571 Cc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-14-3-4-19(26-25-14)11-23-21(27)17-7-18(22-24-10-15(2)30-22)9-20(8-17)29-13-16-5-6-28-12-16/h3-4,7-10,16H,5-6,11-13H2,1-2H3,(H,23,27)/t16-/m0/s1 SKNHRCMFBDROGE-INIZCTEOSA-N 319899 N-[(6- Methylpyridazin- 3-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 66::US10202369, Example 66::US10472354, Example 66 P2X purinoceptor 2/3 Homo sapiens 6295 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319899&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397153 384223179 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842572 Cc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-14-8-24-19(10-23-14)11-25-21(27)17-5-18(22-26-9-15(2)30-22)7-20(6-17)29-13-16-3-4-28-12-16/h5-10,16H,3-4,11-13H2,1-2H3,(H,25,27)/t16-/m0/s1 MFTNZVDLSIJVDH-INIZCTEOSA-N 319900 N-[(5- Methylpyrazin- 2-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 67::US10202369, Example 67::US10472354, Example 67 P2X purinoceptor 3 Homo sapiens 186 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319900&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397127 384223180 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842573 Cc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-14-8-24-19(10-23-14)11-25-21(27)17-5-18(22-26-9-15(2)30-22)7-20(6-17)29-13-16-3-4-28-12-16/h5-10,16H,3-4,11-13H2,1-2H3,(H,25,27)/t16-/m0/s1 MFTNZVDLSIJVDH-INIZCTEOSA-N 319900 N-[(5- Methylpyrazin- 2-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 67::US10202369, Example 67::US10472354, Example 67 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319900&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397127 384223180 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842574 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-14-9-25-21(11-24-14)16(3)27-22(28)18-6-19(23-26-10-15(2)31-23)8-20(7-18)30-13-17-4-5-29-12-17/h6-11,16-17H,4-5,12-13H2,1-3H3,(H,27,28)/t16-,17+/m1/s1 VCKXOWQZUNTNDF-SJORKVTESA-N 319901 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 68::US10202369, Example 68::US10472354, Example 68 P2X purinoceptor 3 Homo sapiens 44.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319901&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397617 384223181 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842575 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-14-9-25-21(11-24-14)16(3)27-22(28)18-6-19(23-26-10-15(2)31-23)8-20(7-18)30-13-17-4-5-29-12-17/h6-11,16-17H,4-5,12-13H2,1-3H3,(H,27,28)/t16-,17+/m1/s1 VCKXOWQZUNTNDF-SJORKVTESA-N 319901 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 68::US10202369, Example 68::US10472354, Example 68 P2X purinoceptor 2/3 Homo sapiens 1617 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319901&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397617 384223181 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842576 CC(NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C23H23ClFN3O3S/c1-13-9-27-23(32-13)17-5-16(6-19(7-17)31-12-15-3-4-30-11-15)22(29)28-14(2)21-20(24)8-18(25)10-26-21/h5-10,14-15H,3-4,11-12H2,1-2H3,(H,28,29)/t14?,15-/m0/s1 UNHVUPCUCRZLRC-LOACHALJSA-N 319902 N-[1-(3- Chloro-5- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 69::US10202369, Example 69::US10472354, Example 69 P2X purinoceptor 3 Homo sapiens 15.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319902&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 134338444 384223182 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842577 CC(NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C23H23ClFN3O3S/c1-13-9-27-23(32-13)17-5-16(6-19(7-17)31-12-15-3-4-30-11-15)22(29)28-14(2)21-20(24)8-18(25)10-26-21/h5-10,14-15H,3-4,11-12H2,1-2H3,(H,28,29)/t14?,15-/m0/s1 UNHVUPCUCRZLRC-LOACHALJSA-N 319902 N-[1-(3- Chloro-5- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 69::US10202369, Example 69::US10472354, Example 69 P2X purinoceptor 2/3 Homo sapiens 937 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319902&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 134338444 384223182 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842578 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-8-27-21(34-13)17-5-16(6-19(7-17)33-12-15-3-4-32-11-15)20(31)30-14(2)18-9-28-22(29-10-18)23(24,25)26/h5-10,14-15H,3-4,11-12H2,1-2H3,(H,30,31)/t14-,15+/m1/s1 CHPCVIFXIKJNGF-CABCVRRESA-N 319903 3-(5-Methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy]- N-[(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl] benzamide::US10174016, Example 70::US10202369, Example 70::US10472354, Example 70 P2X purinoceptor 3 Homo sapiens 3.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319903&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397748 384223183 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842579 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-8-27-21(34-13)17-5-16(6-19(7-17)33-12-15-3-4-32-11-15)20(31)30-14(2)18-9-28-22(29-10-18)23(24,25)26/h5-10,14-15H,3-4,11-12H2,1-2H3,(H,30,31)/t14-,15+/m1/s1 CHPCVIFXIKJNGF-CABCVRRESA-N 319903 3-(5-Methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy]- N-[(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl] benzamide::US10174016, Example 70::US10202369, Example 70::US10472354, Example 70 P2X purinoceptor 2/3 Homo sapiens 78.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319903&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397748 384223183 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842580 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-14-4-5-21(27-26-14)16(3)25-22(28)18-8-19(23-24-11-15(2)31-23)10-20(9-18)30-13-17-6-7-29-12-17/h4-5,8-11,16-17H,6-7,12-13H2,1-3H3,(H,25,28)/t16-,17+/m1/s1 DJBMUKYGNBBQBO-SJORKVTESA-N 319904 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 71::US10202369, Example 71::US10472354, Example 71 P2X purinoceptor 3 Homo sapiens 15.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319904&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397305 384223184 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842581 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-14-4-5-21(27-26-14)16(3)25-22(28)18-8-19(23-24-11-15(2)31-23)10-20(9-18)30-13-17-6-7-29-12-17/h4-5,8-11,16-17H,6-7,12-13H2,1-3H3,(H,25,28)/t16-,17+/m1/s1 DJBMUKYGNBBQBO-SJORKVTESA-N 319904 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 71::US10202369, Example 71::US10472354, Example 71 P2X purinoceptor 2/3 Homo sapiens 315 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319904&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397305 384223184 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842582 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-10-27-22(34-13)17-7-16(8-18(9-17)33-12-15-5-6-32-11-15)21(31)28-14(2)19-3-4-20(30-29-19)23(24,25)26/h3-4,7-10,14-15H,5-6,11-12H2,1-2H3,(H,28,31)/t14-,15+/m1/s1 BICIIZABCQYPPY-CABCVRRESA-N 319905 3-(5-Methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy]- N-[(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl] benzamide::US10174016, Example 72::US10202369, Example 72::US10472354, Example 72 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319905&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397781 384223185 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842583 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-10-27-22(34-13)17-7-16(8-18(9-17)33-12-15-5-6-32-11-15)21(31)28-14(2)19-3-4-20(30-29-19)23(24,25)26/h3-4,7-10,14-15H,5-6,11-12H2,1-2H3,(H,28,31)/t14-,15+/m1/s1 BICIIZABCQYPPY-CABCVRRESA-N 319905 3-(5-Methyl- 1,3-thiazol-2- yl)-5-[(3S)- tetrahydrofuran- 3-ylmethoxy]- N-[(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl] benzamide::US10174016, Example 72::US10202369, Example 72::US10472354, Example 72 P2X purinoceptor 2/3 Homo sapiens 330 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319905&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397781 384223185 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842584 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-8-27-21(34-13)17-5-16(6-19(7-17)33-12-15-3-4-32-11-15)20(31)30-14(2)18-9-28-22(29-10-18)23(24,25)26/h5-10,14-15H,3-4,11-12H2,1-2H3,(H,30,31)/t14-,15-/m1/s1 CHPCVIFXIKJNGF-HUUCEWRRSA-N 319906 3-(5-Methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy]- N-[(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl] benzamide::US10174016, Example 73::US10202369, Example 73::US10472354, Example 73 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319906&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397238 384223186 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842585 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-8-27-21(34-13)17-5-16(6-19(7-17)33-12-15-3-4-32-11-15)20(31)30-14(2)18-9-28-22(29-10-18)23(24,25)26/h5-10,14-15H,3-4,11-12H2,1-2H3,(H,30,31)/t14-,15-/m1/s1 CHPCVIFXIKJNGF-HUUCEWRRSA-N 319906 3-(5-Methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy]- N-[(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl] benzamide::US10174016, Example 73::US10202369, Example 73::US10472354, Example 73 P2X purinoceptor 2/3 Homo sapiens 101 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319906&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397238 384223186 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842586 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-14-9-25-21(11-24-14)16(3)27-22(28)18-6-19(23-26-10-15(2)31-23)8-20(7-18)30-13-17-4-5-29-12-17/h6-11,16-17H,4-5,12-13H2,1-3H3,(H,27,28)/t16-,17-/m1/s1 VCKXOWQZUNTNDF-IAGOWNOFSA-N 319907 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 74::US10202369, Example 74::US10472354, Example 74 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319907&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397532 384223187 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842587 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-14-9-25-21(11-24-14)16(3)27-22(28)18-6-19(23-26-10-15(2)31-23)8-20(7-18)30-13-17-4-5-29-12-17/h6-11,16-17H,4-5,12-13H2,1-3H3,(H,27,28)/t16-,17-/m1/s1 VCKXOWQZUNTNDF-IAGOWNOFSA-N 319907 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 74::US10202369, Example 74::US10472354, Example 74 P2X purinoceptor 2/3 Homo sapiens 1107 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319907&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397532 384223187 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842588 Cc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-14-3-4-19(26-25-14)11-23-21(27)17-7-18(22-24-10-15(2)30-22)9-20(8-17)29-13-16-5-6-28-12-16/h3-4,7-10,16H,5-6,11-13H2,1-2H3,(H,23,27)/t16-/m1/s1 SKNHRCMFBDROGE-MRXNPFEDSA-N 319908 N-[(6- Methylpyridazin- 3-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 75::US10202369, Example 75::US10472354, Example 75 P2X purinoceptor 3 Homo sapiens 38.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319908&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397221 384223188 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842589 Cc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-14-3-4-19(26-25-14)11-23-21(27)17-7-18(22-24-10-15(2)30-22)9-20(8-17)29-13-16-5-6-28-12-16/h3-4,7-10,16H,5-6,11-13H2,1-2H3,(H,23,27)/t16-/m1/s1 SKNHRCMFBDROGE-MRXNPFEDSA-N 319908 N-[(6- Methylpyridazin- 3-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 75::US10202369, Example 75::US10472354, Example 75 P2X purinoceptor 2/3 Homo sapiens 6638 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319908&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397221 384223188 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842590 Cc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-14-8-24-19(10-23-14)11-25-21(27)17-5-18(22-26-9-15(2)30-22)7-20(6-17)29-13-16-3-4-28-12-16/h5-10,16H,3-4,11-13H2,1-2H3,(H,25,27)/t16-/m1/s1 MFTNZVDLSIJVDH-MRXNPFEDSA-N 319909 N-[(5- Methylpyrazin- 2-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 76::US10202369, Example 76::US10472354, Example 76 P2X purinoceptor 3 Homo sapiens 201 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319909&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397850 384223189 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842591 Cc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-14-8-24-19(10-23-14)11-25-21(27)17-5-18(22-26-9-15(2)30-22)7-20(6-17)29-13-16-3-4-28-12-16/h5-10,16H,3-4,11-13H2,1-2H3,(H,25,27)/t16-/m1/s1 MFTNZVDLSIJVDH-MRXNPFEDSA-N 319909 N-[(5- Methylpyrazin- 2-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 76::US10202369, Example 76::US10472354, Example 76 P2X purinoceptor 2/3 Homo sapiens 5789 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319909&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397850 384223189 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842592 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-14-4-5-21(27-26-14)16(3)25-22(28)18-8-19(23-24-11-15(2)31-23)10-20(9-18)30-13-17-6-7-29-12-17/h4-5,8-11,16-17H,6-7,12-13H2,1-3H3,(H,25,28)/t16-,17-/m1/s1 DJBMUKYGNBBQBO-IAGOWNOFSA-N 319910 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzomide::US10174016, Example 77::US10202369, Example 77::US10472354, Example 77 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319910&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397806 384223190 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842593 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-14-4-5-21(27-26-14)16(3)25-22(28)18-8-19(23-24-11-15(2)31-23)10-20(9-18)30-13-17-6-7-29-12-17/h4-5,8-11,16-17H,6-7,12-13H2,1-3H3,(H,25,28)/t16-,17-/m1/s1 DJBMUKYGNBBQBO-IAGOWNOFSA-N 319910 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzomide::US10174016, Example 77::US10202369, Example 77::US10472354, Example 77 P2X purinoceptor 2/3 Homo sapiens 183 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319910&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397806 384223190 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842594 CC(NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C23H23ClFN3O3S/c1-13-9-27-23(32-13)17-5-16(6-19(7-17)31-12-15-3-4-30-11-15)22(29)28-14(2)21-20(25)8-18(24)10-26-21/h5-10,14-15H,3-4,11-12H2,1-2H3,(H,28,29)/t14?,15-/m1/s1 NHGFOVVSFOISFI-YSSOQSIOSA-N 319911 N-[1-(5- Chloro-3- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 78::US10202369, Example 78::US10472354, Example 78 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319911&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397720 384223191 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842595 CC(NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C23H23ClFN3O3S/c1-13-9-27-23(32-13)17-5-16(6-19(7-17)31-12-15-3-4-30-11-15)22(29)28-14(2)21-20(25)8-18(24)10-26-21/h5-10,14-15H,3-4,11-12H2,1-2H3,(H,28,29)/t14?,15-/m1/s1 NHGFOVVSFOISFI-YSSOQSIOSA-N 319911 N-[1-(5- Chloro-3- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy] benzamide::US10174016, Example 78::US10202369, Example 78::US10472354, Example 78 P2X purinoceptor 2/3 Homo sapiens 83.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319911&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397720 384223191 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842596 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-10-27-22(34-13)17-7-16(8-18(9-17)33-12-15-5-6-32-11-15)21(31)28-14(2)19-3-4-20(30-29-19)23(24,25)26/h3-4,7-10,14-15H,5-6,11-12H2,1-2H3,(H,28,31)/t14-,15-/m1/s1 BICIIZABCQYPPY-HUUCEWRRSA-N 319912 3-(5-Methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy]- N-[(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl] benzamide::US10174016, Example 79::US10202369, Example 79::US10472354, Example 79 P2X purinoceptor 3 Homo sapiens 9.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319912&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397596 384223192 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842597 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-10-27-22(34-13)17-7-16(8-18(9-17)33-12-15-5-6-32-11-15)21(31)28-14(2)19-3-4-20(30-29-19)23(24,25)26/h3-4,7-10,14-15H,5-6,11-12H2,1-2H3,(H,28,31)/t14-,15-/m1/s1 BICIIZABCQYPPY-HUUCEWRRSA-N 319912 3-(5-Methyl- 1,3-thiazol-2- yl)-5-[(3R)- tetrahydrofuran- 3-ylmethoxy]- N-[(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl] benzamide::US10174016, Example 79::US10202369, Example 79::US10472354, Example 79 P2X purinoceptor 2/3 Homo sapiens 413 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319912&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397596 384223192 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842598 CC(NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C23H23ClFN3O3S/c1-13-11-27-23(32-13)16-7-15(8-19(9-16)31-18-3-5-30-6-4-18)22(29)28-14(2)21-20(24)10-17(25)12-26-21/h7-12,14,18H,3-6H2,1-2H3,(H,28,29) SBZIYANVWYKJKX-UHFFFAOYSA-N 319913 N-[1-(3- Chloro-5- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 80::US10202369, Example 80::US10472354, Example 80 P2X purinoceptor 3 Homo sapiens 12.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319913&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397324 384223193 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842599 CC(NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C23H23ClFN3O3S/c1-13-11-27-23(32-13)16-7-15(8-19(9-16)31-18-3-5-30-6-4-18)22(29)28-14(2)21-20(24)10-17(25)12-26-21/h7-12,14,18H,3-6H2,1-2H3,(H,28,29) SBZIYANVWYKJKX-UHFFFAOYSA-N 319913 N-[1-(3- Chloro-5- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 80::US10202369, Example 80::US10472354, Example 80 P2X purinoceptor 2/3 Homo sapiens 339 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319913&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397324 384223193 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842600 CC(NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C23H23ClFN3O3S/c1-13-11-27-23(32-13)16-7-15(8-19(9-16)31-18-3-5-30-6-4-18)22(29)28-14(2)21-20(25)10-17(24)12-26-21/h7-12,14,18H,3-6H2,1-2H3,(H,28,29) UXQVDYSQMZTJPS-UHFFFAOYSA-N 319914 N-[1-(5- Chloro-3- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 81::US10202369, Example 81::US10472354, Example 81 P2X purinoceptor 3 Homo sapiens 3.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319914&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397622 384223194 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842601 CC(NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C23H23ClFN3O3S/c1-13-11-27-23(32-13)16-7-15(8-19(9-16)31-18-3-5-30-6-4-18)22(29)28-14(2)21-20(25)10-17(24)12-26-21/h7-12,14,18H,3-6H2,1-2H3,(H,28,29) UXQVDYSQMZTJPS-UHFFFAOYSA-N 319914 N-[1-(5- Chloro-3- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 81::US10202369, Example 81::US10472354, Example 81 P2X purinoceptor 2/3 Homo sapiens 34.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319914&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397622 384223194 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842602 Cc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-14-3-4-18(26-25-14)13-23-21(27)16-9-17(22-24-12-15(2)30-22)11-20(10-16)29-19-5-7-28-8-6-19/h3-4,9-12,19H,5-8,13H2,1-2H3,(H,23,27) LSYGQIAUTJTZDJ-UHFFFAOYSA-N 319915 N-[(6- Methylpyridazin- 3-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 82::US10202369, Example 82::US10472354, Example 82 P2X purinoceptor 3 Homo sapiens 28.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319915&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397341 384223195 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842603 Cc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C22H24N4O3S/c1-14-3-4-18(26-25-14)13-23-21(27)16-9-17(22-24-12-15(2)30-22)11-20(10-16)29-19-5-7-28-8-6-19/h3-4,9-12,19H,5-8,13H2,1-2H3,(H,23,27) LSYGQIAUTJTZDJ-UHFFFAOYSA-N 319915 N-[(6- Methylpyridazin- 3-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 82::US10202369, Example 82::US10472354, Example 82 P2X purinoceptor 2/3 Homo sapiens 380 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319915&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397341 384223195 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842604 Cc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-14-10-24-18(12-23-14)13-25-21(27)16-7-17(22-26-11-15(2)30-22)9-20(8-16)29-19-3-5-28-6-4-19/h7-12,19H,3-6,13H2,1-2H3,(H,25,27) YXUSESJBYZNMQE-UHFFFAOYSA-N 319916 N-[(5- Methylpyrazin- 2-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 83::US10202369, Example 83::US10472354, Example 83 P2X purinoceptor 3 Homo sapiens 125 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319916&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397170 384223196 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842605 Cc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C22H24N4O3S/c1-14-10-24-18(12-23-14)13-25-21(27)16-7-17(22-26-11-15(2)30-22)9-20(8-16)29-19-3-5-28-6-4-19/h7-12,19H,3-6,13H2,1-2H3,(H,25,27) YXUSESJBYZNMQE-UHFFFAOYSA-N 319916 N-[(5- Methylpyrazin- 2-yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 83::US10202369, Example 83::US10472354, Example 83 P2X purinoceptor 2/3 Homo sapiens 1164 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319916&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397170 384223196 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842606 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-14-11-25-21(13-24-14)16(3)27-22(28)17-8-18(23-26-12-15(2)31-23)10-20(9-17)30-19-4-6-29-7-5-19/h8-13,16,19H,4-7H2,1-3H3,(H,27,28)/t16-/m1/s1 USCQOVGUOPYDKF-MRXNPFEDSA-N 319917 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 84::US10202369, Example 84::US10472354, Example 84 P2X purinoceptor 3 Homo sapiens 26.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319917&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397618 384223197 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842607 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-14-11-25-21(13-24-14)16(3)27-22(28)17-8-18(23-26-12-15(2)31-23)10-20(9-17)30-19-4-6-29-7-5-19/h8-13,16,19H,4-7H2,1-3H3,(H,27,28)/t16-/m1/s1 USCQOVGUOPYDKF-MRXNPFEDSA-N 319917 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 84::US10202369, Example 84::US10472354, Example 84 P2X purinoceptor 2/3 Homo sapiens 527 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319917&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397618 384223197 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842608 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-10-27-21(34-13)16-7-15(8-19(9-16)33-18-3-5-32-6-4-18)20(31)30-14(2)17-11-28-22(29-12-17)23(24,25)26/h7-12,14,18H,3-6H2,1-2H3,(H,30,31)/t14-/m1/s1 WGQQHPGXKFPPTQ-CQSZACIVSA-N 319918 3-(5-Methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 85::US10202369, Example 85::US10472354, Example 85 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319918&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397801 384223198 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842609 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-10-27-21(34-13)16-7-15(8-19(9-16)33-18-3-5-32-6-4-18)20(31)30-14(2)17-11-28-22(29-12-17)23(24,25)26/h7-12,14,18H,3-6H2,1-2H3,(H,30,31)/t14-/m1/s1 WGQQHPGXKFPPTQ-CQSZACIVSA-N 319918 3-(5-Methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 85::US10202369, Example 85::US10472354, Example 85 P2X purinoceptor 2/3 Homo sapiens 36.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319918&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397801 384223198 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842610 COc1ccc(cn1)[C@@H](C)NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1 InChI=1S/C24H27N3O4S/c1-15-13-26-24(32-15)19-10-18(11-21(12-19)31-20-6-8-30-9-7-20)23(28)27-16(2)17-4-5-22(29-3)25-14-17/h4-5,10-14,16,20H,6-9H2,1-3H3,(H,27,28)/t16-/m1/s1 HOSIWEZQKWEZJW-MRXNPFEDSA-N 319919 N-[(1R)-1-(6- Methoxypyridin- 3-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 86::US10202369, Example 86::US10472354, Example 86 P2X purinoceptor 3 Homo sapiens 12.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319919&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397310 384223199 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842611 COc1ccc(cn1)[C@@H](C)NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1 InChI=1S/C24H27N3O4S/c1-15-13-26-24(32-15)19-10-18(11-21(12-19)31-20-6-8-30-9-7-20)23(28)27-16(2)17-4-5-22(29-3)25-14-17/h4-5,10-14,16,20H,6-9H2,1-3H3,(H,27,28)/t16-/m1/s1 HOSIWEZQKWEZJW-MRXNPFEDSA-N 319919 N-[(1R)-1-(6- Methoxypyridin- 3-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 86::US10202369, Example 86::US10472354, Example 86 P2X purinoceptor 2/3 Homo sapiens 144 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319919&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397310 384223199 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842612 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-14-4-5-21(27-26-14)16(3)25-22(28)17-10-18(23-24-13-15(2)31-23)12-20(11-17)30-19-6-8-29-9-7-19/h4-5,10-13,16,19H,6-9H2,1-3H3,(H,25,28)/t16-/m1/s1 OIHQARAAGWIFBW-MRXNPFEDSA-N 319920 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 87::US10202369, Example 87::US10472354, Example 87 P2X purinoceptor 3 Homo sapiens 15.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319920&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397290 384223200 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842613 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-14-4-5-21(27-26-14)16(3)25-22(28)17-10-18(23-24-13-15(2)31-23)12-20(11-17)30-19-6-8-29-9-7-19/h4-5,10-13,16,19H,6-9H2,1-3H3,(H,25,28)/t16-/m1/s1 OIHQARAAGWIFBW-MRXNPFEDSA-N 319920 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 87::US10202369, Example 87::US10472354, Example 87 P2X purinoceptor 2/3 Homo sapiens 119 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319920&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397290 384223200 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842614 COc1ccc(CNC(=O)c2cc(OC3CCOCC3)cc(c2)-c2ncc(C)s2)nn1 InChI=1S/C22H24N4O4S/c1-14-12-24-22(31-14)16-9-15(10-19(11-16)30-18-5-7-29-8-6-18)21(27)23-13-17-3-4-20(28-2)26-25-17/h3-4,9-12,18H,5-8,13H2,1-2H3,(H,23,27) FUPOQWQPMIFATK-UHFFFAOYSA-N 319921 N-[(6- Methoxy- pyridazin-3- yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 88::US10202369, Example 88::US10472354, Example 88 P2X purinoceptor 3 Homo sapiens 30.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319921&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397556 384223201 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842615 COc1ccc(CNC(=O)c2cc(OC3CCOCC3)cc(c2)-c2ncc(C)s2)nn1 InChI=1S/C22H24N4O4S/c1-14-12-24-22(31-14)16-9-15(10-19(11-16)30-18-5-7-29-8-6-18)21(27)23-13-17-3-4-20(28-2)26-25-17/h3-4,9-12,18H,5-8,13H2,1-2H3,(H,23,27) FUPOQWQPMIFATK-UHFFFAOYSA-N 319921 N-[(6- Methoxy- pyridazin-3- yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy) benzamide::US10174016, Example 88::US10202369, Example 88::US10472354, Example 88 P2X purinoceptor 2/3 Homo sapiens 217 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319921&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397556 384223201 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842616 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-12-27-22(34-13)16-9-15(10-18(11-16)33-17-5-7-32-8-6-17)21(31)28-14(2)19-3-4-20(30-29-19)23(24,25)26/h3-4,9-12,14,17H,5-8H2,1-2H3,(H,28,31)/t14-/m1/s1 RJKHHNIHJKFMMR-CQSZACIVSA-N 319922 3-(5-Methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin- 3-yl]ethyl} benzamide::US10174016, Example 89::US10202369, Example 89::US10472354, Example 89 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319922&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397595 384223202 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842617 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-12-27-22(34-13)16-9-15(10-18(11-16)33-17-5-7-32-8-6-17)21(31)28-14(2)19-3-4-20(30-29-19)23(24,25)26/h3-4,9-12,14,17H,5-8H2,1-2H3,(H,28,31)/t14-/m1/s1 RJKHHNIHJKFMMR-CQSZACIVSA-N 319922 3-(5-Methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin- 3-yl]ethyl} benzamide::US10174016, Example 89::US10202369, Example 89::US10472354, Example 89 P2X purinoceptor 2/3 Homo sapiens 199 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319922&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397595 384223202 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842618 CC[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20(17-12-29-23(30-13-17)24(25,26)27)31-21(32)15-8-16(22-28-11-14(2)35-22)10-19(9-15)34-18-4-6-33-7-5-18/h8-13,18,20H,3-7H2,1-2H3,(H,31,32)/t20-/m1/s1 ULSBLOPPTNALIT-HXUWFJFHSA-N 319923 3-(5-Methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy)-N-{(1R)- 1-[2- (trifluorometh- yl)pyrimidin-5- yl]propyl}benz- amide::US10174016, Example 90::US10202369, Example 90::US10472354, Example 90 P2X purinoceptor 3 Homo sapiens 111 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319923&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397769 384223203 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842619 CC[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20(17-12-29-23(30-13-17)24(25,26)27)31-21(32)15-8-16(22-28-11-14(2)35-22)10-19(9-15)34-18-4-6-33-7-5-18/h8-13,18,20H,3-7H2,1-2H3,(H,31,32)/t20-/m1/s1 ULSBLOPPTNALIT-HXUWFJFHSA-N 319923 3-(5-Methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- yloxy)-N-{(1R)- 1-[2- (trifluorometh- yl)pyrimidin-5- yl]propyl}benz- amide::US10174016, Example 90::US10202369, Example 90::US10472354, Example 90 P2X purinoceptor 2/3 Homo sapiens 710 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319923&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397769 384223203 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842620 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C24H27N3O3S/c1-15-4-5-18(14-25-15)17(3)27-23(28)19-10-20(24-26-13-16(2)31-24)12-22(11-19)30-21-6-8-29-9-7-21/h4-5,10-14,17,21H,6-9H2,1-3H3,(H,27,28)/t17-/m1/s1 VKTBTGUHIBZLBJ-QGZVFWFLSA-N 319924 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (tetrahydro- 2H-pyran-4- yloxy)benzamide::US10174016, Example 91::US10202369, Example 91::US10472354, Example 91 P2X purinoceptor 3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319924&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397502 384223204 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842621 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C24H27N3O3S/c1-15-4-5-18(14-25-15)17(3)27-23(28)19-10-20(24-26-13-16(2)31-24)12-22(11-19)30-21-6-8-29-9-7-21/h4-5,10-14,17,21H,6-9H2,1-3H3,(H,27,28)/t17-/m1/s1 VKTBTGUHIBZLBJ-QGZVFWFLSA-N 319924 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (tetrahydro- 2H-pyran-4- yloxy)benzamide::US10174016, Example 91::US10202369, Example 91::US10472354, Example 91 P2X purinoceptor 2/3 Homo sapiens 133 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319924&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397502 384223204 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842622 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1nnc(C)s1 InChI=1S/C21H24N4O3S2/c1-12-11-22-21(29-12)16-8-15(9-18(10-16)28-17-4-6-27-7-5-17)19(26)23-13(2)20-25-24-14(3)30-20/h8-11,13,17H,4-7H2,1-3H3,(H,23,26)/t13-/m1/s1 GHXRECQLMZGPIV-CYBMUJFWSA-N 319925 N-[(1R)-1-(5- Methyl-1,3,4- thiadiazol-2- yl)ethyl]-3-(5- methyl-1,3- thiazol-2-yl)-5- (tetrahydro- 2H-pyran-4- yloxy)benzamide::US10174016, Example 92::US10202369, Example 92::US10472354, Example 92 P2X purinoceptor 3 Homo sapiens 24.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319925&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397542 384223205 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842623 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1nnc(C)s1 InChI=1S/C21H24N4O3S2/c1-12-11-22-21(29-12)16-8-15(9-18(10-16)28-17-4-6-27-7-5-17)19(26)23-13(2)20-25-24-14(3)30-20/h8-11,13,17H,4-7H2,1-3H3,(H,23,26)/t13-/m1/s1 GHXRECQLMZGPIV-CYBMUJFWSA-N 319925 N-[(1R)-1-(5- Methyl-1,3,4- thiadiazol-2- yl)ethyl]-3-(5- methyl-1,3- thiazol-2-yl)-5- (tetrahydro- 2H-pyran-4- yloxy)benzamide::US10174016, Example 92::US10202369, Example 92::US10472354, Example 92 P2X purinoceptor 2/3 Homo sapiens 317 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319925&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397542 384223205 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842624 Cc1cnc(s1)-c1cc(OCC2CCOCC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-15-3-4-20(27-26-15)13-24-22(28)18-9-19(23-25-12-16(2)31-23)11-21(10-18)30-14-17-5-7-29-8-6-17/h3-4,9-12,17H,5-8,13-14H2,1-2H3,(H,24,28) QOXIPNMWVVZPOQ-UHFFFAOYSA-N 319926 N-[(6- Methyl- pyridazin-3- yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy) benzamide::US10174016, Example 93::US10202369, Example 93::US10472354, Example 93 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319926&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397788 384223206 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842625 Cc1cnc(s1)-c1cc(OCC2CCOCC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-15-3-4-20(27-26-15)13-24-22(28)18-9-19(23-25-12-16(2)31-23)11-21(10-18)30-14-17-5-7-29-8-6-17/h3-4,9-12,17H,5-8,13-14H2,1-2H3,(H,24,28) QOXIPNMWVVZPOQ-UHFFFAOYSA-N 319926 N-[(6- Methyl- pyridazin-3- yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy) benzamide::US10174016, Example 93::US10202369, Example 93::US10472354, Example 93 P2X purinoceptor 2/3 Homo sapiens 385 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319926&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397788 384223206 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842626 C[C@@H](NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-15-11-26-22(13-25-15)17(3)28-23(29)19-8-20(24-27-12-16(2)32-24)10-21(9-19)31-14-18-4-6-30-7-5-18/h8-13,17-18H,4-7,14H2,1-3H3,(H,28,29)/t17-/m1/s1 HCAZTDIYUNBLAC-QGZVFWFLSA-N 319927 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy) benzamide::US10174016, Example 94::US10202369, Example 94::US10472354, Example 94 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319927&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397604 384223207 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842627 C[C@@H](NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-15-11-26-22(13-25-15)17(3)28-23(29)19-8-20(24-27-12-16(2)32-24)10-21(9-19)31-14-18-4-6-30-7-5-18/h8-13,17-18H,4-7,14H2,1-3H3,(H,28,29)/t17-/m1/s1 HCAZTDIYUNBLAC-QGZVFWFLSA-N 319927 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy) benzamide::US10174016, Example 94::US10202369, Example 94::US10472354, Example 94 P2X purinoceptor 2/3 Homo sapiens 132 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319927&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397604 384223207 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842628 CC(NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C24H25ClFN3O3S/c1-14-11-28-24(33-14)18-7-17(8-20(9-18)32-13-16-3-5-31-6-4-16)23(30)29-15(2)22-21(26)10-19(25)12-27-22/h7-12,15-16H,3-6,13H2,1-2H3,(H,29,30) WLBXKEKEIMKGRV-UHFFFAOYSA-N 319928 N-[1-(5- Chloro-3- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran--4- ylmethoxy) benzamide::US10174016, Example 95::US10202369, Example 95::US10472354, Example 95 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319928&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397656 384223208 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842629 CC(NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C24H25ClFN3O3S/c1-14-11-28-24(33-14)18-7-17(8-20(9-18)32-13-16-3-5-31-6-4-16)23(30)29-15(2)22-21(26)10-19(25)12-27-22/h7-12,15-16H,3-6,13H2,1-2H3,(H,29,30) WLBXKEKEIMKGRV-UHFFFAOYSA-N 319928 N-[1-(5- Chloro-3- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran--4- ylmethoxy) benzamide::US10174016, Example 95::US10202369, Example 95::US10472354, Example 95 P2X purinoceptor 2/3 Homo sapiens 129 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319928&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397656 384223208 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842630 CC(NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C24H25ClFN3O3S/c1-14-11-28-24(33-14)18-7-17(8-20(9-18)32-13-16-3-5-31-6-4-16)23(30)29-15(2)22-21(25)10-19(26)12-27-22/h7-12,15-16H,3-6,13H2,1-2H3,(H,29,30) YAVBCOZWMZVERS-UHFFFAOYSA-N 319929 N-[1-(3- Chloro-5- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy) benzamide::US10174016, Example 96::US10202369, Example 96::US10472354, Example 96 P2X purinoceptor 3 Homo sapiens 18.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319929&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397482 384223209 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842631 CC(NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C24H25ClFN3O3S/c1-14-11-28-24(33-14)18-7-17(8-20(9-18)32-13-16-3-5-31-6-4-16)23(30)29-15(2)22-21(25)10-19(26)12-27-22/h7-12,15-16H,3-6,13H2,1-2H3,(H,29,30) YAVBCOZWMZVERS-UHFFFAOYSA-N 319929 N-[1-(3- Chloro-5- fluoropyridin- 2-yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy) benzamide::US10174016, Example 96::US10202369, Example 96::US10472354, Example 96 P2X purinoceptor 2/3 Homo sapiens 1077 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319929&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397482 384223209 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842632 Cc1cnc(s1)-c1cc(OCC2CCOCC2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-15-10-25-20(12-24-15)13-26-22(28)18-7-19(23-27-11-16(2)31-23)9-21(8-18)30-14-17-3-5-29-6-4-17/h7-12,17H,3-6,13-14H2,1-2H3,(H,26,28) VSGRXICPAXTBHX-UHFFFAOYSA-N 319930 N-[(5- Methylpyrazin- 2- yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy) benzamide::US10174016, Example 97::US10202369, Example 97::US10472354, Example 97 P2X purinoceptor 3 Homo sapiens 15.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319930&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397814 384223210 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842633 Cc1cnc(s1)-c1cc(OCC2CCOCC2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-15-10-25-20(12-24-15)13-26-22(28)18-7-19(23-27-11-16(2)31-23)9-21(8-18)30-14-17-3-5-29-6-4-17/h7-12,17H,3-6,13-14H2,1-2H3,(H,26,28) VSGRXICPAXTBHX-UHFFFAOYSA-N 319930 N-[(5- Methylpyrazin- 2- yl)methyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy) benzamide::US10174016, Example 97::US10202369, Example 97::US10472354, Example 97 P2X purinoceptor 2/3 Homo sapiens 1687 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319930&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397814 384223210 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842634 C[C@@H](NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-22(35-14)18-7-17(8-20(9-18)34-13-16-3-5-33-6-4-16)21(32)31-15(2)19-11-29-23(30-12-19)24(25,26)27/h7-12,15-16H,3-6,13H2,1-2H3,(H,31,32)/t15-/m1/s1 MBJQALPRFLKOPN-OAHLLOKOSA-N 319931 3-(5-Methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy)- N-[(1R)-1-[2- (trifluorometh- yl)pyrimidin- 5- yl]ethyl] benzamide::US10174016, Example 98::US10202369, Example 98::US10472354, Example 98 P2X purinoceptor 3 Homo sapiens 1.000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319931&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397231 384223211 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842635 C[C@@H](NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-22(35-14)18-7-17(8-20(9-18)34-13-16-3-5-33-6-4-16)21(32)31-15(2)19-11-29-23(30-12-19)24(25,26)27/h7-12,15-16H,3-6,13H2,1-2H3,(H,31,32)/t15-/m1/s1 MBJQALPRFLKOPN-OAHLLOKOSA-N 319931 3-(5-Methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy)- N-[(1R)-1-[2- (trifluorometh- yl)pyrimidin- 5- yl]ethyl] benzamide::US10174016, Example 98::US10202369, Example 98::US10472354, Example 98 P2X purinoceptor 2/3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319931&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397231 384223211 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842636 C[C@@H](NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-15-4-5-22(28-27-15)17(3)26-23(29)19-10-20(24-25-13-16(2)32-24)12-21(11-19)31-14-18-6-8-30-9-7-18/h4-5,10-13,17-18H,6-9,14H2,1-3H3,(H,26,29)/t17-/m1/s1 FNFCPAXHCILJLE-QGZVFWFLSA-N 319932 N-[(1R)-1-(6- Methyl- pyridazin-3- yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy) benzamide::US10174016, Example 99::US10202369, Example 99::US10472354, Example 99 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319932&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397399 384223212 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842637 C[C@@H](NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-15-4-5-22(28-27-15)17(3)26-23(29)19-10-20(24-25-13-16(2)32-24)12-21(11-19)31-14-18-6-8-30-9-7-18/h4-5,10-13,17-18H,6-9,14H2,1-3H3,(H,26,29)/t17-/m1/s1 FNFCPAXHCILJLE-QGZVFWFLSA-N 319932 N-[(1R)-1-(6- Methyl- pyridazin-3- yl)ethyl]-3- (5-methyl- 1,3-thiazol-2- yl)-5- (tetrahydro- 2H-pyran-4- ylmethoxy) benzamide::US10174016, Example 99::US10202369, Example 99::US10472354, Example 99 P2X purinoceptor 2/3 Homo sapiens 27.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319932&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397399 384223212 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842638 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C24H23N5O2S/c1-14-5-6-22(29-28-14)17(4)27-23(30)18-10-19(24-26-13-16(3)32-24)12-21(11-18)31-20-7-8-25-15(2)9-20/h5-13,17H,1-4H3,(H,27,30)/t17-/m1/s1 AOJXRFXYSRJHEO-QGZVFWFLSA-N 319933 N-[(1R)-1-(6- Methyl- pyridazin-3- yl)ethyl]-3- [(2- methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)benzamide::US10174016, Example 100::US10202369, Example 100::US10472354, Example 100 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319933&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397202 384223213 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842639 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C24H23N5O2S/c1-14-5-6-22(29-28-14)17(4)27-23(30)18-10-19(24-26-13-16(3)32-24)12-21(11-18)31-20-7-8-25-15(2)9-20/h5-13,17H,1-4H3,(H,27,30)/t17-/m1/s1 AOJXRFXYSRJHEO-QGZVFWFLSA-N 319933 N-[(1R)-1-(6- Methyl- pyridazin-3- yl)ethyl]-3- [(2- methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)benzamide::US10174016, Example 100::US10202369, Example 100::US10472354, Example 100 P2X purinoceptor 2/3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319933&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397202 384223213 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842640 Cc1cnc(s1)-c1cc(Oc2ccnc(C)c2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C23H21N5O2S/c1-14-4-5-19(28-27-14)13-25-22(29)17-9-18(23-26-12-16(3)31-23)11-21(10-17)30-20-6-7-24-15(2)8-20/h4-12H,13H2,1-3H3,(H,25,29) XCSQCNBYINKWNK-UHFFFAOYSA-N 319934 N-[(6- Methyl- pyridazin-3- yl)methyl]-3- [(2- methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)benzamide::US10174016, Example 101::US10202369, Example 101::US10472354, Example 101 P2X purinoceptor 3 Homo sapiens 15.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319934&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397744 384223214 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842641 Cc1cnc(s1)-c1cc(Oc2ccnc(C)c2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C23H21N5O2S/c1-14-4-5-19(28-27-14)13-25-22(29)17-9-18(23-26-12-16(3)31-23)11-21(10-17)30-20-6-7-24-15(2)8-20/h4-12H,13H2,1-3H3,(H,25,29) XCSQCNBYINKWNK-UHFFFAOYSA-N 319934 N-[(6- Methyl- pyridazin-3- yl)methyl]-3- [(2- methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)benzamide::US10174016, Example 101::US10202369, Example 101::US10472354, Example 101 P2X purinoceptor 2/3 Homo sapiens 60.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319934&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397744 384223214 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842642 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C24H23N5O2S/c1-14-7-20(5-6-25-14)31-21-9-18(8-19(10-21)24-28-12-16(3)32-24)23(30)29-17(4)22-13-26-15(2)11-27-22/h5-13,17H,1-4H3,(H,29,30)/t17-/m1/s1 QEKNBUCJINMCOL-QGZVFWFLSA-N 319935 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]- 3-[(2- methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)benzamide::US10174016, Example 102::US10202369, Example 102::US10472354, Example 102 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319935&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397697 384223215 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842643 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C24H23N5O2S/c1-14-7-20(5-6-25-14)31-21-9-18(8-19(10-21)24-28-12-16(3)32-24)23(30)29-17(4)22-13-26-15(2)11-27-22/h5-13,17H,1-4H3,(H,29,30)/t17-/m1/s1 QEKNBUCJINMCOL-QGZVFWFLSA-N 319935 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]- 3-[(2- methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)benzamide::US10174016, Example 102::US10202369, Example 102::US10472354, Example 102 P2X purinoceptor 2/3 Homo sapiens 57.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319935&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397697 384223215 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842644 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H20F3N5O2S/c1-13-6-19(4-5-28-13)34-20-8-16(7-17(9-20)22-29-10-14(2)35-22)21(33)32-15(3)18-11-30-23(31-12-18)24(25,26)27/h4-12,15H,1-3H3,(H,32,33)/t15-/m1/s1 JXFGKHKXOUTTKZ-OAHLLOKOSA-N 319936 3-[(2- Methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)-N-{(1R)-1- [2- (trifluorometh- yl)pyrimidin- 5- yl]ethyl} benzamide::US10174016, Example 103::US10202369, Example 103::US10472354, Example 103 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319936&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397214 384223216 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842645 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H20F3N5O2S/c1-13-6-19(4-5-28-13)34-20-8-16(7-17(9-20)22-29-10-14(2)35-22)21(33)32-15(3)18-11-30-23(31-12-18)24(25,26)27/h4-12,15H,1-3H3,(H,32,33)/t15-/m1/s1 JXFGKHKXOUTTKZ-OAHLLOKOSA-N 319936 3-[(2- Methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)-N-{(1R)-1- [2- (trifluorometh- yl)pyrimidin- 5- yl]ethyl} benzamide::US10174016, Example 103::US10202369, Example 103::US10472354, Example 103 P2X purinoceptor 2/3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319936&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397214 384223216 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842646 Cc1cnc(s1)-c1cc(Oc2ccnc(C)c2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C23H21N5O2S/c1-14-6-20(4-5-24-14)30-21-8-17(7-18(9-21)23-28-11-16(3)31-23)22(29)27-13-19-12-25-15(2)10-26-19/h4-12H,13H2,1-3H3,(H,27,29) FHRXECCRJLFVTP-UHFFFAOYSA-N 319937 N-[(5- Methylpyrazin- 2- yl)methyl]-3- [(2- methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)benzamide::US10174016, Example 104::US10202369, Example 104::US10472354, Example 104 P2X purinoceptor 3 Homo sapiens 51.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319937&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397645 384223217 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842647 Cc1cnc(s1)-c1cc(Oc2ccnc(C)c2)cc(c1)C(=O)NCc1cnc(C)cn1 InChI=1S/C23H21N5O2S/c1-14-6-20(4-5-24-14)30-21-8-17(7-18(9-21)23-28-11-16(3)31-23)22(29)27-13-19-12-25-15(2)10-26-19/h4-12H,13H2,1-3H3,(H,27,29) FHRXECCRJLFVTP-UHFFFAOYSA-N 319937 N-[(5- Methylpyrazin- 2- yl)methyl]-3- [(2- methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)benzamide::US10174016, Example 104::US10202369, Example 104::US10472354, Example 104 P2X purinoceptor 2/3 Homo sapiens 377 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319937&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397645 384223217 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842648 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H20F3N5O2S/c1-13-8-18(6-7-28-13)34-19-10-16(9-17(11-19)23-29-12-14(2)35-23)22(33)30-15(3)20-4-5-21(32-31-20)24(25,26)27/h4-12,15H,1-3H3,(H,30,33)/t15-/m1/s1 DZQXNDYGTRQHHO-OAHLLOKOSA-N 319938 3-[(2- Methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)-N-{(1R)-1- [6- (trifluorometh- yl)pyridazin- 3- yl]ethyl} benzamide::US10174016, Example 105::US10202369, Example 105::US10472354, Example 105 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319938&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397847 384223218 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842649 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H20F3N5O2S/c1-13-8-18(6-7-28-13)34-19-10-16(9-17(11-19)23-29-12-14(2)35-23)22(33)30-15(3)20-4-5-21(32-31-20)24(25,26)27/h4-12,15H,1-3H3,(H,30,33)/t15-/m1/s1 DZQXNDYGTRQHHO-OAHLLOKOSA-N 319938 3-[(2- Methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)-N-{(1R)-1- [6- (trifluorometh- yl)pyridazin- 3- yl]ethyl} benzamide::US10174016, Example 105::US10202369, Example 105::US10472354, Example 105 P2X purinoceptor 2/3 Homo sapiens 39.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319938&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397847 384223218 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842650 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C24H23N5O2S/c1-14-7-21(5-6-25-14)31-22-9-18(8-19(10-22)24-28-11-15(2)32-24)23(30)29-16(3)20-12-26-17(4)27-13-20/h5-13,16H,1-4H3,(H,29,30)/t16-/m1/s1 AVOXIOANORGYFZ-MRXNPFEDSA-N 319939 3-[(2-methylpyridin-4-yl)oxy]-N-[(1R)-1-(2-methylpyrimidin-5-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 106::US10202369, Example 106::US10472354, Example 106 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319939&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397227 384223219 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842651 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C24H23N5O2S/c1-14-7-21(5-6-25-14)31-22-9-18(8-19(10-22)24-28-11-15(2)32-24)23(30)29-16(3)20-12-26-17(4)27-13-20/h5-13,16H,1-4H3,(H,29,30)/t16-/m1/s1 AVOXIOANORGYFZ-MRXNPFEDSA-N 319939 3-[(2-methylpyridin-4-yl)oxy]-N-[(1R)-1-(2-methylpyrimidin-5-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 106::US10202369, Example 106::US10472354, Example 106 P2X purinoceptor 2/3 Homo sapiens 41.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319939&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397227 384223219 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842652 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C25H24N4O2S/c1-15-5-6-19(14-27-15)18(4)29-24(30)20-10-21(25-28-13-17(3)32-25)12-23(11-20)31-22-7-8-26-16(2)9-22/h5-14,18H,1-4H3,(H,29,30)/t18-/m1/s1 PNIOXTPFLIQKJT-GOSISDBHSA-N 319940 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]- 3-[(2- methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)benzamide::US10174016, Example 107::US10202369, Example 107::US10472354, Example 107 P2X purinoceptor 3 Homo sapiens 9.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319940&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397329 384223220 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842653 C[C@@H](NC(=O)c1cc(Oc2ccnc(C)c2)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C25H24N4O2S/c1-15-5-6-19(14-27-15)18(4)29-24(30)20-10-21(25-28-13-17(3)32-25)12-23(11-20)31-22-7-8-26-16(2)9-22/h5-14,18H,1-4H3,(H,29,30)/t18-/m1/s1 PNIOXTPFLIQKJT-GOSISDBHSA-N 319940 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]- 3-[(2- methylpyridin- 4-yl)oxy]-5- (5-methyl- 1,3-thiazol-2- yl)benzamide::US10174016, Example 107::US10202369, Example 107::US10472354, Example 107 P2X purinoceptor 2/3 Homo sapiens 17.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319940&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397329 384223220 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842654 C[C@@H](NC(=O)c1cc(Oc2ccc(C)nc2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H20F3N5O2S/c1-13-4-5-19(12-28-13)34-20-7-16(6-17(8-20)22-29-9-14(2)35-22)21(33)32-15(3)18-10-30-23(31-11-18)24(25,26)27/h4-12,15H,1-3H3,(H,32,33)/t15-/m1/s1 ASXORIIIQIGPLA-OAHLLOKOSA-N 319941 3-[(6-Methylpyridin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 108::US10202369, Example 108::US10472354, Example 108 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319941&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397249 384223221 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842655 C[C@@H](NC(=O)c1cc(Oc2ccc(C)nc2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H20F3N5O2S/c1-13-4-5-19(12-28-13)34-20-7-16(6-17(8-20)22-29-9-14(2)35-22)21(33)32-15(3)18-10-30-23(31-11-18)24(25,26)27/h4-12,15H,1-3H3,(H,32,33)/t15-/m1/s1 ASXORIIIQIGPLA-OAHLLOKOSA-N 319941 3-[(6-Methylpyridin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 108::US10202369, Example 108::US10472354, Example 108 P2X purinoceptor 2/3 Homo sapiens 83.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319941&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397249 384223221 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842656 C[C@@H](NC(=O)c1cc(Oc2nnc(C)s2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C21H20N6O2S2/c1-11-8-23-18(10-22-11)13(3)25-19(28)15-5-16(20-24-9-12(2)30-20)7-17(6-15)29-21-27-26-14(4)31-21/h5-10,13H,1-4H3,(H,25,28)/t13-/m1/s1 SHPJQOXSFBKQMY-CYBMUJFWSA-N 319942 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]-3- [(5-methyl- 1,3,4- thiadiazol-2- yl)oxy]-5-(5- methyl-1,3- thiazol-2- yl)benzamide::US10174016, Example 109::US10202369, Example 109::US10472354, Example 109 P2X purinoceptor 3 Homo sapiens 235 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319942&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397425 384223222 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842657 C[C@@H](NC(=O)c1cc(Oc2nnc(C)s2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C21H20N6O2S2/c1-11-8-23-18(10-22-11)13(3)25-19(28)15-5-16(20-24-9-12(2)30-20)7-17(6-15)29-21-27-26-14(4)31-21/h5-10,13H,1-4H3,(H,25,28)/t13-/m1/s1 SHPJQOXSFBKQMY-CYBMUJFWSA-N 319942 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]-3- [(5-methyl- 1,3,4- thiadiazol-2- yl)oxy]-5-(5- methyl-1,3- thiazol-2- yl)benzamide::US10174016, Example 109::US10202369, Example 109::US10472354, Example 109 P2X purinoceptor 2/3 Homo sapiens 2412 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319942&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397425 384223222 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842658 C[C@@H](NC(=O)c1cc(Oc2nnc(C)s2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C21H20N6O2S2/c1-11-5-6-18(26-24-11)13(3)23-19(28)15-7-16(20-22-10-12(2)30-20)9-17(8-15)29-21-27-25-14(4)31-21/h5-10,13H,1-4H3,(H,23,28)/t13-/m1/s1 YBUIRLYLJALMRA-CYBMUJFWSA-N 319943 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]- 3-[(5-methyl- 1,3,4- thiadiazol-2- yl)oxy]-5-(5- methyl-1,3- thiazol-2- yl)benzamide::US10174016, Example 110::US10202369, Example 110::US10472354, Example 110 P2X purinoceptor 3 Homo sapiens 114 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319943&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397265 384223223 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842659 C[C@@H](NC(=O)c1cc(Oc2nnc(C)s2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C21H20N6O2S2/c1-11-5-6-18(26-24-11)13(3)23-19(28)15-7-16(20-22-10-12(2)30-20)9-17(8-15)29-21-27-25-14(4)31-21/h5-10,13H,1-4H3,(H,23,28)/t13-/m1/s1 YBUIRLYLJALMRA-CYBMUJFWSA-N 319943 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]- 3-[(5-methyl- 1,3,4- thiadiazol-2- yl)oxy]-5-(5- methyl-1,3- thiazol-2- yl)benzamide::US10174016, Example 110::US10202369, Example 110::US10472354, Example 110 P2X purinoceptor 2/3 Homo sapiens 1451 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319943&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397265 384223223 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842660 C[C@@H](NC(=O)c1cc(Oc2nnc(C)s2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C21H17F3N6O2S2/c1-10-7-25-18(33-10)14-4-13(5-16(6-14)32-20-30-29-12(3)34-20)17(31)28-11(2)15-8-26-19(27-9-15)21(22,23)24/h4-9,11H,1-3H3,(H,28,31)/t11-/m1/s1 FIVDAXBJTLXBHI-LLVKDONJSA-N 319944 3-[(5-Methyl- 1,3,4- thiadiazol-2- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)- N-[(1R)-1-[2- (trifluorometh- yl)pyrimidin-5- yl]ethyl] benzamide::US10174016, Example 111::US10202369, Example 111::US10472354, Example 111 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319944&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397223 384223224 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842661 C[C@@H](NC(=O)c1cc(Oc2nnc(C)s2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C21H17F3N6O2S2/c1-10-7-25-18(33-10)14-4-13(5-16(6-14)32-20-30-29-12(3)34-20)17(31)28-11(2)15-8-26-19(27-9-15)21(22,23)24/h4-9,11H,1-3H3,(H,28,31)/t11-/m1/s1 FIVDAXBJTLXBHI-LLVKDONJSA-N 319944 3-[(5-Methyl- 1,3,4- thiadiazol-2- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)- N-[(1R)-1-[2- (trifluorometh- yl)pyrimidin-5- yl]ethyl] benzamide::US10174016, Example 111::US10202369, Example 111::US10472354, Example 111 P2X purinoceptor 2/3 Homo sapiens 380 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319944&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397223 384223224 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842662 C[C@@H](NC(=O)c1cc(Oc2nccs2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C21H19N5O2S2/c1-12-9-24-18(11-23-12)14(3)26-19(27)15-6-16(20-25-10-13(2)30-20)8-17(7-15)28-21-22-4-5-29-21/h4-11,14H,1-3H3,(H,26,27)/t14-/m1/s1 QJIZPYNDSFDLFQ-CQSZACIVSA-N 319945 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (1,3-thiazol-2- yloxy)benzamide::US10174016, Example 112::US10472354, Example 112 P2X purinoceptor 3 Homo sapiens 61.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319945&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397232 384223225 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842663 C[C@@H](NC(=O)c1cc(Oc2nccs2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C21H19N5O2S2/c1-12-9-24-18(11-23-12)14(3)26-19(27)15-6-16(20-25-10-13(2)30-20)8-17(7-15)28-21-22-4-5-29-21/h4-11,14H,1-3H3,(H,26,27)/t14-/m1/s1 QJIZPYNDSFDLFQ-CQSZACIVSA-N 319945 N-[(1R)-1-(5- Methylpyrazin- 2-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (1,3-thiazol-2- yloxy)benzamide::US10174016, Example 112::US10472354, Example 112 P2X purinoceptor 2/3 Homo sapiens 772 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319945&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397232 384223225 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842664 C[C@@H](NC(=O)c1cc(Oc2nccs2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C21H19N5O2S2/c1-12-4-5-18(26-25-12)14(3)24-19(27)15-8-16(20-23-11-13(2)30-20)10-17(9-15)28-21-22-6-7-29-21/h4-11,14H,1-3H3,(H,24,27)/t14-/m1/s1 KTZHJRKMBNLACT-CQSZACIVSA-N 319946 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-(1,3- thiazol-2- yloxy)benzamide::US10174016, Example 113::US10202369, Example 113::US10472354, Example 113 P2X purinoceptor 3 Homo sapiens 43.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319946&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397679 384223226 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842665 C[C@@H](NC(=O)c1cc(Oc2nccs2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C21H19N5O2S2/c1-12-4-5-18(26-25-12)14(3)24-19(27)15-8-16(20-23-11-13(2)30-20)10-17(9-15)28-21-22-6-7-29-21/h4-11,14H,1-3H3,(H,24,27)/t14-/m1/s1 KTZHJRKMBNLACT-CQSZACIVSA-N 319946 N-[(1R)-1-(6- Methylpyridazin- 3-yl)ethyl]- 3-(5-methyl- 1,3-thiazol-2- yl)-5-(1,3- thiazol-2- yloxy)benzamide::US10174016, Example 113::US10202369, Example 113::US10472354, Example 113 P2X purinoceptor 2/3 Homo sapiens 387 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319946&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397679 384223226 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842666 C[C@@H](NC(=O)c1cc(Oc2nccs2)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C22H20N4O2S2/c1-13-4-5-16(12-24-13)15(3)26-20(27)17-8-18(21-25-11-14(2)30-21)10-19(9-17)28-22-23-6-7-29-22/h4-12,15H,1-3H3,(H,26,27)/t15-/m1/s1 WJNIKDPPMLYZOS-OAHLLOKOSA-N 319947 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (1,3-thiazol-2- yloxy)benzamide::US10174016, Example 114::US10202369, Example 114::US10472354, Example 114 P2X purinoceptor 3 Homo sapiens 38.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319947&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397612 384223227 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842667 C[C@@H](NC(=O)c1cc(Oc2nccs2)cc(c1)-c1ncc(C)s1)c1ccc(C)nc1 InChI=1S/C22H20N4O2S2/c1-13-4-5-16(12-24-13)15(3)26-20(27)17-8-18(21-25-11-14(2)30-21)10-19(9-17)28-22-23-6-7-29-22/h4-12,15H,1-3H3,(H,26,27)/t15-/m1/s1 WJNIKDPPMLYZOS-OAHLLOKOSA-N 319947 N-[(1R)-1-(6- Methylpyridin- 3-yl)ethyl]-3- (5-methyl-1,3- thiazol-2-yl)-5- (1,3-thiazol-2- yloxy)benzamide::US10174016, Example 114::US10202369, Example 114::US10472354, Example 114 P2X purinoceptor 2/3 Homo sapiens 414 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319947&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397612 384223227 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842668 COC(C)(C)COc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1ccc(Cl)cn1 InChI=1S/C22H23Cl2N3O3S/c1-13(18-6-5-16(23)10-25-18)27-20(28)14-7-15(21-26-11-19(24)31-21)9-17(8-14)30-12-22(2,3)29-4/h5-11,13H,12H2,1-4H3,(H,27,28)/t13-/m1/s1 MHZRDUGBKYAKKB-CYBMUJFWSA-N 319948 N-[(1R)-1-(5-Chloropyridin-2-yl)ethyl]-3-(5-chloro-1,3-thiazol-2-yl)-5-(2-methoxy-2-methylpropoxy)benzamide::US10174016, Example 115::US10202369, Example 115::US10472354, Example 115 P2X purinoceptor 3 Homo sapiens 15.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319948&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397201 384223228 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842669 COC(C)(C)COc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1ccc(Cl)cn1 InChI=1S/C22H23Cl2N3O3S/c1-13(18-6-5-16(23)10-25-18)27-20(28)14-7-15(21-26-11-19(24)31-21)9-17(8-14)30-12-22(2,3)29-4/h5-11,13H,12H2,1-4H3,(H,27,28)/t13-/m1/s1 MHZRDUGBKYAKKB-CYBMUJFWSA-N 319948 N-[(1R)-1-(5-Chloropyridin-2-yl)ethyl]-3-(5-chloro-1,3-thiazol-2-yl)-5-(2-methoxy-2-methylpropoxy)benzamide::US10174016, Example 115::US10202369, Example 115::US10472354, Example 115 P2X purinoceptor 2/3 Homo sapiens 187 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319948&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397201 384223228 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842670 COC(C)(C)COc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H22ClF3N4O3S/c1-12(15-8-28-20(29-9-15)22(24,25)26)30-18(31)13-5-14(19-27-10-17(23)34-19)7-16(6-13)33-11-21(2,3)32-4/h5-10,12H,11H2,1-4H3,(H,30,31)/t12-/m1/s1 QSHVLLWXZBADRN-GFCCVEGCSA-N 319949 3-(5-Chloro-1,3-thiazol-2-yl)-5-(2-methoxy-2-methylpropoxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 116::US10202369, Example 116::US10472354, Example 116 P2X purinoceptor 3 Homo sapiens 210 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319949&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397235 384223229 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842671 COC(C)(C)COc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H22ClF3N4O3S/c1-12(15-8-28-20(29-9-15)22(24,25)26)30-18(31)13-5-14(19-27-10-17(23)34-19)7-16(6-13)33-11-21(2,3)32-4/h5-10,12H,11H2,1-4H3,(H,30,31)/t12-/m1/s1 QSHVLLWXZBADRN-GFCCVEGCSA-N 319949 3-(5-Chloro-1,3-thiazol-2-yl)-5-(2-methoxy-2-methylpropoxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 116::US10202369, Example 116::US10472354, Example 116 P2X purinoceptor 2/3 Homo sapiens 6430 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319949&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397235 384223229 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842672 COC(C)(C)COc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C22H25ClN4O3S/c1-13-9-25-18(10-24-13)14(2)27-20(28)15-6-16(21-26-11-19(23)31-21)8-17(7-15)30-12-22(3,4)29-5/h6-11,14H,12H2,1-5H3,(H,27,28)/t14-/m1/s1 IVUVTQZOIPAQFU-CQSZACIVSA-N 319950 3-(5-Chloro-1,3-thiazol-2-yl)-5-(2-methoxy-2-methylpropoxy)-N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]benzamide::US10174016, Example 117::US10202369, Example 117::US10472354, Example 117 P2X purinoceptor 3 Homo sapiens 36.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319950&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397711 384223230 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842673 COC(C)(C)COc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C22H25ClN4O3S/c1-13-9-25-18(10-24-13)14(2)27-20(28)15-6-16(21-26-11-19(23)31-21)8-17(7-15)30-12-22(3,4)29-5/h6-11,14H,12H2,1-5H3,(H,27,28)/t14-/m1/s1 IVUVTQZOIPAQFU-CQSZACIVSA-N 319950 3-(5-Chloro-1,3-thiazol-2-yl)-5-(2-methoxy-2-methylpropoxy)-N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]benzamide::US10174016, Example 117::US10202369, Example 117::US10472354, Example 117 P2X purinoceptor 2/3 Homo sapiens 883 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319950&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397711 384223230 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842674 Cc1ccc(CNC(=O)c2cc(OCC3CCOCC3)cc(c2)-c2ncc(s2)C(F)(F)F)nn1 InChI=1S/C23H23F3N4O3S/c1-14-2-3-18(30-29-14)11-27-21(31)16-8-17(22-28-12-20(34-22)23(24,25)26)10-19(9-16)33-13-15-4-6-32-7-5-15/h2-3,8-10,12,15H,4-7,11,13H2,1H3,(H,27,31) JVFRARFSFIRWBD-UHFFFAOYSA-N 319951 N-[(6-Methylpyridazin-3-yl)methyl]-3-(tetrahydro-2H-pyran-4-ylmethoxy)-5-[5-(trifluoromethyl)-1,3-thiazol-2-yl]benzamide::US10174016, Example 118::US10202369, Example 118::US10472354, Example 118 P2X purinoceptor 3 Homo sapiens 198 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319951&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397366 384223231 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842675 Cc1ccc(CNC(=O)c2cc(OCC3CCOCC3)cc(c2)-c2ncc(s2)C(F)(F)F)nn1 InChI=1S/C23H23F3N4O3S/c1-14-2-3-18(30-29-14)11-27-21(31)16-8-17(22-28-12-20(34-22)23(24,25)26)10-19(9-16)33-13-15-4-6-32-7-5-15/h2-3,8-10,12,15H,4-7,11,13H2,1H3,(H,27,31) JVFRARFSFIRWBD-UHFFFAOYSA-N 319951 N-[(6-Methylpyridazin-3-yl)methyl]-3-(tetrahydro-2H-pyran-4-ylmethoxy)-5-[5-(trifluoromethyl)-1,3-thiazol-2-yl]benzamide::US10174016, Example 118::US10202369, Example 118::US10472354, Example 118 P2X purinoceptor 2/3 Homo sapiens 1134 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319951&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397366 384223231 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842676 Cc1ccc(CNC(=O)c2cc(OCC3CCOCC3)cc(c2)-c2ncc(s2)C2CCC2)nn1 InChI=1S/C26H30N4O3S/c1-17-5-6-22(30-29-17)14-27-25(31)20-11-21(26-28-15-24(34-26)19-3-2-4-19)13-23(12-20)33-16-18-7-9-32-10-8-18/h5-6,11-13,15,18-19H,2-4,7-10,14,16H2,1H3,(H,27,31) UIEYRDUAWDAEID-UHFFFAOYSA-N 319952 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(6-methylpyridazin-3-yl)methyl]-5-(tetrahydro-2H-pyran-4-ylmethoxy)benzamide::US10174016, Example 119::US10202369, Example 119::US10472354, Example 119 P2X purinoceptor 3 Homo sapiens 24.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319952&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397447 384223232 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842677 Cc1ccc(CNC(=O)c2cc(OCC3CCOCC3)cc(c2)-c2ncc(s2)C2CCC2)nn1 InChI=1S/C26H30N4O3S/c1-17-5-6-22(30-29-17)14-27-25(31)20-11-21(26-28-15-24(34-26)19-3-2-4-19)13-23(12-20)33-16-18-7-9-32-10-8-18/h5-6,11-13,15,18-19H,2-4,7-10,14,16H2,1H3,(H,27,31) UIEYRDUAWDAEID-UHFFFAOYSA-N 319952 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(6-methylpyridazin-3-yl)methyl]-5-(tetrahydro-2H-pyran-4-ylmethoxy)benzamide::US10174016, Example 119::US10202369, Example 119::US10472354, Example 119 P2X purinoceptor 2/3 Homo sapiens 190 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319952&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397447 384223232 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842678 C[C@@H](NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C27H29F3N4O3S/c1-16(21-12-32-26(33-13-21)27(28,29)30)34-24(35)19-9-20(25-31-14-23(38-25)18-3-2-4-18)11-22(10-19)37-15-17-5-7-36-8-6-17/h9-14,16-18H,2-8,15H2,1H3,(H,34,35)/t16-/m1/s1 XFOWUTGLWQUPCN-MRXNPFEDSA-N 319953 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-5-(tetrahydro-2H-pyran-4-ylmethoxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 120::US10202369, Example 120::US10472354, Example 120 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319953&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397437 384223233 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842679 C[C@@H](NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C27H29F3N4O3S/c1-16(21-12-32-26(33-13-21)27(28,29)30)34-24(35)19-9-20(25-31-14-23(38-25)18-3-2-4-18)11-22(10-19)37-15-17-5-7-36-8-6-17/h9-14,16-18H,2-8,15H2,1H3,(H,34,35)/t16-/m1/s1 XFOWUTGLWQUPCN-MRXNPFEDSA-N 319953 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-5-(tetrahydro-2H-pyran-4-ylmethoxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 120::US10202369, Example 120::US10472354, Example 120 P2X purinoceptor 2/3 Homo sapiens 104 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319953&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397437 384223233 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842680 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C26H30N4O3S/c1-16-11-28-23(12-27-16)17(2)30-25(31)20-8-21(26-29-13-24(34-26)19-4-3-5-19)10-22(9-20)33-15-18-6-7-32-14-18/h8-13,17-19H,3-7,14-15H2,1-2H3,(H,30,31)/t17-,18+/m1/s1 ZBRXLMDGZXDHGV-MSOLQXFVSA-N 319954 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-5-[(3S)-tetrahydrofuran-3-ylmethoxy]benzamide::US10174016, Example 121::US10202369, Example 121::US10472354, Example 271 P2X purinoceptor 3 Homo sapiens 79.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319954&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397486 384223234 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842681 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C26H30N4O3S/c1-16-11-28-23(12-27-16)17(2)30-25(31)20-8-21(26-29-13-24(34-26)19-4-3-5-19)10-22(9-20)33-15-18-6-7-32-14-18/h8-13,17-19H,3-7,14-15H2,1-2H3,(H,30,31)/t17-,18+/m1/s1 ZBRXLMDGZXDHGV-MSOLQXFVSA-N 319954 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-5-[(3S)-tetrahydrofuran-3-ylmethoxy]benzamide::US10174016, Example 121::US10202369, Example 121::US10472354, Example 271 P2X purinoceptor 2/3 Homo sapiens 279 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319954&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397486 384223234 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842682 Cc1ccc(CNC(=O)c2cc(OC[C@H]3CCOC3)cc(c2)-c2ncc(s2)C2CCC2)nn1 InChI=1S/C25H28N4O3S/c1-16-5-6-21(29-28-16)12-26-24(30)19-9-20(25-27-13-23(33-25)18-3-2-4-18)11-22(10-19)32-15-17-7-8-31-14-17/h5-6,9-11,13,17-18H,2-4,7-8,12,14-15H2,1H3,(H,26,30)/t17-/m0/s1 DCRIJNFHBDAZLX-KRWDZBQOSA-N 319955 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(6-methylpyridazin-3-yl)methyl]-5-[(3S)-tetrahydrofuran-3-ylmethoxy]benzamide::US10174016, Example 122::US10202369, Example 122::US10472354, Example 122 P2X purinoceptor 3 Homo sapiens 106 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319955&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397270 384223235 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842683 Cc1ccc(CNC(=O)c2cc(OC[C@H]3CCOC3)cc(c2)-c2ncc(s2)C2CCC2)nn1 InChI=1S/C25H28N4O3S/c1-16-5-6-21(29-28-16)12-26-24(30)19-9-20(25-27-13-23(33-25)18-3-2-4-18)11-22(10-19)32-15-17-7-8-31-14-17/h5-6,9-11,13,17-18H,2-4,7-8,12,14-15H2,1H3,(H,26,30)/t17-/m0/s1 DCRIJNFHBDAZLX-KRWDZBQOSA-N 319955 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(6-methylpyridazin-3-yl)methyl]-5-[(3S)-tetrahydrofuran-3-ylmethoxy]benzamide::US10174016, Example 122::US10202369, Example 122::US10472354, Example 122 P2X purinoceptor 2/3 Homo sapiens 1167 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319955&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397270 384223235 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842684 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(20-10-31-25(32-11-20)26(27,28)29)33-23(34)18-7-19(24-30-12-22(37-24)17-3-2-4-17)9-21(8-18)36-14-16-5-6-35-13-16/h7-12,15-17H,2-6,13-14H2,1H3,(H,33,34)/t15-,16+/m1/s1 JWRPHAGJMIAQMD-CVEARBPZSA-N 319956 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 123::US10202369, Example 123::US10472354, Example 272 P2X purinoceptor 3 Homo sapiens 46.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319956&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397161 384223236 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842685 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(20-10-31-25(32-11-20)26(27,28)29)33-23(34)18-7-19(24-30-12-22(37-24)17-3-2-4-17)9-21(8-18)36-14-16-5-6-35-13-16/h7-12,15-17H,2-6,13-14H2,1H3,(H,33,34)/t15-,16+/m1/s1 JWRPHAGJMIAQMD-CVEARBPZSA-N 319956 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 123::US10202369, Example 123::US10472354, Example 272 P2X purinoceptor 2/3 Homo sapiens 164 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319956&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397161 384223236 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842686 C[C@@H](NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)nc1 InChI=1S/C27H32N4O3S/c1-17(23-13-28-18(2)29-14-23)31-26(32)21-10-22(27-30-15-25(35-27)20-4-3-5-20)12-24(11-21)34-16-19-6-8-33-9-7-19/h10-15,17,19-20H,3-9,16H2,1-2H3,(H,31,32)/t17-/m1/s1 WEHPOEFAIDTUPC-QGZVFWFLSA-N 319957 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(2-methylpyrimidin-5-yl)ethyl]-5-(tetrahydro-2H-pyran-4-ylmethoxy)benzamide::US10174016, Example 124::US10202369, Example 124::US10472354, Example 124 P2X purinoceptor 3 Homo sapiens 27.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319957&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397614 384223237 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842687 C[C@@H](NC(=O)c1cc(OCC2CCOCC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)nc1 InChI=1S/C27H32N4O3S/c1-17(23-13-28-18(2)29-14-23)31-26(32)21-10-22(27-30-15-25(35-27)20-4-3-5-20)12-24(11-21)34-16-19-6-8-33-9-7-19/h10-15,17,19-20H,3-9,16H2,1-2H3,(H,31,32)/t17-/m1/s1 WEHPOEFAIDTUPC-QGZVFWFLSA-N 319957 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(2-methylpyrimidin-5-yl)ethyl]-5-(tetrahydro-2H-pyran-4-ylmethoxy)benzamide::US10174016, Example 124::US10202369, Example 124::US10472354, Example 124 P2X purinoceptor 2/3 Homo sapiens 165 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319957&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397614 384223237 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842688 CCc1cnc(s1)-c1cc(OCC2CCOCC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)nc1 InChI=1S/C25H30N4O3S/c1-4-23-14-28-25(33-23)20-9-19(10-22(11-20)32-15-18-5-7-31-8-6-18)24(30)29-16(2)21-12-26-17(3)27-13-21/h9-14,16,18H,4-8,15H2,1-3H3,(H,29,30)/t16-/m1/s1 DTZIYRRTWOGOEN-MRXNPFEDSA-N 319958 3-(5-Ethyl-1,3-thiazol-2-yl)-N-[(1R)-1-(2-methylpyrimidin-5-yl)ethyl]-5-(tetrahydro-2H-pyran-4-ylmethoxy)benzamide::US10174016, Example 125::US10202369, Example 125::US10472354, Example 125 P2X purinoceptor 3 Homo sapiens 3.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319958&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397256 384223238 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842689 CCc1cnc(s1)-c1cc(OCC2CCOCC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)nc1 InChI=1S/C25H30N4O3S/c1-4-23-14-28-25(33-23)20-9-19(10-22(11-20)32-15-18-5-7-31-8-6-18)24(30)29-16(2)21-12-26-17(3)27-13-21/h9-14,16,18H,4-8,15H2,1-3H3,(H,29,30)/t16-/m1/s1 DTZIYRRTWOGOEN-MRXNPFEDSA-N 319958 3-(5-Ethyl-1,3-thiazol-2-yl)-N-[(1R)-1-(2-methylpyrimidin-5-yl)ethyl]-5-(tetrahydro-2H-pyran-4-ylmethoxy)benzamide::US10174016, Example 125::US10202369, Example 125::US10472354, Example 125 P2X purinoceptor 2/3 Homo sapiens 27.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319958&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397256 384223238 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842690 CC(C)c1cnc(s1)-c1cc(OCC2CCOCC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)nc1 InChI=1S/C26H32N4O3S/c1-16(2)24-14-29-26(34-24)21-9-20(10-23(11-21)33-15-19-5-7-32-8-6-19)25(31)30-17(3)22-12-27-18(4)28-13-22/h9-14,16-17,19H,5-8,15H2,1-4H3,(H,30,31)/t17-/m1/s1 OFIYJECBOJUELW-QGZVFWFLSA-N 319959 N-[(1R)-1-(2-Methylpyrimidin-5-yl)ethyl]-3-[5-(propan-2-yl)-1,3-thiazol-2-yl]-5-(tetrahydro-2H-pyran-4-ylmethoxy)benzamide::US10174016, Example 126::US10202369, Example 126::US10472354, Example 126 P2X purinoceptor 3 Homo sapiens 34.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319959&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397136 384223239 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842691 CC(C)c1cnc(s1)-c1cc(OCC2CCOCC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)nc1 InChI=1S/C26H32N4O3S/c1-16(2)24-14-29-26(34-24)21-9-20(10-23(11-21)33-15-19-5-7-32-8-6-19)25(31)30-17(3)22-12-27-18(4)28-13-22/h9-14,16-17,19H,5-8,15H2,1-4H3,(H,30,31)/t17-/m1/s1 OFIYJECBOJUELW-QGZVFWFLSA-N 319959 N-[(1R)-1-(2-Methylpyrimidin-5-yl)ethyl]-3-[5-(propan-2-yl)-1,3-thiazol-2-yl]-5-(tetrahydro-2H-pyran-4-ylmethoxy)benzamide::US10174016, Example 126::US10202369, Example 126::US10472354, Example 126 P2X purinoceptor 2/3 Homo sapiens 532 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319959&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397136 384223239 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842692 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C26H30N4O3S/c1-16-6-7-23(30-29-16)17(2)28-25(31)19-12-20(26-27-15-24(34-26)18-4-3-5-18)14-22(13-19)33-21-8-10-32-11-9-21/h6-7,12-15,17-18,21H,3-5,8-11H2,1-2H3,(H,28,31)/t17-/m1/s1 WWWCBSCSEOPHLV-QGZVFWFLSA-N 319960 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-5-(tetrahydro-2H-pyran-4-yloxy)benzamide::US10174016, Example 127::US10202369, Example 127::US10472354, Example 127 P2X purinoceptor 3 Homo sapiens 111 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319960&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397331 384223240 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842693 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C26H30N4O3S/c1-16-6-7-23(30-29-16)17(2)28-25(31)19-12-20(26-27-15-24(34-26)18-4-3-5-18)14-22(13-19)33-21-8-10-32-11-9-21/h6-7,12-15,17-18,21H,3-5,8-11H2,1-2H3,(H,28,31)/t17-/m1/s1 WWWCBSCSEOPHLV-QGZVFWFLSA-N 319960 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-5-(tetrahydro-2H-pyran-4-yloxy)benzamide::US10174016, Example 127::US10202369, Example 127::US10472354, Example 127 P2X purinoceptor 2/3 Homo sapiens 536 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319960&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397331 384223240 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842694 CCc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-4-21-14-25-24(32-21)18-11-17(12-20(13-18)31-19-7-9-30-10-8-19)23(29)26-16(3)22-6-5-15(2)27-28-22/h5-6,11-14,16,19H,4,7-10H2,1-3H3,(H,26,29)/t16-/m1/s1 ZSPSPZOSCRXZOC-MRXNPFEDSA-N 319961 3-(5-Ethyl-1,3-thiazol-2-yl)-N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-5-(tetrahydro-2H-pyran-4-yloxy)benzamide::US10174016, Example 128::US10202369, Example 128::US10472354, Example 128 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319961&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397510 384223241 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842695 CCc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-4-21-14-25-24(32-21)18-11-17(12-20(13-18)31-19-7-9-30-10-8-19)23(29)26-16(3)22-6-5-15(2)27-28-22/h5-6,11-14,16,19H,4,7-10H2,1-3H3,(H,26,29)/t16-/m1/s1 ZSPSPZOSCRXZOC-MRXNPFEDSA-N 319961 3-(5-Ethyl-1,3-thiazol-2-yl)-N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-5-(tetrahydro-2H-pyran-4-yloxy)benzamide::US10174016, Example 128::US10202369, Example 128::US10472354, Example 128 P2X purinoceptor 2/3 Homo sapiens 91.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319961&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397510 384223241 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842696 CCc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20-13-28-22(35-20)16-8-15(9-19(10-16)34-18-4-6-33-7-5-18)21(32)31-14(2)17-11-29-23(30-12-17)24(25,26)27/h8-14,18H,3-7H2,1-2H3,(H,31,32)/t14-/m1/s1 HAECKPIYFMDTPM-CQSZACIVSA-N 319962 3-(5-Ethyl-1,3-thiazol-2-yl)-5-(tetrahydro-2H-pyran-4-yloxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 129::US10202369, Example 129::US10472354, Example 129 P2X purinoceptor 3 Homo sapiens 3.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319962&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397362 384223242 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842697 CCc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20-13-28-22(35-20)16-8-15(9-19(10-16)34-18-4-6-33-7-5-18)21(32)31-14(2)17-11-29-23(30-12-17)24(25,26)27/h8-14,18H,3-7H2,1-2H3,(H,31,32)/t14-/m1/s1 HAECKPIYFMDTPM-CQSZACIVSA-N 319962 3-(5-Ethyl-1,3-thiazol-2-yl)-5-(tetrahydro-2H-pyran-4-yloxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 129::US10202369, Example 129::US10472354, Example 129 P2X purinoceptor 2/3 Homo sapiens 33.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319962&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397362 384223242 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842698 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C22H24N4O3S/c1-13-9-25-22(30-13)17-6-16(7-20(8-17)29-19-4-5-28-12-19)21(27)26-14(2)18-10-23-15(3)24-11-18/h6-11,14,19H,4-5,12H2,1-3H3,(H,26,27)/t14-,19+/m1/s1 RHVHBKMOULQMJQ-KUHUBIRLSA-N 319963 N-[(1R)-1-(2-Methylpyrimidin-5-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 130::US10202369, Example 130::US10472354, Example 130 P2X purinoceptor 3 Homo sapiens 74.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319963&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397599 384223243 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842699 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C22H24N4O3S/c1-13-9-25-22(30-13)17-6-16(7-20(8-17)29-19-4-5-28-12-19)21(27)26-14(2)18-10-23-15(3)24-11-18/h6-11,14,19H,4-5,12H2,1-3H3,(H,26,27)/t14-,19+/m1/s1 RHVHBKMOULQMJQ-KUHUBIRLSA-N 319963 N-[(1R)-1-(2-Methylpyrimidin-5-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 130::US10202369, Example 130::US10472354, Example 130 P2X purinoceptor 2/3 Homo sapiens 1349 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319963&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397599 384223243 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842700 C[C@@H](NC(=O)c1cc(Oc2ccc(C)nc2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C24H23N5O2S/c1-14-5-6-20(12-25-14)31-21-8-18(7-19(9-21)24-28-11-16(3)32-24)23(30)29-17(4)22-13-26-15(2)10-27-22/h5-13,17H,1-4H3,(H,29,30)/t17-/m1/s1 PZARJLLATJAKMG-QGZVFWFLSA-N 319964 N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-3-[(6-methylpyridin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 131::US10202369, Example 131::US10472354, Example 131 P2X purinoceptor 3 Homo sapiens 134 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319964&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397434 384223244 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842701 C[C@@H](NC(=O)c1cc(Oc2ccc(C)nc2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C24H23N5O2S/c1-14-5-6-20(12-25-14)31-21-8-18(7-19(9-21)24-28-11-16(3)32-24)23(30)29-17(4)22-13-26-15(2)10-27-22/h5-13,17H,1-4H3,(H,29,30)/t17-/m1/s1 PZARJLLATJAKMG-QGZVFWFLSA-N 319964 N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-3-[(6-methylpyridin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 131::US10202369, Example 131::US10472354, Example 131 P2X purinoceptor 2/3 Homo sapiens 730 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319964&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397434 384223244 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842702 CC(NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C22H21ClFN3O3S/c1-12-9-26-22(31-12)15-5-14(6-18(7-15)30-17-3-4-29-11-17)21(28)27-13(2)20-19(23)8-16(24)10-25-20/h5-10,13,17H,3-4,11H2,1-2H3,(H,27,28)/t13?,17-/m0/s1 YETTUNLUNMEXML-RUINGEJQSA-N 319965 N-[1-(3-Chloro-5-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 132::US10202369, Example 132::US10472354, Example 132 P2X purinoceptor 3 Homo sapiens 75.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319965&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397504 384223245 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842703 CC(NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(F)cc1Cl InChI=1S/C22H21ClFN3O3S/c1-12-9-26-22(31-12)15-5-14(6-18(7-15)30-17-3-4-29-11-17)21(28)27-13(2)20-19(23)8-16(24)10-25-20/h5-10,13,17H,3-4,11H2,1-2H3,(H,27,28)/t13?,17-/m0/s1 YETTUNLUNMEXML-RUINGEJQSA-N 319965 N-[1-(3-Chloro-5-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 132::US10202369, Example 132::US10472354, Example 132 P2X purinoceptor 2/3 Homo sapiens 2051 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319965&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397504 384223245 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842704 Cc1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C21H22N4O3S/c1-13-3-4-17(25-24-13)11-22-20(26)15-7-16(21-23-10-14(2)29-21)9-19(8-15)28-18-5-6-27-12-18/h3-4,7-10,18H,5-6,11-12H2,1-2H3,(H,22,26)/t18-/m0/s1 VKRRMZCTKMLCQJ-SFHVURJKSA-N 319966 N-[(6-Methylpyridazin-3-yl)methyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 133::US10202369, Example 133::US10472354, Example 133 P2X purinoceptor 3 Homo sapiens 177 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319966&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397536 384223246 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842705 Cc1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C21H22N4O3S/c1-13-3-4-17(25-24-13)11-22-20(26)15-7-16(21-23-10-14(2)29-21)9-19(8-15)28-18-5-6-27-12-18/h3-4,7-10,18H,5-6,11-12H2,1-2H3,(H,22,26)/t18-/m0/s1 VKRRMZCTKMLCQJ-SFHVURJKSA-N 319966 N-[(6-Methylpyridazin-3-yl)methyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 133::US10202369, Example 133::US10472354, Example 133 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319966&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397536 384223246 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842706 CC(NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C22H21ClFN3O3S/c1-12-9-26-22(31-12)15-5-14(6-18(7-15)30-17-3-4-29-11-17)21(28)27-13(2)20-19(24)8-16(23)10-25-20/h5-10,13,17H,3-4,11H2,1-2H3,(H,27,28)/t13?,17-/m0/s1 DLODQDUFIVUCLQ-RUINGEJQSA-N 319967 N-[1-(5-Chloro-3-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 134::US10202369, Example 134::US10472354, Example 134 P2X purinoceptor 3 Homo sapiens 15.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319967&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397151 384223247 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842707 CC(NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ncc(Cl)cc1F InChI=1S/C22H21ClFN3O3S/c1-12-9-26-22(31-12)15-5-14(6-18(7-15)30-17-3-4-29-11-17)21(28)27-13(2)20-19(24)8-16(23)10-25-20/h5-10,13,17H,3-4,11H2,1-2H3,(H,27,28)/t13?,17-/m0/s1 DLODQDUFIVUCLQ-RUINGEJQSA-N 319967 N-[1-(5-Chloro-3-fluoropyridin-2-yl)ethyl]-3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide::US10174016, Example 134::US10202369, Example 134::US10472354, Example 134 P2X purinoceptor 2/3 Homo sapiens 210 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319967&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397151 384223247 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842708 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C26H30N4O3S/c1-16-6-7-23(30-29-16)17(2)28-25(31)20-10-21(26-27-13-24(34-26)19-4-3-5-19)12-22(11-20)33-15-18-8-9-32-14-18/h6-7,10-13,17-19H,3-5,8-9,14-15H2,1-2H3,(H,28,31)/t17-,18+/m1/s1 KRMAXJMLJAVOGJ-MSOLQXFVSA-N 319968 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-5-[(3S)-tetrahydrofuran-3-ylmethoxy]benzamide::US10174016, Example 135::US10202369, Example 135::US10472354, Example 270 P2X purinoceptor 3 Homo sapiens 35.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319968&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397422 384223248 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842709 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C26H30N4O3S/c1-16-6-7-23(30-29-16)17(2)28-25(31)20-10-21(26-27-13-24(34-26)19-4-3-5-19)12-22(11-20)33-15-18-8-9-32-14-18/h6-7,10-13,17-19H,3-5,8-9,14-15H2,1-2H3,(H,28,31)/t17-,18+/m1/s1 KRMAXJMLJAVOGJ-MSOLQXFVSA-N 319968 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-5-[(3S)-tetrahydrofuran-3-ylmethoxy]benzamide::US10174016, Example 135::US10202369, Example 135::US10472354, Example 270 P2X purinoceptor 2/3 Homo sapiens 209 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319968&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397422 384223248 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842710 COCCOc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(C)nc1 InChI=1S/C21H24N4O3S/c1-13-10-24-21(29-13)17-7-16(8-19(9-17)28-6-5-27-4)20(26)25-14(2)18-11-22-15(3)23-12-18/h7-12,14H,5-6H2,1-4H3,(H,25,26)/t14-/m1/s1 NMXUVEDIBFBQMK-CQSZACIVSA-N 319969 3-(2-Methoxyethoxy)-N-[(1R)-1-(2-methylpyrimidin-5-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 136::US10202369, Example 136::US10472354, Example 136 P2X purinoceptor 3 Homo sapiens 196 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319969&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397574 384223249 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842711 COCCOc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(C)nc1 InChI=1S/C21H24N4O3S/c1-13-10-24-21(29-13)17-7-16(8-19(9-17)28-6-5-27-4)20(26)25-14(2)18-11-22-15(3)23-12-18/h7-12,14H,5-6H2,1-4H3,(H,25,26)/t14-/m1/s1 NMXUVEDIBFBQMK-CQSZACIVSA-N 319969 3-(2-Methoxyethoxy)-N-[(1R)-1-(2-methylpyrimidin-5-yl)ethyl]-5-(5-methyl-1,3-thiazol-2-yl)benzamide::US10174016, Example 136::US10202369, Example 136::US10472354, Example 136 P2X purinoceptor 2/3 Homo sapiens 2780 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319969&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397574 384223249 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842712 C[C@@H](NC(=O)c1cc(OC2CCN(CC2)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O4S/c1-16-13-32-24(41-16)19-10-18(23(37)35-17(2)20-14-33-25(34-15-20)28(29,30)31)11-22(12-19)39-21-6-8-36(9-7-21)26(38)40-27(3,4)5/h10-15,17,21H,6-9H2,1-5H3,(H,35,37)/t17-/m1/s1 FLJTWWMLFZUWSL-QGZVFWFLSA-N 319970 US10174016, Example 137::US10472354, Example 137::tert-Butyl 4-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]piperidine-1-carboxylate P2X purinoceptor 3 Homo sapiens 26.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319970&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397466 384223250 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842713 C[C@@H](NC(=O)c1cc(OC2CCN(CC2)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O4S/c1-16-13-32-24(41-16)19-10-18(23(37)35-17(2)20-14-33-25(34-15-20)28(29,30)31)11-22(12-19)39-21-6-8-36(9-7-21)26(38)40-27(3,4)5/h10-15,17,21H,6-9H2,1-5H3,(H,35,37)/t17-/m1/s1 FLJTWWMLFZUWSL-QGZVFWFLSA-N 319970 US10174016, Example 137::US10472354, Example 137::tert-Butyl 4-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]piperidine-1-carboxylate P2X purinoceptor 2/3 Homo sapiens 328 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319970&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397466 384223250 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842714 C[C@@H](NC(=O)c1cc(OC2CCNCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-10-28-21(34-13)16-7-15(8-19(9-16)33-18-3-5-27-6-4-18)20(32)31-14(2)17-11-29-22(30-12-17)23(24,25)26/h7-12,14,18,27H,3-6H2,1-2H3,(H,31,32)/t14-/m1/s1 AUEVADIQWKJNQT-CQSZACIVSA-N 319971 3-(5-Methyl-1,3-thiazol-2-yl)-5-(piperidin-4-yloxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 138::US10202369, Example 138::US10472354, Example 138 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319971&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397389 384223251 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842715 C[C@@H](NC(=O)c1cc(OC2CCNCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-10-28-21(34-13)16-7-15(8-19(9-16)33-18-3-5-27-6-4-18)20(32)31-14(2)17-11-29-22(30-12-17)23(24,25)26/h7-12,14,18,27H,3-6H2,1-2H3,(H,31,32)/t14-/m1/s1 AUEVADIQWKJNQT-CQSZACIVSA-N 319971 3-(5-Methyl-1,3-thiazol-2-yl)-5-(piperidin-4-yloxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 138::US10202369, Example 138::US10472354, Example 138 P2X purinoceptor 2/3 Homo sapiens 559 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319971&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397389 384223251 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842716 C[C@@H](NC(=O)c1cc(OC2CCN(C)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-11-28-22(35-14)17-8-16(9-20(10-17)34-19-4-6-32(3)7-5-19)21(33)31-15(2)18-12-29-23(30-13-18)24(25,26)27/h8-13,15,19H,4-7H2,1-3H3,(H,31,33)/t15-/m1/s1 BKNIRTNEYAOJDL-OAHLLOKOSA-N 319972 3-[(1-Methylpiperidin-4-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 139::US10202369, Example 139::US10472354, Example 215 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319972&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397521 384223252 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842717 C[C@@H](NC(=O)c1cc(OC2CCN(C)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-11-28-22(35-14)17-8-16(9-20(10-17)34-19-4-6-32(3)7-5-19)21(33)31-15(2)18-12-29-23(30-13-18)24(25,26)27/h8-13,15,19H,4-7H2,1-3H3,(H,31,33)/t15-/m1/s1 BKNIRTNEYAOJDL-OAHLLOKOSA-N 319972 3-[(1-Methylpiperidin-4-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 139::US10202369, Example 139::US10472354, Example 215 P2X purinoceptor 2/3 Homo sapiens 962 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319972&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397521 384223252 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842718 CC(C)N1CCC(CC1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C26H30F3N5O2S/c1-15(2)34-7-5-21(6-8-34)36-22-10-18(9-19(11-22)24-30-12-16(3)37-24)23(35)33-17(4)20-13-31-25(32-14-20)26(27,28)29/h9-15,17,21H,5-8H2,1-4H3,(H,33,35)/t17-/m1/s1 JAJQPYKLEVBCIY-QGZVFWFLSA-N 319973 3-(5-Methyl-1,3-thiazol-2-yl)-5-{[1-(propan-2-yl)piperidin-4-yl]oxy}-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 140::US10202369, Example 140::US10472354, Example 140 P2X purinoceptor 3 Homo sapiens 33.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319973&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397336 384223253 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842719 CC(C)N1CCC(CC1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C26H30F3N5O2S/c1-15(2)34-7-5-21(6-8-34)36-22-10-18(9-19(11-22)24-30-12-16(3)37-24)23(35)33-17(4)20-13-31-25(32-14-20)26(27,28)29/h9-15,17,21H,5-8H2,1-4H3,(H,33,35)/t17-/m1/s1 JAJQPYKLEVBCIY-QGZVFWFLSA-N 319973 3-(5-Methyl-1,3-thiazol-2-yl)-5-{[1-(propan-2-yl)piperidin-4-yl]oxy}-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 140::US10202369, Example 140::US10472354, Example 140 P2X purinoceptor 2/3 Homo sapiens 1295 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319973&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397336 384223253 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842720 C[C@@H](NC(=O)c1cc(O[C@@H]2CCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-9-27-21(34-13)16-6-15(7-19(8-16)33-18-4-5-31(3)12-18)20(32)30-14(2)17-10-28-22(29-11-17)23(24,25)26/h6-11,14,18H,4-5,12H2,1-3H3,(H,30,32)/t14-,18-/m1/s1 RNHSPVKPEXJLAD-RDTXWAMCSA-N 319974 3-{[(3R)-1-Methylpyrrolidin-3-yl]oxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 141::US10202369, Example 141::US10472354, Example 141 P2X purinoceptor 3 Homo sapiens 43.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319974&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397272 384223254 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842721 C[C@@H](NC(=O)c1cc(O[C@@H]2CCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-9-27-21(34-13)16-6-15(7-19(8-16)33-18-4-5-31(3)12-18)20(32)30-14(2)17-10-28-22(29-11-17)23(24,25)26/h6-11,14,18H,4-5,12H2,1-3H3,(H,30,32)/t14-,18-/m1/s1 RNHSPVKPEXJLAD-RDTXWAMCSA-N 319974 3-{[(3R)-1-Methylpyrrolidin-3-yl]oxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 141::US10202369, Example 141::US10472354, Example 141 P2X purinoceptor 2/3 Homo sapiens 2201 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319974&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397272 384223254 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842722 C[C@@H](NC(=O)c1cc(O[C@H]2CCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-9-27-21(34-13)16-6-15(7-19(8-16)33-18-4-5-31(3)12-18)20(32)30-14(2)17-10-28-22(29-11-17)23(24,25)26/h6-11,14,18H,4-5,12H2,1-3H3,(H,30,32)/t14-,18+/m1/s1 RNHSPVKPEXJLAD-KDOFPFPSSA-N 319975 3-{[(3S)-1-Methylpyrrolidin-3-yl]oxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 142::US10202369, Example 142::US10472354, Example 142 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319975&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397181 384223255 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842723 C[C@@H](NC(=O)c1cc(O[C@H]2CCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-9-27-21(34-13)16-6-15(7-19(8-16)33-18-4-5-31(3)12-18)20(32)30-14(2)17-10-28-22(29-11-17)23(24,25)26/h6-11,14,18H,4-5,12H2,1-3H3,(H,30,32)/t14-,18+/m1/s1 RNHSPVKPEXJLAD-KDOFPFPSSA-N 319975 3-{[(3S)-1-Methylpyrrolidin-3-yl]oxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 142::US10202369, Example 142::US10472354, Example 142 P2X purinoceptor 2/3 Homo sapiens 222 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319975&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397181 384223255 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842724 C[C@@H](NC(=O)c1cc(OC2CN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H22F3N5O2S/c1-12-7-26-20(33-12)15-4-14(5-17(6-15)32-18-10-30(3)11-18)19(31)29-13(2)16-8-27-21(28-9-16)22(23,24)25/h4-9,13,18H,10-11H2,1-3H3,(H,29,31)/t13-/m1/s1 NFRXFSQBXDHWHW-CYBMUJFWSA-N 319976 3-[(1-Methylazetidin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 143::US10202369, Example 143::US10472354, Example 143 P2X purinoceptor 3 Homo sapiens 84.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319976&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397519 384223256 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842725 C[C@@H](NC(=O)c1cc(OC2CN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H22F3N5O2S/c1-12-7-26-20(33-12)15-4-14(5-17(6-15)32-18-10-30(3)11-18)19(31)29-13(2)16-8-27-21(28-9-16)22(23,24)25/h4-9,13,18H,10-11H2,1-3H3,(H,29,31)/t13-/m1/s1 NFRXFSQBXDHWHW-CYBMUJFWSA-N 319976 3-[(1-Methylazetidin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 143::US10202369, Example 143::US10472354, Example 143 P2X purinoceptor 2/3 Homo sapiens 3047 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319976&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397519 384223256 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842726 C[C@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C21H17F3N4O2S/c1-4-5-30-17-7-14(6-15(8-17)19-25-9-12(2)31-19)18(29)28-13(3)16-10-26-20(27-11-16)21(22,23)24/h1,6-11,13H,5H2,2-3H3,(H,28,29)/t13-/m0/s1 BTRSFHCVZJPJKT-ZDUSSCGKSA-N 319977 3-(5-Methyl-1,3-thiazol-2-yl)-5-(prop-2-yn-1-yloxy)-N-{(1S)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 144::US10202369, Example 144::US10472354, Example 144 P2X purinoceptor 3 Homo sapiens 825 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319977&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397460 384223257 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842727 C[C@H](NC(=O)c1cc(OCC#C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C21H17F3N4O2S/c1-4-5-30-17-7-14(6-15(8-17)19-25-9-12(2)31-19)18(29)28-13(3)16-10-26-20(27-11-16)21(22,23)24/h1,6-11,13H,5H2,2-3H3,(H,28,29)/t13-/m0/s1 BTRSFHCVZJPJKT-ZDUSSCGKSA-N 319977 3-(5-Methyl-1,3-thiazol-2-yl)-5-(prop-2-yn-1-yloxy)-N-{(1S)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 144::US10202369, Example 144::US10472354, Example 144 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319977&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397460 384223257 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842728 C[C@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-10-27-21(34-13)16-7-15(8-19(9-16)33-18-3-5-32-6-4-18)20(31)30-14(2)17-11-28-22(29-12-17)23(24,25)26/h7-12,14,18H,3-6H2,1-2H3,(H,30,31)/t14-/m0/s1 WGQQHPGXKFPPTQ-AWEZNQCLSA-N 319978 3-(5-Methyl-1,3-thiazol-2-yl)-5-(tetrahydro-2H-pyran-4-yloxy)-N-{(1S)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 145::US10202369, Example 145::US10472354, Example 145 P2X purinoceptor 3 Homo sapiens 271 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319978&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397306 384223258 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842729 C[C@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-10-27-21(34-13)16-7-15(8-19(9-16)33-18-3-5-32-6-4-18)20(31)30-14(2)17-11-28-22(29-12-17)23(24,25)26/h7-12,14,18H,3-6H2,1-2H3,(H,30,31)/t14-/m0/s1 WGQQHPGXKFPPTQ-AWEZNQCLSA-N 319978 3-(5-Methyl-1,3-thiazol-2-yl)-5-(tetrahydro-2H-pyran-4-yloxy)-N-{(1S)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 145::US10202369, Example 145::US10472354, Example 145 P2X purinoceptor 2/3 Homo sapiens 4461 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319978&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397306 384223258 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842730 C[C@@H](NC(=O)c1cc(OC2CC3(C2)CN(C3)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C29H32F3N5O4S/c1-16-11-33-24(42-16)19-6-18(23(38)36-17(2)20-12-34-25(35-13-20)29(30,31)32)7-21(8-19)40-22-9-28(10-22)14-37(15-28)26(39)41-27(3,4)5/h6-8,11-13,17,22H,9-10,14-15H2,1-5H3,(H,36,38)/t17-/m1/s1 GOFUMWOIVIXXIJ-QGZVFWFLSA-N 319979 US10174016, Example 146::US10202369, Example 146::US10472354, Example 146::tert-butyl 6-[3-(5- methyl-1,3- thiazol-2-yl)-5- ({(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}carbamoyl) phenoxy]-2- azaspiro[3.3]heptane- 2-carboxylate P2X purinoceptor 3 Homo sapiens 45.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319979&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397340 384223259 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842731 C[C@@H](NC(=O)c1cc(OC2CC3(C2)CN(C3)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C29H32F3N5O4S/c1-16-11-33-24(42-16)19-6-18(23(38)36-17(2)20-12-34-25(35-13-20)29(30,31)32)7-21(8-19)40-22-9-28(10-22)14-37(15-28)26(39)41-27(3,4)5/h6-8,11-13,17,22H,9-10,14-15H2,1-5H3,(H,36,38)/t17-/m1/s1 GOFUMWOIVIXXIJ-QGZVFWFLSA-N 319979 US10174016, Example 146::US10202369, Example 146::US10472354, Example 146::tert-butyl 6-[3-(5- methyl-1,3- thiazol-2-yl)-5- ({(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}carbamoyl) phenoxy]-2- azaspiro[3.3]heptane- 2-carboxylate P2X purinoceptor 2/3 Homo sapiens 159 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319979&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397340 384223259 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842732 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(cn1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-8-28-21(33-12)15-5-14(6-17(7-15)32-16-3-4-31-11-16)20(30)29-13(2)18-9-27-19(10-26-18)22(23,24)25/h5-10,13,16H,3-4,11H2,1-2H3,(H,29,30)/t13-,16-/m1/s1 DVMONFUPUPPMFW-CZUORRHYSA-N 319980 3-(5-methyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [5- (trifluoromethyl) pyrazin-2- yl]ethyl}benzamide::US10174016, Example 147::US10202369, Example 147::US10472354, Example 147 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319980&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397189 384223260 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842733 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(cn1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-8-28-21(33-12)15-5-14(6-17(7-15)32-16-3-4-31-11-16)20(30)29-13(2)18-9-27-19(10-26-18)22(23,24)25/h5-10,13,16H,3-4,11H2,1-2H3,(H,29,30)/t13-,16-/m1/s1 DVMONFUPUPPMFW-CZUORRHYSA-N 319980 3-(5-methyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [5- (trifluoromethyl) pyrazin-2- yl]ethyl}benzamide::US10174016, Example 147::US10202369, Example 147::US10472354, Example 147 P2X purinoceptor 2/3 Homo sapiens 132 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319980&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397189 384223260 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842734 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C22H20F3N3O3S/c1-12-8-27-21(32-12)16-5-15(6-17(7-16)31-18-10-30-11-18)20(29)28-13(2)14-3-4-19(26-9-14)22(23,24)25/h3-9,13,18H,10-11H2,1-2H3,(H,28,29)/t13-/m1/s1 NAXHTXVAPBZYNR-CYBMUJFWSA-N 319981 3-(5-methyl-1,3- thiazol-2-yl)-5- (oxetan-3-yloxy)- N-{(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 148::US10202369, Example 148::US10472354, Example 148 P2X purinoceptor 3 Homo sapiens 33.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319981&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397138 384223261 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842735 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C22H20F3N3O3S/c1-12-8-27-21(32-12)16-5-15(6-17(7-16)31-18-10-30-11-18)20(29)28-13(2)14-3-4-19(26-9-14)22(23,24)25/h3-9,13,18H,10-11H2,1-2H3,(H,28,29)/t13-/m1/s1 NAXHTXVAPBZYNR-CYBMUJFWSA-N 319981 3-(5-methyl-1,3- thiazol-2-yl)-5- (oxetan-3-yloxy)- N-{(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 148::US10202369, Example 148::US10472354, Example 148 P2X purinoceptor 2/3 Homo sapiens 794 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319981&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397138 384223261 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842736 C[C@@H](NC(=O)c1cc(OC23CCN(CC2)CC3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O2S/c1-15-12-29-22(36-15)18-9-17(10-20(11-18)35-24-3-6-33(7-4-24)8-5-24)21(34)32-16(2)19-13-30-23(31-14-19)25(26,27)28/h9-14,16H,3-8H2,1-2H3,(H,32,34)/t16-/m1/s1 RAGSAJSSGMANHP-MRXNPFEDSA-N 319982 3-(1- azabicyclo[2.2.2] oct-4-yloxy)-5-(5- methyl-1,3- thiazol-3-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 149::US10202369, Example 149::US10472354, Example 149 P2X purinoceptor 3 Homo sapiens 21.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319982&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397715 384223262 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842737 C[C@@H](NC(=O)c1cc(OC23CCN(CC2)CC3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O2S/c1-15-12-29-22(36-15)18-9-17(10-20(11-18)35-24-3-6-33(7-4-24)8-5-24)21(34)32-16(2)19-13-30-23(31-14-19)25(26,27)28/h9-14,16H,3-8H2,1-2H3,(H,32,34)/t16-/m1/s1 RAGSAJSSGMANHP-MRXNPFEDSA-N 319982 3-(1- azabicyclo[2.2.2] oct-4-yloxy)-5-(5- methyl-1,3- thiazol-3-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 149::US10202369, Example 149::US10472354, Example 149 P2X purinoceptor 2/3 Homo sapiens 936 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319982&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397715 384223262 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842738 C[C@@H](NC(=O)c1cc(OC2CCN(CC2)C(C)=O)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O3S/c1-14-11-29-23(37-14)18-8-17(9-21(10-18)36-20-4-6-33(7-5-20)16(3)34)22(35)32-15(2)19-12-30-24(31-13-19)25(26,27)28/h8-13,15,20H,4-7H2,1-3H3,(H,32,35)/t15-/m1/s1 ISMQQTCWBNBFKY-OAHLLOKOSA-N 319983 3-[(1- acetylpiperidin-4- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 150::US10202369, Example 150::US10472354, Example 150 P2X purinoceptor 3 Homo sapiens 12.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319983&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397215 384223263 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842739 C[C@@H](NC(=O)c1cc(OC2CCN(CC2)C(C)=O)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O3S/c1-14-11-29-23(37-14)18-8-17(9-21(10-18)36-20-4-6-33(7-5-20)16(3)34)22(35)32-15(2)19-12-30-24(31-13-19)25(26,27)28/h8-13,15,20H,4-7H2,1-3H3,(H,32,35)/t15-/m1/s1 ISMQQTCWBNBFKY-OAHLLOKOSA-N 319983 3-[(1- acetylpiperidin-4- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 150::US10202369, Example 150::US10472354, Example 150 P2X purinoceptor 2/3 Homo sapiens 83.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319983&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397215 384223263 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842740 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)F InChI=1S/C22H22F2N4O3S/c1-12-8-27-22(32-12)15-5-14(6-18(7-15)31-17-3-4-30-11-17)21(29)28-13(2)16-9-25-20(19(23)24)26-10-16/h5-10,13,17,19H,3-4,11H2,1-2H3,(H,28,29)/t13-,17+/m1/s1 AUVRCFBFFFYNAV-DYVFJYSZSA-N 319984 N-{(1R)-1-[2- (difluoromethyl) pyrimidin-5- yl]ethyl}-3-(5- methyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 151::US10202369, Example 151::US10472354, Example 151 P2X purinoceptor 3 Homo sapiens 31.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319984&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397480 384223264 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842741 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)F InChI=1S/C22H22F2N4O3S/c1-12-8-27-22(32-12)15-5-14(6-18(7-15)31-17-3-4-30-11-17)21(29)28-13(2)16-9-25-20(19(23)24)26-10-16/h5-10,13,17,19H,3-4,11H2,1-2H3,(H,28,29)/t13-,17+/m1/s1 AUVRCFBFFFYNAV-DYVFJYSZSA-N 319984 N-{(1R)-1-[2- (difluoromethyl) pyrimidin-5- yl]ethyl}-3-(5- methyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 151::US10202369, Example 151::US10472354, Example 151 P2X purinoceptor 2/3 Homo sapiens 333 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319984&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397480 384223264 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842742 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)F InChI=1S/C21H20F2N4O3S/c1-11-6-26-21(31-11)14-3-13(4-16(5-14)30-17-9-29-10-17)20(28)27-12(2)15-7-24-19(18(22)23)25-8-15/h3-8,12,17-18H,9-10H2,1-2H3,(H,27,28)/t12-/m1/s1 YTKWIWSPGJOVJL-GFCCVEGCSA-N 319985 N-{(1R)-1-[2- (difluoromethyl) pyrimidin-5- yl]ethyl}-3-(5- methyl-1,3- thiazol-2-yl)-5- (oxetan-3- yloxy)benzamide::US10174016, Example 152::US10202369, Example 152::US10472354, Example 152 P2X purinoceptor 3 Homo sapiens 45.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319985&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397528 384223265 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842743 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)F InChI=1S/C21H20F2N4O3S/c1-11-6-26-21(31-11)14-3-13(4-16(5-14)30-17-9-29-10-17)20(28)27-12(2)15-7-24-19(18(22)23)25-8-15/h3-8,12,17-18H,9-10H2,1-2H3,(H,27,28)/t12-/m1/s1 YTKWIWSPGJOVJL-GFCCVEGCSA-N 319985 N-{(1R)-1-[2- (difluoromethyl) pyrimidin-5- yl]ethyl}-3-(5- methyl-1,3- thiazol-2-yl)-5- (oxetan-3- yloxy)benzamide::US10174016, Example 152::US10202369, Example 152::US10472354, Example 152 P2X purinoceptor 2/3 Homo sapiens 523 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319985&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397528 384223265 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842744 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)F InChI=1S/C22H22F2N4O3S/c1-12-8-27-22(32-12)15-5-14(6-18(7-15)31-17-3-4-30-11-17)21(29)28-13(2)16-9-25-20(19(23)24)26-10-16/h5-10,13,17,19H,3-4,11H2,1-2H3,(H,28,29)/t13-,17-/m1/s1 AUVRCFBFFFYNAV-CXAGYDPISA-N 319986 N-{(1R)-1-[2- (difluoromethyl) pyrimidin-5- yl]ethyl}-3-(5- methyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 153::US10202369, Example 153::US10472354, Example 153 P2X purinoceptor 3 Homo sapiens 27.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319986&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397665 384223266 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842745 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)F InChI=1S/C22H22F2N4O3S/c1-12-8-27-22(32-12)15-5-14(6-18(7-15)31-17-3-4-30-11-17)21(29)28-13(2)16-9-25-20(19(23)24)26-10-16/h5-10,13,17,19H,3-4,11H2,1-2H3,(H,28,29)/t13-,17-/m1/s1 AUVRCFBFFFYNAV-CXAGYDPISA-N 319986 N-{(1R)-1-[2- (difluoromethyl) pyrimidin-5- yl]ethyl}-3-(5- methyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 153::US10202369, Example 153::US10472354, Example 153 P2X purinoceptor 2/3 Homo sapiens 304 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319986&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397665 384223266 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842746 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)F InChI=1S/C23H24F2N4O3S/c1-13-10-28-23(33-13)16-7-15(8-19(9-16)32-18-3-5-31-6-4-18)22(30)29-14(2)17-11-26-21(20(24)25)27-12-17/h7-12,14,18,20H,3-6H2,1-2H3,(H,29,30)/t14-/m1/s1 RQWRZCMIWXGQJP-CQSZACIVSA-N 319987 N-{(1R)-1-[2- (difluoromethyl) pyrimidin-5- yl]ethyl}-3-(5- methyl-1,3- thiazol-2-yl)-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 154::US10202369, Example 154::US10472354, Example 154 P2X purinoceptor 3 Homo sapiens 18.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319987&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397560 384223267 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842747 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)F InChI=1S/C23H24F2N4O3S/c1-13-10-28-23(33-13)16-7-15(8-19(9-16)32-18-3-5-31-6-4-18)22(30)29-14(2)17-11-26-21(20(24)25)27-12-17/h7-12,14,18,20H,3-6H2,1-2H3,(H,29,30)/t14-/m1/s1 RQWRZCMIWXGQJP-CQSZACIVSA-N 319987 N-{(1R)-1-[2- (difluoromethyl) pyrimidin-5- yl]ethyl}-3-(5- methyl-1,3- thiazol-2-yl)-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 154::US10202369, Example 154::US10472354, Example 154 P2X purinoceptor 2/3 Homo sapiens 130 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319987&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397560 384223267 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842748 C[C@@H](NC(=O)c1cc(O[C@H]2CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-19-5-4-6-32(3)13-19)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19+/m1/s1 DNVWWBHMIGZIMX-BEFAXECRSA-N 319988 3-{[(3S)-1- methylpiperidin-3- yl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 155::US10174016, Example 221::US10202369, Example 155::US10472354, Example 155 P2X purinoceptor 3 Homo sapiens 40.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319988&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397794 384223268 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842749 C[C@@H](NC(=O)c1cc(O[C@H]2CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-19-5-4-6-32(3)13-19)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19+/m1/s1 DNVWWBHMIGZIMX-BEFAXECRSA-N 319988 3-{[(3S)-1- methylpiperidin-3- yl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 155::US10174016, Example 221::US10202369, Example 155::US10472354, Example 155 P2X purinoceptor 2/3 Homo sapiens 2267 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319988&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397794 384223268 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842750 C[C@@H](NC(=O)c1cc(OC2(C)COC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-7-26-19(33-12)15-4-14(5-17(6-15)32-21(3)10-31-11-21)18(30)29-13(2)16-8-27-20(28-9-16)22(23,24)25/h4-9,13H,10-11H2,1-3H3,(H,29,30)/t13-/m1/s1 OYDLDEWAXBGGBJ-CYBMUJFWSA-N 319989 3-[(3- methyloxetan-3- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 156::US10202369, Example 156::US10472354, Example 156 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319989&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397627 384223269 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842751 C[C@@H](NC(=O)c1cc(OC2(C)COC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-7-26-19(33-12)15-4-14(5-17(6-15)32-21(3)10-31-11-21)18(30)29-13(2)16-8-27-20(28-9-16)22(23,24)25/h4-9,13H,10-11H2,1-3H3,(H,29,30)/t13-/m1/s1 OYDLDEWAXBGGBJ-CYBMUJFWSA-N 319989 3-[(3- methyloxetan-3- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 156::US10202369, Example 156::US10472354, Example 156 P2X purinoceptor 2/3 Homo sapiens 163 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319989&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397627 384223269 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842752 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C23H22F3N3O3S/c1-13-10-28-22(33-13)17-7-16(8-19(9-17)32-18-5-6-31-12-18)21(30)29-14(2)15-3-4-20(27-11-15)23(24,25)26/h3-4,7-11,14,18H,5-6,12H2,1-2H3,(H,29,30)/t14-,18-/m1/s1 RHAXZNLWUJRHEA-RDTXWAMCSA-N 319990 3-(5-methyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 157::US10202369, Example 157::US10472354, Example 157 P2X purinoceptor 3 Homo sapiens 17.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319990 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319990&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397372 384223270 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842753 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C23H22F3N3O3S/c1-13-10-28-22(33-13)17-7-16(8-19(9-17)32-18-5-6-31-12-18)21(30)29-14(2)15-3-4-20(27-11-15)23(24,25)26/h3-4,7-11,14,18H,5-6,12H2,1-2H3,(H,29,30)/t14-,18-/m1/s1 RHAXZNLWUJRHEA-RDTXWAMCSA-N 319990 3-(5-methyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 157::US10202369, Example 157::US10472354, Example 157 P2X purinoceptor 2/3 Homo sapiens 534 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319990 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319990&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397372 384223270 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842754 C[C@@H](NC(=O)c1cc(O[C@@H]2CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-19-5-4-6-32(3)13-19)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19-/m1/s1 DNVWWBHMIGZIMX-DNVCBOLYSA-N 319991 3-{[(3R)-1- methylpiperidin-3- yl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 158::US10174016, Example 220::US10202369, Example 158::US10472354, Example 158 P2X purinoceptor 3 Homo sapiens 21.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319991&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397414 384223271 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842755 C[C@@H](NC(=O)c1cc(O[C@@H]2CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-19-5-4-6-32(3)13-19)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19-/m1/s1 DNVWWBHMIGZIMX-DNVCBOLYSA-N 319991 3-{[(3R)-1- methylpiperidin-3- yl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 158::US10174016, Example 220::US10202369, Example 158::US10472354, Example 158 P2X purinoceptor 2/3 Homo sapiens 1939 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319991&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397414 384223271 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842756 C[C@@H](NC(=O)c1cc(OCCn2cncn2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H20F3N7O2S/c1-13-8-27-20(35-13)16-5-15(6-18(7-16)34-4-3-32-12-26-11-30-32)19(33)31-14(2)17-9-28-21(29-10-17)22(23,24)25/h5-12,14H,3-4H2,1-2H3,(H,31,33)/t14-/m1/s1 HYNLHPVSAUUUKN-CQSZACIVSA-N 319992 3-(5-methyl-1,3- thiazol-2-yl)-5-[2- (1H-1,2,4-triazol- 1-yl)ethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 159::US10202369, Example 159::US10472354, Example 159 P2X purinoceptor 3 Homo sapiens 28.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319992&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397126 384223272 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842757 C[C@@H](NC(=O)c1cc(OCCn2cncn2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H20F3N7O2S/c1-13-8-27-20(35-13)16-5-15(6-18(7-16)34-4-3-32-12-26-11-30-32)19(33)31-14(2)17-9-28-21(29-10-17)22(23,24)25/h5-12,14H,3-4H2,1-2H3,(H,31,33)/t14-/m1/s1 HYNLHPVSAUUUKN-CQSZACIVSA-N 319992 3-(5-methyl-1,3- thiazol-2-yl)-5-[2- (1H-1,2,4-triazol- 1-yl)ethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 159::US10202369, Example 159::US10472354, Example 159 P2X purinoceptor 2/3 Homo sapiens 1233 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319992&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397126 384223272 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842758 C[C@@H](NC(=O)c1cc(OCCn2cncn2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C23H21F3N6O2S/c1-14-10-29-22(35-14)18-7-17(8-19(9-18)34-6-5-32-13-27-12-30-32)21(33)31-15(2)16-3-4-20(28-11-16)23(24,25)26/h3-4,7-13,15H,5-6H2,1-2H3,(H,31,33)/t15-/m1/s1 ZEDPNXXTTLJFPM-OAHLLOKOSA-N 319993 3-(5-methyl-1,3- thiazol-2-yl)-5-[2- (1H-1,2,4-triazol- 1-yl)ethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 160::US10202369, Example 160::US10472354, Example 160 P2X purinoceptor 3 Homo sapiens 28.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319993&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397838 384223273 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842759 C[C@@H](NC(=O)c1cc(OCCn2cncn2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C23H21F3N6O2S/c1-14-10-29-22(35-14)18-7-17(8-19(9-18)34-6-5-32-13-27-12-30-32)21(33)31-15(2)16-3-4-20(28-11-16)23(24,25)26/h3-4,7-13,15H,5-6H2,1-2H3,(H,31,33)/t15-/m1/s1 ZEDPNXXTTLJFPM-OAHLLOKOSA-N 319993 3-(5-methyl-1,3- thiazol-2-yl)-5-[2- (1H-1,2,4-triazol- 1-yl)ethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 160::US10202369, Example 160::US10472354, Example 160 P2X purinoceptor 2/3 Homo sapiens 1007 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319993&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397838 384223273 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842760 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C21H19F3N4O3S/c1-11-8-25-20(32-11)14-5-13(6-15(7-14)31-16-9-30-10-16)19(29)26-12(2)17-3-4-18(28-27-17)21(22,23)24/h3-8,12,16H,9-10H2,1-2H3,(H,26,29)/t12-/m1/s1 GINDYDBHFAVPIL-GFCCVEGCSA-N 319994 3-(5-methyl-1,3- thiazol-2-yl)-5- (oxetan-3-yloxy)- N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 161::US10202369, Example 161::US10472354, Example 161 P2X purinoceptor 3 Homo sapiens 32.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319994&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397757 384223274 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842761 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C21H19F3N4O3S/c1-11-8-25-20(32-11)14-5-13(6-15(7-14)31-16-9-30-10-16)19(29)26-12(2)17-3-4-18(28-27-17)21(22,23)24/h3-8,12,16H,9-10H2,1-2H3,(H,26,29)/t12-/m1/s1 GINDYDBHFAVPIL-GFCCVEGCSA-N 319994 3-(5-methyl-1,3- thiazol-2-yl)-5- (oxetan-3-yloxy)- N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 161::US10202369, Example 161::US10472354, Example 161 P2X purinoceptor 2/3 Homo sapiens 632 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319994&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397757 384223274 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842762 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-8-26-20(33-11)16-5-15(6-18(7-16)32-14(4)13(3)30)19(31)29-12(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,29,31)/t12-,13?,14?/m0/s1 FSGDRFBLPAILDE-HSBZDZAISA-N 319996 US10174016, Example 163::US10202369, Example 340::US10472354, Example 162 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319996&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 134328174 384223276 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842763 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-8-26-20(33-11)16-5-15(6-18(7-16)32-14(4)13(3)30)19(31)29-12(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,29,31)/t12-,13?,14?/m0/s1 FSGDRFBLPAILDE-HSBZDZAISA-N 319996 US10174016, Example 163::US10202369, Example 340::US10472354, Example 162 P2X purinoceptor 2/3 Homo sapiens 74.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319996&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 134328174 384223276 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842764 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-8-26-20(33-11)16-5-15(6-18(7-16)32-14(4)13(3)30)19(31)29-12(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,29,31)/t12-,13?,14?/m1/s1 FSGDRFBLPAILDE-IYXRBSQSSA-N 319995 3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 162::US10174016, Example 338::US10202369, Example 339::US10472354, Example 338 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319995&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397269 384223275 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842765 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-8-26-20(33-11)16-5-15(6-18(7-16)32-14(4)13(3)30)19(31)29-12(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,29,31)/t12-,13?,14?/m1/s1 FSGDRFBLPAILDE-IYXRBSQSSA-N 319995 3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 162::US10174016, Example 338::US10202369, Example 339::US10472354, Example 338 P2X purinoceptor 2/3 Homo sapiens 83.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319995&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397269 384223275 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842766 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)F InChI=1S/C22H21F2N3O3S/c1-12-8-26-22(31-12)16-5-15(6-17(7-16)30-18-10-29-11-18)21(28)27-13(2)14-3-4-19(20(23)24)25-9-14/h3-9,13,18,20H,10-11H2,1-2H3,(H,27,28)/t13-/m1/s1 VIFFUASYGYMCSF-CYBMUJFWSA-N 319997 N-{[(1R)-1-[6- (difluoromethyl) pyridin-3-yl]ethyl}-3- (5-methyl-1,3- thiazol-2-yl)-5- (oxetan-3- yloxy)benzamide::US10174016, Example 164::US10202369, Example 164::US10472354, Example 164 P2X purinoceptor 3 Homo sapiens 60.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319997&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397252 384223277 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842767 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)F InChI=1S/C22H21F2N3O3S/c1-12-8-26-22(31-12)16-5-15(6-17(7-16)30-18-10-29-11-18)21(28)27-13(2)14-3-4-19(20(23)24)25-9-14/h3-9,13,18,20H,10-11H2,1-2H3,(H,27,28)/t13-/m1/s1 VIFFUASYGYMCSF-CYBMUJFWSA-N 319997 N-{[(1R)-1-[6- (difluoromethyl) pyridin-3-yl]ethyl}-3- (5-methyl-1,3- thiazol-2-yl)-5- (oxetan-3- yloxy)benzamide::US10174016, Example 164::US10202369, Example 164::US10472354, Example 164 P2X purinoceptor 2/3 Homo sapiens 1107 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319997&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397252 384223277 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842768 C[C@@H](NC(=O)c1cc(O[C@H]2C[C@@H](C2)N(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-13-10-28-22(35-13)16-5-15(6-19(7-16)34-20-8-18(9-20)32(3)4)21(33)31-14(2)17-11-29-23(30-12-17)24(25,26)27/h5-7,10-12,14,18,20H,8-9H2,1-4H3,(H,31,33)/t14-,18-,20-/m1/s1 AGHYBRFMKRJHNY-LXGCGDOSSA-N 319998 3-{[trans-3- (dimethylamino) cyclobutyl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 165::US10202369, Example 165::US10472354, Example 165 P2X purinoceptor 3 Homo sapiens 81.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319998&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397549 384223278 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842769 C[C@@H](NC(=O)c1cc(O[C@H]2C[C@@H](C2)N(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-13-10-28-22(35-13)16-5-15(6-19(7-16)34-20-8-18(9-20)32(3)4)21(33)31-14(2)17-11-29-23(30-12-17)24(25,26)27/h5-7,10-12,14,18,20H,8-9H2,1-4H3,(H,31,33)/t14-,18-,20-/m1/s1 AGHYBRFMKRJHNY-LXGCGDOSSA-N 319998 3-{[trans-3- (dimethylamino) cyclobutyl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 165::US10202369, Example 165::US10472354, Example 165 P2X purinoceptor 2/3 Homo sapiens 1923 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319998&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397549 384223278 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842770 Cc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)NCc1cnc(nc1)C(F)(F)F InChI=1S/C21H19F3N4O3S/c1-12-7-26-19(32-12)15-4-14(5-17(6-15)31-16-2-3-30-11-16)18(29)25-8-13-9-27-20(28-10-13)21(22,23)24/h4-7,9-10,16H,2-3,8,11H2,1H3,(H,25,29)/t16-/m1/s1 MLKRPMMAEMGGNI-MRXNPFEDSA-N 319999 3-(5-methyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{[2- (trifluoromethyl) pyrimidin-5- yl]methyl}benzamide::US10174016, Example 166::US10202369, Example 166::US10472354, Example 166 P2X purinoceptor 3 Homo sapiens 40.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319999&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397360 384223279 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842771 Cc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)NCc1cnc(nc1)C(F)(F)F InChI=1S/C21H19F3N4O3S/c1-12-7-26-19(32-12)15-4-14(5-17(6-15)31-16-2-3-30-11-16)18(29)25-8-13-9-27-20(28-10-13)21(22,23)24/h4-7,9-10,16H,2-3,8,11H2,1H3,(H,25,29)/t16-/m1/s1 MLKRPMMAEMGGNI-MRXNPFEDSA-N 319999 3-(5-methyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{[2- (trifluoromethyl) pyrimidin-5- yl]methyl}benzamide::US10174016, Example 166::US10202369, Example 166::US10472354, Example 166 P2X purinoceptor 2/3 Homo sapiens 461 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319999&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397360 384223279 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842772 Cc1cnc(s1)-c1cc(OC2COC2)cc(c1)C(=O)NCc1cnc(nc1)C(F)(F)F InChI=1S/C20H17F3N4O3S/c1-11-5-25-18(31-11)14-2-13(3-15(4-14)30-16-9-29-10-16)17(28)24-6-12-7-26-19(27-8-12)20(21,22)23/h2-5,7-8,16H,6,9-10H2,1H3,(H,24,28) AWMOXCQCRBHEDH-UHFFFAOYSA-N 320000 3-(5-methyl-1,3- thiazol-2-yl)-5- (oxetan-3-yloxy)- N-{[2- (trifluoromethyl) pyrimidin-5- yl]methyl}benzamide::US10174016, Example 167::US10202369, Example 167::US10472354, Example 167 P2X purinoceptor 3 Homo sapiens 72.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320000&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397228 384223280 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842773 Cc1cnc(s1)-c1cc(OC2COC2)cc(c1)C(=O)NCc1cnc(nc1)C(F)(F)F InChI=1S/C20H17F3N4O3S/c1-11-5-25-18(31-11)14-2-13(3-15(4-14)30-16-9-29-10-16)17(28)24-6-12-7-26-19(27-8-12)20(21,22)23/h2-5,7-8,16H,6,9-10H2,1H3,(H,24,28) AWMOXCQCRBHEDH-UHFFFAOYSA-N 320000 3-(5-methyl-1,3- thiazol-2-yl)-5- (oxetan-3-yloxy)- N-{[2- (trifluoromethyl) pyrimidin-5- yl]methyl}benzamide::US10174016, Example 167::US10202369, Example 167::US10472354, Example 167 P2X purinoceptor 2/3 Homo sapiens 893 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320000&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397228 384223280 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842774 C[C@@H](NC(=O)c1cc(O[C@H]2CN3CCC2CC3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O2S/c1-14-10-29-23(36-14)18-7-17(8-20(9-18)35-21-13-33-5-3-16(21)4-6-33)22(34)32-15(2)19-11-30-24(31-12-19)25(26,27)28/h7-12,15-16,21H,3-6,13H2,1-2H3,(H,32,34)/t15-,21+/m1/s1 XGNFOBIXAZWFEF-VFNWGFHPSA-N 320001 3-[(3R)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 168::US10202369, Example 168::US10472354, Example 168 P2X purinoceptor 3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320001&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397190 384223281 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842775 C[C@@H](NC(=O)c1cc(O[C@H]2CN3CCC2CC3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O2S/c1-14-10-29-23(36-14)18-7-17(8-20(9-18)35-21-13-33-5-3-16(21)4-6-33)22(34)32-15(2)19-11-30-24(31-12-19)25(26,27)28/h7-12,15-16,21H,3-6,13H2,1-2H3,(H,32,34)/t15-,21+/m1/s1 XGNFOBIXAZWFEF-VFNWGFHPSA-N 320001 3-[(3R)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 168::US10202369, Example 168::US10472354, Example 168 P2X purinoceptor 2/3 Homo sapiens 1600 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320001&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397190 384223281 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842776 CCc1cnc(s1)-c1cc(OC2COC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-3-18-9-26-20(33-18)14-4-13(5-16(6-14)32-17-10-31-11-17)19(30)29-12(2)15-7-27-21(28-8-15)22(23,24)25/h4-9,12,17H,3,10-11H2,1-2H3,(H,29,30)/t12-/m1/s1 KJLXSAGNAKDMHX-GFCCVEGCSA-N 320002 3-(5-ethyl-1,3- thiazol-2-yl)-5- (oxetan-3-yloxy)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 169::US10202369, Example 169::US10472354, Example 169 P2X purinoceptor 3 Homo sapiens 9.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320002&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397192 384223282 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842777 CCc1cnc(s1)-c1cc(OC2COC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-3-18-9-26-20(33-18)14-4-13(5-16(6-14)32-17-10-31-11-17)19(30)29-12(2)15-7-27-21(28-8-15)22(23,24)25/h4-9,12,17H,3,10-11H2,1-2H3,(H,29,30)/t12-/m1/s1 KJLXSAGNAKDMHX-GFCCVEGCSA-N 320002 3-(5-ethyl-1,3- thiazol-2-yl)-5- (oxetan-3-yloxy)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 169::US10202369, Example 169::US10472354, Example 169 P2X purinoceptor 2/3 Homo sapiens 70.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320002&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397192 384223282 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842778 C[C@@H](NC(=O)c1cc(Oc2ccc(C)nn2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H19F3N6O2S/c1-12-4-5-19(32-31-12)34-18-7-15(6-16(8-18)21-27-9-13(2)35-21)20(33)30-14(3)17-10-28-22(29-11-17)23(24,25)26/h4-11,14H,1-3H3,(H,30,33)/t14-/m1/s1 YBWKZVABJNKBEG-CQSZACIVSA-N 320003 3-[(6- methylpyridazin-3- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 170::US10202369, Example 170::US10472354, Example 170 P2X purinoceptor 3 Homo sapiens 165 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320003&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397298 384223283 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842779 C[C@@H](NC(=O)c1cc(Oc2ccc(C)nn2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H19F3N6O2S/c1-12-4-5-19(32-31-12)34-18-7-15(6-16(8-18)21-27-9-13(2)35-21)20(33)30-14(3)17-10-28-22(29-11-17)23(24,25)26/h4-11,14H,1-3H3,(H,30,33)/t14-/m1/s1 YBWKZVABJNKBEG-CQSZACIVSA-N 320003 3-[(6- methylpyridazin-3- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 170::US10202369, Example 170::US10472354, Example 170 P2X purinoceptor 2/3 Homo sapiens 2020 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320003&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397298 384223283 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842780 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)F InChI=1S/C23H23F2N3O3S/c1-13-10-27-23(32-13)17-7-16(8-19(9-17)31-18-5-6-30-12-18)22(29)28-14(2)15-3-4-20(21(24)25)26-11-15/h3-4,7-11,14,18,21H,5-6,12H2,1-2H3,(H,28,29)/t14-,18-/m1/s1 UIFKRKFOSZCXTP-RDTXWAMCSA-N 320004 N-{(1R)-1-[6- (difluoromethyl) pyridin-3-yl]ethyl}-3- (5-methyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 171::US10202369, Example 171::US10472354, Example 171 P2X purinoceptor 3 Homo sapiens 26.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320004&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397544 384223284 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842781 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)F InChI=1S/C23H23F2N3O3S/c1-13-10-27-23(32-13)17-7-16(8-19(9-17)31-18-5-6-30-12-18)22(29)28-14(2)15-3-4-20(21(24)25)26-11-15/h3-4,7-11,14,18,21H,5-6,12H2,1-2H3,(H,28,29)/t14-,18-/m1/s1 UIFKRKFOSZCXTP-RDTXWAMCSA-N 320004 N-{(1R)-1-[6- (difluoromethyl) pyridin-3-yl]ethyl}-3- (5-methyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 171::US10202369, Example 171::US10472354, Example 171 P2X purinoceptor 2/3 Homo sapiens 573 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320004&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397544 384223284 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842782 C[C@@H](NC(=O)c1cc(O[C@H]2CN3CCC2CC3)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O2S/c1-15-12-31-25(36-15)20-9-19(10-21(11-20)35-22-14-33-7-5-17(22)6-8-33)24(34)32-16(2)18-3-4-23(30-13-18)26(27,28)29/h3-4,9-13,16-17,22H,5-8,14H2,1-2H3,(H,32,34)/t16-,22+/m1/s1 BTZKHRISYBAOIH-ZHRRBRCNSA-N 320005 3-[(3R)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 172::US10202369, Example 172::US10472354, Example 172 P2X purinoceptor 3 Homo sapiens 31.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320005&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397643 384223285 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842783 C[C@@H](NC(=O)c1cc(O[C@H]2CN3CCC2CC3)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O2S/c1-15-12-31-25(36-15)20-9-19(10-21(11-20)35-22-14-33-7-5-17(22)6-8-33)24(34)32-16(2)18-3-4-23(30-13-18)26(27,28)29/h3-4,9-13,16-17,22H,5-8,14H2,1-2H3,(H,32,34)/t16-,22+/m1/s1 BTZKHRISYBAOIH-ZHRRBRCNSA-N 320005 3-[(3R)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 172::US10202369, Example 172::US10472354, Example 172 P2X purinoceptor 2/3 Homo sapiens 2107 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320005&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397643 384223285 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842784 CCc1cnc(s1)-c1cc(O[C@@H]2CN3CCC2CC3)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O2S/c1-3-21-13-30-24(37-21)18-8-17(9-20(10-18)36-22-14-34-6-4-16(22)5-7-34)23(35)33-15(2)19-11-31-25(32-12-19)26(27,28)29/h8-13,15-16,22H,3-7,14H2,1-2H3,(H,33,35)/t15-,22-/m1/s1 SVMXJSAEFPTNIN-IVZQSRNASA-N 320006 3-[(3S)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- ethyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 173::US10202369, Example 173::US10472354, Example 173 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320006&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397592 384223286 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842785 CCc1cnc(s1)-c1cc(O[C@@H]2CN3CCC2CC3)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O2S/c1-3-21-13-30-24(37-21)18-8-17(9-20(10-18)36-22-14-34-6-4-16(22)5-7-34)23(35)33-15(2)19-11-31-25(32-12-19)26(27,28)29/h8-13,15-16,22H,3-7,14H2,1-2H3,(H,33,35)/t15-,22-/m1/s1 SVMXJSAEFPTNIN-IVZQSRNASA-N 320006 3-[(3S)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- ethyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 173::US10202369, Example 173::US10472354, Example 173 P2X purinoceptor 2/3 Homo sapiens 311 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320006&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397592 384223286 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842786 CCc1cnc(s1)-c1cc(O[C@H]2CN3CCC2CC3)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O2S/c1-3-21-13-30-24(37-21)18-8-17(9-20(10-18)36-22-14-34-6-4-16(22)5-7-34)23(35)33-15(2)19-11-31-25(32-12-19)26(27,28)29/h8-13,15-16,22H,3-7,14H2,1-2H3,(H,33,35)/t15-,22+/m1/s1 SVMXJSAEFPTNIN-QRQCRPRQSA-N 320007 3-[(3R)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- ethyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 174::US10202369, Example 174::US10472354, Example 174 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320007&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397479 384223287 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842787 CCc1cnc(s1)-c1cc(O[C@H]2CN3CCC2CC3)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O2S/c1-3-21-13-30-24(37-21)18-8-17(9-20(10-18)36-22-14-34-6-4-16(22)5-7-34)23(35)33-15(2)19-11-31-25(32-12-19)26(27,28)29/h8-13,15-16,22H,3-7,14H2,1-2H3,(H,33,35)/t15-,22+/m1/s1 SVMXJSAEFPTNIN-QRQCRPRQSA-N 320007 3-[(3R)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- ethyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 174::US10202369, Example 174::US10472354, Example 174 P2X purinoceptor 2/3 Homo sapiens 790 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320007&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397479 384223287 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842788 C[C@@H](NC(=O)c1cc(O[C@@H]2CN3CCC2CC3)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O2S/c1-15-12-31-25(36-15)20-9-19(10-21(11-20)35-22-14-33-7-5-17(22)6-8-33)24(34)32-16(2)18-3-4-23(30-13-18)26(27,28)29/h3-4,9-13,16-17,22H,5-8,14H2,1-2H3,(H,32,34)/t16-,22-/m1/s1 BTZKHRISYBAOIH-OPAMFIHVSA-N 320008 3-[(3S)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 175::US10202369, Example 175::US10472354, Example 175 P2X purinoceptor 3 Homo sapiens 23.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320008&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397558 384223288 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842789 C[C@@H](NC(=O)c1cc(O[C@@H]2CN3CCC2CC3)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O2S/c1-15-12-31-25(36-15)20-9-19(10-21(11-20)35-22-14-33-7-5-17(22)6-8-33)24(34)32-16(2)18-3-4-23(30-13-18)26(27,28)29/h3-4,9-13,16-17,22H,5-8,14H2,1-2H3,(H,32,34)/t16-,22-/m1/s1 BTZKHRISYBAOIH-OPAMFIHVSA-N 320008 3-[(3S)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 175::US10202369, Example 175::US10472354, Example 175 P2X purinoceptor 2/3 Homo sapiens 1274 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320008&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397558 384223288 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842790 C[C@@H](NC(=O)c1cc(Oc2nnc(C)s2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C22H18F3N5O2S2/c1-11-9-27-20(33-11)16-6-15(7-17(8-16)32-21-30-29-13(3)34-21)19(31)28-12(2)14-4-5-18(26-10-14)22(23,24)25/h4-10,12H,1-3H3,(H,28,31)/t12-/m1/s1 IWXLKQRNUPTLAV-GFCCVEGCSA-N 320009 3-[(5-methyl- 1,3,4-thiadiazol-2- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 176::US10202369, Example 176::US10472354, Example 176 P2X purinoceptor 3 Homo sapiens 29.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320009&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397692 384223289 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842791 C[C@@H](NC(=O)c1cc(Oc2nnc(C)s2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C22H18F3N5O2S2/c1-11-9-27-20(33-11)16-6-15(7-17(8-16)32-21-30-29-13(3)34-21)19(31)28-12(2)14-4-5-18(26-10-14)22(23,24)25/h4-10,12H,1-3H3,(H,28,31)/t12-/m1/s1 IWXLKQRNUPTLAV-GFCCVEGCSA-N 320009 3-[(5-methyl- 1,3,4-thiadiazol-2- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 176::US10202369, Example 176::US10472354, Example 176 P2X purinoceptor 2/3 Homo sapiens 607 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320009&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397692 384223289 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842792 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C24H24F3N3O4S/c1-14-10-29-23(35-14)18-7-17(8-19(9-18)34-13-20-12-32-5-6-33-20)22(31)30-15(2)16-3-4-21(28-11-16)24(25,26)27/h3-4,7-11,15,20H,5-6,12-13H2,1-2H3,(H,30,31)/t15-,20-/m1/s1 LZEBVIBIWJOALL-FOIQADDNSA-N 320010 3-[(2R)-1,4-dioxan-2- ylmethoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 177::US10202369, Example 177::US10472354, Example 177 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320010&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397515 384223290 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842793 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C24H24F3N3O4S/c1-14-10-29-23(35-14)18-7-17(8-19(9-18)34-13-20-12-32-5-6-33-20)22(31)30-15(2)16-3-4-21(28-11-16)24(25,26)27/h3-4,7-11,15,20H,5-6,12-13H2,1-2H3,(H,30,31)/t15-,20-/m1/s1 LZEBVIBIWJOALL-FOIQADDNSA-N 320010 3-[(2R)-1,4-dioxan-2- ylmethoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl}benzamide::US10174016, Example 177::US10202369, Example 177::US10472354, Example 177 P2X purinoceptor 2/3 Homo sapiens 887 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320010&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397515 384223290 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842794 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O4S/c1-13-8-27-21(35-13)16-5-15(6-18(7-16)34-12-19-11-32-3-4-33-19)20(31)30-14(2)17-9-28-22(29-10-17)23(24,25)26/h5-10,14,19H,3-4,11-12H2,1-2H3,(H,30,31)/t14-,19-/m1/s1 NQEFGEXCJWOEFF-AUUYWEPGSA-N 320011 3-[(2R)-1,4-dioxan-2- ylmethoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 178::US10202369, Example 178::US10472354, Example 178 P2X purinoceptor 3 Homo sapiens 39.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320011&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397229 384223291 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842795 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O4S/c1-13-8-27-21(35-13)16-5-15(6-18(7-16)34-12-19-11-32-3-4-33-19)20(31)30-14(2)17-9-28-22(29-10-17)23(24,25)26/h5-10,14,19H,3-4,11-12H2,1-2H3,(H,30,31)/t14-,19-/m1/s1 NQEFGEXCJWOEFF-AUUYWEPGSA-N 320011 3-[(2R)-1,4-dioxan-2- ylmethoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 178::US10202369, Example 178::US10472354, Example 178 P2X purinoceptor 2/3 Homo sapiens 1880 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320011&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397229 384223291 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842796 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O4S/c1-13-10-27-22(35-13)16-7-15(8-17(9-16)34-12-18-11-32-5-6-33-18)21(31)28-14(2)19-3-4-20(30-29-19)23(24,25)26/h3-4,7-10,14,18H,5-6,11-12H2,1-2H3,(H,28,31)/t14-,18-/m1/s1 PZDPWIRLHUGUOG-RDTXWAMCSA-N 320012 3-[(2R)-1,4-dioxan-2- ylmethoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3-yl]ethyl} benzamide::US10174016, Example 179::US10202369, Example 179::US10472354, Example 179 P2X purinoceptor 3 Homo sapiens 13.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320012&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397371 384223292 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842797 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O4S/c1-13-10-27-22(35-13)16-7-15(8-17(9-16)34-12-18-11-32-5-6-33-18)21(31)28-14(2)19-3-4-20(30-29-19)23(24,25)26/h3-4,7-10,14,18H,5-6,11-12H2,1-2H3,(H,28,31)/t14-,18-/m1/s1 PZDPWIRLHUGUOG-RDTXWAMCSA-N 320012 3-[(2R)-1,4-dioxan-2- ylmethoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3-yl]ethyl} benzamide::US10174016, Example 179::US10202369, Example 179::US10472354, Example 179 P2X purinoceptor 2/3 Homo sapiens 703 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320012&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397371 384223292 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842798 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C24H24F3N3O4S/c1-14-10-29-23(35-14)18-7-17(8-19(9-18)34-13-20-12-32-5-6-33-20)22(31)30-15(2)16-3-4-21(28-11-16)24(25,26)27/h3-4,7-11,15,20H,5-6,12-13H2,1-2H3,(H,30,31)/t15-,20+/m1/s1 LZEBVIBIWJOALL-QRWLVFNGSA-N 320013 3-[(2S)-1,4-dioxan- 2-ylmethoxy]-5-(5- methyl-1,3-thiazol-2-yl)- N-{(1R)-1-[6- (trifluoromethyl)pyridin- 3-yl]ethyl}benzamide::US10174016, Example 180::US10202369, Example 180::US10472354, Example 180 P2X purinoceptor 3 Homo sapiens 31.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320013&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397137 384223293 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842799 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C24H24F3N3O4S/c1-14-10-29-23(35-14)18-7-17(8-19(9-18)34-13-20-12-32-5-6-33-20)22(31)30-15(2)16-3-4-21(28-11-16)24(25,26)27/h3-4,7-11,15,20H,5-6,12-13H2,1-2H3,(H,30,31)/t15-,20+/m1/s1 LZEBVIBIWJOALL-QRWLVFNGSA-N 320013 3-[(2S)-1,4-dioxan- 2-ylmethoxy]-5-(5- methyl-1,3-thiazol-2-yl)- N-{(1R)-1-[6- (trifluoromethyl)pyridin- 3-yl]ethyl}benzamide::US10174016, Example 180::US10202369, Example 180::US10472354, Example 180 P2X purinoceptor 2/3 Homo sapiens 1399 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320013&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397137 384223293 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842800 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O4S/c1-13-8-27-21(35-13)16-5-15(6-18(7-16)34-12-19-11-32-3-4-33-19)20(31)30-14(2)17-9-28-22(29-10-17)23(24,25)26/h5-10,14,19H,3-4,11-12H2,1-2H3,(H,30,31)/t14-,19+/m1/s1 NQEFGEXCJWOEFF-KUHUBIRLSA-N 320014 3-[(2S)-1,4-dioxan- 2-ylmethoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 181::US10202369, Example 181::US10472354, Example 181 P2X purinoceptor 3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320014&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397128 384223294 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842801 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O4S/c1-13-8-27-21(35-13)16-5-15(6-18(7-16)34-12-19-11-32-3-4-33-19)20(31)30-14(2)17-9-28-22(29-10-17)23(24,25)26/h5-10,14,19H,3-4,11-12H2,1-2H3,(H,30,31)/t14-,19+/m1/s1 NQEFGEXCJWOEFF-KUHUBIRLSA-N 320014 3-[(2S)-1,4-dioxan- 2-ylmethoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 181::US10202369, Example 181::US10472354, Example 181 P2X purinoceptor 2/3 Homo sapiens 1181 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320014&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397128 384223294 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842802 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O4S/c1-13-10-27-22(35-13)16-7-15(8-17(9-16)34-12-18-11-32-5-6-33-18)21(31)28-14(2)19-3-4-20(30-29-19)23(24,25)26/h3-4,7-10,14,18H,5-6,11-12H2,1-2H3,(H,28,31)/t14-,18+/m1/s1 PZDPWIRLHUGUOG-KDOFPFPSSA-N 320015 3-[(2S)-1,4-dioxan- 2-ylmethoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 182::US10202369, Example 182::US10472354, Example 182 P2X purinoceptor 3 Homo sapiens 63.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320015&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397642 384223295 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842803 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H23F3N4O4S/c1-13-10-27-22(35-13)16-7-15(8-17(9-16)34-12-18-11-32-5-6-33-18)21(31)28-14(2)19-3-4-20(30-29-19)23(24,25)26/h3-4,7-10,14,18H,5-6,11-12H2,1-2H3,(H,28,31)/t14-,18+/m1/s1 PZDPWIRLHUGUOG-KDOFPFPSSA-N 320015 3-[(2S)-1,4-dioxan- 2-ylmethoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 182::US10202369, Example 182::US10472354, Example 182 P2X purinoceptor 2/3 Homo sapiens 1943 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320015&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397642 384223295 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842804 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-10-26-21(33-11)16-7-15(8-17(9-16)32-14(4)13(3)30)20(31)27-12(2)18-5-6-19(29-28-18)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,27,31)/t12-,13?,14?/m1/s1 LMHZXBDHIYABCN-IYXRBSQSSA-N 320016 Trans Isomer 1; 3- {[3-hydroxybutan- 2-yl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 183::US10202369, Example 230::US10472354, Example 231 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320016&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397175 384223296 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842805 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-10-26-21(33-11)16-7-15(8-17(9-16)32-14(4)13(3)30)20(31)27-12(2)18-5-6-19(29-28-18)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,27,31)/t12-,13?,14?/m1/s1 LMHZXBDHIYABCN-IYXRBSQSSA-N 320016 Trans Isomer 1; 3- {[3-hydroxybutan- 2-yl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 183::US10202369, Example 230::US10472354, Example 231 P2X purinoceptor 2/3 Homo sapiens 398 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320016&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397175 384223296 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842806 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C21H20ClF3N4O3S/c1-10(15-7-27-20(28-8-15)21(23,24)25)29-18(31)13-4-14(19-26-9-17(22)33-19)6-16(5-13)32-12(3)11(2)30/h4-12,30H,1-3H3,(H,29,31)/t10-,11?,12?/m1/s1 QTLJKKFADUZLKR-VOMCLLRMSA-N 320017 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [2-(trifluoromethyl) pyrimidin-5-yl]ethyl} benzamide::US10174016, Example 184::US10174016, Example 185::US10174016, Example 187::US10174016, Example 188::US10202369, Example 188::US10472354, Example 188 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320017&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397494 384223297 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842807 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C21H20ClF3N4O3S/c1-10(15-7-27-20(28-8-15)21(23,24)25)29-18(31)13-4-14(19-26-9-17(22)33-19)6-16(5-13)32-12(3)11(2)30/h4-12,30H,1-3H3,(H,29,31)/t10-,11?,12?/m1/s1 QTLJKKFADUZLKR-VOMCLLRMSA-N 320017 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [2-(trifluoromethyl) pyrimidin-5-yl]ethyl} benzamide::US10174016, Example 184::US10174016, Example 185::US10174016, Example 187::US10174016, Example 188::US10202369, Example 188::US10472354, Example 188 P2X purinoceptor 2/3 Homo sapiens 128 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320017&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397494 384223297 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842808 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C21H20ClF3N4O3S/c1-10(15-7-27-20(28-8-15)21(23,24)25)29-18(31)13-4-14(19-26-9-17(22)33-19)6-16(5-13)32-12(3)11(2)30/h4-12,30H,1-3H3,(H,29,31)/t10-,11?,12?/m1/s1 QTLJKKFADUZLKR-VOMCLLRMSA-N 320017 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [2-(trifluoromethyl) pyrimidin-5-yl]ethyl} benzamide::US10174016, Example 184::US10174016, Example 185::US10174016, Example 187::US10174016, Example 188::US10202369, Example 188::US10472354, Example 188 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320017&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397494 384223297 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842809 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C21H20ClF3N4O3S/c1-10(15-7-27-20(28-8-15)21(23,24)25)29-18(31)13-4-14(19-26-9-17(22)33-19)6-16(5-13)32-12(3)11(2)30/h4-12,30H,1-3H3,(H,29,31)/t10-,11?,12?/m1/s1 QTLJKKFADUZLKR-VOMCLLRMSA-N 320017 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [2-(trifluoromethyl) pyrimidin-5-yl]ethyl} benzamide::US10174016, Example 184::US10174016, Example 185::US10174016, Example 187::US10174016, Example 188::US10202369, Example 188::US10472354, Example 188 P2X purinoceptor 2/3 Homo sapiens 123 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320017&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397494 384223297 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842810 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1ccc(nc1)C(F)(F)F InChI=1S/C22H21ClF3N3O3S/c1-11(14-4-5-18(27-9-14)22(24,25)26)29-20(31)15-6-16(21-28-10-19(23)33-21)8-17(7-15)32-13(3)12(2)30/h4-13,30H,1-3H3,(H,29,31)/t11-,12?,13?/m1/s1 HTVWJAQZHONFAU-PNESKVBLSA-N 320019 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [6-(trifluoromethyl) pyridin-3-yl]ethyl} benzamide::US10174016, Example 186::US10174016, Example 189::US10202369, Example 189::US10472354, Example 189 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320019&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397322 384223298 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842811 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1ccc(nc1)C(F)(F)F InChI=1S/C22H21ClF3N3O3S/c1-11(14-4-5-18(27-9-14)22(24,25)26)29-20(31)15-6-16(21-28-10-19(23)33-21)8-17(7-15)32-13(3)12(2)30/h4-13,30H,1-3H3,(H,29,31)/t11-,12?,13?/m1/s1 HTVWJAQZHONFAU-PNESKVBLSA-N 320019 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [6-(trifluoromethyl) pyridin-3-yl]ethyl} benzamide::US10174016, Example 186::US10174016, Example 189::US10202369, Example 189::US10472354, Example 189 P2X purinoceptor 2/3 Homo sapiens 247 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320019&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397322 384223298 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842812 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C21H20ClF3N4O3S/c1-10(15-7-27-20(28-8-15)21(23,24)25)29-18(31)13-4-14(19-26-9-17(22)33-19)6-16(5-13)32-12(3)11(2)30/h4-12,30H,1-3H3,(H,29,31)/t10-,11?,12?/m1/s1 QTLJKKFADUZLKR-VOMCLLRMSA-N 320017 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [2-(trifluoromethyl) pyrimidin-5-yl]ethyl} benzamide::US10174016, Example 184::US10174016, Example 185::US10174016, Example 187::US10174016, Example 188::US10202369, Example 188::US10472354, Example 188 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320017&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397494 384223297 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842813 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C21H20ClF3N4O3S/c1-10(15-7-27-20(28-8-15)21(23,24)25)29-18(31)13-4-14(19-26-9-17(22)33-19)6-16(5-13)32-12(3)11(2)30/h4-12,30H,1-3H3,(H,29,31)/t10-,11?,12?/m1/s1 QTLJKKFADUZLKR-VOMCLLRMSA-N 320017 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [2-(trifluoromethyl) pyrimidin-5-yl]ethyl} benzamide::US10174016, Example 184::US10174016, Example 185::US10174016, Example 187::US10174016, Example 188::US10202369, Example 188::US10472354, Example 188 P2X purinoceptor 2/3 Homo sapiens 218 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320017&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397494 384223297 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842814 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C21H20ClF3N4O3S/c1-10(15-7-27-20(28-8-15)21(23,24)25)29-18(31)13-4-14(19-26-9-17(22)33-19)6-16(5-13)32-12(3)11(2)30/h4-12,30H,1-3H3,(H,29,31)/t10-,11?,12?/m1/s1 QTLJKKFADUZLKR-VOMCLLRMSA-N 320017 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [2-(trifluoromethyl) pyrimidin-5-yl]ethyl} benzamide::US10174016, Example 184::US10174016, Example 185::US10174016, Example 187::US10174016, Example 188::US10202369, Example 188::US10472354, Example 188 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320017&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397494 384223297 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842815 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C21H20ClF3N4O3S/c1-10(15-7-27-20(28-8-15)21(23,24)25)29-18(31)13-4-14(19-26-9-17(22)33-19)6-16(5-13)32-12(3)11(2)30/h4-12,30H,1-3H3,(H,29,31)/t10-,11?,12?/m1/s1 QTLJKKFADUZLKR-VOMCLLRMSA-N 320017 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [2-(trifluoromethyl) pyrimidin-5-yl]ethyl} benzamide::US10174016, Example 184::US10174016, Example 185::US10174016, Example 187::US10174016, Example 188::US10202369, Example 188::US10472354, Example 188 P2X purinoceptor 2/3 Homo sapiens 164 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320017&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397494 384223297 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842816 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1ccc(nc1)C(F)(F)F InChI=1S/C22H21ClF3N3O3S/c1-11(14-4-5-18(27-9-14)22(24,25)26)29-20(31)15-6-16(21-28-10-19(23)33-21)8-17(7-15)32-13(3)12(2)30/h4-13,30H,1-3H3,(H,29,31)/t11-,12?,13?/m1/s1 HTVWJAQZHONFAU-PNESKVBLSA-N 320019 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [6-(trifluoromethyl) pyridin-3-yl]ethyl} benzamide::US10174016, Example 186::US10174016, Example 189::US10202369, Example 189::US10472354, Example 189 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320019&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397322 384223298 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842817 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(Cl)s1)C(=O)N[C@H](C)c1ccc(nc1)C(F)(F)F InChI=1S/C22H21ClF3N3O3S/c1-11(14-4-5-18(27-9-14)22(24,25)26)29-20(31)15-6-16(21-28-10-19(23)33-21)8-17(7-15)32-13(3)12(2)30/h4-13,30H,1-3H3,(H,29,31)/t11-,12?,13?/m1/s1 HTVWJAQZHONFAU-PNESKVBLSA-N 320019 Trans Isomer 1; 3- (5-chloro-1,3- thiazol-2-yl)-5-{[3- hydroxybutan-2- yl]oxy}-N-{(1R)-1- [6-(trifluoromethyl) pyridin-3-yl]ethyl} benzamide::US10174016, Example 186::US10174016, Example 189::US10202369, Example 189::US10472354, Example 189 P2X purinoceptor 2/3 Homo sapiens 258 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320019&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397322 384223298 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842818 C[C@@H](NC(=O)c1cc(OC2CCCN(C2)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O4S/c1-16-12-32-24(41-16)19-9-18(23(37)35-17(2)20-13-33-25(34-14-20)28(29,30)31)10-22(11-19)39-21-7-6-8-36(15-21)26(38)40-27(3,4)5/h9-14,17,21H,6-8,15H2,1-5H3,(H,35,37)/t17-,21?/m1/s1 GMVSECYUKAWWNE-OQHSHRKDSA-N 320023 US10174016, Example 190::US10202369, Example 190::US10472354, Example 190::tert-Butyl (3R)-3-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]piperidine-1-carboxylate, as a mixture of diastereoisomers P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320023&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 134338447 384223299 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842819 C[C@@H](NC(=O)c1cc(OC2CCCN(C2)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O4S/c1-16-12-32-24(41-16)19-9-18(23(37)35-17(2)20-13-33-25(34-14-20)28(29,30)31)10-22(11-19)39-21-7-6-8-36(15-21)26(38)40-27(3,4)5/h9-14,17,21H,6-8,15H2,1-5H3,(H,35,37)/t17-,21?/m1/s1 GMVSECYUKAWWNE-OQHSHRKDSA-N 320023 US10174016, Example 190::US10202369, Example 190::US10472354, Example 190::tert-Butyl (3R)-3-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]piperidine-1-carboxylate, as a mixture of diastereoisomers P2X purinoceptor 2/3 Homo sapiens 207 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320023&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 134338447 384223299 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842820 CC#CCOc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C22H22N4O2S/c1-5-6-9-28-19-11-17(10-18(12-19)22-23-13-15(3)29-22)21(27)24-16(4)20-8-7-14(2)25-26-20/h7-8,10-13,16H,9H2,1-4H3,(H,24,27)/t16-/m1/s1 WEKOJPFCJMIPGB-MRXNPFEDSA-N 320024 3-(but-2-yn-1- yloxy)-N-[(1R)- 1-(6- methylpyridazin- 3- yl)ethyl]-5- (5-methyl- 1,3-thiazol-2-yl) benzamide::US10174016, Example 191::US10202369, Example 191::US10472354, Example 191 P2X purinoceptor 3 Homo sapiens 61.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320024&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397657 384223300 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842821 CC#CCOc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C22H22N4O2S/c1-5-6-9-28-19-11-17(10-18(12-19)22-23-13-15(3)29-22)21(27)24-16(4)20-8-7-14(2)25-26-20/h7-8,10-13,16H,9H2,1-4H3,(H,24,27)/t16-/m1/s1 WEKOJPFCJMIPGB-MRXNPFEDSA-N 320024 3-(but-2-yn-1- yloxy)-N-[(1R)- 1-(6- methylpyridazin- 3- yl)ethyl]-5- (5-methyl- 1,3-thiazol-2-yl) benzamide::US10174016, Example 191::US10202369, Example 191::US10472354, Example 191 P2X purinoceptor 2/3 Homo sapiens 364 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320024&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397657 384223300 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842822 C[C@@H](NC(=O)c1cc(O[C@@H]2CN3CCC2CC3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O2S/c1-14-10-29-23(36-14)18-7-17(8-20(9-18)35-21-13-33-5-3-16(21)4-6-33)22(34)32-15(2)19-11-30-24(31-12-19)25(26,27)28/h7-12,15-16,21H,3-6,13H2,1-2H3,(H,32,34)/t15-,21-/m1/s1 XGNFOBIXAZWFEF-QVKFZJNVSA-N 320025 3-[(3S)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl} benzamide::US10174016, Example 192::US10202369, Example 192::US10472354, Example 192 P2X purinoceptor 3 Homo sapiens 12.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320025&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397263 384223301 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842823 C[C@@H](NC(=O)c1cc(O[C@@H]2CN3CCC2CC3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O2S/c1-14-10-29-23(36-14)18-7-17(8-20(9-18)35-21-13-33-5-3-16(21)4-6-33)22(34)32-15(2)19-11-30-24(31-12-19)25(26,27)28/h7-12,15-16,21H,3-6,13H2,1-2H3,(H,32,34)/t15-,21-/m1/s1 XGNFOBIXAZWFEF-QVKFZJNVSA-N 320025 3-[(3S)-1- azabicyclo[2.2.2] oct-3-yloxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl} benzamide::US10174016, Example 192::US10202369, Example 192::US10472354, Example 192 P2X purinoceptor 2/3 Homo sapiens 910 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320025&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397263 384223301 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842824 C[C@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C19H17F3N4O3S2/c1-9-6-23-17(30-9)12-3-11(4-13(5-12)29-14-7-28-8-14)15(27)24-10(2)16-25-26-18(31-16)19(20,21)22/h3-6,10,14H,7-8H2,1-2H3,(H,24,27)/t10-/m0/s1 CAKLWYTTWVXMCY-JTQLQIEISA-N 320027 US10174016, Example 194::US10202369, Example 193::US10472354, Example 193 P2X purinoceptor 3 Homo sapiens 2705 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320027&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374897 384223303 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842825 C[C@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C19H17F3N4O3S2/c1-9-6-23-17(30-9)12-3-11(4-13(5-12)29-14-7-28-8-14)15(27)24-10(2)16-25-26-18(31-16)19(20,21)22/h3-6,10,14H,7-8H2,1-2H3,(H,24,27)/t10-/m0/s1 CAKLWYTTWVXMCY-JTQLQIEISA-N 320027 US10174016, Example 194::US10202369, Example 193::US10472354, Example 193 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320027&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374897 384223303 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842826 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C19H17F3N4O3S2/c1-9-6-23-17(30-9)12-3-11(4-13(5-12)29-14-7-28-8-14)15(27)24-10(2)16-25-26-18(31-16)19(20,21)22/h3-6,10,14H,7-8H2,1-2H3,(H,24,27)/t10-/m1/s1 CAKLWYTTWVXMCY-SNVBAGLBSA-N 320026 3-(5-Methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)-N-{1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]ethyl}benzamide::US10174016, Example 193::US10202369, Example 194::US10472354, Example 194 P2X purinoceptor 3 Homo sapiens 46.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320026&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374896 384223302 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842827 C[C@@H](NC(=O)c1cc(OC2COC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C19H17F3N4O3S2/c1-9-6-23-17(30-9)12-3-11(4-13(5-12)29-14-7-28-8-14)15(27)24-10(2)16-25-26-18(31-16)19(20,21)22/h3-6,10,14H,7-8H2,1-2H3,(H,24,27)/t10-/m1/s1 CAKLWYTTWVXMCY-SNVBAGLBSA-N 320026 3-(5-Methyl-1,3-thiazol-2-yl)-5-(oxetan-3-yloxy)-N-{1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]ethyl}benzamide::US10174016, Example 193::US10202369, Example 194::US10472354, Example 194 P2X purinoceptor 2/3 Homo sapiens 579 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320026&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374896 384223302 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842828 C[C@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C21H21F3N4O3S2/c1-11-10-25-19(32-11)14-7-13(8-16(9-14)31-15-3-5-30-6-4-15)17(29)26-12(2)18-27-28-20(33-18)21(22,23)24/h7-10,12,15H,3-6H2,1-2H3,(H,26,29)/t12-/m0/s1 NWTVSPCFEGLAFO-LBPRGKRZSA-N 320029 US10174016, Example 196::US10202369, Example 195::US10472354, Example 195 P2X purinoceptor 3 Homo sapiens 380 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320029&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374899 384223305 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842829 C[C@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C21H21F3N4O3S2/c1-11-10-25-19(32-11)14-7-13(8-16(9-14)31-15-3-5-30-6-4-15)17(29)26-12(2)18-27-28-20(33-18)21(22,23)24/h7-10,12,15H,3-6H2,1-2H3,(H,26,29)/t12-/m0/s1 NWTVSPCFEGLAFO-LBPRGKRZSA-N 320029 US10174016, Example 196::US10202369, Example 195::US10472354, Example 195 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320029&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374899 384223305 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842830 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C21H21F3N4O3S2/c1-11-10-25-19(32-11)14-7-13(8-16(9-14)31-15-3-5-30-6-4-15)17(29)26-12(2)18-27-28-20(33-18)21(22,23)24/h7-10,12,15H,3-6H2,1-2H3,(H,26,29)/t12-/m1/s1 NWTVSPCFEGLAFO-GFCCVEGCSA-N 320028 3-(5-methyl-1,3-thiazol-2-yl)-5-(tetrahydro-2H-pyran-4-yloxy)-N-{1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]ethyl}benzamide::US10174016, Example 195::US10202369, Example 196::US10472354, Example 196 P2X purinoceptor 3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320028&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374898 384223304 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842831 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C21H21F3N4O3S2/c1-11-10-25-19(32-11)14-7-13(8-16(9-14)31-15-3-5-30-6-4-15)17(29)26-12(2)18-27-28-20(33-18)21(22,23)24/h7-10,12,15H,3-6H2,1-2H3,(H,26,29)/t12-/m1/s1 NWTVSPCFEGLAFO-GFCCVEGCSA-N 320028 3-(5-methyl-1,3-thiazol-2-yl)-5-(tetrahydro-2H-pyran-4-yloxy)-N-{1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]ethyl}benzamide::US10174016, Example 195::US10202369, Example 196::US10472354, Example 196 P2X purinoceptor 2/3 Homo sapiens 293 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320028&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374898 384223304 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842832 C[C@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C20H19F3N4O3S2/c1-10-8-24-18(31-10)13-5-12(6-15(7-13)30-14-3-4-29-9-14)16(28)25-11(2)17-26-27-19(32-17)20(21,22)23/h5-8,11,14H,3-4,9H2,1-2H3,(H,25,28)/t11-,14+/m0/s1 SHLRNWXFYHGFLL-SMDDNHRTSA-N 320031 US10174016, Example 198::US10202369, Example 197::US10472354, Example 197 P2X purinoceptor 3 Homo sapiens 1152 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320031&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374900 384223307 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842833 C[C@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C20H19F3N4O3S2/c1-10-8-24-18(31-10)13-5-12(6-15(7-13)30-14-3-4-29-9-14)16(28)25-11(2)17-26-27-19(32-17)20(21,22)23/h5-8,11,14H,3-4,9H2,1-2H3,(H,25,28)/t11-,14+/m0/s1 SHLRNWXFYHGFLL-SMDDNHRTSA-N 320031 US10174016, Example 198::US10202369, Example 197::US10472354, Example 197 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320031&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374900 384223307 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842834 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C20H19F3N4O3S2/c1-10-8-24-18(31-10)13-5-12(6-15(7-13)30-14-3-4-29-9-14)16(28)25-11(2)17-26-27-19(32-17)20(21,22)23/h5-8,11,14H,3-4,9H2,1-2H3,(H,25,28)/t11-,14-/m1/s1 SHLRNWXFYHGFLL-BXUZGUMPSA-N 320030 3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]ethyl}benzamide::US10174016, Example 197::US10202369, Example 198::US10472354, Example 198 P2X purinoceptor 3 Homo sapiens 30.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320030&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397585 384223306 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842835 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C20H19F3N4O3S2/c1-10-8-24-18(31-10)13-5-12(6-15(7-13)30-14-3-4-29-9-14)16(28)25-11(2)17-26-27-19(32-17)20(21,22)23/h5-8,11,14H,3-4,9H2,1-2H3,(H,25,28)/t11-,14-/m1/s1 SHLRNWXFYHGFLL-BXUZGUMPSA-N 320030 3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]ethyl}benzamide::US10174016, Example 197::US10202369, Example 198::US10472354, Example 198 P2X purinoceptor 2/3 Homo sapiens 245 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320030&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397585 384223306 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842836 C[C@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C20H19F3N4O3S2/c1-10-8-24-18(31-10)13-5-12(6-15(7-13)30-14-3-4-29-9-14)16(28)25-11(2)17-26-27-19(32-17)20(21,22)23/h5-8,11,14H,3-4,9H2,1-2H3,(H,25,28)/t11-,14-/m0/s1 SHLRNWXFYHGFLL-FZMZJTMJSA-N 320033 US10174016, Example 200::US10202369, Example 199::US10472354, Example 199 P2X purinoceptor 3 Homo sapiens 1544 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320033&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374901 384223309 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842837 C[C@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C20H19F3N4O3S2/c1-10-8-24-18(31-10)13-5-12(6-15(7-13)30-14-3-4-29-9-14)16(28)25-11(2)17-26-27-19(32-17)20(21,22)23/h5-8,11,14H,3-4,9H2,1-2H3,(H,25,28)/t11-,14-/m0/s1 SHLRNWXFYHGFLL-FZMZJTMJSA-N 320033 US10174016, Example 200::US10202369, Example 199::US10472354, Example 199 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320033&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374901 384223309 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842838 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C20H19F3N4O3S2/c1-10-8-24-18(31-10)13-5-12(6-15(7-13)30-14-3-4-29-9-14)16(28)25-11(2)17-26-27-19(32-17)20(21,22)23/h5-8,11,14H,3-4,9H2,1-2H3,(H,25,28)/t11-,14+/m1/s1 SHLRNWXFYHGFLL-RISCZKNCSA-N 320032 3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]-N-{1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]ethyl}benzamide::US10174016, Example 199::US10202369, Example 200::US10472354, Example 200 P2X purinoceptor 3 Homo sapiens 30.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320032&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397243 384223308 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842839 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1nnc(s1)C(F)(F)F InChI=1S/C20H19F3N4O3S2/c1-10-8-24-18(31-10)13-5-12(6-15(7-13)30-14-3-4-29-9-14)16(28)25-11(2)17-26-27-19(32-17)20(21,22)23/h5-8,11,14H,3-4,9H2,1-2H3,(H,25,28)/t11-,14+/m1/s1 SHLRNWXFYHGFLL-RISCZKNCSA-N 320032 3-(5-methyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]-N-{1-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]ethyl}benzamide::US10174016, Example 199::US10202369, Example 200::US10472354, Example 200 P2X purinoceptor 2/3 Homo sapiens 546 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320032&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397243 384223308 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842840 C[C@@H](NC(=O)c1cc(OC2CCNCC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-12-28-22(34-13)16-9-15(10-18(11-16)33-17-5-7-27-8-6-17)21(32)29-14(2)19-3-4-20(31-30-19)23(24,25)26/h3-4,9-12,14,17,27H,5-8H2,1-2H3,(H,29,32)/t14-/m1/s1 JTGZQMREWDOCMX-CQSZACIVSA-N 320034 3-(5-methyl-1,3-thiazol-2-yl)-5-(piperidin-4-yloxy)-N-{(1R)-1-[6-(trifluoromethyl)pyridazin-3-yl]ethyl}benzamide::US10174016, Example 201::US10202369, Example 201::US10472354, Example 201 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320034&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397404 384223310 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842841 C[C@@H](NC(=O)c1cc(OC2CCNCC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-12-28-22(34-13)16-9-15(10-18(11-16)33-17-5-7-27-8-6-17)21(32)29-14(2)19-3-4-20(31-30-19)23(24,25)26/h3-4,9-12,14,17,27H,5-8H2,1-2H3,(H,29,32)/t14-/m1/s1 JTGZQMREWDOCMX-CQSZACIVSA-N 320034 3-(5-methyl-1,3-thiazol-2-yl)-5-(piperidin-4-yloxy)-N-{(1R)-1-[6-(trifluoromethyl)pyridazin-3-yl]ethyl}benzamide::US10174016, Example 201::US10202369, Example 201::US10472354, Example 201 P2X purinoceptor 2/3 Homo sapiens 1854 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320034&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397404 384223310 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842842 C[C@@H](NC(=O)c1cc(OC2CC3(CNC3)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O2S/c1-13-8-29-21(35-13)16-3-15(4-18(5-16)34-19-6-23(7-19)11-28-12-23)20(33)32-14(2)17-9-30-22(31-10-17)24(25,26)27/h3-5,8-10,14,19,28H,6-7,11-12H2,1-2H3,(H,32,33)/t14-/m1/s1 KMHSWHWDZALJOK-CQSZACIVSA-N 320035 3-(2- azaspiro[3.3] hept- 6-yloxy)-5-(5- methyl-1,3- thiazol-2- yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 202::US10202369, Example 202::US10472354, Example 202 P2X purinoceptor 3 Homo sapiens 42.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320035 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320035&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397731 384223311 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842843 C[C@@H](NC(=O)c1cc(OC2CC3(CNC3)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O2S/c1-13-8-29-21(35-13)16-3-15(4-18(5-16)34-19-6-23(7-19)11-28-12-23)20(33)32-14(2)17-9-30-22(31-10-17)24(25,26)27/h3-5,8-10,14,19,28H,6-7,11-12H2,1-2H3,(H,32,33)/t14-/m1/s1 KMHSWHWDZALJOK-CQSZACIVSA-N 320035 3-(2- azaspiro[3.3] hept- 6-yloxy)-5-(5- methyl-1,3- thiazol-2- yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 202::US10202369, Example 202::US10472354, Example 202 P2X purinoceptor 2/3 Homo sapiens 1710 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320035 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320035&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397731 384223311 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842844 C[C@@H](NC(=O)c1cc(O[C@H]2CCNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H22F3N5O2S/c1-12-8-27-20(33-12)15-5-14(6-18(7-15)32-17-3-4-26-11-17)19(31)30-13(2)16-9-28-21(29-10-16)22(23,24)25/h5-10,13,17,26H,3-4,11H2,1-2H3,(H,30,31)/t13-,17+/m1/s1 IUOVXWVSORDTAX-DYVFJYSZSA-N 320036 3-(5-methyl- 1,3-thiazol-2- yl)-5-[(3S)- pyrrolidin-3- yloxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 203::US10202369, Example 203::US10472354, Example 203 P2X purinoceptor 3 Homo sapiens 36.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320036&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397829 384223312 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842845 C[C@@H](NC(=O)c1cc(O[C@H]2CCNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H22F3N5O2S/c1-12-8-27-20(33-12)15-5-14(6-18(7-15)32-17-3-4-26-11-17)19(31)30-13(2)16-9-28-21(29-10-16)22(23,24)25/h5-10,13,17,26H,3-4,11H2,1-2H3,(H,30,31)/t13-,17+/m1/s1 IUOVXWVSORDTAX-DYVFJYSZSA-N 320036 3-(5-methyl- 1,3-thiazol-2- yl)-5-[(3S)- pyrrolidin-3- yloxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 203::US10202369, Example 203::US10472354, Example 203 P2X purinoceptor 2/3 Homo sapiens 1561 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320036&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397829 384223312 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842846 C[C@@H](NC(=O)c1cc(OC2CCNCC2F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F4N5O2S/c1-12-8-29-21(35-12)15-5-14(6-17(7-15)34-19-3-4-28-11-18(19)24)20(33)32-13(2)16-9-30-22(31-10-16)23(25,26)27/h5-10,13,18-19,28H,3-4,11H2,1-2H3,(H,32,33)/t13-,18?,19?/m1/s1 IVYMHMMQRKFONZ-XYJCDUHRSA-N 320037 3-{[3- fluoropiperidin- 4-yl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide, as a mixture of cis isomers::US10174016, Example 204::US10202369, Example 204::US10472354, Example 204 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320037&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397537 384223313 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842847 C[C@@H](NC(=O)c1cc(OC2CCNCC2F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F4N5O2S/c1-12-8-29-21(35-12)15-5-14(6-17(7-15)34-19-3-4-28-11-18(19)24)20(33)32-13(2)16-9-30-22(31-10-16)23(25,26)27/h5-10,13,18-19,28H,3-4,11H2,1-2H3,(H,32,33)/t13-,18?,19?/m1/s1 IVYMHMMQRKFONZ-XYJCDUHRSA-N 320037 3-{[3- fluoropiperidin- 4-yl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide, as a mixture of cis isomers::US10174016, Example 204::US10202369, Example 204::US10472354, Example 204 P2X purinoceptor 2/3 Homo sapiens 82.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320037&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397537 384223313 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842848 C[C@H](NC(=O)c1cc(OC2CCCNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-9-28-21(34-13)16-6-15(7-19(8-16)33-18-4-3-5-27-12-18)20(32)31-14(2)17-10-29-22(30-11-17)23(24,25)26/h6-11,14,18,27H,3-5,12H2,1-2H3,(H,31,32)/t14-,18?/m0/s1 YIMSHVDFMHXVTO-PIVQAISJSA-N 322395 US10183937, Example 206::US10202369, Example 206::US10472354, Example 205 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322395&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138375407 384225458 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842849 C[C@H](NC(=O)c1cc(OC2CCCNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-9-28-21(34-13)16-6-15(7-19(8-16)33-18-4-3-5-27-12-18)20(32)31-14(2)17-10-29-22(30-11-17)23(24,25)26/h6-11,14,18,27H,3-5,12H2,1-2H3,(H,31,32)/t14-,18?/m0/s1 YIMSHVDFMHXVTO-PIVQAISJSA-N 322395 US10183937, Example 206::US10202369, Example 206::US10472354, Example 205 P2X purinoceptor 2/3 Homo sapiens 272 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322395&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138375407 384225458 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842850 C[C@@H](NC(=O)c1cc(OC2CCCNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-9-28-21(34-13)16-6-15(7-19(8-16)33-18-4-3-5-27-12-18)20(32)31-14(2)17-10-29-22(30-11-17)23(24,25)26/h6-11,14,18,27H,3-5,12H2,1-2H3,(H,31,32)/t14-,18?/m1/s1 YIMSHVDFMHXVTO-IKJXHCRLSA-N 322394 3-(5-methyl-1,3-thiazol-2-yl)-5-(piperidin-3-yloxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10183937, Example 205::US10202369, Example 205::US10472354, Example 206 P2X purinoceptor 3 Homo sapiens 31.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322394&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397478 384225457 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842851 C[C@@H](NC(=O)c1cc(OC2CCCNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O2S/c1-13-9-28-21(34-13)16-6-15(7-19(8-16)33-18-4-3-5-27-12-18)20(32)31-14(2)17-10-29-22(30-11-17)23(24,25)26/h6-11,14,18,27H,3-5,12H2,1-2H3,(H,31,32)/t14-,18?/m1/s1 YIMSHVDFMHXVTO-IKJXHCRLSA-N 322394 3-(5-methyl-1,3-thiazol-2-yl)-5-(piperidin-3-yloxy)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10183937, Example 205::US10202369, Example 205::US10472354, Example 206 P2X purinoceptor 2/3 Homo sapiens 1676 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322394&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397478 384225457 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842852 C[C@H](NC(=O)c1cc(OC2CCNC(C2)C(F)(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H23F6N5O2S/c1-12-9-32-21(38-12)15-5-14(6-18(7-15)37-17-3-4-31-19(8-17)23(25,26)27)20(36)35-13(2)16-10-33-22(34-11-16)24(28,29)30/h5-7,9-11,13,17,19,31H,3-4,8H2,1-2H3,(H,35,36)/t13-,17?,19?/m0/s1 RLIMWYRKEDYMPQ-LJSZUPLFSA-N 322397 US10183937, Example 208::US10202369, Example 208::US10472354, Example 207 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322397&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138375408 384225460 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842853 C[C@H](NC(=O)c1cc(OC2CCNC(C2)C(F)(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H23F6N5O2S/c1-12-9-32-21(38-12)15-5-14(6-18(7-15)37-17-3-4-31-19(8-17)23(25,26)27)20(36)35-13(2)16-10-33-22(34-11-16)24(28,29)30/h5-7,9-11,13,17,19,31H,3-4,8H2,1-2H3,(H,35,36)/t13-,17?,19?/m0/s1 RLIMWYRKEDYMPQ-LJSZUPLFSA-N 322397 US10183937, Example 208::US10202369, Example 208::US10472354, Example 207 P2X purinoceptor 2/3 Homo sapiens 87.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322397&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138375408 384225460 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842854 C[C@@H](NC(=O)c1cc(OC2CCNC(C2)C(F)(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H23F6N5O2S/c1-12-9-32-21(38-12)15-5-14(6-18(7-15)37-17-3-4-31-19(8-17)23(25,26)27)20(36)35-13(2)16-10-33-22(34-11-16)24(28,29)30/h5-7,9-11,13,17,19,31H,3-4,8H2,1-2H3,(H,35,36)/t13-,17?,19?/m1/s1 RLIMWYRKEDYMPQ-UYCDIGJJSA-N 322396 3-(5-methyl-1,3-thiazol-2-yl)-5-{[2-(trifluoromethyl)piperidin-4-yl]oxy}-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10183937, Example 207::US10202369, Example 207::US10472354, Example 208 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322396&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397615 384225459 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842855 C[C@@H](NC(=O)c1cc(OC2CCNC(C2)C(F)(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H23F6N5O2S/c1-12-9-32-21(38-12)15-5-14(6-18(7-15)37-17-3-4-31-19(8-17)23(25,26)27)20(36)35-13(2)16-10-33-22(34-11-16)24(28,29)30/h5-7,9-11,13,17,19,31H,3-4,8H2,1-2H3,(H,35,36)/t13-,17?,19?/m1/s1 RLIMWYRKEDYMPQ-UYCDIGJJSA-N 322396 3-(5-methyl-1,3-thiazol-2-yl)-5-{[2-(trifluoromethyl)piperidin-4-yl]oxy}-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10183937, Example 207::US10202369, Example 207::US10472354, Example 208 P2X purinoceptor 2/3 Homo sapiens 89.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322396&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397615 384225459 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842856 C[C@@H](NC(=O)c1cc(OC2CC3CC2CN3C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O2S/c1-13-9-29-23(36-13)16-4-15(6-20(7-16)35-21-8-19-5-17(21)12-33(19)3)22(34)32-14(2)18-10-30-24(31-11-18)25(26,27)28/h4,6-7,9-11,14,17,19,21H,5,8,12H2,1-3H3,(H,32,34)/t14-,17?,19?,21?/m1/s1 BQHHMEMNTIGDMM-LXOQGKBISA-N 320042 3-{[2-methyl-2-azabicyclo[2.2.1]hept-5-yl]oxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 209::US10202369, Example 209::US10472354, Example 209 P2X purinoceptor 3 Homo sapiens 30.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320042 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320042&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397807 384223318 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842857 C[C@@H](NC(=O)c1cc(OC2CC3CC2CN3C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O2S/c1-13-9-29-23(36-13)16-4-15(6-20(7-16)35-21-8-19-5-17(21)12-33(19)3)22(34)32-14(2)18-10-30-24(31-11-18)25(26,27)28/h4,6-7,9-11,14,17,19,21H,5,8,12H2,1-3H3,(H,32,34)/t14-,17?,19?,21?/m1/s1 BQHHMEMNTIGDMM-LXOQGKBISA-N 320042 3-{[2-methyl-2-azabicyclo[2.2.1]hept-5-yl]oxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 209::US10202369, Example 209::US10472354, Example 209 P2X purinoceptor 2/3 Homo sapiens 1470 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320042 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320042&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397807 384223318 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842858 C[C@@H](NC(=O)c1cc(OC2CCN(C)CC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-13-28-23(35-14)17-10-16(11-19(12-17)34-18-6-8-32(3)9-7-18)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,10-13,15,18H,6-9H2,1-3H3,(H,29,33)/t15-/m1/s1 HKVPHDDZBSOGJS-OAHLLOKOSA-N 320043 3-[(1- methylpiperidin- 4-yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10174016, Example 210::US10202369, Example 210::US10472354, Example 210 P2X purinoceptor 3 Homo sapiens 12.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320043&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397346 384223319 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842859 C[C@@H](NC(=O)c1cc(OC2CCN(C)CC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-13-28-23(35-14)17-10-16(11-19(12-17)34-18-6-8-32(3)9-7-18)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,10-13,15,18H,6-9H2,1-3H3,(H,29,33)/t15-/m1/s1 HKVPHDDZBSOGJS-OAHLLOKOSA-N 320043 3-[(1- methylpiperidin- 4-yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10174016, Example 210::US10202369, Example 210::US10472354, Example 210 P2X purinoceptor 2/3 Homo sapiens 1012 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320043&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397346 384223319 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842860 C[C@@H](NC(=O)c1cc(OC2CN(C)C2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C22H22F3N5O2S/c1-12-9-26-21(33-12)15-6-14(7-16(8-15)32-17-10-30(3)11-17)20(31)27-13(2)18-4-5-19(29-28-18)22(23,24)25/h4-9,13,17H,10-11H2,1-3H3,(H,27,31)/t13-/m1/s1 IRYKBWGBPIOTOU-CYBMUJFWSA-N 320044 3-[(1- methylazetidin- 3-yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10174016, Example 211::US10202369, Example 211::US10472354, Example 211 P2X purinoceptor 3 Homo sapiens 395 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320044&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397301 384223320 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842861 C[C@@H](NC(=O)c1cc(OC2CN(C)C2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C22H22F3N5O2S/c1-12-9-26-21(33-12)15-6-14(7-16(8-15)32-17-10-30(3)11-17)20(31)27-13(2)18-4-5-19(29-28-18)22(23,24)25/h4-9,13,17H,10-11H2,1-3H3,(H,27,31)/t13-/m1/s1 IRYKBWGBPIOTOU-CYBMUJFWSA-N 320044 3-[(1- methylazetidin- 3-yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10174016, Example 211::US10202369, Example 211::US10472354, Example 211 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320044&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397301 384223320 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842862 C[C@@H](NC(=O)c1cc(OC2CCN(C)CC2F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F4N5O2S/c1-13-9-29-22(36-13)16-6-15(7-18(8-16)35-20-4-5-33(3)12-19(20)25)21(34)32-14(2)17-10-30-23(31-11-17)24(26,27)28/h6-11,14,19-20H,4-5,12H2,1-3H3,(H,32,34)/t14-,19?,20?/m1/s1 XFFHESNTQMKRAI-WPUWVODUSA-N 320045 3-[(3-fluoro-1- methylpiperidin-4- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide, as a single unknown isomer::US10174016, Example 212::US10202369, Example 212::US10472354, Example 212 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320045&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397317 384223321 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842863 C[C@@H](NC(=O)c1cc(OC2CCN(C)CC2F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F4N5O2S/c1-13-9-29-22(36-13)16-6-15(7-18(8-16)35-20-4-5-33(3)12-19(20)25)21(34)32-14(2)17-10-30-23(31-11-17)24(26,27)28/h6-11,14,19-20H,4-5,12H2,1-3H3,(H,32,34)/t14-,19?,20?/m1/s1 XFFHESNTQMKRAI-WPUWVODUSA-N 320045 3-[(3-fluoro-1- methylpiperidin-4- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide, as a single unknown isomer::US10174016, Example 212::US10202369, Example 212::US10472354, Example 212 P2X purinoceptor 2/3 Homo sapiens 46.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320045&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397317 384223321 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842864 C[C@@H](NC(=O)c1cc(OCC2(CC2)N(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)34-13-23(5-6-23)32(3)4)20(33)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,5-6,13H2,1-4H3,(H,31,33)/t15-/m1/s1 GWFQILAPUSJPLG-OAHLLOKOSA-N 320046 3-{[1- (dimethylamino) cyclopropyl] methoxy}- 5-(5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 213::US10202369, Example 213::US10472354, Example 213 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320046&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397636 384223322 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842865 C[C@@H](NC(=O)c1cc(OCC2(CC2)N(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)34-13-23(5-6-23)32(3)4)20(33)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,5-6,13H2,1-4H3,(H,31,33)/t15-/m1/s1 GWFQILAPUSJPLG-OAHLLOKOSA-N 320046 3-{[1- (dimethylamino) cyclopropyl] methoxy}- 5-(5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 213::US10202369, Example 213::US10472354, Example 213 P2X purinoceptor 2/3 Homo sapiens 81.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320046&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397636 384223322 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842866 C[C@@H](NC(=O)c1cc(OC2CC3(C2)CN(C)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O2S/c1-14-9-29-22(36-14)17-4-16(5-19(6-17)35-20-7-24(8-20)12-33(3)13-24)21(34)32-15(2)18-10-30-23(31-11-18)25(26,27)28/h4-6,9-11,15,20H,7-8,12-13H2,1-3H3,(H,32,34)/t15-/m1/s1 HKONVGJPBICXCZ-OAHLLOKOSA-N 320047 3-[(2-methyl-2- azaspiro [3.3]hept- 6-yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 214::US10202369, Example 214::US10472354, Example 214 P2X purinoceptor 3 Homo sapiens 47.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320047&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397792 384223323 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842867 C[C@@H](NC(=O)c1cc(OC2CC3(C2)CN(C)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O2S/c1-14-9-29-22(36-14)17-4-16(5-19(6-17)35-20-7-24(8-20)12-33(3)13-24)21(34)32-15(2)18-10-30-23(31-11-18)25(26,27)28/h4-6,9-11,15,20H,7-8,12-13H2,1-3H3,(H,32,34)/t15-/m1/s1 HKONVGJPBICXCZ-OAHLLOKOSA-N 320047 3-[(2-methyl-2- azaspiro [3.3]hept- 6-yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 214::US10202369, Example 214::US10472354, Example 214 P2X purinoceptor 2/3 Homo sapiens 3392 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320047&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397792 384223323 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842868 C[C@@H](NC(=O)c1cc(OC2CCN(C)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-11-28-22(35-14)17-8-16(9-20(10-17)34-19-4-6-32(3)7-5-19)21(33)31-15(2)18-12-29-23(30-13-18)24(25,26)27/h8-13,15,19H,4-7H2,1-3H3,(H,31,33)/t15-/m1/s1 BKNIRTNEYAOJDL-OAHLLOKOSA-N 319972 3-[(1-Methylpiperidin-4-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 139::US10202369, Example 139::US10472354, Example 215 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319972&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397521 384223252 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842869 C[C@@H](NC(=O)c1cc(OC2CCN(C)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-11-28-22(35-14)17-8-16(9-20(10-17)34-19-4-6-32(3)7-5-19)21(33)31-15(2)18-12-29-23(30-13-18)24(25,26)27/h8-13,15,19H,4-7H2,1-3H3,(H,31,33)/t15-/m1/s1 BKNIRTNEYAOJDL-OAHLLOKOSA-N 319972 3-[(1-Methylpiperidin-4-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 139::US10202369, Example 139::US10472354, Example 215 P2X purinoceptor 2/3 Homo sapiens 992 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319972&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397521 384223252 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842870 C[C@@H](NC(=O)c1cc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O2S/c1-14-11-30-24(37-14)17-6-16(7-21(8-17)36-22-9-19-4-5-20(10-22)34(19)3)23(35)33-15(2)18-12-31-25(32-13-18)26(27,28)29/h6-8,11-13,15,19-20,22H,4-5,9-10H2,1-3H3,(H,33,35)/t15-,19-,20+,22+/m1/s1 BLUSEIUVKSVVTE-DZUANBCISA-N 320049 3-{[(3-endo)-8- methyl-8- azabicyclo[3.2.1] oct-3-yl]oxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 216::US10202369, Example 216::US10472354, Example 216 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320049&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397314 384223325 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842871 C[C@@H](NC(=O)c1cc(O[C@@H]2C[C@@H]3CC[C@H](C2)N3C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O2S/c1-14-11-30-24(37-14)17-6-16(7-21(8-17)36-22-9-19-4-5-20(10-22)34(19)3)23(35)33-15(2)18-12-31-25(32-13-18)26(27,28)29/h6-8,11-13,15,19-20,22H,4-5,9-10H2,1-3H3,(H,33,35)/t15-,19-,20+,22+/m1/s1 BLUSEIUVKSVVTE-DZUANBCISA-N 320049 3-{[(3-endo)-8- methyl-8- azabicyclo[3.2.1] oct-3-yl]oxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 216::US10202369, Example 216::US10472354, Example 216 P2X purinoceptor 2/3 Homo sapiens 928 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320049&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397314 384223325 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842872 C[C@@H](NC(=O)c1cc(O[C@H]2C[C@@H]3CC[C@H](C2)N3C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O2S/c1-14-11-30-24(37-14)17-6-16(7-21(8-17)36-22-9-19-4-5-20(10-22)34(19)3)23(35)33-15(2)18-12-31-25(32-13-18)26(27,28)29/h6-8,11-13,15,19-20,22H,4-5,9-10H2,1-3H3,(H,33,35)/t15-,19-,20+,22-/m1/s1 BLUSEIUVKSVVTE-BWKKGPAXSA-N 320050 3-{[(3-exo)-8- methyl-8- azabicyclo[3.2.1] oct-3-yl]oxy}- 5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 217::US10202369, Example 217::US10472354, Example 217 P2X purinoceptor 3 Homo sapiens 25.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320050&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397314 384223326 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842873 C[C@@H](NC(=O)c1cc(O[C@H]2C[C@@H]3CC[C@H](C2)N3C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O2S/c1-14-11-30-24(37-14)17-6-16(7-21(8-17)36-22-9-19-4-5-20(10-22)34(19)3)23(35)33-15(2)18-12-31-25(32-13-18)26(27,28)29/h6-8,11-13,15,19-20,22H,4-5,9-10H2,1-3H3,(H,33,35)/t15-,19-,20+,22-/m1/s1 BLUSEIUVKSVVTE-BWKKGPAXSA-N 320050 3-{[(3-exo)-8- methyl-8- azabicyclo[3.2.1] oct-3-yl]oxy}- 5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 217::US10202369, Example 217::US10472354, Example 217 P2X purinoceptor 2/3 Homo sapiens 1750 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320050&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397314 384223326 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842874 C[C@@H](NC(=O)c1cc(O[C@@H]2CC[C@H]3[C@H]2OCCN3C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O3S/c1-14-11-30-24(38-14)17-8-16(23(35)33-15(2)18-12-31-25(32-13-18)26(27,28)29)9-19(10-17)37-21-5-4-20-22(21)36-7-6-34(20)3/h8-13,15,20-22H,4-7H2,1-3H3,(H,33,35)/t15-,20+,21-,22-/m1/s1 FEZSJTOXTJNSGQ-WWGKXEARSA-N 320051 3-{[(4aS,7R, 7aR)-4- methyloctahydro- cyclopenta [b][1,4] oxazin-7-yl] oxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 218::US10202369, Example 218::US10472354, Example 218 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320051&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397834 384223327 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842875 C[C@@H](NC(=O)c1cc(O[C@@H]2CC[C@H]3[C@H]2OCCN3C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O3S/c1-14-11-30-24(38-14)17-8-16(23(35)33-15(2)18-12-31-25(32-13-18)26(27,28)29)9-19(10-17)37-21-5-4-20-22(21)36-7-6-34(20)3/h8-13,15,20-22H,4-7H2,1-3H3,(H,33,35)/t15-,20+,21-,22-/m1/s1 FEZSJTOXTJNSGQ-WWGKXEARSA-N 320051 3-{[(4aS,7R, 7aR)-4- methyloctahydro- cyclopenta [b][1,4] oxazin-7-yl] oxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 218::US10202369, Example 218::US10472354, Example 218 P2X purinoceptor 2/3 Homo sapiens 281 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320051&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397834 384223327 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842876 C[C@@H](NC(=O)c1cc(O[C@H]2CC[C@H]3[C@H]2OCCN3C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O3S/c1-14-11-30-24(38-14)17-8-16(23(35)33-15(2)18-12-31-25(32-13-18)26(27,28)29)9-19(10-17)37-21-5-4-20-22(21)36-7-6-34(20)3/h8-13,15,20-22H,4-7H2,1-3H3,(H,33,35)/t15-,20+,21+,22-/m1/s1 FEZSJTOXTJNSGQ-NSEXGNSCSA-N 320052 3-{[(4aS,7S, 7aR)-4- methylocta- hydro- cyclopenta[b] [1,4]oxazin- 7-yl]oxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 219::US10202369, Example 219::US10472354, Example 219 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320052&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397597 384223328 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842877 C[C@@H](NC(=O)c1cc(O[C@H]2CC[C@H]3[C@H]2OCCN3C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O3S/c1-14-11-30-24(38-14)17-8-16(23(35)33-15(2)18-12-31-25(32-13-18)26(27,28)29)9-19(10-17)37-21-5-4-20-22(21)36-7-6-34(20)3/h8-13,15,20-22H,4-7H2,1-3H3,(H,33,35)/t15-,20+,21+,22-/m1/s1 FEZSJTOXTJNSGQ-NSEXGNSCSA-N 320052 3-{[(4aS,7S, 7aR)-4- methylocta- hydro- cyclopenta[b] [1,4]oxazin- 7-yl]oxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 219::US10202369, Example 219::US10472354, Example 219 P2X purinoceptor 2/3 Homo sapiens 199 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320052&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397597 384223328 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842878 C[C@H](NC(=O)c1cc(OC2CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-19-5-4-6-32(3)13-19)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19?/m0/s1 DNVWWBHMIGZIMX-FUKCDUGKSA-N 322410 US10183937, Example 221::US10202369, Example 221::US10472354, Example 220 P2X purinoceptor 3 Homo sapiens 62.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322410&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138375409 384225472 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842879 C[C@H](NC(=O)c1cc(OC2CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-19-5-4-6-32(3)13-19)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19?/m0/s1 DNVWWBHMIGZIMX-FUKCDUGKSA-N 322410 US10183937, Example 221::US10202369, Example 221::US10472354, Example 220 P2X purinoceptor 2/3 Homo sapiens 2502 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322410&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138375409 384225472 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842880 C[C@@H](NC(=O)c1cc(OC2CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-19-5-4-6-32(3)13-19)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19?/m1/s1 DNVWWBHMIGZIMX-NYRJJRHWSA-N 322409 3-[(1-methylpiperidin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10183937, Example 220::US10202369, Example 220::US10472354, Example 221 P2X purinoceptor 3 Homo sapiens 26.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322409&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397678 384225471 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842881 C[C@@H](NC(=O)c1cc(OC2CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-19-5-4-6-32(3)13-19)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19?/m1/s1 DNVWWBHMIGZIMX-NYRJJRHWSA-N 322409 3-[(1-methylpiperidin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10183937, Example 220::US10202369, Example 220::US10472354, Example 221 P2X purinoceptor 2/3 Homo sapiens 1358 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322409&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397678 384225471 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842882 C[C@H](NC(=O)c1cc(OC2CCN(C)C(C2)C(F)(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F6N5O2S/c1-13-10-32-22(39-13)16-6-15(21(37)35-14(2)17-11-33-23(34-12-17)25(29,30)31)7-19(8-16)38-18-4-5-36(3)20(9-18)24(26,27)28/h6-8,10-12,14,18,20H,4-5,9H2,1-3H3,(H,35,37)/t14-,18?,20?/m0/s1 ALJCLRFXPKVCLC-KLOIUYPJSA-N 322412 US10183937, Example 223::US10202369, Example 223::US10472354, Example 222 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322412&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138375410 384225474 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842883 C[C@H](NC(=O)c1cc(OC2CCN(C)C(C2)C(F)(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F6N5O2S/c1-13-10-32-22(39-13)16-6-15(21(37)35-14(2)17-11-33-23(34-12-17)25(29,30)31)7-19(8-16)38-18-4-5-36(3)20(9-18)24(26,27)28/h6-8,10-12,14,18,20H,4-5,9H2,1-3H3,(H,35,37)/t14-,18?,20?/m0/s1 ALJCLRFXPKVCLC-KLOIUYPJSA-N 322412 US10183937, Example 223::US10202369, Example 223::US10472354, Example 222 P2X purinoceptor 2/3 Homo sapiens 108 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322412&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138375410 384225474 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842884 C[C@@H](NC(=O)c1cc(OC2CCN(C)C(C2)C(F)(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F6N5O2S/c1-13-10-32-22(39-13)16-6-15(21(37)35-14(2)17-11-33-23(34-12-17)25(29,30)31)7-19(8-16)38-18-4-5-36(3)20(9-18)24(26,27)28/h6-8,10-12,14,18,20H,4-5,9H2,1-3H3,(H,35,37)/t14-,18?,20?/m1/s1 ALJCLRFXPKVCLC-FHTBDLFWSA-N 322411 3-(5-methyl-1,3-thiazol-2-yl)-5-{[1-methyl-2-(trifluoromethyl)piperidin-4-yl]oxy}-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10183937, Example 222::US10202369, Example 222::US10472354, Example 223 P2X purinoceptor 3 Homo sapiens 3.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322411&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397819 384225473 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842885 C[C@@H](NC(=O)c1cc(OC2CCN(C)C(C2)C(F)(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F6N5O2S/c1-13-10-32-22(39-13)16-6-15(21(37)35-14(2)17-11-33-23(34-12-17)25(29,30)31)7-19(8-16)38-18-4-5-36(3)20(9-18)24(26,27)28/h6-8,10-12,14,18,20H,4-5,9H2,1-3H3,(H,35,37)/t14-,18?,20?/m1/s1 ALJCLRFXPKVCLC-FHTBDLFWSA-N 322411 3-(5-methyl-1,3-thiazol-2-yl)-5-{[1-methyl-2-(trifluoromethyl)piperidin-4-yl]oxy}-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10183937, Example 222::US10202369, Example 222::US10472354, Example 223 P2X purinoceptor 2/3 Homo sapiens 109 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322411&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397819 384225473 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842886 CC(C)N1CCC(CC1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C26H30F3N5O2S/c1-15(2)34-9-7-20(8-10-34)36-21-12-18(11-19(13-21)25-30-14-16(3)37-25)24(35)31-17(4)22-5-6-23(33-32-22)26(27,28)29/h5-6,11-15,17,20H,7-10H2,1-4H3,(H,31,35)/t17-/m1/s1 KRNISEGUXIGIEE-QGZVFWFLSA-N 320057 3-(5-Methyl-1,3-thiazol-2-yl)-5-{[1-(propan-2-yl)piperidin-4-yl]oxy}-N-{(1R)-1-[6-(trifluoromethyl)pyridazin-3-yl]ethyl}benzamide::US10174016, Example 224::US10202369, Example 224::US10472354, Example 224 P2X purinoceptor 3 Homo sapiens 9.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320057&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397429 384223331 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842887 CC(C)N1CCC(CC1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C26H30F3N5O2S/c1-15(2)34-9-7-20(8-10-34)36-21-12-18(11-19(13-21)25-30-14-16(3)37-25)24(35)31-17(4)22-5-6-23(33-32-22)26(27,28)29/h5-6,11-15,17,20H,7-10H2,1-4H3,(H,31,35)/t17-/m1/s1 KRNISEGUXIGIEE-QGZVFWFLSA-N 320057 3-(5-Methyl-1,3-thiazol-2-yl)-5-{[1-(propan-2-yl)piperidin-4-yl]oxy}-N-{(1R)-1-[6-(trifluoromethyl)pyridazin-3-yl]ethyl}benzamide::US10174016, Example 224::US10202369, Example 224::US10472354, Example 224 P2X purinoceptor 2/3 Homo sapiens 569 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320057&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397429 384223331 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842888 CC(C)N1CC[C@@H](C1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H28F3N5O2S/c1-14(2)33-6-5-20(13-33)35-21-8-17(7-18(9-21)23-29-10-15(3)36-23)22(34)32-16(4)19-11-30-24(31-12-19)25(26,27)28/h7-12,14,16,20H,5-6,13H2,1-4H3,(H,32,34)/t16-,20+/m1/s1 AIBFTYSUMUVEOU-UZLBHIALSA-N 320058 3-(5-methyl- 1,3-thiazol- 2-yl)-5- {[(3S)-1- (propan-2- yl)pyrrolidin- 3-yl]oxy}-N- {(1R)-1- [2-(trifluoro- methyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 225::US10202369, Example 225::US10472354, Example 225 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320058&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397786 384223332 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842889 CC(C)N1CC[C@@H](C1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H28F3N5O2S/c1-14(2)33-6-5-20(13-33)35-21-8-17(7-18(9-21)23-29-10-15(3)36-23)22(34)32-16(4)19-11-30-24(31-12-19)25(26,27)28/h7-12,14,16,20H,5-6,13H2,1-4H3,(H,32,34)/t16-,20+/m1/s1 AIBFTYSUMUVEOU-UZLBHIALSA-N 320058 3-(5-methyl- 1,3-thiazol- 2-yl)-5- {[(3S)-1- (propan-2- yl)pyrrolidin- 3-yl]oxy}-N- {(1R)-1- [2-(trifluoro- methyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 225::US10202369, Example 225::US10472354, Example 225 P2X purinoceptor 2/3 Homo sapiens 1145 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320058&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397786 384223332 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842890 COC(=O)N1CCC(CC1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O4S/c1-14-11-29-22(38-14)17-8-16(9-20(10-17)37-19-4-6-33(7-5-19)24(35)36-3)21(34)32-15(2)18-12-30-23(31-13-18)25(26,27)28/h8-13,15,19H,4-7H2,1-3H3,(H,32,34)/t15-/m1/s1 XKGQQPBORAHPPR-OAHLLOKOSA-N 320059 Methyl 4-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]piperidine-1-carboxylate::US10174016, Example 226::US10202369, Example 226::US10472354, Example 226 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320059&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397135 384223333 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842891 COC(=O)N1CCC(CC1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O4S/c1-14-11-29-22(38-14)17-8-16(9-20(10-17)37-19-4-6-33(7-5-19)24(35)36-3)21(34)32-15(2)18-12-30-23(31-13-18)25(26,27)28/h8-13,15,19H,4-7H2,1-3H3,(H,32,34)/t15-/m1/s1 XKGQQPBORAHPPR-OAHLLOKOSA-N 320059 Methyl 4-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]piperidine-1-carboxylate::US10174016, Example 226::US10202369, Example 226::US10472354, Example 226 P2X purinoceptor 2/3 Homo sapiens 59.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320059&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397135 384223333 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842892 CCOC(=O)N1CCC(CC1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O4S/c1-4-37-25(36)34-7-5-20(6-8-34)38-21-10-17(9-18(11-21)23-30-12-15(2)39-23)22(35)33-16(3)19-13-31-24(32-14-19)26(27,28)29/h9-14,16,20H,4-8H2,1-3H3,(H,33,35)/t16-/m1/s1 VLNWCOYPKWPZPZ-MRXNPFEDSA-N 320060 Ethyl 4-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]piperidine-1-carboxylate::US10174016, Example 227::US10202369, Example 227::US10472354, Example 227 P2X purinoceptor 3 Homo sapiens 13.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320060&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397225 384223334 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842893 CCOC(=O)N1CCC(CC1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O4S/c1-4-37-25(36)34-7-5-20(6-8-34)38-21-10-17(9-18(11-21)23-30-12-15(2)39-23)22(35)33-16(3)19-13-31-24(32-14-19)26(27,28)29/h9-14,16,20H,4-8H2,1-3H3,(H,33,35)/t16-/m1/s1 VLNWCOYPKWPZPZ-MRXNPFEDSA-N 320060 Ethyl 4-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]piperidine-1-carboxylate::US10174016, Example 227::US10202369, Example 227::US10472354, Example 227 P2X purinoceptor 2/3 Homo sapiens 161 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320060&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397225 384223334 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842894 CCOC(=O)N1CC[C@@H](C1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O4S/c1-4-36-24(35)33-6-5-19(13-33)37-20-8-16(7-17(9-20)22-29-10-14(2)38-22)21(34)32-15(3)18-11-30-23(31-12-18)25(26,27)28/h7-12,15,19H,4-6,13H2,1-3H3,(H,32,34)/t15-,19+/m1/s1 ZKABVOKJBCLEBM-BEFAXECRSA-N 320061 Ethyl (3S)-3-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]pyrrolidine-1-carboxylate::US10174016, Example 228::US10202369, Example 228::US10472354, Example 228 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320061&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 134338446 384223335 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842895 CCOC(=O)N1CC[C@@H](C1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O4S/c1-4-36-24(35)33-6-5-19(13-33)37-20-8-16(7-17(9-20)22-29-10-14(2)38-22)21(34)32-15(3)18-11-30-23(31-12-18)25(26,27)28/h7-12,15,19H,4-6,13H2,1-3H3,(H,32,34)/t15-,19+/m1/s1 ZKABVOKJBCLEBM-BEFAXECRSA-N 320061 Ethyl (3S)-3-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]pyrrolidine-1-carboxylate::US10174016, Example 228::US10202369, Example 228::US10472354, Example 228 P2X purinoceptor 2/3 Homo sapiens 54.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320061&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 134338446 384223335 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842896 CC(C)N1CC(C1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-13(2)32-11-20(12-32)34-19-6-16(5-17(7-19)22-28-8-14(3)35-22)21(33)31-15(4)18-9-29-23(30-10-18)24(25,26)27/h5-10,13,15,20H,11-12H2,1-4H3,(H,31,33)/t15-/m1/s1 ZGCTZBYNIOVVEC-OAHLLOKOSA-N 320062 3-(5-Methyl-1,3-thiazol-2-yl)-5-{[1-(propan-2-yl)azetidin-3-yl]oxy}-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 229::US10202369, Example 229::US10472354, Example 229 P2X purinoceptor 3 Homo sapiens 44.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320062&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397633 384223336 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842897 CC(C)N1CC(C1)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-13(2)32-11-20(12-32)34-19-6-16(5-17(7-19)22-28-8-14(3)35-22)21(33)31-15(4)18-9-29-23(30-10-18)24(25,26)27/h5-10,13,15,20H,11-12H2,1-4H3,(H,31,33)/t15-/m1/s1 ZGCTZBYNIOVVEC-OAHLLOKOSA-N 320062 3-(5-Methyl-1,3-thiazol-2-yl)-5-{[1-(propan-2-yl)azetidin-3-yl]oxy}-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 229::US10202369, Example 229::US10472354, Example 229 P2X purinoceptor 2/3 Homo sapiens 2276 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320062&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397633 384223336 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842898 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-10-26-21(33-11)16-7-15(8-17(9-16)32-14(4)13(3)30)20(31)27-12(2)18-5-6-19(29-28-18)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,27,31)/t12-,13?,14?/m0/s1 LMHZXBDHIYABCN-HSBZDZAISA-N 322420 US10183937, Example 231::US10202369, Example 231::US10472354, Example 230 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322420&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138375411 384225482 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842899 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-10-26-21(33-11)16-7-15(8-17(9-16)32-14(4)13(3)30)20(31)27-12(2)18-5-6-19(29-28-18)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,27,31)/t12-,13?,14?/m0/s1 LMHZXBDHIYABCN-HSBZDZAISA-N 322420 US10183937, Example 231::US10202369, Example 231::US10472354, Example 230 P2X purinoceptor 2/3 Homo sapiens 209 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322420 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322420&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138375411 384225482 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842900 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-10-26-21(33-11)16-7-15(8-17(9-16)32-14(4)13(3)30)20(31)27-12(2)18-5-6-19(29-28-18)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,27,31)/t12-,13?,14?/m1/s1 LMHZXBDHIYABCN-IYXRBSQSSA-N 320016 Trans Isomer 1; 3- {[3-hydroxybutan- 2-yl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 183::US10202369, Example 230::US10472354, Example 231 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320016&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397175 384223296 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842901 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-10-26-21(33-11)16-7-15(8-17(9-16)32-14(4)13(3)30)20(31)27-12(2)18-5-6-19(29-28-18)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,27,31)/t12-,13?,14?/m1/s1 LMHZXBDHIYABCN-IYXRBSQSSA-N 320016 Trans Isomer 1; 3- {[3-hydroxybutan- 2-yl]oxy}-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 183::US10202369, Example 230::US10472354, Example 231 P2X purinoceptor 2/3 Homo sapiens 706 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320016&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397175 384223296 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842902 C[C@@H](NC(=O)c1cc(OC2CCS(=O)(=O)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O4S2/c1-13-10-27-21(35-13)16-7-15(8-19(9-16)34-18-3-5-36(32,33)6-4-18)20(31)30-14(2)17-11-28-22(29-12-17)23(24,25)26/h7-12,14,18H,3-6H2,1-2H3,(H,30,31)/t14-/m1/s1 JTWSIDWRGZSZAA-CQSZACIVSA-N 320065 3-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 232::US10202369, Example 232::US10472354, Example 232 P2X purinoceptor 3 Homo sapiens 13.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320065&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397851 384223339 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842903 C[C@@H](NC(=O)c1cc(OC2CCS(=O)(=O)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O4S2/c1-13-10-27-21(35-13)16-7-15(8-19(9-16)34-18-3-5-36(32,33)6-4-18)20(31)30-14(2)17-11-28-22(29-12-17)23(24,25)26/h7-12,14,18H,3-6H2,1-2H3,(H,30,31)/t14-/m1/s1 JTWSIDWRGZSZAA-CQSZACIVSA-N 320065 3-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 232::US10202369, Example 232::US10472354, Example 232 P2X purinoceptor 2/3 Homo sapiens 759 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320065&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397851 384223339 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842904 C[C@@H](NC(=O)c1cc(OC2CCS(=O)(=O)CC2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C24H24F3N3O4S2/c1-14-12-29-23(35-14)18-9-17(10-20(11-18)34-19-5-7-36(32,33)8-6-19)22(31)30-15(2)16-3-4-21(28-13-16)24(25,26)27/h3-4,9-13,15,19H,5-8H2,1-2H3,(H,30,31)/t15-/m1/s1 BRFDVYQZWOBZCT-OAHLLOKOSA-N 320066 3-[(1,1- dioxidotetrahydro- 2H-thiopyran-4- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3-yl]ethyl} benzamide::US10174016, Example 233::US10202369, Example 233::US10472354, Example 233 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320066&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397139 384223340 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842905 C[C@@H](NC(=O)c1cc(OC2CCS(=O)(=O)CC2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C24H24F3N3O4S2/c1-14-12-29-23(35-14)18-9-17(10-20(11-18)34-19-5-7-36(32,33)8-6-19)22(31)30-15(2)16-3-4-21(28-13-16)24(25,26)27/h3-4,9-13,15,19H,5-8H2,1-2H3,(H,30,31)/t15-/m1/s1 BRFDVYQZWOBZCT-OAHLLOKOSA-N 320066 3-[(1,1- dioxidotetrahydro- 2H-thiopyran-4- yl)oxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3-yl]ethyl} benzamide::US10174016, Example 233::US10202369, Example 233::US10472354, Example 233 P2X purinoceptor 2/3 Homo sapiens 753 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320066&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397139 384223340 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842906 CCc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-4-21-13-27-24(32-21)18-9-17(10-20(11-18)31-19-5-7-30-8-6-19)23(29)28-16(3)22-14-25-15(2)12-26-22/h9-14,16,19H,4-8H2,1-3H3,(H,28,29)/t16-/m1/s1 DYONOLZVTXITOM-MRXNPFEDSA-N 320067 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 234::US10202369, Example 234::US10472354, Example 234 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320067&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397540 384223341 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842907 CCc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-4-21-13-27-24(32-21)18-9-17(10-20(11-18)31-19-5-7-30-8-6-19)23(29)28-16(3)22-14-25-15(2)12-26-22/h9-14,16,19H,4-8H2,1-3H3,(H,28,29)/t16-/m1/s1 DYONOLZVTXITOM-MRXNPFEDSA-N 320067 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 234::US10202369, Example 234::US10472354, Example 234 P2X purinoceptor 2/3 Homo sapiens 152 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320067&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397540 384223341 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842908 CCc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-3-21-14-25-23(31-21)17-10-16(11-20(12-17)30-19-6-8-29-9-7-19)22(28)24-13-18-5-4-15(2)26-27-18/h4-5,10-12,14,19H,3,6-9,13H2,1-2H3,(H,24,28) BZFPOECMUNEZDH-UHFFFAOYSA-N 320068 3-(5-ethyl-1,3- thiazol-2-yl)-N-[(6- methylpyridazin-3- yl)methyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 235::US10202369, Example 235::US10472354, Example 235 P2X purinoceptor 3 Homo sapiens 18.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320068&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397197 384223342 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842909 CCc1cnc(s1)-c1cc(OC2CCOCC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-3-21-14-25-23(31-21)17-10-16(11-20(12-17)30-19-6-8-29-9-7-19)22(28)24-13-18-5-4-15(2)26-27-18/h4-5,10-12,14,19H,3,6-9,13H2,1-2H3,(H,24,28) BZFPOECMUNEZDH-UHFFFAOYSA-N 320068 3-(5-ethyl-1,3- thiazol-2-yl)-N-[(6- methylpyridazin-3- yl)methyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 235::US10202369, Example 235::US10472354, Example 235 P2X purinoceptor 2/3 Homo sapiens 70.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320068&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397197 384223342 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842910 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C26H30N4O3S/c1-16-13-28-23(14-27-16)17(2)30-25(31)19-10-20(26-29-15-24(34-26)18-4-3-5-18)12-22(11-19)33-21-6-8-32-9-7-21/h10-15,17-18,21H,3-9H2,1-2H3,(H,30,31)/t17-/m1/s1 QOZNFPLCSPWJRX-QGZVFWFLSA-N 320069 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 236::US10202369, Example 236::US10472354, Example 236 P2X purinoceptor 3 Homo sapiens 76.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320069&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397529 384223343 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842911 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C26H30N4O3S/c1-16-13-28-23(14-27-16)17(2)30-25(31)19-10-20(26-29-15-24(34-26)18-4-3-5-18)12-22(11-19)33-21-6-8-32-9-7-21/h10-15,17-18,21H,3-9H2,1-2H3,(H,30,31)/t17-/m1/s1 QOZNFPLCSPWJRX-QGZVFWFLSA-N 320069 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 236::US10202369, Example 236::US10472354, Example 236 P2X purinoceptor 2/3 Homo sapiens 1012 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320069&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397529 384223343 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842912 Cc1ccc(CNC(=O)c2cc(OC3CCOCC3)cc(c2)-c2ncc(s2)C2CCC2)nn1 InChI=1S/C25H28N4O3S/c1-16-5-6-20(29-28-16)14-26-24(30)18-11-19(25-27-15-23(33-25)17-3-2-4-17)13-22(12-18)32-21-7-9-31-10-8-21/h5-6,11-13,15,17,21H,2-4,7-10,14H2,1H3,(H,26,30) KYDTWNODFNIYNY-UHFFFAOYSA-N 320070 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(6- methylpyridazin-3- yl)methyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 237::US10202369, Example 237::US10472354, Example 237 P2X purinoceptor 3 Homo sapiens 177 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320070&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397323 384223344 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842913 Cc1ccc(CNC(=O)c2cc(OC3CCOCC3)cc(c2)-c2ncc(s2)C2CCC2)nn1 InChI=1S/C25H28N4O3S/c1-16-5-6-20(29-28-16)14-26-24(30)18-11-19(25-27-15-23(33-25)17-3-2-4-17)13-22(12-18)32-21-7-9-31-10-8-21/h5-6,11-13,15,17,21H,2-4,7-10,14H2,1H3,(H,26,30) KYDTWNODFNIYNY-UHFFFAOYSA-N 320070 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(6- methylpyridazin-3- yl)methyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 237::US10202369, Example 237::US10472354, Example 237 P2X purinoceptor 2/3 Homo sapiens 537 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320070&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397323 384223344 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842914 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(19-12-31-25(32-13-19)26(27,28)29)33-23(34)17-9-18(24-30-14-22(37-24)16-3-2-4-16)11-21(10-17)36-20-5-7-35-8-6-20/h9-16,20H,2-8H2,1H3,(H,33,34)/t15-/m1/s1 KTFAMKPHNDUKLL-OAHLLOKOSA-N 320071 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- (tetrahydro-2H- pyran-4-yloxy)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 238::US10202369, Example 238::US10472354, Example 238 P2X purinoceptor 3 Homo sapiens 38.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320071&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397176 384223345 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842915 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(19-12-31-25(32-13-19)26(27,28)29)33-23(34)17-9-18(24-30-14-22(37-24)16-3-2-4-16)11-21(10-17)36-20-5-7-35-8-6-20/h9-16,20H,2-8H2,1H3,(H,33,34)/t15-/m1/s1 KTFAMKPHNDUKLL-OAHLLOKOSA-N 320071 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- (tetrahydro-2H- pyran-4-yloxy)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 238::US10202369, Example 238::US10472354, Example 238 P2X purinoceptor 2/3 Homo sapiens 397 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320071&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397176 384223345 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842916 C[C@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(20-10-31-25(32-11-20)26(27,28)29)33-23(34)18-7-19(24-30-12-22(37-24)17-3-2-4-17)9-21(8-18)36-14-16-5-6-35-13-16/h7-12,15-17H,2-6,13-14H2,1H3,(H,33,34)/t15-,16-/m0/s1 JWRPHAGJMIAQMD-HOTGVXAUSA-N 320072 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1S)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 239::US10202369, Example 239::US10472354, Example 239 P2X purinoceptor 3 Homo sapiens 1420 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320072&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397719 384223346 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842917 C[C@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(20-10-31-25(32-11-20)26(27,28)29)33-23(34)18-7-19(24-30-12-22(37-24)17-3-2-4-17)9-21(8-18)36-14-16-5-6-35-13-16/h7-12,15-17H,2-6,13-14H2,1H3,(H,33,34)/t15-,16-/m0/s1 JWRPHAGJMIAQMD-HOTGVXAUSA-N 320072 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1S)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 239::US10202369, Example 239::US10472354, Example 239 P2X purinoceptor 2/3 Homo sapiens 2171 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320072&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397719 384223346 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842918 CCc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-4-20-12-24-23(31-20)17-9-16(10-19(11-17)30-18-7-8-29-13-18)22(28)25-15(3)21-6-5-14(2)26-27-21/h5-6,9-12,15,18H,4,7-8,13H2,1-3H3,(H,25,28)/t15-,18-/m1/s1 OXXUGGORGDKECE-CRAIPNDOSA-N 320073 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 240::US10202369, Example 249::US10472354, Example 240 P2X purinoceptor 3 Homo sapiens 12.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320073&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397178 384223347 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842919 CCc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-4-20-12-24-23(31-20)17-9-16(10-19(11-17)30-18-7-8-29-13-18)22(28)25-15(3)21-6-5-14(2)26-27-21/h5-6,9-12,15,18H,4,7-8,13H2,1-3H3,(H,25,28)/t15-,18-/m1/s1 OXXUGGORGDKECE-CRAIPNDOSA-N 320073 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 240::US10202369, Example 249::US10472354, Example 240 P2X purinoceptor 2/3 Homo sapiens 35.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320073&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397178 384223347 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842920 CCc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-4-20-11-26-23(31-20)17-7-16(8-19(9-17)30-18-5-6-29-13-18)22(28)27-15(3)21-12-24-14(2)10-25-21/h7-12,15,18H,4-6,13H2,1-3H3,(H,27,28)/t15-,18-/m1/s1 GGGFDTSSCKHCGY-CRAIPNDOSA-N 320074 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 241::US10202369, Example 241::US10472354, Example 241 P2X purinoceptor 3 Homo sapiens 12.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320074&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397675 384223348 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842921 CCc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-4-20-11-26-23(31-20)17-7-16(8-19(9-17)30-18-5-6-29-13-18)22(28)27-15(3)21-12-24-14(2)10-25-21/h7-12,15,18H,4-6,13H2,1-3H3,(H,27,28)/t15-,18-/m1/s1 GGGFDTSSCKHCGY-CRAIPNDOSA-N 320074 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 241::US10202369, Example 241::US10472354, Example 241 P2X purinoceptor 2/3 Homo sapiens 533 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320074&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397675 384223348 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842922 CCc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-3-19-11-27-21(34-19)15-6-14(7-18(8-15)33-17-4-5-32-12-17)20(31)30-13(2)16-9-28-22(29-10-16)23(24,25)26/h6-11,13,17H,3-5,12H2,1-2H3,(H,30,31)/t13-,17-/m1/s1 CPHCWMUXIASQAI-CXAGYDPISA-N 320075 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 242::US10202369, Example 242::US10472354, Example 242 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320075&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397732 384223349 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842923 CCc1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-3-19-11-27-21(34-19)15-6-14(7-18(8-15)33-17-4-5-32-12-17)20(31)30-13(2)16-9-28-22(29-10-16)23(24,25)26/h6-11,13,17H,3-5,12H2,1-2H3,(H,30,31)/t13-,17-/m1/s1 CPHCWMUXIASQAI-CXAGYDPISA-N 320075 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 242::US10202369, Example 242::US10472354, Example 242 P2X purinoceptor 2/3 Homo sapiens 22.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320075&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397732 384223349 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842924 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C25H28N4O3S/c1-15-6-7-22(29-28-15)16(2)27-24(30)18-10-19(12-21(11-18)32-20-8-9-31-14-20)25-26-13-23(33-25)17-4-3-5-17/h6-7,10-13,16-17,20H,3-5,8-9,14H2,1-2H3,(H,27,30)/t16-,20-/m1/s1 GBDWWYIZWHGLEN-OXQOHEQNSA-N 320076 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 243::US10202369, Example 243::US10472354, Example 243 P2X purinoceptor 3 Homo sapiens 117 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320076&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397824 384223350 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842925 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C25H28N4O3S/c1-15-6-7-22(29-28-15)16(2)27-24(30)18-10-19(12-21(11-18)32-20-8-9-31-14-20)25-26-13-23(33-25)17-4-3-5-17/h6-7,10-13,16-17,20H,3-5,8-9,14H2,1-2H3,(H,27,30)/t16-,20-/m1/s1 GBDWWYIZWHGLEN-OXQOHEQNSA-N 320076 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 243::US10202369, Example 243::US10472354, Example 243 P2X purinoceptor 2/3 Homo sapiens 259 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320076&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397824 384223350 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842926 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C25H28N4O3S/c1-15-11-27-22(12-26-15)16(2)29-24(30)18-8-19(10-21(9-18)32-20-6-7-31-14-20)25-28-13-23(33-25)17-4-3-5-17/h8-13,16-17,20H,3-7,14H2,1-2H3,(H,29,30)/t16-,20-/m1/s1 FVGXVLFIHFQXPP-OXQOHEQNSA-N 320077 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 244::US10202369, Example 244::US10472354, Example 244 P2X purinoceptor 3 Homo sapiens 75.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320077&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397416 384223351 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842927 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C25H28N4O3S/c1-15-11-27-22(12-26-15)16(2)29-24(30)18-8-19(10-21(9-18)32-20-6-7-31-14-20)25-28-13-23(33-25)17-4-3-5-17/h8-13,16-17,20H,3-7,14H2,1-2H3,(H,29,30)/t16-,20-/m1/s1 FVGXVLFIHFQXPP-OXQOHEQNSA-N 320077 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 244::US10202369, Example 244::US10472354, Example 244 P2X purinoceptor 2/3 Homo sapiens 555 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320077&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397416 384223351 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842928 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F3N4O3S/c1-14(18-10-30-24(31-11-18)25(26,27)28)32-22(33)16-7-17(9-20(8-16)35-19-5-6-34-13-19)23-29-12-21(36-23)15-3-2-4-15/h7-12,14-15,19H,2-6,13H2,1H3,(H,32,33)/t14-,19-/m1/s1 IDGMWIXZIVCDCF-AUUYWEPGSA-N 320078 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2-(trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 245::US10202369, Example 245::US10472354, Example 245 P2X purinoceptor 3 Homo sapiens 34.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320078&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397471 384223352 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842929 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F3N4O3S/c1-14(18-10-30-24(31-11-18)25(26,27)28)32-22(33)16-7-17(9-20(8-16)35-19-5-6-34-13-19)23-29-12-21(36-23)15-3-2-4-15/h7-12,14-15,19H,2-6,13H2,1H3,(H,32,33)/t14-,19-/m1/s1 IDGMWIXZIVCDCF-AUUYWEPGSA-N 320078 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2-(trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 245::US10202369, Example 245::US10472354, Example 245 P2X purinoceptor 2/3 Homo sapiens 142 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320078&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397471 384223352 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842930 CC(C)c1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-14(2)22-12-25-24(32-22)18-9-17(10-20(11-18)31-19-7-8-30-13-19)23(29)26-16(4)21-6-5-15(3)27-28-21/h5-6,9-12,14,16,19H,7-8,13H2,1-4H3,(H,26,29)/t16-,19-/m1/s1 AZADLHFQZQVHQV-VQIMIIECSA-N 320079 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 246::US10202369, Example 246::US10472354, Example 246 P2X purinoceptor 3 Homo sapiens 266 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320079&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397745 384223353 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842931 CC(C)c1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-14(2)22-12-25-24(32-22)18-9-17(10-20(11-18)31-19-7-8-30-13-19)23(29)26-16(4)21-6-5-15(3)27-28-21/h5-6,9-12,14,16,19H,7-8,13H2,1-4H3,(H,26,29)/t16-,19-/m1/s1 AZADLHFQZQVHQV-VQIMIIECSA-N 320079 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 246::US10202369, Example 246::US10472354, Example 246 P2X purinoceptor 2/3 Homo sapiens 982 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320079&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397745 384223353 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842932 CC(C)c1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-14(2)22-12-27-24(32-22)18-7-17(8-20(9-18)31-19-5-6-30-13-19)23(29)28-16(4)21-11-25-15(3)10-26-21/h7-12,14,16,19H,5-6,13H2,1-4H3,(H,28,29)/t16-,19-/m1/s1 ULUQVVVXKLITBV-VQIMIIECSA-N 320080 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 247::US10202369, Example 247::US10472354, Example 247 P2X purinoceptor 3 Homo sapiens 205 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320080&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397213 384223354 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842933 CC(C)c1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-14(2)22-12-27-24(32-22)18-7-17(8-20(9-18)31-19-5-6-30-13-19)23(29)28-16(4)21-11-25-15(3)10-26-21/h7-12,14,16,19H,5-6,13H2,1-4H3,(H,28,29)/t16-,19-/m1/s1 ULUQVVVXKLITBV-VQIMIIECSA-N 320080 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 247::US10202369, Example 247::US10472354, Example 247 P2X purinoceptor 2/3 Homo sapiens 963 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320080&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397213 384223354 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842934 CC(C)c1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-13(2)20-11-28-22(35-20)16-6-15(7-19(8-16)34-18-4-5-33-12-18)21(32)31-14(3)17-9-29-23(30-10-17)24(25,26)27/h6-11,13-14,18H,4-5,12H2,1-3H3,(H,31,32)/t14-,18-/m1/s1 COCLYUAEQYUAPW-RDTXWAMCSA-N 320081 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 248::US10202369, Example 248::US10472354, Example 248 P2X purinoceptor 3 Homo sapiens 44.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320081&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397577 384223355 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842935 CC(C)c1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-13(2)20-11-28-22(35-20)16-6-15(7-19(8-16)34-18-4-5-33-12-18)21(32)31-14(3)17-9-29-23(30-10-17)24(25,26)27/h6-11,13-14,18H,4-5,12H2,1-3H3,(H,31,32)/t14-,18-/m1/s1 COCLYUAEQYUAPW-RDTXWAMCSA-N 320081 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 248::US10202369, Example 248::US10472354, Example 248 P2X purinoceptor 2/3 Homo sapiens 273 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320081&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397577 384223355 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842936 CCc1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-4-20-12-24-23(31-20)17-9-16(10-19(11-17)30-18-7-8-29-13-18)22(28)25-15(3)21-6-5-14(2)26-27-21/h5-6,9-12,15,18H,4,7-8,13H2,1-3H3,(H,25,28)/t15-,18+/m1/s1 OXXUGGORGDKECE-QAPCUYQASA-N 320082 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 249::US10472354, Example 249 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320082&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397606 384223356 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842937 CCc1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C23H26N4O3S/c1-4-20-12-24-23(31-20)17-9-16(10-19(11-17)30-18-7-8-29-13-18)22(28)25-15(3)21-6-5-14(2)26-27-21/h5-6,9-12,15,18H,4,7-8,13H2,1-3H3,(H,25,28)/t15-,18+/m1/s1 OXXUGGORGDKECE-QAPCUYQASA-N 320082 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 249::US10472354, Example 249 P2X purinoceptor 2/3 Homo sapiens 57.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320082&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397606 384223356 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842938 CCc1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-4-20-11-26-23(31-20)17-7-16(8-19(9-17)30-18-5-6-29-13-18)22(28)27-15(3)21-12-24-14(2)10-25-21/h7-12,15,18H,4-6,13H2,1-3H3,(H,27,28)/t15-,18+/m1/s1 GGGFDTSSCKHCGY-QAPCUYQASA-N 320083 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 250::US10202369, Example 250::US10472354, Example 250 P2X purinoceptor 3 Homo sapiens 15.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320083&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397653 384223357 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842939 CCc1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C23H26N4O3S/c1-4-20-11-26-23(31-20)17-7-16(8-19(9-17)30-18-5-6-29-13-18)22(28)27-15(3)21-12-24-14(2)10-25-21/h7-12,15,18H,4-6,13H2,1-3H3,(H,27,28)/t15-,18+/m1/s1 GGGFDTSSCKHCGY-QAPCUYQASA-N 320083 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 250::US10202369, Example 250::US10472354, Example 250 P2X purinoceptor 2/3 Homo sapiens 299 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320083&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397653 384223357 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842940 CCc1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-3-19-11-27-21(34-19)15-6-14(7-18(8-15)33-17-4-5-32-12-17)20(31)30-13(2)16-9-28-22(29-10-16)23(24,25)26/h6-11,13,17H,3-5,12H2,1-2H3,(H,30,31)/t13-,17+/m1/s1 CPHCWMUXIASQAI-DYVFJYSZSA-N 320084 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 251::US10202369, Example 251::US10472354, Example 251 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320084&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397624 384223358 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842941 CCc1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-3-19-11-27-21(34-19)15-6-14(7-18(8-15)33-17-4-5-32-12-17)20(31)30-13(2)16-9-28-22(29-10-16)23(24,25)26/h6-11,13,17H,3-5,12H2,1-2H3,(H,30,31)/t13-,17+/m1/s1 CPHCWMUXIASQAI-DYVFJYSZSA-N 320084 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 251::US10202369, Example 251::US10472354, Example 251 P2X purinoceptor 2/3 Homo sapiens 38.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320084&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397624 384223358 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842942 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C25H28N4O3S/c1-15-6-7-22(29-28-15)16(2)27-24(30)18-10-19(12-21(11-18)32-20-8-9-31-14-20)25-26-13-23(33-25)17-4-3-5-17/h6-7,10-13,16-17,20H,3-5,8-9,14H2,1-2H3,(H,27,30)/t16-,20+/m1/s1 GBDWWYIZWHGLEN-UZLBHIALSA-N 320085 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 252::US10202369, Example 252::US10472354, Example 252 P2X purinoceptor 3 Homo sapiens 75.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320085&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397825 384223359 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842943 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C25H28N4O3S/c1-15-6-7-22(29-28-15)16(2)27-24(30)18-10-19(12-21(11-18)32-20-8-9-31-14-20)25-26-13-23(33-25)17-4-3-5-17/h6-7,10-13,16-17,20H,3-5,8-9,14H2,1-2H3,(H,27,30)/t16-,20+/m1/s1 GBDWWYIZWHGLEN-UZLBHIALSA-N 320085 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 252::US10202369, Example 252::US10472354, Example 252 P2X purinoceptor 2/3 Homo sapiens 275 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320085&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397825 384223359 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842944 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C25H28N4O3S/c1-15-11-27-22(12-26-15)16(2)29-24(30)18-8-19(10-21(9-18)32-20-6-7-31-14-20)25-28-13-23(33-25)17-4-3-5-17/h8-13,16-17,20H,3-7,14H2,1-2H3,(H,29,30)/t16-,20+/m1/s1 FVGXVLFIHFQXPP-UZLBHIALSA-N 320086 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 253::US10202369, Example 253::US10472354, Example 253 P2X purinoceptor 3 Homo sapiens 99.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320086&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397513 384223360 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842945 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C25H28N4O3S/c1-15-11-27-22(12-26-15)16(2)29-24(30)18-8-19(10-21(9-18)32-20-6-7-31-14-20)25-28-13-23(33-25)17-4-3-5-17/h8-13,16-17,20H,3-7,14H2,1-2H3,(H,29,30)/t16-,20+/m1/s1 FVGXVLFIHFQXPP-UZLBHIALSA-N 320086 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 253::US10202369, Example 253::US10472354, Example 253 P2X purinoceptor 2/3 Homo sapiens 598 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320086&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397513 384223360 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842946 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F3N4O3S/c1-14(18-10-30-24(31-11-18)25(26,27)28)32-22(33)16-7-17(9-20(8-16)35-19-5-6-34-13-19)23-29-12-21(36-23)15-3-2-4-15/h7-12,14-15,19H,2-6,13H2,1H3,(H,32,33)/t14-,19+/m1/s1 IDGMWIXZIVCDCF-KUHUBIRLSA-N 320087 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 254::US10202369, Example 254::US10472354, Example 254 P2X purinoceptor 3 Homo sapiens 28.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320087&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397641 384223361 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842947 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F3N4O3S/c1-14(18-10-30-24(31-11-18)25(26,27)28)32-22(33)16-7-17(9-20(8-16)35-19-5-6-34-13-19)23-29-12-21(36-23)15-3-2-4-15/h7-12,14-15,19H,2-6,13H2,1H3,(H,32,33)/t14-,19+/m1/s1 IDGMWIXZIVCDCF-KUHUBIRLSA-N 320087 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 254::US10202369, Example 254::US10472354, Example 254 P2X purinoceptor 2/3 Homo sapiens 116 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320087&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397641 384223361 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842948 CC(C)c1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-14(2)22-12-25-24(32-22)18-9-17(10-20(11-18)31-19-7-8-30-13-19)23(29)26-16(4)21-6-5-15(3)27-28-21/h5-6,9-12,14,16,19H,7-8,13H2,1-4H3,(H,26,29)/t16-,19+/m1/s1 AZADLHFQZQVHQV-APWZRJJASA-N 320088 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 255::US10202369, Example 255::US10472354, Example 255 P2X purinoceptor 3 Homo sapiens 254 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320088&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397188 384223362 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842949 CC(C)c1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-14(2)22-12-25-24(32-22)18-9-17(10-20(11-18)31-19-7-8-30-13-19)23(29)26-16(4)21-6-5-15(3)27-28-21/h5-6,9-12,14,16,19H,7-8,13H2,1-4H3,(H,26,29)/t16-,19+/m1/s1 AZADLHFQZQVHQV-APWZRJJASA-N 320088 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 255::US10202369, Example 255::US10472354, Example 255 P2X purinoceptor 2/3 Homo sapiens 449 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320088&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397188 384223362 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842950 CC(C)c1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-14(2)22-12-27-24(32-22)18-7-17(8-20(9-18)31-19-5-6-30-13-19)23(29)28-16(4)21-11-25-15(3)10-26-21/h7-12,14,16,19H,5-6,13H2,1-4H3,(H,28,29)/t16-,19+/m1/s1 ULUQVVVXKLITBV-APWZRJJASA-N 320089 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 256::US10202369, Example 256::US10472354, Example 256 P2X purinoceptor 3 Homo sapiens 136 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320089&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397239 384223363 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842951 CC(C)c1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-14(2)22-12-27-24(32-22)18-7-17(8-20(9-18)31-19-5-6-30-13-19)23(29)28-16(4)21-11-25-15(3)10-26-21/h7-12,14,16,19H,5-6,13H2,1-4H3,(H,28,29)/t16-,19+/m1/s1 ULUQVVVXKLITBV-APWZRJJASA-N 320089 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 256::US10202369, Example 256::US10472354, Example 256 P2X purinoceptor 2/3 Homo sapiens 1494 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320089&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397239 384223363 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842952 CC(C)c1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-13(2)20-11-28-22(35-20)16-6-15(7-19(8-16)34-18-4-5-33-12-18)21(32)31-14(3)17-9-29-23(30-10-17)24(25,26)27/h6-11,13-14,18H,4-5,12H2,1-3H3,(H,31,32)/t14-,18+/m1/s1 COCLYUAEQYUAPW-KDOFPFPSSA-N 320090 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 257::US10202369, Example 257::US10472354, Example 257 P2X purinoceptor 3 Homo sapiens 47.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320090&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397534 384223364 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842953 CC(C)c1cnc(s1)-c1cc(O[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-13(2)20-11-28-22(35-20)16-6-15(7-19(8-16)34-18-4-5-33-12-18)21(32)31-14(3)17-9-29-23(30-10-17)24(25,26)27/h6-11,13-14,18H,4-5,12H2,1-3H3,(H,31,32)/t14-,18+/m1/s1 COCLYUAEQYUAPW-KDOFPFPSSA-N 320090 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 257::US10202369, Example 257::US10472354, Example 257 P2X purinoceptor 2/3 Homo sapiens 324 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320090&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397534 384223364 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842954 CCc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-4-21-12-25-24(32-21)19-9-18(10-20(11-19)31-14-17-7-8-30-13-17)23(29)26-16(3)22-6-5-15(2)27-28-22/h5-6,9-12,16-17H,4,7-8,13-14H2,1-3H3,(H,26,29)/t16-,17-/m1/s1 CPQUPRVXRIYFHX-IAGOWNOFSA-N 320091 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 258::US10202369, Example 258::US10472354, Example 282 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320091&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397177 384223365 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842955 CCc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-4-21-12-25-24(32-21)19-9-18(10-20(11-19)31-14-17-7-8-30-13-17)23(29)26-16(3)22-6-5-15(2)27-28-22/h5-6,9-12,16-17H,4,7-8,13-14H2,1-3H3,(H,26,29)/t16-,17-/m1/s1 CPQUPRVXRIYFHX-IAGOWNOFSA-N 320091 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 258::US10202369, Example 258::US10472354, Example 282 P2X purinoceptor 2/3 Homo sapiens 38.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320091&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397177 384223365 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842956 CCc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-4-21-11-27-24(32-21)19-7-18(8-20(9-19)31-14-17-5-6-30-13-17)23(29)28-16(3)22-12-25-15(2)10-26-22/h7-12,16-17H,4-6,13-14H2,1-3H3,(H,28,29)/t16-,17-/m1/s1 PZFOCXJBZDWRSU-IAGOWNOFSA-N 320092 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 259::US10202369, Example 259::US10472354, Example 283 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320092&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397564 384223366 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842957 CCc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-4-21-11-27-24(32-21)19-7-18(8-20(9-19)31-14-17-5-6-30-13-17)23(29)28-16(3)22-12-25-15(2)10-26-22/h7-12,16-17H,4-6,13-14H2,1-3H3,(H,28,29)/t16-,17-/m1/s1 PZFOCXJBZDWRSU-IAGOWNOFSA-N 320092 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 259::US10202369, Example 259::US10472354, Example 283 P2X purinoceptor 2/3 Homo sapiens 102 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320092&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397564 384223366 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842958 CCc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20-11-28-22(35-20)17-6-16(7-19(8-17)34-13-15-4-5-33-12-15)21(32)31-14(2)18-9-29-23(30-10-18)24(25,26)27/h6-11,14-15H,3-5,12-13H2,1-2H3,(H,31,32)/t14-,15-/m1/s1 VOKPPDDBRIDGES-HUUCEWRRSA-N 320093 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 260::US10202369, Example 260::US10472354, Example 260 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320093&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397266 384223367 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842959 CCc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20-11-28-22(35-20)17-6-16(7-19(8-17)34-13-15-4-5-33-12-15)21(32)31-14(2)18-9-29-23(30-10-18)24(25,26)27/h6-11,14-15H,3-5,12-13H2,1-2H3,(H,31,32)/t14-,15-/m1/s1 VOKPPDDBRIDGES-HUUCEWRRSA-N 320093 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 260::US10202369, Example 260::US10472354, Example 260 P2X purinoceptor 2/3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320093&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397266 384223367 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842960 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C26H30N4O3S/c1-16-6-7-23(30-29-16)17(2)28-25(31)20-10-21(26-27-13-24(34-26)19-4-3-5-19)12-22(11-20)33-15-18-8-9-32-14-18/h6-7,10-13,17-19H,3-5,8-9,14-15H2,1-2H3,(H,28,31)/t17-,18-/m1/s1 KRMAXJMLJAVOGJ-QZTJIDSGSA-N 320094 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 261::US10202369, Example 261::US10472354, Example 261 P2X purinoceptor 3 Homo sapiens 45.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320094&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397842 384223368 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842961 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C26H30N4O3S/c1-16-6-7-23(30-29-16)17(2)28-25(31)20-10-21(26-27-13-24(34-26)19-4-3-5-19)12-22(11-20)33-15-18-8-9-32-14-18/h6-7,10-13,17-19H,3-5,8-9,14-15H2,1-2H3,(H,28,31)/t17-,18-/m1/s1 KRMAXJMLJAVOGJ-QZTJIDSGSA-N 320094 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 261::US10202369, Example 261::US10472354, Example 261 P2X purinoceptor 2/3 Homo sapiens 317 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320094&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397842 384223368 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842962 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C26H30N4O3S/c1-16-11-28-23(12-27-16)17(2)30-25(31)20-8-21(26-29-13-24(34-26)19-4-3-5-19)10-22(9-20)33-15-18-6-7-32-14-18/h8-13,17-19H,3-7,14-15H2,1-2H3,(H,30,31)/t17-,18-/m1/s1 ZBRXLMDGZXDHGV-QZTJIDSGSA-N 320095 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 262::US10202369, Example 262::US10472354, Example 262 P2X purinoceptor 3 Homo sapiens 85.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320095&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397383 384223369 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842963 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C26H30N4O3S/c1-16-11-28-23(12-27-16)17(2)30-25(31)20-8-21(26-29-13-24(34-26)19-4-3-5-19)10-22(9-20)33-15-18-6-7-32-14-18/h8-13,17-19H,3-7,14-15H2,1-2H3,(H,30,31)/t17-,18-/m1/s1 ZBRXLMDGZXDHGV-QZTJIDSGSA-N 320095 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 262::US10202369, Example 262::US10472354, Example 262 P2X purinoceptor 2/3 Homo sapiens 383 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320095&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397383 384223369 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842964 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(20-10-31-25(32-11-20)26(27,28)29)33-23(34)18-7-19(24-30-12-22(37-24)17-3-2-4-17)9-21(8-18)36-14-16-5-6-35-13-16/h7-12,15-17H,2-6,13-14H2,1H3,(H,33,34)/t15-,16-/m1/s1 JWRPHAGJMIAQMD-HZPDHXFCSA-N 320096 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 263::US10202369, Example 263::US10472354, Example 263 P2X purinoceptor 3 Homo sapiens 33.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320096&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397122 384223370 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842965 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(20-10-31-25(32-11-20)26(27,28)29)33-23(34)18-7-19(24-30-12-22(37-24)17-3-2-4-17)9-21(8-18)36-14-16-5-6-35-13-16/h7-12,15-17H,2-6,13-14H2,1H3,(H,33,34)/t15-,16-/m1/s1 JWRPHAGJMIAQMD-HZPDHXFCSA-N 320096 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 263::US10202369, Example 263::US10472354, Example 263 P2X purinoceptor 2/3 Homo sapiens 170 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320096&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397122 384223370 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842966 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-26-25(33-23)20-9-19(10-21(11-20)32-14-18-7-8-31-13-18)24(30)27-17(4)22-6-5-16(3)28-29-22/h5-6,9-12,15,17-18H,7-8,13-14H2,1-4H3,(H,27,30)/t17-,18-/m1/s1 HVLSFPXITWENER-QZTJIDSGSA-N 320097 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 264::US10202369, Example 264::US10472354, Example 264 P2X purinoceptor 3 Homo sapiens 81.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320097&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397620 384223371 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842967 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-26-25(33-23)20-9-19(10-21(11-20)32-14-18-7-8-31-13-18)24(30)27-17(4)22-6-5-16(3)28-29-22/h5-6,9-12,15,17-18H,7-8,13-14H2,1-4H3,(H,27,30)/t17-,18-/m1/s1 HVLSFPXITWENER-QZTJIDSGSA-N 320097 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 264::US10202369, Example 264::US10472354, Example 264 P2X purinoceptor 2/3 Homo sapiens 530 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320097&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397620 384223371 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842968 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-28-25(33-23)20-7-19(8-21(9-20)32-14-18-5-6-31-13-18)24(30)29-17(4)22-11-26-16(3)10-27-22/h7-12,15,17-18H,5-6,13-14H2,1-4H3,(H,29,30)/t17-,18-/m1/s1 MWBSFWZECXCRJX-QZTJIDSGSA-N 320098 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 265::US10202369, Example 265::US10472354, Example 265 P2X purinoceptor 3 Homo sapiens 104 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320098&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397233 384223372 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842969 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-28-25(33-23)20-7-19(8-21(9-20)32-14-18-5-6-31-13-18)24(30)29-17(4)22-11-26-16(3)10-27-22/h7-12,15,17-18H,5-6,13-14H2,1-4H3,(H,29,30)/t17-,18-/m1/s1 MWBSFWZECXCRJX-QZTJIDSGSA-N 320098 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 265::US10202369, Example 265::US10472354, Example 265 P2X purinoceptor 2/3 Homo sapiens 696 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320098&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397233 384223372 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842970 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-11-29-23(36-21)18-6-17(7-20(8-18)35-13-16-4-5-34-12-16)22(33)32-15(3)19-9-30-24(31-10-19)25(26,27)28/h6-11,14-16H,4-5,12-13H2,1-3H3,(H,32,33)/t15-,16-/m1/s1 JZRSBKDBMGCFDH-HZPDHXFCSA-N 320099 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 266::US10202369, Example 266::US10472354, Example 266 P2X purinoceptor 3 Homo sapiens 41.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320099&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397337 384223373 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842971 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-11-29-23(36-21)18-6-17(7-20(8-18)35-13-16-4-5-34-12-16)22(33)32-15(3)19-9-30-24(31-10-19)25(26,27)28/h6-11,14-16H,4-5,12-13H2,1-3H3,(H,32,33)/t15-,16-/m1/s1 JZRSBKDBMGCFDH-HZPDHXFCSA-N 320099 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 266::US10202369, Example 266::US10472354, Example 266 P2X purinoceptor 2/3 Homo sapiens 367 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320099&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397337 384223373 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842972 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-4-21-12-25-24(32-21)19-9-18(10-20(11-19)31-14-17-7-8-30-13-17)23(29)26-16(3)22-6-5-15(2)27-28-22/h5-6,9-12,16-17H,4,7-8,13-14H2,1-3H3,(H,26,29)/t16-,17+/m1/s1 CPQUPRVXRIYFHX-SJORKVTESA-N 320109 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 276::US10472354, Example 276 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320109&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397609 384223383 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842973 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-4-21-12-25-24(32-21)19-9-18(10-20(11-19)31-14-17-7-8-30-13-17)23(29)26-16(3)22-6-5-15(2)27-28-22/h5-6,9-12,16-17H,4,7-8,13-14H2,1-3H3,(H,26,29)/t16-,17+/m1/s1 CPQUPRVXRIYFHX-SJORKVTESA-N 320109 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 276::US10472354, Example 276 P2X purinoceptor 2/3 Homo sapiens 173 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320109&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397609 384223383 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842974 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-4-21-11-27-24(32-21)19-7-18(8-20(9-19)31-14-17-5-6-30-13-17)23(29)28-16(3)22-12-25-15(2)10-26-22/h7-12,16-17H,4-6,13-14H2,1-3H3,(H,28,29)/t16-,17+/m1/s1 PZFOCXJBZDWRSU-SJORKVTESA-N 320110 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 277::US10472354, Example 277 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320110&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397468 384223384 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842975 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-4-21-11-27-24(32-21)19-7-18(8-20(9-19)31-14-17-5-6-30-13-17)23(29)28-16(3)22-12-25-15(2)10-26-22/h7-12,16-17H,4-6,13-14H2,1-3H3,(H,28,29)/t16-,17+/m1/s1 PZFOCXJBZDWRSU-SJORKVTESA-N 320110 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 277::US10472354, Example 277 P2X purinoceptor 2/3 Homo sapiens 392 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320110&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397468 384223384 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842976 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20-11-28-22(35-20)17-6-16(7-19(8-17)34-13-15-4-5-33-12-15)21(32)31-14(2)18-9-29-23(30-10-18)24(25,26)27/h6-11,14-15H,3-5,12-13H2,1-2H3,(H,31,32)/t14-,15+/m1/s1 VOKPPDDBRIDGES-CABCVRRESA-N 320111 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 278::US10472354, Example 278 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320111&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397387 384223385 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842977 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20-11-28-22(35-20)17-6-16(7-19(8-17)34-13-15-4-5-33-12-15)21(32)31-14(2)18-9-29-23(30-10-18)24(25,26)27/h6-11,14-15H,3-5,12-13H2,1-2H3,(H,31,32)/t14-,15+/m1/s1 VOKPPDDBRIDGES-CABCVRRESA-N 320111 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 278::US10472354, Example 278 P2X purinoceptor 2/3 Homo sapiens 35.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320111&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397387 384223385 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842978 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C26H30N4O3S/c1-16-6-7-23(30-29-16)17(2)28-25(31)20-10-21(26-27-13-24(34-26)19-4-3-5-19)12-22(11-20)33-15-18-8-9-32-14-18/h6-7,10-13,17-19H,3-5,8-9,14-15H2,1-2H3,(H,28,31)/t17-,18+/m1/s1 KRMAXJMLJAVOGJ-MSOLQXFVSA-N 319968 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-5-[(3S)-tetrahydrofuran-3-ylmethoxy]benzamide::US10174016, Example 135::US10202369, Example 135::US10472354, Example 270 P2X purinoceptor 3 Homo sapiens 25.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319968&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397422 384223248 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842979 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C26H30N4O3S/c1-16-6-7-23(30-29-16)17(2)28-25(31)20-10-21(26-27-13-24(34-26)19-4-3-5-19)12-22(11-20)33-15-18-8-9-32-14-18/h6-7,10-13,17-19H,3-5,8-9,14-15H2,1-2H3,(H,28,31)/t17-,18+/m1/s1 KRMAXJMLJAVOGJ-MSOLQXFVSA-N 319968 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(6-methylpyridazin-3-yl)ethyl]-5-[(3S)-tetrahydrofuran-3-ylmethoxy]benzamide::US10174016, Example 135::US10202369, Example 135::US10472354, Example 270 P2X purinoceptor 2/3 Homo sapiens 100.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319968&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397422 384223248 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842980 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C26H30N4O3S/c1-16-11-28-23(12-27-16)17(2)30-25(31)20-8-21(26-29-13-24(34-26)19-4-3-5-19)10-22(9-20)33-15-18-6-7-32-14-18/h8-13,17-19H,3-7,14-15H2,1-2H3,(H,30,31)/t17-,18+/m1/s1 ZBRXLMDGZXDHGV-MSOLQXFVSA-N 319954 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-5-[(3S)-tetrahydrofuran-3-ylmethoxy]benzamide::US10174016, Example 121::US10202369, Example 121::US10472354, Example 271 P2X purinoceptor 3 Homo sapiens 45.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319954&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397486 384223234 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842981 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C26H30N4O3S/c1-16-11-28-23(12-27-16)17(2)30-25(31)20-8-21(26-29-13-24(34-26)19-4-3-5-19)10-22(9-20)33-15-18-6-7-32-14-18/h8-13,17-19H,3-7,14-15H2,1-2H3,(H,30,31)/t17-,18+/m1/s1 ZBRXLMDGZXDHGV-MSOLQXFVSA-N 319954 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-N-[(1R)-1-(5-methylpyrazin-2-yl)ethyl]-5-[(3S)-tetrahydrofuran-3-ylmethoxy]benzamide::US10174016, Example 121::US10202369, Example 121::US10472354, Example 271 P2X purinoceptor 2/3 Homo sapiens 230 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319954&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397486 384223234 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842982 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(20-10-31-25(32-11-20)26(27,28)29)33-23(34)18-7-19(24-30-12-22(37-24)17-3-2-4-17)9-21(8-18)36-14-16-5-6-35-13-16/h7-12,15-17H,2-6,13-14H2,1H3,(H,33,34)/t15-,16+/m1/s1 JWRPHAGJMIAQMD-CVEARBPZSA-N 319956 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 123::US10202369, Example 123::US10472354, Example 272 P2X purinoceptor 3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319956&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397161 384223236 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842983 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(20-10-31-25(32-11-20)26(27,28)29)33-23(34)18-7-19(24-30-12-22(37-24)17-3-2-4-17)9-21(8-18)36-14-16-5-6-35-13-16/h7-12,15-17H,2-6,13-14H2,1H3,(H,33,34)/t15-,16+/m1/s1 JWRPHAGJMIAQMD-CVEARBPZSA-N 319956 3-(5-Cyclobutyl-1,3-thiazol-2-yl)-5-[(3S)-tetrahydrofuran-3-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 123::US10202369, Example 123::US10472354, Example 272 P2X purinoceptor 2/3 Homo sapiens 128 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319956&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397161 384223236 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842984 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-26-25(33-23)20-9-19(10-21(11-20)32-14-18-7-8-31-13-18)24(30)27-17(4)22-6-5-16(3)28-29-22/h5-6,9-12,15,17-18H,7-8,13-14H2,1-4H3,(H,27,30)/t17-,18+/m1/s1 HVLSFPXITWENER-MSOLQXFVSA-N 320112 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 279::US10472354, Example 279 P2X purinoceptor 3 Homo sapiens 28.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320112&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397672 384223386 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842985 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-26-25(33-23)20-9-19(10-21(11-20)32-14-18-7-8-31-13-18)24(30)27-17(4)22-6-5-16(3)28-29-22/h5-6,9-12,15,17-18H,7-8,13-14H2,1-4H3,(H,27,30)/t17-,18+/m1/s1 HVLSFPXITWENER-MSOLQXFVSA-N 320112 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 279::US10472354, Example 279 P2X purinoceptor 2/3 Homo sapiens 254 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320112&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397672 384223386 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842986 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-28-25(33-23)20-7-19(8-21(9-20)32-14-18-5-6-31-13-18)24(30)29-17(4)22-11-26-16(3)10-27-22/h7-12,15,17-18H,5-6,13-14H2,1-4H3,(H,29,30)/t17-,18+/m1/s1 MWBSFWZECXCRJX-MSOLQXFVSA-N 320113 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 280::US10472354, Example 280 P2X purinoceptor 3 Homo sapiens 75.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320113&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397160 384223387 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842987 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-28-25(33-23)20-7-19(8-21(9-20)32-14-18-5-6-31-13-18)24(30)29-17(4)22-11-26-16(3)10-27-22/h7-12,15,17-18H,5-6,13-14H2,1-4H3,(H,29,30)/t17-,18+/m1/s1 MWBSFWZECXCRJX-MSOLQXFVSA-N 320113 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 280::US10472354, Example 280 P2X purinoceptor 2/3 Homo sapiens 873 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320113&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397160 384223387 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842988 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-11-29-23(36-21)18-6-17(7-20(8-18)35-13-16-4-5-34-12-16)22(33)32-15(3)19-9-30-24(31-10-19)25(26,27)28/h6-11,14-16H,4-5,12-13H2,1-3H3,(H,32,33)/t15-,16+/m1/s1 JZRSBKDBMGCFDH-CVEARBPZSA-N 320114 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 281::US10472354, Example 281 P2X purinoceptor 3 Homo sapiens 21.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320114&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397335 384223388 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842989 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-11-29-23(36-21)18-6-17(7-20(8-18)35-13-16-4-5-34-12-16)22(33)32-15(3)19-9-30-24(31-10-19)25(26,27)28/h6-11,14-16H,4-5,12-13H2,1-3H3,(H,32,33)/t15-,16+/m1/s1 JZRSBKDBMGCFDH-CVEARBPZSA-N 320114 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 281::US10472354, Example 281 P2X purinoceptor 2/3 Homo sapiens 191 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320114&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397335 384223388 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842990 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-4-21-12-25-24(32-21)19-9-18(10-20(11-19)31-14-17-7-8-30-13-17)23(29)26-16(3)22-6-5-15(2)27-28-22/h5-6,9-12,16-17H,4,7-8,13-14H2,1-3H3,(H,26,29)/t16-,17+/m1/s1 CPQUPRVXRIYFHX-SJORKVTESA-N 320109 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 276::US10472354, Example 276 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320109&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397609 384223383 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842991 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-4-21-12-25-24(32-21)19-9-18(10-20(11-19)31-14-17-7-8-30-13-17)23(29)26-16(3)22-6-5-15(2)27-28-22/h5-6,9-12,16-17H,4,7-8,13-14H2,1-3H3,(H,26,29)/t16-,17+/m1/s1 CPQUPRVXRIYFHX-SJORKVTESA-N 320109 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 276::US10472354, Example 276 P2X purinoceptor 2/3 Homo sapiens 76.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320109&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397609 384223383 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842992 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-4-21-11-27-24(32-21)19-7-18(8-20(9-19)31-14-17-5-6-30-13-17)23(29)28-16(3)22-12-25-15(2)10-26-22/h7-12,16-17H,4-6,13-14H2,1-3H3,(H,28,29)/t16-,17+/m1/s1 PZFOCXJBZDWRSU-SJORKVTESA-N 320110 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 277::US10472354, Example 277 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320110&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397468 384223384 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842993 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-4-21-11-27-24(32-21)19-7-18(8-20(9-19)31-14-17-5-6-30-13-17)23(29)28-16(3)22-12-25-15(2)10-26-22/h7-12,16-17H,4-6,13-14H2,1-3H3,(H,28,29)/t16-,17+/m1/s1 PZFOCXJBZDWRSU-SJORKVTESA-N 320110 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 277::US10472354, Example 277 P2X purinoceptor 2/3 Homo sapiens 96.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320110&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397468 384223384 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842994 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20-11-28-22(35-20)17-6-16(7-19(8-17)34-13-15-4-5-33-12-15)21(32)31-14(2)18-9-29-23(30-10-18)24(25,26)27/h6-11,14-15H,3-5,12-13H2,1-2H3,(H,31,32)/t14-,15+/m1/s1 VOKPPDDBRIDGES-CABCVRRESA-N 320111 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 278::US10472354, Example 278 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320111&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397387 384223385 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842995 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20-11-28-22(35-20)17-6-16(7-19(8-17)34-13-15-4-5-33-12-15)21(32)31-14(2)18-9-29-23(30-10-18)24(25,26)27/h6-11,14-15H,3-5,12-13H2,1-2H3,(H,31,32)/t14-,15+/m1/s1 VOKPPDDBRIDGES-CABCVRRESA-N 320111 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 278::US10472354, Example 278 P2X purinoceptor 2/3 Homo sapiens 23.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320111&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397387 384223385 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842996 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-26-25(33-23)20-9-19(10-21(11-20)32-14-18-7-8-31-13-18)24(30)27-17(4)22-6-5-16(3)28-29-22/h5-6,9-12,15,17-18H,7-8,13-14H2,1-4H3,(H,27,30)/t17-,18+/m1/s1 HVLSFPXITWENER-MSOLQXFVSA-N 320112 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 279::US10472354, Example 279 P2X purinoceptor 3 Homo sapiens 115 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320112&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397672 384223386 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842997 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-26-25(33-23)20-9-19(10-21(11-20)32-14-18-7-8-31-13-18)24(30)27-17(4)22-6-5-16(3)28-29-22/h5-6,9-12,15,17-18H,7-8,13-14H2,1-4H3,(H,27,30)/t17-,18+/m1/s1 HVLSFPXITWENER-MSOLQXFVSA-N 320112 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 279::US10472354, Example 279 P2X purinoceptor 2/3 Homo sapiens 956 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320112&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397672 384223386 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 842998 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-28-25(33-23)20-7-19(8-21(9-20)32-14-18-5-6-31-13-18)24(30)29-17(4)22-11-26-16(3)10-27-22/h7-12,15,17-18H,5-6,13-14H2,1-4H3,(H,29,30)/t17-,18+/m1/s1 MWBSFWZECXCRJX-MSOLQXFVSA-N 320113 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 280::US10472354, Example 280 P2X purinoceptor 3 Homo sapiens 51.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320113&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397160 384223387 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 842999 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C25H30N4O3S/c1-15(2)23-12-28-25(33-23)20-7-19(8-21(9-20)32-14-18-5-6-31-13-18)24(30)29-17(4)22-11-26-16(3)10-27-22/h7-12,15,17-18H,5-6,13-14H2,1-4H3,(H,29,30)/t17-,18+/m1/s1 MWBSFWZECXCRJX-MSOLQXFVSA-N 320113 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 280::US10472354, Example 280 P2X purinoceptor 2/3 Homo sapiens 682 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320113&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397160 384223387 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843000 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-11-29-23(36-21)18-6-17(7-20(8-18)35-13-16-4-5-34-12-16)22(33)32-15(3)19-9-30-24(31-10-19)25(26,27)28/h6-11,14-16H,4-5,12-13H2,1-3H3,(H,32,33)/t15-,16+/m1/s1 JZRSBKDBMGCFDH-CVEARBPZSA-N 320114 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 281::US10472354, Example 281 P2X purinoceptor 3 Homo sapiens 26.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320114&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397335 384223388 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843001 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-11-29-23(36-21)18-6-17(7-20(8-18)35-13-16-4-5-34-12-16)22(33)32-15(3)19-9-30-24(31-10-19)25(26,27)28/h6-11,14-16H,4-5,12-13H2,1-3H3,(H,32,33)/t15-,16+/m1/s1 JZRSBKDBMGCFDH-CVEARBPZSA-N 320114 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 281::US10472354, Example 281 P2X purinoceptor 2/3 Homo sapiens 198 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320114&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397335 384223388 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843002 CCc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-4-21-12-25-24(32-21)19-9-18(10-20(11-19)31-14-17-7-8-30-13-17)23(29)26-16(3)22-6-5-15(2)27-28-22/h5-6,9-12,16-17H,4,7-8,13-14H2,1-3H3,(H,26,29)/t16-,17-/m1/s1 CPQUPRVXRIYFHX-IAGOWNOFSA-N 320091 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 258::US10202369, Example 258::US10472354, Example 282 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320091&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397177 384223365 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843003 CCc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C24H28N4O3S/c1-4-21-12-25-24(32-21)19-9-18(10-20(11-19)31-14-17-7-8-30-13-17)23(29)26-16(3)22-6-5-15(2)27-28-22/h5-6,9-12,16-17H,4,7-8,13-14H2,1-3H3,(H,26,29)/t16-,17-/m1/s1 CPQUPRVXRIYFHX-IAGOWNOFSA-N 320091 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 258::US10202369, Example 258::US10472354, Example 282 P2X purinoceptor 2/3 Homo sapiens 209 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320091&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397177 384223365 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843004 CCc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-4-21-11-27-24(32-21)19-7-18(8-20(9-19)31-14-17-5-6-30-13-17)23(29)28-16(3)22-12-25-15(2)10-26-22/h7-12,16-17H,4-6,13-14H2,1-3H3,(H,28,29)/t16-,17-/m1/s1 PZFOCXJBZDWRSU-IAGOWNOFSA-N 320092 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 259::US10202369, Example 259::US10472354, Example 283 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320092&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397564 384223366 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843005 CCc1cnc(s1)-c1cc(OC[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C24H28N4O3S/c1-4-21-11-27-24(32-21)19-7-18(8-20(9-19)31-14-17-5-6-30-13-17)23(29)28-16(3)22-12-25-15(2)10-26-22/h7-12,16-17H,4-6,13-14H2,1-3H3,(H,28,29)/t16-,17-/m1/s1 PZFOCXJBZDWRSU-IAGOWNOFSA-N 320092 3-(5-ethyl-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- ylmethoxy] benzamide::US10174016, Example 259::US10202369, Example 259::US10472354, Example 283 P2X purinoceptor 2/3 Homo sapiens 379 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320092&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397564 384223366 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843006 CCc1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20-12-28-22(35-20)16-7-15(8-19(9-16)34-13-18-5-4-6-33-18)21(32)31-14(2)17-10-29-23(30-11-17)24(25,26)27/h7-12,14,18H,3-6,13H2,1-2H3,(H,31,32)/t14-,18+/m1/s1 IDFXYIYQWCENGA-KDOFPFPSSA-N 320117 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 284::US10202369, Example 284::US10472354, Example 284 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320117&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397623 384223391 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843007 CCc1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-20-12-28-22(35-20)16-7-15(8-19(9-16)34-13-18-5-4-6-33-18)21(32)31-14(2)17-10-29-23(30-11-17)24(25,26)27/h7-12,14,18H,3-6,13H2,1-2H3,(H,31,32)/t14-,18+/m1/s1 IDFXYIYQWCENGA-KDOFPFPSSA-N 320117 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 284::US10202369, Example 284::US10472354, Example 284 P2X purinoceptor 2/3 Homo sapiens 57.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320117&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397623 384223391 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843008 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C26H30N4O3S/c1-16-8-9-23(30-29-16)17(2)28-25(31)19-11-20(26-27-14-24(34-26)18-5-3-6-18)13-22(12-19)33-15-21-7-4-10-32-21/h8-9,11-14,17-18,21H,3-7,10,15H2,1-2H3,(H,28,31)/t17-,21+/m1/s1 NLLVDMMXBRFWGS-UTKZUKDTSA-N 320118 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(2S)- tetrahydrofuran-2- ylmethoxy] benzamide::US10174016, Example 285::US10202369, Example 285::US10472354, Example 285 P2X purinoceptor 3 Homo sapiens 113 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320118&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397163 384223392 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843009 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(C)nn1 InChI=1S/C26H30N4O3S/c1-16-8-9-23(30-29-16)17(2)28-25(31)19-11-20(26-27-14-24(34-26)18-5-3-6-18)13-22(12-19)33-15-21-7-4-10-32-21/h8-9,11-14,17-18,21H,3-7,10,15H2,1-2H3,(H,28,31)/t17-,21+/m1/s1 NLLVDMMXBRFWGS-UTKZUKDTSA-N 320118 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(2S)- tetrahydrofuran-2- ylmethoxy] benzamide::US10174016, Example 285::US10202369, Example 285::US10472354, Example 285 P2X purinoceptor 2/3 Homo sapiens 760 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320118&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397163 384223392 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843010 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C26H30N4O3S/c1-16-12-28-23(13-27-16)17(2)30-25(31)19-9-20(26-29-14-24(34-26)18-5-3-6-18)11-22(10-19)33-15-21-7-4-8-32-21/h9-14,17-18,21H,3-8,15H2,1-2H3,(H,30,31)/t17-,21+/m1/s1 BHRXSWOPMLFOCG-UTKZUKDTSA-N 320119 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(2S)- tetrahydrofuran-2- ylmethoxy]benzamide::US10174016, Example 286::US10202369, Example 286::US10472354, Example 286 P2X purinoceptor 3 Homo sapiens 87.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320119&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397754 384223393 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843011 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(C)cn1 InChI=1S/C26H30N4O3S/c1-16-12-28-23(13-27-16)17(2)30-25(31)19-9-20(26-29-14-24(34-26)18-5-3-6-18)11-22(10-19)33-15-21-7-4-8-32-21/h9-14,17-18,21H,3-8,15H2,1-2H3,(H,30,31)/t17-,21+/m1/s1 BHRXSWOPMLFOCG-UTKZUKDTSA-N 320119 3-(5-cyclobutyl- 1,3-thiazol-2-yl)- N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(2S)- tetrahydrofuran-2- ylmethoxy]benzamide::US10174016, Example 286::US10202369, Example 286::US10472354, Example 286 P2X purinoceptor 2/3 Homo sapiens 1234 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320119&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397754 384223393 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843012 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(19-11-31-25(32-12-19)26(27,28)29)33-23(34)17-8-18(24-30-13-22(37-24)16-4-2-5-16)10-21(9-17)36-14-20-6-3-7-35-20/h8-13,15-16,20H,2-7,14H2,1H3,(H,33,34)/t15-,20+/m1/s1 ZERBIURYMMOJBU-QRWLVFNGSA-N 320120 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 287::US10202369, Example 287::US10472354, Example 287 P2X purinoceptor 3 Homo sapiens 35.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320120&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397159 384223394 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843013 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(s1)C1CCC1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(19-11-31-25(32-12-19)26(27,28)29)33-23(34)17-8-18(24-30-13-22(37-24)16-4-2-5-16)10-21(9-17)36-14-20-6-3-7-35-20/h8-13,15-16,20H,2-7,14H2,1H3,(H,33,34)/t15-,20+/m1/s1 ZERBIURYMMOJBU-QRWLVFNGSA-N 320120 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 287::US10202369, Example 287::US10472354, Example 287 P2X purinoceptor 2/3 Homo sapiens 275 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320120&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397159 384223394 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843014 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C25H30N4O3S/c1-15(2)23-13-26-25(33-23)19-10-18(11-21(12-19)32-14-20-6-5-9-31-20)24(30)27-17(4)22-8-7-16(3)28-29-22/h7-8,10-13,15,17,20H,5-6,9,14H2,1-4H3,(H,27,30)/t17-,20+/m1/s1 UAMKMSQRQBQFJK-XLIONFOSSA-N 320121 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(2S)- tetrahydrofuran-2- ylmethoxy] benzamide::US10174016, Example 288::US10202369, Example 288::US10472354, Example 288 P2X purinoceptor 3 Homo sapiens 150 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320121&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397738 384223395 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843015 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(C)nn1 InChI=1S/C25H30N4O3S/c1-15(2)23-13-26-25(33-23)19-10-18(11-21(12-19)32-14-20-6-5-9-31-20)24(30)27-17(4)22-8-7-16(3)28-29-22/h7-8,10-13,15,17,20H,5-6,9,14H2,1-4H3,(H,27,30)/t17-,20+/m1/s1 UAMKMSQRQBQFJK-XLIONFOSSA-N 320121 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(2S)- tetrahydrofuran-2- ylmethoxy] benzamide::US10174016, Example 288::US10202369, Example 288::US10472354, Example 288 P2X purinoceptor 2/3 Homo sapiens 1314 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320121&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397738 384223395 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843016 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C25H30N4O3S/c1-15(2)23-13-28-25(33-23)19-8-18(9-21(10-19)32-14-20-6-5-7-31-20)24(30)29-17(4)22-12-26-16(3)11-27-22/h8-13,15,17,20H,5-7,14H2,1-4H3,(H,29,30)/t17-,20+/m1/s1 CNKRLRNKYMMPAE-XLIONFOSSA-N 320122 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(2S)- tetrahydrofuran-2- ylmethoxy]benzamide::US10174016, Example 289::US10202369, Example 289::US10472354, Example 289 P2X purinoceptor 3 Homo sapiens 192 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320122&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397419 384223396 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843017 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1cnc(C)cn1 InChI=1S/C25H30N4O3S/c1-15(2)23-13-28-25(33-23)19-8-18(9-21(10-19)32-14-20-6-5-7-31-20)24(30)29-17(4)22-12-26-16(3)11-27-22/h8-13,15,17,20H,5-7,14H2,1-4H3,(H,29,30)/t17-,20+/m1/s1 CNKRLRNKYMMPAE-XLIONFOSSA-N 320122 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-[5- (propan-2-yl)-1,3- thiazol-2-yl]-5- [(2S)- tetrahydrofuran-2- ylmethoxy]benzamide::US10174016, Example 289::US10202369, Example 289::US10472354, Example 289 P2X purinoceptor 2/3 Homo sapiens 1768 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320122&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397419 384223396 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843018 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-12-29-23(36-21)17-7-16(8-20(9-17)35-13-19-5-4-6-34-19)22(33)32-15(3)18-10-30-24(31-11-18)25(26,27)28/h7-12,14-15,19H,4-6,13H2,1-3H3,(H,32,33)/t15-,19+/m1/s1 KTCCKJLURHRITN-BEFAXECRSA-N 320123 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 290::US10472354, Example 290 P2X purinoceptor 3 Homo sapiens 31.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320123&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397222 384223397 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843019 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-12-29-23(36-21)17-7-16(8-20(9-17)35-13-19-5-4-6-34-19)22(33)32-15(3)18-10-30-24(31-11-18)25(26,27)28/h7-12,14-15,19H,4-6,13H2,1-3H3,(H,32,33)/t15-,19+/m1/s1 KTCCKJLURHRITN-BEFAXECRSA-N 320123 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 290::US10472354, Example 290 P2X purinoceptor 2/3 Homo sapiens 368 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320123&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397222 384223397 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843020 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-8-26-20(33-12)15-5-14(6-18(7-15)32-17-3-4-31-11-17)19(30)29-13(2)16-9-27-21(28-10-16)22(23,24)25/h5-10,13,17H,3-4,11H2,1-2H3,(H,29,30)/t13-,17-/m1/s1 GTQPEQGDLVSFJO-CXAGYDPISA-N 319844 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 11::US10202369, Example 11::US10472354, Example 291 P2X purinoceptor 3 Homo sapiens 1320 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319844&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397587 384223124 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843021 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c1-12-8-26-20(33-12)15-5-14(6-18(7-15)32-17-3-4-31-11-17)19(30)29-13(2)16-9-27-21(28-10-16)22(23,24)25/h5-10,13,17H,3-4,11H2,1-2H3,(H,29,30)/t13-,17-/m1/s1 GTQPEQGDLVSFJO-CXAGYDPISA-N 319844 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 11::US10202369, Example 11::US10472354, Example 291 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319844&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397587 384223124 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843022 CCc1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-19-12-28-23(35-19)16-9-15(10-18(11-16)34-13-17-5-4-8-33-17)22(32)29-14(2)20-6-7-21(31-30-20)24(25,26)27/h6-7,9-12,14,17H,3-5,8,13H2,1-2H3,(H,29,32)/t14-,17+/m1/s1 JBKILHBMFZDIIA-PBHICJAKSA-N 320135 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 302::US10202369, Example 302::US10472354, Example 302 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320135&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397753 384223409 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843023 CCc1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-19-12-28-23(35-19)16-9-15(10-18(11-16)34-13-17-5-4-8-33-17)22(32)29-14(2)20-6-7-21(31-30-20)24(25,26)27/h6-7,9-12,14,17H,3-5,8,13H2,1-2H3,(H,29,32)/t14-,17+/m1/s1 JBKILHBMFZDIIA-PBHICJAKSA-N 320135 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 302::US10202369, Example 302::US10472354, Example 302 P2X purinoceptor 2/3 Homo sapiens 52.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320135&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397753 384223409 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843024 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-12-29-24(36-21)17-9-16(10-19(11-17)35-13-18-5-4-8-34-18)23(33)30-15(3)20-6-7-22(32-31-20)25(26,27)28/h6-7,9-12,14-15,18H,4-5,8,13H2,1-3H3,(H,30,33)/t15-,18+/m1/s1 QOJBRGRPZKZVKC-QAPCUYQASA-N 320134 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 301::US10472354, Example 301 P2X purinoceptor 3 Homo sapiens 63.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320134&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397464 384223408 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843025 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-12-29-24(36-21)17-9-16(10-19(11-17)35-13-18-5-4-8-34-18)23(33)30-15(3)20-6-7-22(32-31-20)25(26,27)28/h6-7,9-12,14-15,18H,4-5,8,13H2,1-3H3,(H,30,33)/t15-,18+/m1/s1 QOJBRGRPZKZVKC-QAPCUYQASA-N 320134 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 301::US10472354, Example 301 P2X purinoceptor 2/3 Homo sapiens 1155 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320134&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397464 384223408 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843026 CC(C)c1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-13(2)20-11-28-23(35-20)16-8-15(9-18(10-16)34-17-6-7-33-12-17)22(32)29-14(3)19-4-5-21(31-30-19)24(25,26)27/h4-5,8-11,13-14,17H,6-7,12H2,1-3H3,(H,29,32)/t14-,17-/m1/s1 ALCUBFBGIYQDIY-RHSMWYFYSA-N 320127 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 294::US10202369, Example 294::US10472354, Example 294 P2X purinoceptor 3 Homo sapiens 101 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320127&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397844 384223401 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843027 CC(C)c1cnc(s1)-c1cc(O[C@@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-13(2)20-11-28-23(35-20)16-8-15(9-18(10-16)34-17-6-7-33-12-17)22(32)29-14(3)19-4-5-21(31-30-19)24(25,26)27/h4-5,8-11,13-14,17H,6-7,12H2,1-3H3,(H,29,32)/t14-,17-/m1/s1 ALCUBFBGIYQDIY-RHSMWYFYSA-N 320127 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 294::US10202369, Example 294::US10472354, Example 294 P2X purinoceptor 2/3 Homo sapiens 1060 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320127&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397844 384223401 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843028 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(nn1)C(F)(F)F InChI=1S/C25H25F3N4O3S/c1-14(20-5-6-22(32-31-20)25(26,27)28)30-23(33)16-9-17(11-19(10-16)35-18-7-8-34-13-18)24-29-12-21(36-24)15-3-2-4-15/h5-6,9-12,14-15,18H,2-4,7-8,13H2,1H3,(H,30,33)/t14-,18+/m1/s1 LCHSLMNVJPMESH-KDOFPFPSSA-N 320128 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- yloxy]-N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 295::US10202369, Example 295::US10472354, Example 295 P2X purinoceptor 3 Homo sapiens 55.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320128&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397441 384223402 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843029 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(nn1)C(F)(F)F InChI=1S/C25H25F3N4O3S/c1-14(20-5-6-22(32-31-20)25(26,27)28)30-23(33)16-9-17(11-19(10-16)35-18-7-8-34-13-18)24-29-12-21(36-24)15-3-2-4-15/h5-6,9-12,14-15,18H,2-4,7-8,13H2,1H3,(H,30,33)/t14-,18+/m1/s1 LCHSLMNVJPMESH-KDOFPFPSSA-N 320128 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- yloxy]-N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 295::US10202369, Example 295::US10472354, Example 295 P2X purinoceptor 2/3 Homo sapiens 557 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320128&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397441 384223402 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843030 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-19-11-28-23(35-19)17-8-16(9-18(10-17)34-13-15-6-7-33-12-15)22(32)29-14(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,14-15H,3,6-7,12-13H2,1-2H3,(H,29,32)/t14-,15+/m1/s1 PGRAVNCJCWWOPT-CABCVRRESA-N 320129 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 296::US10202369, Example 296::US10472354, Example 296 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320129&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397487 384223403 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843031 CCc1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-19-11-28-23(35-19)17-8-16(9-18(10-17)34-13-15-6-7-33-12-15)22(32)29-14(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,14-15H,3,6-7,12-13H2,1-2H3,(H,29,32)/t14-,15+/m1/s1 PGRAVNCJCWWOPT-CABCVRRESA-N 320129 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 296::US10202369, Example 296::US10472354, Example 296 P2X purinoceptor 2/3 Homo sapiens 133 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320129&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397487 384223403 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843032 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(nn1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(21-5-6-23(33-32-21)26(27,28)29)31-24(34)18-9-19(25-30-12-22(37-25)17-3-2-4-17)11-20(10-18)36-14-16-7-8-35-13-16/h5-6,9-12,15-17H,2-4,7-8,13-14H2,1H3,(H,31,34)/t15-,16-/m1/s1 BURFLVDKSSJHQL-HZPDHXFCSA-N 320130 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 297::US10202369, Example 300::US10472354, Example 297 P2X purinoceptor 3 Homo sapiens 56.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320130&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397174 384223404 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843033 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCOC2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(nn1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(21-5-6-23(33-32-21)26(27,28)29)31-24(34)18-9-19(25-30-12-22(37-25)17-3-2-4-17)11-20(10-18)36-14-16-7-8-35-13-16/h5-6,9-12,15-17H,2-4,7-8,13-14H2,1H3,(H,31,34)/t15-,16-/m1/s1 BURFLVDKSSJHQL-HZPDHXFCSA-N 320130 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 297::US10202369, Example 300::US10472354, Example 297 P2X purinoceptor 2/3 Homo sapiens 933 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320130&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397174 384223404 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843034 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-11-29-24(36-21)18-8-17(9-19(10-18)35-13-16-6-7-34-12-16)23(33)30-15(3)20-4-5-22(32-31-20)25(26,27)28/h4-5,8-11,14-16H,6-7,12-13H2,1-3H3,(H,30,33)/t15-,16+/m1/s1 ZWFOSAQPAKMJAC-CVEARBPZSA-N 320131 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 298::US10202369, Example 299::US10472354, Example 298 P2X purinoceptor 3 Homo sapiens 62.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320131&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397407 384223405 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843035 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCOC2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-11-29-24(36-21)18-8-17(9-19(10-18)35-13-16-6-7-34-12-16)23(33)30-15(3)20-4-5-22(32-31-20)25(26,27)28/h4-5,8-11,14-16H,6-7,12-13H2,1-3H3,(H,30,33)/t15-,16+/m1/s1 ZWFOSAQPAKMJAC-CVEARBPZSA-N 320131 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 298::US10202369, Example 299::US10472354, Example 298 P2X purinoceptor 2/3 Homo sapiens 781 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320131&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397407 384223405 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843036 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-12-29-24(36-21)17-9-16(10-19(11-17)35-13-18-5-4-8-34-18)23(33)30-15(3)20-6-7-22(32-31-20)25(26,27)28/h6-7,9-12,14-15,18H,4-5,8,13H2,1-3H3,(H,30,33)/t15-,18-/m1/s1 QOJBRGRPZKZVKC-CRAIPNDOSA-N 320132 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(2R)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 299::US10472354, Example 299 P2X purinoceptor 3 Homo sapiens 37.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320132&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397251 384223406 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843037 CC(C)c1cnc(s1)-c1cc(OC[C@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-12-29-24(36-21)17-9-16(10-19(11-17)35-13-18-5-4-8-34-18)23(33)30-15(3)20-6-7-22(32-31-20)25(26,27)28/h6-7,9-12,14-15,18H,4-5,8,13H2,1-3H3,(H,30,33)/t15-,18-/m1/s1 QOJBRGRPZKZVKC-CRAIPNDOSA-N 320132 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(2R)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 299::US10472354, Example 299 P2X purinoceptor 2/3 Homo sapiens 575 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320132&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397251 384223406 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843038 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(nn1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(21-7-8-23(33-32-21)26(27,28)29)31-24(34)17-10-18(25-30-13-22(37-25)16-4-2-5-16)12-20(11-17)36-14-19-6-3-9-35-19/h7-8,10-13,15-16,19H,2-6,9,14H2,1H3,(H,31,34)/t15-,19+/m1/s1 BFQOMUOMPPUOAS-BEFAXECRSA-N 320133 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 300::US10472354, Example 300 P2X purinoceptor 3 Homo sapiens 78.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320133&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397755 384223407 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843039 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCO2)cc(c1)-c1ncc(s1)C1CCC1)c1ccc(nn1)C(F)(F)F InChI=1S/C26H27F3N4O3S/c1-15(21-7-8-23(33-32-21)26(27,28)29)31-24(34)17-10-18(25-30-13-22(37-25)16-4-2-5-16)12-20(11-17)36-14-19-6-3-9-35-19/h7-8,10-13,15-16,19H,2-6,9,14H2,1H3,(H,31,34)/t15-,19+/m1/s1 BFQOMUOMPPUOAS-BEFAXECRSA-N 320133 3-(5-cyclobutyl- 1,3-thiazol-2-yl)-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 300::US10472354, Example 300 P2X purinoceptor 2/3 Homo sapiens 820 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320133&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397755 384223407 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843040 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-12-29-24(36-21)17-9-16(10-19(11-17)35-13-18-5-4-8-34-18)23(33)30-15(3)20-6-7-22(32-31-20)25(26,27)28/h6-7,9-12,14-15,18H,4-5,8,13H2,1-3H3,(H,30,33)/t15-,18+/m1/s1 QOJBRGRPZKZVKC-QAPCUYQASA-N 320134 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 301::US10472354, Example 301 P2X purinoceptor 3 Homo sapiens 91.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320134&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397464 384223408 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843041 CC(C)c1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-14(2)21-12-29-24(36-21)17-9-16(10-19(11-17)35-13-18-5-4-8-34-18)23(33)30-15(3)20-6-7-22(32-31-20)25(26,27)28/h6-7,9-12,14-15,18H,4-5,8,13H2,1-3H3,(H,30,33)/t15-,18+/m1/s1 QOJBRGRPZKZVKC-QAPCUYQASA-N 320134 3-[5-(propan-2-yl)- 1,3-thiazol-2-yl]-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 301::US10472354, Example 301 P2X purinoceptor 2/3 Homo sapiens 1714 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320134&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397464 384223408 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843042 CCc1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-19-12-28-23(35-19)16-9-15(10-18(11-16)34-13-17-5-4-8-33-17)22(32)29-14(2)20-6-7-21(31-30-20)24(25,26)27/h6-7,9-12,14,17H,3-5,8,13H2,1-2H3,(H,29,32)/t14-,17+/m1/s1 JBKILHBMFZDIIA-PBHICJAKSA-N 320135 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 302::US10202369, Example 302::US10472354, Example 302 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320135&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397753 384223409 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843043 CCc1cnc(s1)-c1cc(OC[C@@H]2CCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-3-19-12-28-23(35-19)16-9-15(10-18(11-16)34-13-17-5-4-8-33-17)22(32)29-14(2)20-6-7-21(31-30-20)24(25,26)27/h6-7,9-12,14,17H,3-5,8,13H2,1-2H3,(H,29,32)/t14-,17+/m1/s1 JBKILHBMFZDIIA-PBHICJAKSA-N 320135 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(2S)- tetrahydrofuran-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 302::US10202369, Example 302::US10472354, Example 302 P2X purinoceptor 2/3 Homo sapiens 145 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320135&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397753 384223409 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843044 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F6N5O2S/c1-14-10-32-22(39-14)17-7-16(21(37)35-15(2)18-11-33-23(34-12-18)25(29,30)31)8-20(9-17)38-19-3-5-36(6-4-19)13-24(26,27)28/h7-12,15,19H,3-6,13H2,1-2H3,(H,35,37)/t15-/m1/s1 HEBACSHOFHMYBR-OAHLLOKOSA-N 320136 3-(5-methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy}- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 303::US10202369, Example 310::US10472354, Example 303 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320136&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397490 384223410 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843045 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F6N5O2S/c1-14-10-32-22(39-14)17-7-16(21(37)35-15(2)18-11-33-23(34-12-18)25(29,30)31)8-20(9-17)38-19-3-5-36(6-4-19)13-24(26,27)28/h7-12,15,19H,3-6,13H2,1-2H3,(H,35,37)/t15-/m1/s1 HEBACSHOFHMYBR-OAHLLOKOSA-N 320136 3-(5-methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy}- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 303::US10202369, Example 310::US10472354, Example 303 P2X purinoceptor 2/3 Homo sapiens 38.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320136&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397490 384223410 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843046 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O2S/c1-14-10-31-23(38-14)17-7-16(8-20(9-17)37-19-3-5-35(6-4-19)13-21(26)27)22(36)34-15(2)18-11-32-24(33-12-18)25(28,29)30/h7-12,15,19,21H,3-6,13H2,1-2H3,(H,34,36)/t15-/m1/s1 LOLIYPRJHUXCPO-OAHLLOKOSA-N 320137 3-{[1-(2,2- difluoroethyl) piperidin-4-yl]oxy}- 5-(5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoroethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 304::US10202369, Example 308::US10472354, Example 304 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320137&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397386 384223411 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843047 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O2S/c1-14-10-31-23(38-14)17-7-16(8-20(9-17)37-19-3-5-35(6-4-19)13-21(26)27)22(36)34-15(2)18-11-32-24(33-12-18)25(28,29)30/h7-12,15,19,21H,3-6,13H2,1-2H3,(H,34,36)/t15-/m1/s1 LOLIYPRJHUXCPO-OAHLLOKOSA-N 320137 3-{[1-(2,2- difluoroethyl) piperidin-4-yl]oxy}- 5-(5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoroethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 304::US10202369, Example 308::US10472354, Example 304 P2X purinoceptor 2/3 Homo sapiens 27.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320137&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397386 384223411 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843048 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)F)CC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C25H29F2N5O2S/c1-15-4-5-22(31-30-15)17(3)29-24(33)18-10-19(25-28-13-16(2)35-25)12-21(11-18)34-20-6-8-32(9-7-20)14-23(26)27/h4-5,10-13,17,20,23H,6-9,14H2,1-3H3,(H,29,33)/t17-/m1/s1 BZVNHOBJGKGQCM-QGZVFWFLSA-N 320138 3-{[1-(2,2- difluoroethyl) piperidin-4-yl]oxy}-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-(5- methyl-1,3- thiazol-2-yl) benzamide::US10174016, Example 305::US10202369, Example 305::US10472354, Example 305 P2X purinoceptor 3 Homo sapiens 9.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320138&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397226 384223412 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843049 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)F)CC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C25H29F2N5O2S/c1-15-4-5-22(31-30-15)17(3)29-24(33)18-10-19(25-28-13-16(2)35-25)12-21(11-18)34-20-6-8-32(9-7-20)14-23(26)27/h4-5,10-13,17,20,23H,6-9,14H2,1-3H3,(H,29,33)/t17-/m1/s1 BZVNHOBJGKGQCM-QGZVFWFLSA-N 320138 3-{[1-(2,2- difluoroethyl) piperidin-4-yl]oxy}-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-(5- methyl-1,3- thiazol-2-yl) benzamide::US10174016, Example 305::US10202369, Example 305::US10472354, Example 305 P2X purinoceptor 2/3 Homo sapiens 44.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320138&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397226 384223412 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843050 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C25H29F2N5O2S/c1-15-11-29-22(13-28-15)17(3)31-24(33)18-8-19(25-30-12-16(2)35-25)10-21(9-18)34-20-4-6-32(7-5-20)14-23(26)27/h8-13,17,20,23H,4-7,14H2,1-3H3,(H,31,33)/t17-/m1/s1 OVUBAZICSOPILB-QGZVFWFLSA-N 320139 3-{[1-(2,2- difluoroethyl) piperidin-4-yl]oxy}-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-(5- methyl-1,3- thiazol-2-yl) benzamide::US10174016, Example 306::US10202369, Example 306::US10472354, Example 306 P2X purinoceptor 3 Homo sapiens 42.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320139&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397132 384223413 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843051 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C25H29F2N5O2S/c1-15-11-29-22(13-28-15)17(3)31-24(33)18-8-19(25-30-12-16(2)35-25)10-21(9-18)34-20-4-6-32(7-5-20)14-23(26)27/h8-13,17,20,23H,4-7,14H2,1-3H3,(H,31,33)/t17-/m1/s1 OVUBAZICSOPILB-QGZVFWFLSA-N 320139 3-{[1-(2,2- difluoroethyl) piperidin-4-yl]oxy}-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-(5- methyl-1,3- thiazol-2-yl) benzamide::US10174016, Example 306::US10202369, Example 306::US10472354, Example 306 P2X purinoceptor 2/3 Homo sapiens 464 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320139&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397132 384223413 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843052 Cc1cnc(s1)-c1cc(OC2CCN(CC(F)F)CC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C24H27F2N5O2S/c1-15-3-4-19(30-29-15)13-27-23(32)17-9-18(24-28-12-16(2)34-24)11-21(10-17)33-20-5-7-31(8-6-20)14-22(25)26/h3-4,9-12,20,22H,5-8,13-14H2,1-2H3,(H,27,32) AGOFJROZQVOSRF-UHFFFAOYSA-N 320140 3-{[1-(2,2- difluoroethyl)piperidin- 4-yl]oxy}-N- [(6-methylpyridazin- 3-yl)methyl]-5-(5- methyl-1,3-thiazol-2- yl)benzamide::US10174016, Example 307::US10202369, Example 307::US10472354, Example 307 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320140&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397369 384223414 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843053 Cc1cnc(s1)-c1cc(OC2CCN(CC(F)F)CC2)cc(c1)C(=O)NCc1ccc(C)nn1 InChI=1S/C24H27F2N5O2S/c1-15-3-4-19(30-29-15)13-27-23(32)17-9-18(24-28-12-16(2)34-24)11-21(10-17)33-20-5-7-31(8-6-20)14-22(25)26/h3-4,9-12,20,22H,5-8,13-14H2,1-2H3,(H,27,32) AGOFJROZQVOSRF-UHFFFAOYSA-N 320140 3-{[1-(2,2- difluoroethyl)piperidin- 4-yl]oxy}-N- [(6-methylpyridazin- 3-yl)methyl]-5-(5- methyl-1,3-thiazol-2- yl)benzamide::US10174016, Example 307::US10202369, Example 307::US10472354, Example 307 P2X purinoceptor 2/3 Homo sapiens 103 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320140&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397369 384223414 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843054 C[C@H](NC(=O)c1cc(OC2CCN(CC(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O2S/c1-14-10-31-23(38-14)17-7-16(8-20(9-17)37-19-3-5-35(6-4-19)13-21(26)27)22(36)34-15(2)18-11-32-24(33-12-18)25(28,29)30/h7-12,15,19,21H,3-6,13H2,1-2H3,(H,34,36)/t15-/m0/s1 LOLIYPRJHUXCPO-HNNXBMFYSA-N 320141 3-{[1-(2,2- difluoroethyl)piperidin- 4-yl]oxy}-5-(5- methyl-1,3-thiazol-2- yl)-N- {(1S)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 308::US10472354, Example 308 P2X purinoceptor 3 Homo sapiens 153 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320141&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397709 384223415 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843055 C[C@H](NC(=O)c1cc(OC2CCN(CC(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O2S/c1-14-10-31-23(38-14)17-7-16(8-20(9-17)37-19-3-5-35(6-4-19)13-21(26)27)22(36)34-15(2)18-11-32-24(33-12-18)25(28,29)30/h7-12,15,19,21H,3-6,13H2,1-2H3,(H,34,36)/t15-/m0/s1 LOLIYPRJHUXCPO-HNNXBMFYSA-N 320141 3-{[1-(2,2- difluoroethyl)piperidin- 4-yl]oxy}-5-(5- methyl-1,3-thiazol-2- yl)-N- {(1S)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 308::US10472354, Example 308 P2X purinoceptor 2/3 Homo sapiens 2586 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320141&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397709 384223415 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843056 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C25H29F2N5O2S/c1-15-11-30-25(35-15)19-8-18(24(33)31-16(2)20-12-28-17(3)29-13-20)9-22(10-19)34-21-4-6-32(7-5-21)14-23(26)27/h8-13,16,21,23H,4-7,14H2,1-3H3,(H,31,33)/t16-/m1/s1 XIVLMPYTLPVWPV-MRXNPFEDSA-N 320142 3-{[1-(2,2- difluoroethyl)piperidin- 4-yl]oxy}-N- [(1R)-1-(2- methylpyrimidin- 5-yl)ethyl]-5-(5- methyl-1,3-thiazol-2- yl)benzamide::US10174016, Example 309::US10202369, Example 309::US10472354, Example 309 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320142&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397638 384223416 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843057 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C25H29F2N5O2S/c1-15-11-30-25(35-15)19-8-18(24(33)31-16(2)20-12-28-17(3)29-13-20)9-22(10-19)34-21-4-6-32(7-5-21)14-23(26)27/h8-13,16,21,23H,4-7,14H2,1-3H3,(H,31,33)/t16-/m1/s1 XIVLMPYTLPVWPV-MRXNPFEDSA-N 320142 3-{[1-(2,2- difluoroethyl)piperidin- 4-yl]oxy}-N- [(1R)-1-(2- methylpyrimidin- 5-yl)ethyl]-5-(5- methyl-1,3-thiazol-2- yl)benzamide::US10174016, Example 309::US10202369, Example 309::US10472354, Example 309 P2X purinoceptor 2/3 Homo sapiens 70.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320142&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397638 384223416 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843058 C[C@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F6N5O2S/c1-14-10-32-22(39-14)17-7-16(21(37)35-15(2)18-11-33-23(34-12-18)25(29,30)31)8-20(9-17)38-19-3-5-36(6-4-19)13-24(26,27)28/h7-12,15,19H,3-6,13H2,1-2H3,(H,35,37)/t15-/m0/s1 HEBACSHOFHMYBR-HNNXBMFYSA-N 320143 3-(5-methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy}-N- {(1S)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 310::US10472354, Example 310 P2X purinoceptor 3 Homo sapiens 116 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320143&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397431 384223417 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843059 C[C@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H25F6N5O2S/c1-14-10-32-22(39-14)17-7-16(21(37)35-15(2)18-11-33-23(34-12-18)25(29,30)31)8-20(9-17)38-19-3-5-36(6-4-19)13-24(26,27)28/h7-12,15,19H,3-6,13H2,1-2H3,(H,35,37)/t15-/m0/s1 HEBACSHOFHMYBR-HNNXBMFYSA-N 320143 3-(5-methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy}-N- {(1S)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 310::US10472354, Example 310 P2X purinoceptor 2/3 Homo sapiens 1678 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320143&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397431 384223417 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843060 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C25H28F3N5O2S/c1-15-4-5-22(32-31-15)17(3)30-23(34)18-10-19(24-29-13-16(2)36-24)12-21(11-18)35-20-6-8-33(9-7-20)14-25(26,27)28/h4-5,10-13,17,20H,6-9,14H2,1-3H3,(H,30,34)/t17-/m1/s1 PEAPNGOBIXQGEJ-QGZVFWFLSA-N 320144 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-(5- methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy} benzamide::US10174016, Example 311::US10202369, Example 311::US10472354, Example 314 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320144&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397300 384223418 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843061 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C25H28F3N5O2S/c1-15-4-5-22(32-31-15)17(3)30-23(34)18-10-19(24-29-13-16(2)36-24)12-21(11-18)35-20-6-8-33(9-7-20)14-25(26,27)28/h4-5,10-13,17,20H,6-9,14H2,1-3H3,(H,30,34)/t17-/m1/s1 PEAPNGOBIXQGEJ-QGZVFWFLSA-N 320144 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-(5- methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy} benzamide::US10174016, Example 311::US10202369, Example 311::US10472354, Example 314 P2X purinoceptor 2/3 Homo sapiens 35.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320144&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397300 384223418 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843062 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C25H25F6N5O2S/c1-14-12-32-23(39-14)17-9-16(22(37)33-15(2)20-3-4-21(35-34-20)25(29,30)31)10-19(11-17)38-18-5-7-36(8-6-18)13-24(26,27)28/h3-4,9-12,15,18H,5-8,13H2,1-2H3,(H,33,37)/t15-/m1/s1 AZRJUXHXOIFVSM-OAHLLOKOSA-N 320145 3-(5-methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy}-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 312::US10202369, Example 312::US10472354, Example 312 P2X purinoceptor 3 Homo sapiens 9.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320145&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397364 384223419 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843063 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C25H25F6N5O2S/c1-14-12-32-23(39-14)17-9-16(22(37)33-15(2)20-3-4-21(35-34-20)25(29,30)31)10-19(11-17)38-18-5-7-36(8-6-18)13-24(26,27)28/h3-4,9-12,15,18H,5-8,13H2,1-2H3,(H,33,37)/t15-/m1/s1 AZRJUXHXOIFVSM-OAHLLOKOSA-N 320145 3-(5-methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy}-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 312::US10202369, Example 312::US10472354, Example 312 P2X purinoceptor 2/3 Homo sapiens 83.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320145&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397364 384223419 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843064 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C25H28F3N5O2S/c1-15-11-30-22(13-29-15)17(3)32-23(34)18-8-19(24-31-12-16(2)36-24)10-21(9-18)35-20-4-6-33(7-5-20)14-25(26,27)28/h8-13,17,20H,4-7,14H2,1-3H3,(H,32,34)/t17-/m1/s1 VOYLEHBGAUIAGN-QGZVFWFLSA-N 320146 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-(5- methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4- yl]oxy}benzamide::US10174016, Example 313::US10202369, Example 313::US10472354, Example 313 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320146&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397805 384223420 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843065 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)cn1 InChI=1S/C25H28F3N5O2S/c1-15-11-30-22(13-29-15)17(3)32-23(34)18-8-19(24-31-12-16(2)36-24)10-21(9-18)35-20-4-6-33(7-5-20)14-25(26,27)28/h8-13,17,20H,4-7,14H2,1-3H3,(H,32,34)/t17-/m1/s1 VOYLEHBGAUIAGN-QGZVFWFLSA-N 320146 N-[(1R)-1-(5- methylpyrazin-2- yl)ethyl]-3-(5- methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4- yl]oxy}benzamide::US10174016, Example 313::US10202369, Example 313::US10472354, Example 313 P2X purinoceptor 2/3 Homo sapiens 200 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320146&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397805 384223420 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843066 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C25H28F3N5O2S/c1-15-4-5-22(32-31-15)17(3)30-23(34)18-10-19(24-29-13-16(2)36-24)12-21(11-18)35-20-6-8-33(9-7-20)14-25(26,27)28/h4-5,10-13,17,20H,6-9,14H2,1-3H3,(H,30,34)/t17-/m1/s1 PEAPNGOBIXQGEJ-QGZVFWFLSA-N 320144 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-(5- methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy} benzamide::US10174016, Example 311::US10202369, Example 311::US10472354, Example 314 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320144&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397300 384223418 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843067 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1ccc(C)nn1 InChI=1S/C25H28F3N5O2S/c1-15-4-5-22(32-31-15)17(3)30-23(34)18-10-19(24-29-13-16(2)36-24)12-21(11-18)35-20-6-8-33(9-7-20)14-25(26,27)28/h4-5,10-13,17,20H,6-9,14H2,1-3H3,(H,30,34)/t17-/m1/s1 PEAPNGOBIXQGEJ-QGZVFWFLSA-N 320144 N-[(1R)-1-(6- methylpyridazin-3- yl)ethyl]-3-(5- methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy} benzamide::US10174016, Example 311::US10202369, Example 311::US10472354, Example 314 P2X purinoceptor 2/3 Homo sapiens 192 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320144&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397300 384223418 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843068 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C25H28F3N5O2S/c1-15-11-31-24(36-15)19-8-18(23(34)32-16(2)20-12-29-17(3)30-13-20)9-22(10-19)35-21-4-6-33(7-5-21)14-25(26,27)28/h8-13,16,21H,4-7,14H2,1-3H3,(H,32,34)/t16-/m1/s1 CJWKMIQNKLHRQL-MRXNPFEDSA-N 320148 N-[(1R)-1-(2- methylpyrimidin- 5-yl)ethyl]-3-(5- methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy} benzamide::US10174016, Example 315::US10202369, Example 315::US10472354, Example 315 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320148&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397608 384223422 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843069 C[C@@H](NC(=O)c1cc(OC2CCN(CC(F)(F)F)CC2)cc(c1)-c1ncc(C)s1)c1cnc(C)nc1 InChI=1S/C25H28F3N5O2S/c1-15-11-31-24(36-15)19-8-18(23(34)32-16(2)20-12-29-17(3)30-13-20)9-22(10-19)35-21-4-6-33(7-5-21)14-25(26,27)28/h8-13,16,21H,4-7,14H2,1-3H3,(H,32,34)/t16-/m1/s1 CJWKMIQNKLHRQL-MRXNPFEDSA-N 320148 N-[(1R)-1-(2- methylpyrimidin- 5-yl)ethyl]-3-(5- methyl-1,3- thiazol-2-yl)-5-{[1- (2,2,2- trifluoroethyl) piperidin-4-yl]oxy} benzamide::US10174016, Example 315::US10202369, Example 315::US10472354, Example 315 P2X purinoceptor 2/3 Homo sapiens 160 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320148&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397608 384223422 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843070 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1ccc(C)nn1 InChI=1S/C22H23ClN4O3S/c1-13-3-4-19(27-26-13)14(2)25-21(28)16-7-17(22-24-10-20(23)31-22)9-18(8-16)30-12-15-5-6-29-11-15/h3-4,7-10,14-15H,5-6,11-12H2,1-2H3,(H,25,28)/t14-,15+/m1/s1 OPFRVFRBCBSDJR-CABCVRRESA-N 320149 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- ylmethoxy]benzamide::US10174016, Example 316::US10472354, Example 316 P2X purinoceptor 3 Homo sapiens 21.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320149&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397598 384223423 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843071 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1ccc(C)nn1 InChI=1S/C22H23ClN4O3S/c1-13-3-4-19(27-26-13)14(2)25-21(28)16-7-17(22-24-10-20(23)31-22)9-18(8-16)30-12-15-5-6-29-11-15/h3-4,7-10,14-15H,5-6,11-12H2,1-2H3,(H,25,28)/t14-,15+/m1/s1 OPFRVFRBCBSDJR-CABCVRRESA-N 320149 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- ylmethoxy]benzamide::US10174016, Example 316::US10472354, Example 316 P2X purinoceptor 2/3 Homo sapiens 250 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320149&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397598 384223423 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843072 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1ccc(C)nn1 InChI=1S/C21H21ClN4O3S/c1-12-3-4-18(26-25-12)13(2)24-20(27)14-7-15(21-23-10-19(22)30-21)9-17(8-14)29-16-5-6-28-11-16/h3-4,7-10,13,16H,5-6,11H2,1-2H3,(H,24,27)/t13-,16-/m1/s1 GKNCXHRLEQHNKW-CZUORRHYSA-N 320150 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 317::US10202369, Example 317::US10472354, Example 317 P2X purinoceptor 3 Homo sapiens 45.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320150&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397433 384223424 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843073 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1ccc(C)nn1 InChI=1S/C21H21ClN4O3S/c1-12-3-4-18(26-25-12)13(2)24-20(27)14-7-15(21-23-10-19(22)30-21)9-17(8-14)29-16-5-6-28-11-16/h3-4,7-10,13,16H,5-6,11H2,1-2H3,(H,24,27)/t13-,16-/m1/s1 GKNCXHRLEQHNKW-CZUORRHYSA-N 320150 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 317::US10202369, Example 317::US10472354, Example 317 P2X purinoceptor 2/3 Homo sapiens 952 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320150&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397433 384223424 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843074 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C21H18ClF3N4O3S/c1-11(16-2-3-17(29-28-16)21(23,24)25)27-19(30)12-6-13(20-26-9-18(22)33-20)8-15(7-12)32-14-4-5-31-10-14/h2-3,6-9,11,14H,4-5,10H2,1H3,(H,27,30)/t11-,14-/m1/s1 WZQSUVWYIQCPQJ-BXUZGUMPSA-N 320151 3-(5-chloro-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 318::US10202369, Example 318::US10472354, Example 318 P2X purinoceptor 3 Homo sapiens 32.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320151&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397509 384223425 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843075 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C21H18ClF3N4O3S/c1-11(16-2-3-17(29-28-16)21(23,24)25)27-19(30)12-6-13(20-26-9-18(22)33-20)8-15(7-12)32-14-4-5-31-10-14/h2-3,6-9,11,14H,4-5,10H2,1H3,(H,27,30)/t11-,14-/m1/s1 WZQSUVWYIQCPQJ-BXUZGUMPSA-N 320151 3-(5-chloro-1,3- thiazol-2-yl)-5- [(3R)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 318::US10202369, Example 318::US10472354, Example 318 P2X purinoceptor 2/3 Homo sapiens 476 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320151&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397509 384223425 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843076 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1cnc(C)cn1 InChI=1S/C21H21ClN4O3S/c1-12-8-24-18(9-23-12)13(2)26-20(27)14-5-15(21-25-10-19(22)30-21)7-17(6-14)29-16-3-4-28-11-16/h5-10,13,16H,3-4,11H2,1-2H3,(H,26,27)/t13-,16-/m1/s1 NPEHDEPJRQIOFY-CZUORRHYSA-N 320152 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 319::US10202369, Example 319::US10472354, Example 319 P2X purinoceptor 3 Homo sapiens 76.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320152&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397412 384223426 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843077 C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1cnc(C)cn1 InChI=1S/C21H21ClN4O3S/c1-12-8-24-18(9-23-12)13(2)26-20(27)14-5-15(21-25-10-19(22)30-21)7-17(6-14)29-16-3-4-28-11-16/h5-10,13,16H,3-4,11H2,1-2H3,(H,26,27)/t13-,16-/m1/s1 NPEHDEPJRQIOFY-CZUORRHYSA-N 320152 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3R)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 319::US10202369, Example 319::US10472354, Example 319 P2X purinoceptor 2/3 Homo sapiens 1324 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320152&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397412 384223426 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843078 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C21H18ClF3N4O3S/c1-11(16-2-3-17(29-28-16)21(23,24)25)27-19(30)12-6-13(20-26-9-18(22)33-20)8-15(7-12)32-14-4-5-31-10-14/h2-3,6-9,11,14H,4-5,10H2,1H3,(H,27,30)/t11-,14+/m1/s1 WZQSUVWYIQCPQJ-RISCZKNCSA-N 320153 3-(5-chloro-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 320::US10202369, Example 320::US10472354, Example 320 P2X purinoceptor 3 Homo sapiens 33.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320153&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397157 384223427 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843079 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C21H18ClF3N4O3S/c1-11(16-2-3-17(29-28-16)21(23,24)25)27-19(30)12-6-13(20-26-9-18(22)33-20)8-15(7-12)32-14-4-5-31-10-14/h2-3,6-9,11,14H,4-5,10H2,1H3,(H,27,30)/t11-,14+/m1/s1 WZQSUVWYIQCPQJ-RISCZKNCSA-N 320153 3-(5-chloro-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- yloxy]-N-{(1R)-1- [6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 320::US10202369, Example 320::US10472354, Example 320 P2X purinoceptor 2/3 Homo sapiens 627 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320153&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397157 384223427 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843080 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1cnc(C)cn1 InChI=1S/C21H21ClN4O3S/c1-12-8-24-18(9-23-12)13(2)26-20(27)14-5-15(21-25-10-19(22)30-21)7-17(6-14)29-16-3-4-28-11-16/h5-10,13,16H,3-4,11H2,1-2H3,(H,26,27)/t13-,16+/m1/s1 NPEHDEPJRQIOFY-CJNGLKHVSA-N 320154 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 321::US10202369, Example 321::US10472354, Example 321 P2X purinoceptor 3 Homo sapiens 120 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320154&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397403 384223428 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843081 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1cnc(C)cn1 InChI=1S/C21H21ClN4O3S/c1-12-8-24-18(9-23-12)13(2)26-20(27)14-5-15(21-25-10-19(22)30-21)7-17(6-14)29-16-3-4-28-11-16/h5-10,13,16H,3-4,11H2,1-2H3,(H,26,27)/t13-,16+/m1/s1 NPEHDEPJRQIOFY-CJNGLKHVSA-N 320154 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 321::US10202369, Example 321::US10472354, Example 321 P2X purinoceptor 2/3 Homo sapiens 1447 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320154&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397403 384223428 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843082 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1ccc(C)nn1 InChI=1S/C21H21ClN4O3S/c1-12-3-4-18(26-25-12)13(2)24-20(27)14-7-15(21-23-10-19(22)30-21)9-17(8-14)29-16-5-6-28-11-16/h3-4,7-10,13,16H,5-6,11H2,1-2H3,(H,24,27)/t13-,16+/m1/s1 GKNCXHRLEQHNKW-CJNGLKHVSA-N 320155 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 322::US10202369, Example 322::US10472354, Example 322 P2X purinoceptor 3 Homo sapiens 49.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320155&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397765 384223429 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843083 C[C@@H](NC(=O)c1cc(O[C@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1ccc(C)nn1 InChI=1S/C21H21ClN4O3S/c1-12-3-4-18(26-25-12)13(2)24-20(27)14-7-15(21-23-10-19(22)30-21)9-17(8-14)29-16-5-6-28-11-16/h3-4,7-10,13,16H,5-6,11H2,1-2H3,(H,24,27)/t13-,16+/m1/s1 GKNCXHRLEQHNKW-CJNGLKHVSA-N 320155 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5-[(3S)- tetrahydrofuran-3- yloxy]benzamide::US10174016, Example 322::US10202369, Example 322::US10472354, Example 322 P2X purinoceptor 2/3 Homo sapiens 498 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320155&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397765 384223429 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843084 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H20ClF3N4O3S/c1-12(16-7-28-21(29-8-16)22(24,25)26)30-19(31)14-4-15(20-27-9-18(23)34-20)6-17(5-14)33-11-13-2-3-32-10-13/h4-9,12-13H,2-3,10-11H2,1H3,(H,30,31)/t12-,13+/m1/s1 SQNSHDCXZQFUAQ-OLZOCXBDSA-N 320156 3-(5-chloro-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 323::US10202369, Example 323::US10472354, Example 323 P2X purinoceptor 3 Homo sapiens 25.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320156&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397761 384223430 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843085 C[C@@H](NC(=O)c1cc(OC[C@H]2CCOC2)cc(c1)-c1ncc(Cl)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H20ClF3N4O3S/c1-12(16-7-28-21(29-8-16)22(24,25)26)30-19(31)14-4-15(20-27-9-18(23)34-20)6-17(5-14)33-11-13-2-3-32-10-13/h4-9,12-13H,2-3,10-11H2,1H3,(H,30,31)/t12-,13+/m1/s1 SQNSHDCXZQFUAQ-OLZOCXBDSA-N 320156 3-(5-chloro-1,3- thiazol-2-yl)-5- [(3S)- tetrahydrofuran-3- ylmethoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 323::US10202369, Example 323::US10472354, Example 323 P2X purinoceptor 2/3 Homo sapiens 411 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320156&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397761 384223430 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843086 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(Cl)s1)c1cnc(C)cn1 InChI=1S/C22H23ClN4O3S/c1-13-10-25-19(11-24-13)14(2)27-21(28)15-7-16(22-26-12-20(23)31-22)9-18(8-15)30-17-3-5-29-6-4-17/h7-12,14,17H,3-6H2,1-2H3,(H,27,28)/t14-/m1/s1 LHUVAVZJRUVQTK-CQSZACIVSA-N 320157 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 324::US10202369, Example 324::US10472354, Example 324 P2X purinoceptor 3 Homo sapiens 46.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320157&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397374 384223431 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843087 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(Cl)s1)c1cnc(C)cn1 InChI=1S/C22H23ClN4O3S/c1-13-10-25-19(11-24-13)14(2)27-21(28)15-7-16(22-26-12-20(23)31-22)9-18(8-15)30-17-3-5-29-6-4-17/h7-12,14,17H,3-6H2,1-2H3,(H,27,28)/t14-/m1/s1 LHUVAVZJRUVQTK-CQSZACIVSA-N 320157 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(5- methylpyrazin-2- yl)ethyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 324::US10202369, Example 324::US10472354, Example 324 P2X purinoceptor 2/3 Homo sapiens 552 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320157&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397374 384223431 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843088 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(Cl)s1)c1ccc(C)nn1 InChI=1S/C22H23ClN4O3S/c1-13-3-4-19(27-26-13)14(2)25-21(28)15-9-16(22-24-12-20(23)31-22)11-18(10-15)30-17-5-7-29-8-6-17/h3-4,9-12,14,17H,5-8H2,1-2H3,(H,25,28)/t14-/m1/s1 WDEIMZWFSWTCLU-CQSZACIVSA-N 320158 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 325::US10202369, Example 325::US10472354, Example 325 P2X purinoceptor 3 Homo sapiens 26.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320158&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397325 384223432 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843089 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(Cl)s1)c1ccc(C)nn1 InChI=1S/C22H23ClN4O3S/c1-13-3-4-19(27-26-13)14(2)25-21(28)15-9-16(22-24-12-20(23)31-22)11-18(10-15)30-17-5-7-29-8-6-17/h3-4,9-12,14,17H,5-8H2,1-2H3,(H,25,28)/t14-/m1/s1 WDEIMZWFSWTCLU-CQSZACIVSA-N 320158 3-(5-chloro-1,3- thiazol-2-yl)-N- [(1R)-1-(6- methylpyridazin-3- yl)ethyl]-5- (tetrahydro-2H- pyran-4- yloxy)benzamide::US10174016, Example 325::US10202369, Example 325::US10472354, Example 325 P2X purinoceptor 2/3 Homo sapiens 235 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320158&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397325 384223432 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843090 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(Cl)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C22H20ClF3N4O3S/c1-12(17-2-3-18(30-29-17)22(24,25)26)28-20(31)13-8-14(21-27-11-19(23)34-21)10-16(9-13)33-15-4-6-32-7-5-15/h2-3,8-12,15H,4-7H2,1H3,(H,28,31)/t12-/m1/s1 LBZPSHGDCXIMLR-GFCCVEGCSA-N 320159 3-(5-chloro-1,3- thiazol-2-yl)-5- (tetrahydro-2H- pyran-4-yloxy)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 326::US10202369, Example 326::US10472354, Example 326 P2X purinoceptor 3 Homo sapiens 21.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320159&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397539 384223433 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843091 C[C@@H](NC(=O)c1cc(OC2CCOCC2)cc(c1)-c1ncc(Cl)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C22H20ClF3N4O3S/c1-12(17-2-3-18(30-29-17)22(24,25)26)28-20(31)13-8-14(21-27-11-19(23)34-21)10-16(9-13)33-15-4-6-32-7-5-15/h2-3,8-12,15H,4-7H2,1H3,(H,28,31)/t12-/m1/s1 LBZPSHGDCXIMLR-GFCCVEGCSA-N 320159 3-(5-chloro-1,3- thiazol-2-yl)-5- (tetrahydro-2H- pyran-4-yloxy)-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl}benzamide::US10174016, Example 326::US10202369, Example 326::US10472354, Example 326 P2X purinoceptor 2/3 Homo sapiens 378 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320159&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397539 384223433 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843092 C[C@@H](NC(=O)c1cc(OCC2(C)COC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-7-27-20(34-13)16-4-15(5-18(6-16)33-12-22(3)10-32-11-22)19(31)30-14(2)17-8-28-21(29-9-17)23(24,25)26/h4-9,14H,10-12H2,1-3H3,(H,30,31)/t14-/m1/s1 JVDZTZBJXQINIP-CQSZACIVSA-N 320160 3-[(3- methyloxetan-3- yl)methoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 327::US10202369, Example 327::US10472354, Example 327 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320160&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397492 384223434 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843093 C[C@@H](NC(=O)c1cc(OCC2(C)COC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F3N4O3S/c1-13-7-27-20(34-13)16-4-15(5-18(6-16)33-12-22(3)10-32-11-22)19(31)30-14(2)17-8-28-21(29-9-17)23(24,25)26/h4-9,14H,10-12H2,1-3H3,(H,30,31)/t14-/m1/s1 JVDZTZBJXQINIP-CQSZACIVSA-N 320160 3-[(3- methyloxetan-3- yl)methoxy]-5-(5- methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 327::US10202369, Example 327::US10472354, Example 327 P2X purinoceptor 2/3 Homo sapiens 239 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320160&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397492 384223434 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843094 C[C@@H](NC(=O)c1cc(OCC(C)(C)O)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-12-8-26-19(33-12)15-5-14(6-17(7-15)32-11-21(3,4)31)18(30)29-13(2)16-9-27-20(28-10-16)22(23,24)25/h5-10,13,31H,11H2,1-4H3,(H,29,30)/t13-/m1/s1 CJANIGLDVDYTLU-CYBMUJFWSA-N 320161 3-(2-hydroxy-2- methylpropoxy)-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl]ethyl} benzamide::US10174016, Example 328::US10472354, Example 328 P2X purinoceptor 3 Homo sapiens 12.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320161&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397727 384223435 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843095 C[C@@H](NC(=O)c1cc(OCC(C)(C)O)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-12-8-26-19(33-12)15-5-14(6-17(7-15)32-11-21(3,4)31)18(30)29-13(2)16-9-27-20(28-10-16)22(23,24)25/h5-10,13,31H,11H2,1-4H3,(H,29,30)/t13-/m1/s1 CJANIGLDVDYTLU-CYBMUJFWSA-N 320161 3-(2-hydroxy-2- methylpropoxy)-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl]ethyl} benzamide::US10174016, Example 328::US10472354, Example 328 P2X purinoceptor 2/3 Homo sapiens 274 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320161&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397727 384223435 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843096 C[C@@H](NC(=O)c1cc(OCC2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23?/m1/s1 LFYNTNZWPQXJEM-NKTHEXPSSA-N 320162 3-[(2-methyltetrahydrofuran-2-yl)methoxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a mixture of two diastereoisomers::US10174016, Example 329::US10202369, Example 330::US10472354, Example 332 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320162&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397698 384223436 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843097 C[C@@H](NC(=O)c1cc(OCC2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23?/m1/s1 LFYNTNZWPQXJEM-NKTHEXPSSA-N 320162 3-[(2-methyltetrahydrofuran-2-yl)methoxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a mixture of two diastereoisomers::US10174016, Example 329::US10202369, Example 330::US10472354, Example 332 P2X purinoceptor 2/3 Homo sapiens 120 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320162&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397698 384223436 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843098 C[C@@H](NC(=O)c1cc(OC[C@]2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23+/m1/s1 LFYNTNZWPQXJEM-CMJOXMDJSA-N 320164 US10174016, Example 331::US10472354, Example 333 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320164&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374910 384223438 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843099 C[C@@H](NC(=O)c1cc(OC[C@]2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23+/m1/s1 LFYNTNZWPQXJEM-CMJOXMDJSA-N 320164 US10174016, Example 331::US10472354, Example 333 P2X purinoceptor 2/3 Homo sapiens 170 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320164&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374910 384223438 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843100 C[C@@H](NC(=O)c1cc(OC[C@@]2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23-/m1/s1 LFYNTNZWPQXJEM-IQMFZBJNSA-N 320163 3-[(2-methyltetrahydrofuran-2-yl)methoxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 330::US10472354, Example 334 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320163&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374909 384223437 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843101 C[C@@H](NC(=O)c1cc(OC[C@@]2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23-/m1/s1 LFYNTNZWPQXJEM-IQMFZBJNSA-N 320163 3-[(2-methyltetrahydrofuran-2-yl)methoxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 330::US10472354, Example 334 P2X purinoceptor 2/3 Homo sapiens 191 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320163&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374909 384223437 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843102 C[C@@H](NC(=O)c1cc(OCC2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23?/m1/s1 LFYNTNZWPQXJEM-NKTHEXPSSA-N 320162 3-[(2-methyltetrahydrofuran-2-yl)methoxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a mixture of two diastereoisomers::US10174016, Example 329::US10202369, Example 330::US10472354, Example 332 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320162&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397698 384223436 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843103 C[C@@H](NC(=O)c1cc(OCC2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23?/m1/s1 LFYNTNZWPQXJEM-NKTHEXPSSA-N 320162 3-[(2-methyltetrahydrofuran-2-yl)methoxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a mixture of two diastereoisomers::US10174016, Example 329::US10202369, Example 330::US10472354, Example 332 P2X purinoceptor 2/3 Homo sapiens 174 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320162&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397698 384223436 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843104 C[C@@H](NC(=O)c1cc(OC[C@]2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23+/m1/s1 LFYNTNZWPQXJEM-CMJOXMDJSA-N 320164 US10174016, Example 331::US10472354, Example 333 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320164&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374910 384223438 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843105 C[C@@H](NC(=O)c1cc(OC[C@]2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23+/m1/s1 LFYNTNZWPQXJEM-CMJOXMDJSA-N 320164 US10174016, Example 331::US10472354, Example 333 P2X purinoceptor 2/3 Homo sapiens 122 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320164&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374910 384223438 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843106 C[C@@H](NC(=O)c1cc(OC[C@@]2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23-/m1/s1 LFYNTNZWPQXJEM-IQMFZBJNSA-N 320163 3-[(2-methyltetrahydrofuran-2-yl)methoxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 330::US10472354, Example 334 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320163&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374909 384223437 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843107 C[C@@H](NC(=O)c1cc(OC[C@@]2(C)CCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F3N4O3S/c1-14-10-28-21(35-14)17-7-16(8-19(9-17)33-13-23(3)5-4-6-34-23)20(32)31-15(2)18-11-29-22(30-12-18)24(25,26)27/h7-12,15H,4-6,13H2,1-3H3,(H,31,32)/t15-,23-/m1/s1 LFYNTNZWPQXJEM-IQMFZBJNSA-N 320163 3-[(2-methyltetrahydrofuran-2-yl)methoxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 330::US10472354, Example 334 P2X purinoceptor 2/3 Homo sapiens 132 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320163&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374909 384223437 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843108 C[C@@H](NC(=O)c1cc(OC2CCC(=O)N(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O3S/c1-13-9-28-22(36-13)16-6-15(7-19(8-16)35-18-4-5-20(33)32(3)12-18)21(34)31-14(2)17-10-29-23(30-11-17)24(25,26)27/h6-11,14,18H,4-5,12H2,1-3H3,(H,31,34)/t14-,18?/m1/s1 CGMVCPWOPCCFBE-IKJXHCRLSA-N 320168 3-[(1-methyl-6-oxopiperidin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a mixture of two diastereoisomers::US10174016, Example 335::US10202369, Example 336::US10472354, Example 335 P2X purinoceptor 3 Homo sapiens 13.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320168&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397147 384223442 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843109 C[C@@H](NC(=O)c1cc(OC2CCC(=O)N(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O3S/c1-13-9-28-22(36-13)16-6-15(7-19(8-16)35-18-4-5-20(33)32(3)12-18)21(34)31-14(2)17-10-29-23(30-11-17)24(25,26)27/h6-11,14,18H,4-5,12H2,1-3H3,(H,31,34)/t14-,18?/m1/s1 CGMVCPWOPCCFBE-IKJXHCRLSA-N 320168 3-[(1-methyl-6-oxopiperidin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a mixture of two diastereoisomers::US10174016, Example 335::US10202369, Example 336::US10472354, Example 335 P2X purinoceptor 2/3 Homo sapiens 541 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320168&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397147 384223442 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843110 C[C@@H](NC(=O)c1cc(O[C@@H]2CCC(=O)N(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O3S/c1-13-9-28-22(36-13)16-6-15(7-19(8-16)35-18-4-5-20(33)32(3)12-18)21(34)31-14(2)17-10-29-23(30-11-17)24(25,26)27/h6-11,14,18H,4-5,12H2,1-3H3,(H,31,34)/t14-,18-/m1/s1 CGMVCPWOPCCFBE-RDTXWAMCSA-N 320169 3-[(1-methyl-6-oxopiperidin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 336::US10472354, Example 336 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320169&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374913 384223443 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843111 C[C@@H](NC(=O)c1cc(O[C@@H]2CCC(=O)N(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O3S/c1-13-9-28-22(36-13)16-6-15(7-19(8-16)35-18-4-5-20(33)32(3)12-18)21(34)31-14(2)17-10-29-23(30-11-17)24(25,26)27/h6-11,14,18H,4-5,12H2,1-3H3,(H,31,34)/t14-,18-/m1/s1 CGMVCPWOPCCFBE-RDTXWAMCSA-N 320169 3-[(1-methyl-6-oxopiperidin-3-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 336::US10472354, Example 336 P2X purinoceptor 2/3 Homo sapiens 443 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320169&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374913 384223443 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843112 C[C@@H](NC(=O)c1cc(O[C@H]2CCC(=O)N(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O3S/c1-13-9-28-22(36-13)16-6-15(7-19(8-16)35-18-4-5-20(33)32(3)12-18)21(34)31-14(2)17-10-29-23(30-11-17)24(25,26)27/h6-11,14,18H,4-5,12H2,1-3H3,(H,31,34)/t14-,18+/m1/s1 CGMVCPWOPCCFBE-KDOFPFPSSA-N 320170 US10174016, Example 337::US10472354, Example 337 P2X purinoceptor 3 Homo sapiens 13.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320170&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374914 384223444 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843113 C[C@@H](NC(=O)c1cc(O[C@H]2CCC(=O)N(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O3S/c1-13-9-28-22(36-13)16-6-15(7-19(8-16)35-18-4-5-20(33)32(3)12-18)21(34)31-14(2)17-10-29-23(30-11-17)24(25,26)27/h6-11,14,18H,4-5,12H2,1-3H3,(H,31,34)/t14-,18+/m1/s1 CGMVCPWOPCCFBE-KDOFPFPSSA-N 320170 US10174016, Example 337::US10472354, Example 337 P2X purinoceptor 2/3 Homo sapiens 257 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320170&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374914 384223444 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843114 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-8-26-20(33-11)16-5-15(6-18(7-16)32-14(4)13(3)30)19(31)29-12(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,29,31)/t12-,13?,14?/m1/s1 FSGDRFBLPAILDE-IYXRBSQSSA-N 319995 3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 162::US10174016, Example 338::US10202369, Example 339::US10472354, Example 338 P2X purinoceptor 3 Homo sapiens 4.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319995&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397269 384223275 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843115 CC(O)C(C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-8-26-20(33-11)16-5-15(6-18(7-16)32-14(4)13(3)30)19(31)29-12(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,29,31)/t12-,13?,14?/m1/s1 FSGDRFBLPAILDE-IYXRBSQSSA-N 319995 3-{[3-hydroxybutan-2-yl]oxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 162::US10174016, Example 338::US10202369, Example 339::US10472354, Example 338 P2X purinoceptor 2/3 Homo sapiens 72.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319995&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397269 384223275 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843116 CC(O)[C@H](C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-8-26-20(33-11)16-5-15(6-18(7-16)32-14(4)13(3)30)19(31)29-12(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,29,31)/t12-,13?,14+/m1/s1 FSGDRFBLPAILDE-YIOYIWSBSA-N 320172 3-[(3-hydroxybutan-2-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 339::US10472354, Example 339 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320172&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374915 384223445 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843117 CC(O)[C@H](C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-8-26-20(33-11)16-5-15(6-18(7-16)32-14(4)13(3)30)19(31)29-12(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,29,31)/t12-,13?,14+/m1/s1 FSGDRFBLPAILDE-YIOYIWSBSA-N 320172 3-[(3-hydroxybutan-2-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 339::US10472354, Example 339 P2X purinoceptor 2/3 Homo sapiens 251 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320172&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374915 384223445 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843118 CC(O)[C@@H](C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-8-26-20(33-11)16-5-15(6-18(7-16)32-14(4)13(3)30)19(31)29-12(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,29,31)/t12-,13?,14-/m1/s1 FSGDRFBLPAILDE-WYAMFQBQSA-N 320173 US10174016, Example 340::US10472354, Example 340 P2X purinoceptor 3 Homo sapiens 3.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320173&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374916 384223446 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843119 CC(O)[C@@H](C)Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C22H23F3N4O3S/c1-11-8-26-20(33-11)16-5-15(6-18(7-16)32-14(4)13(3)30)19(31)29-12(2)17-9-27-21(28-10-17)22(23,24)25/h5-10,12-14,30H,1-4H3,(H,29,31)/t12-,13?,14-/m1/s1 FSGDRFBLPAILDE-WYAMFQBQSA-N 320173 US10174016, Example 340::US10472354, Example 340 P2X purinoceptor 2/3 Homo sapiens 103 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320173&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374916 384223446 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843120 C[C@@H](NC(=O)c1cc(OC2C3COCC2CN(C)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O3S/c1-14-7-30-24(38-14)17-4-16(23(35)33-15(2)18-8-31-25(32-9-18)26(27,28)29)5-21(6-17)37-22-19-10-34(3)11-20(22)13-36-12-19/h4-9,15,19-20,22H,10-13H2,1-3H3,(H,33,35)/t15-,19?,20?,22?/m1/s1 UOQSAFNLRPUQCS-DSXPMEPHSA-N 320174 3-[(7-methyl-3-oxa-7-azabicyclo[3.3.1]non-9-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a Mixture of Two Stereoisomers::US10174016, Example 341::US10202369, Example 342::US10472354, Example 343 P2X purinoceptor 3 Homo sapiens 41.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320174&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397140 384223447 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843121 C[C@@H](NC(=O)c1cc(OC2C3COCC2CN(C)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O3S/c1-14-7-30-24(38-14)17-4-16(23(35)33-15(2)18-8-31-25(32-9-18)26(27,28)29)5-21(6-17)37-22-19-10-34(3)11-20(22)13-36-12-19/h4-9,15,19-20,22H,10-13H2,1-3H3,(H,33,35)/t15-,19?,20?,22?/m1/s1 UOQSAFNLRPUQCS-DSXPMEPHSA-N 320174 3-[(7-methyl-3-oxa-7-azabicyclo[3.3.1]non-9-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a Mixture of Two Stereoisomers::US10174016, Example 341::US10202369, Example 342::US10472354, Example 343 P2X purinoceptor 2/3 Homo sapiens 1242 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320174&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397140 384223447 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843122 C[C@@H](NC(=O)c1cc(OC2C3COCC2CN(C)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O3S/c1-14-7-30-24(38-14)17-4-16(23(35)33-15(2)18-8-31-25(32-9-18)26(27,28)29)5-21(6-17)37-22-19-10-34(3)11-20(22)13-36-12-19/h4-9,15,19-20,22H,10-13H2,1-3H3,(H,33,35)/t15-,19?,20?,22?/m1/s1 UOQSAFNLRPUQCS-DSXPMEPHSA-N 320174 3-[(7-methyl-3-oxa-7-azabicyclo[3.3.1]non-9-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a Mixture of Two Stereoisomers::US10174016, Example 341::US10202369, Example 342::US10472354, Example 343 P2X purinoceptor 3 Homo sapiens 40.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320174&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397140 384223447 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843123 C[C@@H](NC(=O)c1cc(OC2C3COCC2CN(C)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O3S/c1-14-7-30-24(38-14)17-4-16(23(35)33-15(2)18-8-31-25(32-9-18)26(27,28)29)5-21(6-17)37-22-19-10-34(3)11-20(22)13-36-12-19/h4-9,15,19-20,22H,10-13H2,1-3H3,(H,33,35)/t15-,19?,20?,22?/m1/s1 UOQSAFNLRPUQCS-DSXPMEPHSA-N 320174 3-[(7-methyl-3-oxa-7-azabicyclo[3.3.1]non-9-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a Mixture of Two Stereoisomers::US10174016, Example 341::US10202369, Example 342::US10472354, Example 343 P2X purinoceptor 2/3 Homo sapiens 1892 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320174&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397140 384223447 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843124 C[C@@H](NC(=O)c1cc(OC2C3COCC2CN(C)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O3S/c1-14-7-30-24(38-14)17-4-16(23(35)33-15(2)18-8-31-25(32-9-18)26(27,28)29)5-21(6-17)37-22-19-10-34(3)11-20(22)13-36-12-19/h4-9,15,19-20,22H,10-13H2,1-3H3,(H,33,35)/t15-,19?,20?,22?/m1/s1 UOQSAFNLRPUQCS-DSXPMEPHSA-N 320174 3-[(7-methyl-3-oxa-7-azabicyclo[3.3.1]non-9-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a Mixture of Two Stereoisomers::US10174016, Example 341::US10202369, Example 342::US10472354, Example 343 P2X purinoceptor 3 Homo sapiens 135 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320174&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397140 384223447 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843125 C[C@@H](NC(=O)c1cc(OC2C3COCC2CN(C)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C26H28F3N5O3S/c1-14-7-30-24(38-14)17-4-16(23(35)33-15(2)18-8-31-25(32-9-18)26(27,28)29)5-21(6-17)37-22-19-10-34(3)11-20(22)13-36-12-19/h4-9,15,19-20,22H,10-13H2,1-3H3,(H,33,35)/t15-,19?,20?,22?/m1/s1 UOQSAFNLRPUQCS-DSXPMEPHSA-N 320174 3-[(7-methyl-3-oxa-7-azabicyclo[3.3.1]non-9-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a Mixture of Two Stereoisomers::US10174016, Example 341::US10202369, Example 342::US10472354, Example 343 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320174&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397140 384223447 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843126 CC(C)N1CC2COCC(C1)C2Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O3S/c1-15(2)36-11-21-13-38-14-22(12-36)24(21)39-23-6-18(5-19(7-23)26-32-8-16(3)40-26)25(37)35-17(4)20-9-33-27(34-10-20)28(29,30)31/h5-10,15,17,21-22,24H,11-14H2,1-4H3,(H,35,37)/t17-,21?,22?,24?/m1/s1 IQKMSJWJAJKSIQ-CBDSMJNHSA-N 320177 3-[(7-isopropyl-3-oxa-7-azabicyclo[3.3.1]non-9-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a mixture of two stereoisomers::US10174016, Example 344::US10202369, Example 344::US10472354, Example 344 P2X purinoceptor 3 Homo sapiens 34.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320177&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397285 384223450 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843127 CC(C)N1CC2COCC(C1)C2Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O3S/c1-15(2)36-11-21-13-38-14-22(12-36)24(21)39-23-6-18(5-19(7-23)26-32-8-16(3)40-26)25(37)35-17(4)20-9-33-27(34-10-20)28(29,30)31/h5-10,15,17,21-22,24H,11-14H2,1-4H3,(H,35,37)/t17-,21?,22?,24?/m1/s1 IQKMSJWJAJKSIQ-CBDSMJNHSA-N 320177 3-[(7-isopropyl-3-oxa-7-azabicyclo[3.3.1]non-9-yl)oxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a mixture of two stereoisomers::US10174016, Example 344::US10202369, Example 344::US10472354, Example 344 P2X purinoceptor 2/3 Homo sapiens 987 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320177&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397285 384223450 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843128 COC(C)N1CC2COCC(C1)C2Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O4S/c1-15-8-32-26(41-15)19-5-18(25(37)35-16(2)20-9-33-27(34-10-20)28(29,30)31)6-23(7-19)40-24-21-11-36(17(3)38-4)12-22(24)14-39-13-21/h5-10,16-17,21-22,24H,11-14H2,1-4H3,(H,35,37)/t16-,17?,21?,22?,24?/m1/s1 CFYKAOKHKJAYDP-TYFPZMBFSA-N 420284 US10472354, Example 345::methyl 9-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]-3-oxa-7-azabicycle[3.3.1]nonane-7-carboxylate, as a Mixture of Two Stereoisomers P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420284&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843129 COC(C)N1CC2COCC(C1)C2Oc1cc(cc(c1)-c1ncc(C)s1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O4S/c1-15-8-32-26(41-15)19-5-18(25(37)35-16(2)20-9-33-27(34-10-20)28(29,30)31)6-23(7-19)40-24-21-11-36(17(3)38-4)12-22(24)14-39-13-21/h5-10,16-17,21-22,24H,11-14H2,1-4H3,(H,35,37)/t16-,17?,21?,22?,24?/m1/s1 CFYKAOKHKJAYDP-TYFPZMBFSA-N 420284 US10472354, Example 345::methyl 9-[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]-3-oxa-7-azabicycle[3.3.1]nonane-7-carboxylate, as a Mixture of Two Stereoisomers P2X purinoceptor 2/3 Homo sapiens 99.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420284&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843130 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(CCO2)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O5S/c1-16-11-32-24(42-16)19-8-18(23(37)35-17(2)20-12-33-25(34-13-20)28(29,30)31)9-21(10-19)40-15-22-14-36(6-7-39-22)26(38)41-27(3,4)5/h8-13,17,22H,6-7,14-15H2,1-5H3,(H,35,37)/t17-,22-/m1/s1 OEKUZTDVCYAZBS-VGOFRKELSA-N 320179 Tert-butyl (2R)-2-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}morpholine-4-carboxylate::US10174016, Example 346::US10202369, Example 346::US10472354, Example 346 P2X purinoceptor 3 Homo sapiens 13.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320179&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 134338449 384223452 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843131 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(CCO2)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O5S/c1-16-11-32-24(42-16)19-8-18(23(37)35-17(2)20-12-33-25(34-13-20)28(29,30)31)9-21(10-19)40-15-22-14-36(6-7-39-22)26(38)41-27(3,4)5/h8-13,17,22H,6-7,14-15H2,1-5H3,(H,35,37)/t17-,22-/m1/s1 OEKUZTDVCYAZBS-VGOFRKELSA-N 320179 Tert-butyl (2R)-2-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}morpholine-4-carboxylate::US10174016, Example 346::US10202369, Example 346::US10472354, Example 346 P2X purinoceptor 2/3 Homo sapiens 334 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320179&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 134338449 384223452 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843132 C[C@@H](NC(=O)c1cc(OC[C@H]2CNCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O3S/c1-13-8-28-21(35-13)16-5-15(6-18(7-16)34-12-19-11-27-3-4-33-19)20(32)31-14(2)17-9-29-22(30-10-17)23(24,25)26/h5-10,14,19,27H,3-4,11-12H2,1-2H3,(H,31,32)/t14-,19-/m1/s1 HRVUBTPQOQIHTK-AUUYWEPGSA-N 320180 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(2R)-morpholin-2-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 347::US10202369, Example 347::US10472354, Example 347 P2X purinoceptor 3 Homo sapiens 9.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320180&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397601 384223453 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843133 C[C@@H](NC(=O)c1cc(OC[C@H]2CNCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O3S/c1-13-8-28-21(35-13)16-5-15(6-18(7-16)34-12-19-11-27-3-4-33-19)20(32)31-14(2)17-9-29-22(30-10-17)23(24,25)26/h5-10,14,19,27H,3-4,11-12H2,1-2H3,(H,31,32)/t14-,19-/m1/s1 HRVUBTPQOQIHTK-AUUYWEPGSA-N 320180 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(2R)-morpholin-2-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 347::US10202369, Example 347::US10472354, Example 347 P2X purinoceptor 2/3 Homo sapiens 1521 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320180&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397601 384223453 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843134 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-9-28-22(36-14)17-6-16(7-19(8-17)35-13-20-12-32(3)4-5-34-20)21(33)31-15(2)18-10-29-23(30-11-18)24(25,26)27/h6-11,15,20H,4-5,12-13H2,1-3H3,(H,31,33)/t15-,20-/m1/s1 MROBUJILSMBILX-FOIQADDNSA-N 320181 3-{[(2R)-4-methylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 348::US10202369, Example 348::US10472354, Example 348 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320181&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397607 384223454 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843135 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-9-28-22(36-14)17-6-16(7-19(8-17)35-13-20-12-32(3)4-5-34-20)21(33)31-15(2)18-10-29-23(30-11-18)24(25,26)27/h6-11,15,20H,4-5,12-13H2,1-3H3,(H,31,33)/t15-,20-/m1/s1 MROBUJILSMBILX-FOIQADDNSA-N 320181 3-{[(2R)-4-methylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 348::US10202369, Example 348::US10472354, Example 348 P2X purinoceptor 2/3 Homo sapiens 760 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320181&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397607 384223454 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843136 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(CCO2)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O5S/c1-16-11-32-24(42-16)19-8-18(23(37)35-17(2)20-12-33-25(34-13-20)28(29,30)31)9-21(10-19)40-15-22-14-36(6-7-39-22)26(38)41-27(3,4)5/h8-13,17,22H,6-7,14-15H2,1-5H3,(H,35,37)/t17-,22+/m1/s1 OEKUZTDVCYAZBS-VGSWGCGISA-N 320182 Tert-butyl (2S)-2-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}morpholine-4-carboxylate::US10174016, Example 349::US10202369, Example 349::US10472354, Example 349 P2X purinoceptor 3 Homo sapiens 23.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320182&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 134338450 384223455 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843137 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(CCO2)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O5S/c1-16-11-32-24(42-16)19-8-18(23(37)35-17(2)20-12-33-25(34-13-20)28(29,30)31)9-21(10-19)40-15-22-14-36(6-7-39-22)26(38)41-27(3,4)5/h8-13,17,22H,6-7,14-15H2,1-5H3,(H,35,37)/t17-,22+/m1/s1 OEKUZTDVCYAZBS-VGSWGCGISA-N 320182 Tert-butyl (2S)-2-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}morpholine-4-carboxylate::US10174016, Example 349::US10202369, Example 349::US10472354, Example 349 P2X purinoceptor 2/3 Homo sapiens 545 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320182&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 134338450 384223455 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843138 C[C@@H](NC(=O)c1cc(OC[C@@H]2CNCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O3S/c1-13-8-28-21(35-13)16-5-15(6-18(7-16)34-12-19-11-27-3-4-33-19)20(32)31-14(2)17-9-29-22(30-10-17)23(24,25)26/h5-10,14,19,27H,3-4,11-12H2,1-2H3,(H,31,32)/t14-,19+/m1/s1 HRVUBTPQOQIHTK-KUHUBIRLSA-N 320183 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(2S)-morpholin-2-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 350::US10202369, Example 350::US10472354, Example 350 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320183&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397343 384223456 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843139 C[C@@H](NC(=O)c1cc(OC[C@@H]2CNCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O3S/c1-13-8-28-21(35-13)16-5-15(6-18(7-16)34-12-19-11-27-3-4-33-19)20(32)31-14(2)17-9-29-22(30-10-17)23(24,25)26/h5-10,14,19,27H,3-4,11-12H2,1-2H3,(H,31,32)/t14-,19+/m1/s1 HRVUBTPQOQIHTK-KUHUBIRLSA-N 320183 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(2S)-morpholin-2-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 350::US10202369, Example 350::US10472354, Example 350 P2X purinoceptor 2/3 Homo sapiens 1162 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320183&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397343 384223456 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843140 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-9-28-22(36-14)17-6-16(7-19(8-17)35-13-20-12-32(3)4-5-34-20)21(33)31-15(2)18-10-29-23(30-11-18)24(25,26)27/h6-11,15,20H,4-5,12-13H2,1-3H3,(H,31,33)/t15-,20+/m1/s1 MROBUJILSMBILX-QRWLVFNGSA-N 320184 3-{[(2S)-4-methylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 351::US10202369, Example 351::US10472354, Example 351 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320184&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397379 384223457 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843141 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-9-28-22(36-14)17-6-16(7-19(8-17)35-13-20-12-32(3)4-5-34-20)21(33)31-15(2)18-10-29-23(30-11-18)24(25,26)27/h6-11,15,20H,4-5,12-13H2,1-3H3,(H,31,33)/t15-,20+/m1/s1 MROBUJILSMBILX-QRWLVFNGSA-N 320184 3-{[(2S)-4-methylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 351::US10202369, Example 351::US10472354, Example 351 P2X purinoceptor 2/3 Homo sapiens 690 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320184&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397379 384223457 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843142 C[C@@H](NC(=O)c1cc(OCC2CNCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O3S/c1-13-8-28-21(35-13)16-5-15(6-18(7-16)34-12-19-11-27-3-4-33-19)20(32)31-14(2)17-9-29-22(30-10-17)23(24,25)26/h5-10,14,19,27H,3-4,11-12H2,1-2H3,(H,31,32)/t14-,19?/m1/s1 HRVUBTPQOQIHTK-MJTSIZKDSA-N 320185 3-(5-Methyl-1,3-thiazol-2-yl)-5-[morpholin-2-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, Formed as a Mixture of Example 347 (Diastereoisomer 1) and Example 350 (Diastereoisomer 2)::US10174016, Example 352::US10202369, Example 352::US10472354, Example 352 P2X purinoceptor 3 Homo sapiens 18.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320185&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397625 384223458 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843143 C[C@@H](NC(=O)c1cc(OCC2CNCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O3S/c1-13-8-28-21(35-13)16-5-15(6-18(7-16)34-12-19-11-27-3-4-33-19)20(32)31-14(2)17-9-29-22(30-10-17)23(24,25)26/h5-10,14,19,27H,3-4,11-12H2,1-2H3,(H,31,32)/t14-,19?/m1/s1 HRVUBTPQOQIHTK-MJTSIZKDSA-N 320185 3-(5-Methyl-1,3-thiazol-2-yl)-5-[morpholin-2-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, Formed as a Mixture of Example 347 (Diastereoisomer 1) and Example 350 (Diastereoisomer 2)::US10174016, Example 352::US10202369, Example 352::US10472354, Example 352 P2X purinoceptor 2/3 Homo sapiens 1139 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320185&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397625 384223458 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843144 C[C@@H](NC(=O)c1cc(OCC2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-9-28-22(36-14)17-6-16(7-19(8-17)35-13-20-12-32(3)4-5-34-20)21(33)31-15(2)18-10-29-23(30-11-18)24(25,26)27/h6-11,15,20H,4-5,12-13H2,1-3H3,(H,31,33)/t15-,20?/m1/s1 MROBUJILSMBILX-IWPPFLRJSA-N 320186 3-{[4-methylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, formed as a mixture of Example 348 (Diastereoisomer 2) and Example 351 (Diastereoisomer 1)::US10174016, Example 353::US10202369, Example 353::US10472354, Example 353 P2X purinoceptor 3 Homo sapiens 7.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320186&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397299 384223459 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843145 C[C@@H](NC(=O)c1cc(OCC2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-9-28-22(36-14)17-6-16(7-19(8-17)35-13-20-12-32(3)4-5-34-20)21(33)31-15(2)18-10-29-23(30-11-18)24(25,26)27/h6-11,15,20H,4-5,12-13H2,1-3H3,(H,31,33)/t15-,20?/m1/s1 MROBUJILSMBILX-IWPPFLRJSA-N 320186 3-{[4-methylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, formed as a mixture of Example 348 (Diastereoisomer 2) and Example 351 (Diastereoisomer 1)::US10174016, Example 353::US10202369, Example 353::US10472354, Example 353 P2X purinoceptor 2/3 Homo sapiens 427 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320186&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397299 384223459 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843146 C[C@@H](NC(=O)c1cc(OC[C@@]2(F)CCCNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F4N5O2S/c1-14-9-30-21(36-14)17-6-16(7-19(8-17)35-13-23(25)4-3-5-29-12-23)20(34)33-15(2)18-10-31-22(32-11-18)24(26,27)28/h6-11,15,29H,3-5,12-13H2,1-2H3,(H,33,34)/t15-,23-/m1/s1 KEYDTZMORFCFGJ-IQMFZBJNSA-N 320187 3-(Fluoropiperidin-3-yl)methoxyl}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 354::US10472354, Example 354 P2X purinoceptor 3 Homo sapiens 25.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320187&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374918 384223460 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843147 C[C@@H](NC(=O)c1cc(OC[C@@]2(F)CCCNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F4N5O2S/c1-14-9-30-21(36-14)17-6-16(7-19(8-17)35-13-23(25)4-3-5-29-12-23)20(34)33-15(2)18-10-31-22(32-11-18)24(26,27)28/h6-11,15,29H,3-5,12-13H2,1-2H3,(H,33,34)/t15-,23-/m1/s1 KEYDTZMORFCFGJ-IQMFZBJNSA-N 320187 3-(Fluoropiperidin-3-yl)methoxyl}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 354::US10472354, Example 354 P2X purinoceptor 2/3 Homo sapiens 1034 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320187&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374918 384223460 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843148 C[C@@H](NC(=O)c1cc(OC[C@]2(F)CCCNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F4N5O2S/c1-14-9-30-21(36-14)17-6-16(7-19(8-17)35-13-23(25)4-3-5-29-12-23)20(34)33-15(2)18-10-31-22(32-11-18)24(26,27)28/h6-11,15,29H,3-5,12-13H2,1-2H3,(H,33,34)/t15-,23+/m1/s1 KEYDTZMORFCFGJ-CMJOXMDJSA-N 320188 US10174016, Example 355::US10472354, Example 355 P2X purinoceptor 3 Homo sapiens 9.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320188&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374919 384223461 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843149 C[C@@H](NC(=O)c1cc(OC[C@]2(F)CCCNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F4N5O2S/c1-14-9-30-21(36-14)17-6-16(7-19(8-17)35-13-23(25)4-3-5-29-12-23)20(34)33-15(2)18-10-31-22(32-11-18)24(26,27)28/h6-11,15,29H,3-5,12-13H2,1-2H3,(H,33,34)/t15-,23+/m1/s1 KEYDTZMORFCFGJ-CMJOXMDJSA-N 320188 US10174016, Example 355::US10472354, Example 355 P2X purinoceptor 2/3 Homo sapiens 956 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320188&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374919 384223461 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843150 C[C@@H](NC(=O)c1cc(OC[C@@]2(F)CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F4N5O2S/c1-15-10-30-22(37-15)18-7-17(8-20(9-18)36-14-24(26)5-4-6-34(3)13-24)21(35)33-16(2)19-11-31-23(32-12-19)25(27,28)29/h7-12,16H,4-6,13-14H2,1-3H3,(H,33,35)/t16-,24-/m1/s1 JEEGJUGZAOELQB-VOIUYBSRSA-N 320189 3-{[3-fluoro-1-methylpiperidin-3-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 356::US10472354, Example 356 P2X purinoceptor 3 Homo sapiens 29.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320189&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374920 384223462 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843151 C[C@@H](NC(=O)c1cc(OC[C@@]2(F)CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F4N5O2S/c1-15-10-30-22(37-15)18-7-17(8-20(9-18)36-14-24(26)5-4-6-34(3)13-24)21(35)33-16(2)19-11-31-23(32-12-19)25(27,28)29/h7-12,16H,4-6,13-14H2,1-3H3,(H,33,35)/t16-,24-/m1/s1 JEEGJUGZAOELQB-VOIUYBSRSA-N 320189 3-{[3-fluoro-1-methylpiperidin-3-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 356::US10472354, Example 356 P2X purinoceptor 2/3 Homo sapiens 643 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320189&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374920 384223462 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843152 C[C@@H](NC(=O)c1cc(OC[C@]2(F)CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F4N5O2S/c1-15-10-30-22(37-15)18-7-17(8-20(9-18)36-14-24(26)5-4-6-34(3)13-24)21(35)33-16(2)19-11-31-23(32-12-19)25(27,28)29/h7-12,16H,4-6,13-14H2,1-3H3,(H,33,35)/t16-,24+/m1/s1 JEEGJUGZAOELQB-GYCJOSAFSA-N 320190 US10174016, Example 357::US10472354, Example 357 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320190&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374921 384223463 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843153 C[C@@H](NC(=O)c1cc(OC[C@]2(F)CCCN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H27F4N5O2S/c1-15-10-30-22(37-15)18-7-17(8-20(9-18)36-14-24(26)5-4-6-34(3)13-24)21(35)33-16(2)19-11-31-23(32-12-19)25(27,28)29/h7-12,16H,4-6,13-14H2,1-3H3,(H,33,35)/t16-,24+/m1/s1 JEEGJUGZAOELQB-GYCJOSAFSA-N 320190 US10174016, Example 357::US10472354, Example 357 P2X purinoceptor 2/3 Homo sapiens 310 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320190&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374921 384223463 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843154 C[C@@H](NC(=O)c1cc(OCC2(F)CNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F4N5O2S/c1-12-6-28-19(34-12)15-3-14(4-17(5-15)33-11-21(23)9-27-10-21)18(32)31-13(2)16-7-29-20(30-8-16)22(24,25)26/h3-8,13,27H,9-11H2,1-2H3,(H,31,32)/t13-/m1/s1 BCJGFEUMNVQMPR-CYBMUJFWSA-N 320191 3-[(3- fluoroazetidin- 3-yl)methoxy]- 5-(5-methyl- 1,3-thiazol-2- yl)-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 358::US10202369, Example 358::US10472354, Example 358 P2X purinoceptor 3 Homo sapiens 57.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320191&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397395 384223464 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843155 C[C@@H](NC(=O)c1cc(OCC2(F)CNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H21F4N5O2S/c1-12-6-28-19(34-12)15-3-14(4-17(5-15)33-11-21(23)9-27-10-21)18(32)31-13(2)16-7-29-20(30-8-16)22(24,25)26/h3-8,13,27H,9-11H2,1-2H3,(H,31,32)/t13-/m1/s1 BCJGFEUMNVQMPR-CYBMUJFWSA-N 320191 3-[(3- fluoroazetidin- 3-yl)methoxy]- 5-(5-methyl- 1,3-thiazol-2- yl)-N-{(1R)-1- [2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 358::US10202369, Example 358::US10472354, Example 358 P2X purinoceptor 2/3 Homo sapiens 1441 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320191&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397395 384223464 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843156 C[C@@H](NC(=O)c1cc(OCC2CNCCC2(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F5N5O2S/c1-13-8-31-21(37-13)16-5-15(6-19(7-16)36-12-18-11-30-4-3-23(18,25)26)20(35)34-14(2)17-9-32-22(33-10-17)24(27,28)29/h5-10,14,18,30H,3-4,11-12H2,1-2H3,(H,34,35)/t14-,18?/m1/s1 GMFUIUUSPXQCGC-IKJXHCRLSA-N 320192 3-{[4,4- difluoropiperidin- 3- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide, as a mixture of 2 diastereoisomers::US10174016, Example 359::US10202369, Example 359::US10472354, Example 359 P2X purinoceptor 3 Homo sapiens 6.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320192&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397568 384223465 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843157 C[C@@H](NC(=O)c1cc(OCC2CNCCC2(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F5N5O2S/c1-13-8-31-21(37-13)16-5-15(6-19(7-16)36-12-18-11-30-4-3-23(18,25)26)20(35)34-14(2)17-9-32-22(33-10-17)24(27,28)29/h5-10,14,18,30H,3-4,11-12H2,1-2H3,(H,34,35)/t14-,18?/m1/s1 GMFUIUUSPXQCGC-IKJXHCRLSA-N 320192 3-{[4,4- difluoropiperidin- 3- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide, as a mixture of 2 diastereoisomers::US10174016, Example 359::US10202369, Example 359::US10472354, Example 359 P2X purinoceptor 2/3 Homo sapiens 200 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320192&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397568 384223465 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843158 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-9-28-22(36-14)17-6-16(7-20(8-17)35-13-19-12-34-5-4-32(19)3)21(33)31-15(2)18-10-29-23(30-11-18)24(25,26)27/h6-11,15,19H,4-5,12-13H2,1-3H3,(H,31,33)/t15-,19-/m1/s1 QQIYVSYWBHUFSE-DNVCBOLYSA-N 320193 3-{[(3R)-4-methylmorpholin-3-yl]methoxyl}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 360::US10202369, Example 360::US10472354, Example 360 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320193&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397664 384223466 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843159 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-9-28-22(36-14)17-6-16(7-20(8-17)35-13-19-12-34-5-4-32(19)3)21(33)31-15(2)18-10-29-23(30-11-18)24(25,26)27/h6-11,15,19H,4-5,12-13H2,1-3H3,(H,31,33)/t15-,19-/m1/s1 QQIYVSYWBHUFSE-DNVCBOLYSA-N 320193 3-{[(3R)-4-methylmorpholin-3-yl]methoxyl}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 360::US10202369, Example 360::US10472354, Example 360 P2X purinoceptor 2/3 Homo sapiens 455 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320193&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397664 384223466 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843160 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-15-11-30-24(36-15)19-8-18(9-21(10-19)35-14-20-13-34-7-6-32(20)3)23(33)31-16(2)17-4-5-22(29-12-17)25(26,27)28/h4-5,8-12,16,20H,6-7,13-14H2,1-3H3,(H,31,33)/t16-,20+/m1/s1 VDLXIDIXMUFWTI-UZLBHIALSA-N 320194 3-{[(3S)-4- methylmorpholin- 3- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl} benzamide::US10174016, Example 361::US10202369, Example 361::US10472354, Example 361 P2X purinoceptor 3 Homo sapiens 14.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320194&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397445 384223467 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843161 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-15-11-30-24(36-15)19-8-18(9-21(10-19)35-14-20-13-34-7-6-32(20)3)23(33)31-16(2)17-4-5-22(29-12-17)25(26,27)28/h4-5,8-12,16,20H,6-7,13-14H2,1-3H3,(H,31,33)/t16-,20+/m1/s1 VDLXIDIXMUFWTI-UZLBHIALSA-N 320194 3-{[(3S)-4- methylmorpholin- 3- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl} benzamide::US10174016, Example 361::US10202369, Example 361::US10472354, Example 361 P2X purinoceptor 2/3 Homo sapiens 1254 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320194&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397445 384223467 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843162 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-9-28-22(36-14)17-6-16(7-20(8-17)35-13-19-12-34-5-4-32(19)3)21(33)31-15(2)18-10-29-23(30-11-18)24(25,26)27/h6-11,15,19H,4-5,12-13H2,1-3H3,(H,31,33)/t15-,19+/m1/s1 QQIYVSYWBHUFSE-BEFAXECRSA-N 320195 3-{[(3S)-4- methylmorpholin- 3- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyridin-5- yl]ethyl} benzamide::US10174016, Example 362::US10202369, Example 362::US10472354, Example 362 P2X purinoceptor 3 Homo sapiens 8.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320195&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397415 384223468 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843163 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-9-28-22(36-14)17-6-16(7-20(8-17)35-13-19-12-34-5-4-32(19)3)21(33)31-15(2)18-10-29-23(30-11-18)24(25,26)27/h6-11,15,19H,4-5,12-13H2,1-3H3,(H,31,33)/t15-,19+/m1/s1 QQIYVSYWBHUFSE-BEFAXECRSA-N 320195 3-{[(3S)-4- methylmorpholin- 3- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyridin-5- yl]ethyl} benzamide::US10174016, Example 362::US10202369, Example 362::US10472354, Example 362 P2X purinoceptor 2/3 Homo sapiens 1014 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320195&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397415 384223468 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843164 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-15-11-30-24(36-15)19-8-18(9-21(10-19)35-14-20-13-34-7-6-32(20)3)23(33)31-16(2)17-4-5-22(29-12-17)25(26,27)28/h4-5,8-12,16,20H,6-7,13-14H2,1-3H3,(H,31,33)/t16-,20-/m1/s1 VDLXIDIXMUFWTI-OXQOHEQNSA-N 320196 3-{[(3R)-4- methylmorpholin- 3- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl} benzamide::US10174016, Example 363::US10472354, Example 363 P2X purinoceptor 3 Homo sapiens 12.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320196&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397368 384223469 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843165 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-15-11-30-24(36-15)19-8-18(9-21(10-19)35-14-20-13-34-7-6-32(20)3)23(33)31-16(2)17-4-5-22(29-12-17)25(26,27)28/h4-5,8-12,16,20H,6-7,13-14H2,1-3H3,(H,31,33)/t16-,20-/m1/s1 VDLXIDIXMUFWTI-OXQOHEQNSA-N 320196 3-{[(3R)-4- methylmorpholin- 3- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl} benzamide::US10174016, Example 363::US10472354, Example 363 P2X purinoceptor 2/3 Homo sapiens 717 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320196&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397368 384223469 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843166 C[C@@H](NC(=O)c1cc(OCC2CC(F)CN2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F4N5O2S/c1-13-8-29-22(36-13)16-4-15(5-20(6-16)35-12-19-7-18(25)11-33(19)3)21(34)32-14(2)17-9-30-23(31-10-17)24(26,27)28/h4-6,8-10,14,18-19H,7,11-12H2,1-3H3,(H,32,34)/t14-,18?,19?/m1/s1 UCQIVXMFKURDDU-FTXHTYHOSA-N 320197 3-{[4-fluoro-1- methylpyrrolidin- 2- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide, as a mixture of stereoisomers::US10174016, Example 364::US10202369, Example 364::US10472354, Example 364 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320197&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397240 384223470 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843167 C[C@@H](NC(=O)c1cc(OCC2CC(F)CN2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H25F4N5O2S/c1-13-8-29-22(36-13)16-4-15(5-20(6-16)35-12-19-7-18(25)11-33(19)3)21(34)32-14(2)17-9-30-23(31-10-17)24(26,27)28/h4-6,8-10,14,18-19H,7,11-12H2,1-3H3,(H,32,34)/t14-,18?,19?/m1/s1 UCQIVXMFKURDDU-FTXHTYHOSA-N 320197 3-{[4-fluoro-1- methylpyrrolidin- 2- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide, as a mixture of stereoisomers::US10174016, Example 364::US10202369, Example 364::US10472354, Example 364 P2X purinoceptor 2/3 Homo sapiens 943 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320197&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397240 384223470 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843168 C[C@@H](NC(=O)c1cc(OCC2CC(F)CN2C)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C25H26F4N4O2S/c1-14-10-31-24(36-14)18-6-17(7-21(8-18)35-13-20-9-19(26)12-33(20)3)23(34)32-15(2)16-4-5-22(30-11-16)25(27,28)29/h4-8,10-11,15,19-20H,9,12-13H2,1-3H3,(H,32,34)/t15-,19?,20?/m1/s1 XNRRWTQJTXNPEU-APMMTJHUSA-N 320198 3-{[4-fluoro-1- methylpyrrolidin- 2- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl} benzamide, as a mixture of stereoisomers::US10174016, Example 365::US10202369, Example 365::US10472354, Example 365 P2X purinoceptor 3 Homo sapiens 21.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320198&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397581 384223471 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843169 C[C@@H](NC(=O)c1cc(OCC2CC(F)CN2C)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C25H26F4N4O2S/c1-14-10-31-24(36-14)18-6-17(7-21(8-18)35-13-20-9-19(26)12-33(20)3)23(34)32-15(2)16-4-5-22(30-11-16)25(27,28)29/h4-8,10-11,15,19-20H,9,12-13H2,1-3H3,(H,32,34)/t15-,19?,20?/m1/s1 XNRRWTQJTXNPEU-APMMTJHUSA-N 320198 3-{[4-fluoro-1- methylpyrrolidin- 2- yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl} benzamide, as a mixture of stereoisomers::US10174016, Example 365::US10202369, Example 365::US10472354, Example 365 P2X purinoceptor 2/3 Homo sapiens 1049 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320198&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397581 384223471 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843170 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-15-11-30-24(36-15)19-8-18(9-20(10-19)35-14-21-13-32(3)6-7-34-21)23(33)31-16(2)17-4-5-22(29-12-17)25(26,27)28/h4-5,8-12,16,21H,6-7,13-14H2,1-3H3,(H,31,33)/t16-,21-/m1/s1 PQZKBUDIGDWISA-IIBYNOLFSA-N 320199 3-{[(2R)-4-methylmorpholin-2-yl]methoxyl}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}benzamide::US10174016, Example 366::US10202369, Example 366::US10472354, Example 366 P2X purinoceptor 3 Homo sapiens 18.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320199&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397655 384223472 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843171 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-15-11-30-24(36-15)19-8-18(9-20(10-19)35-14-21-13-32(3)6-7-34-21)23(33)31-16(2)17-4-5-22(29-12-17)25(26,27)28/h4-5,8-12,16,21H,6-7,13-14H2,1-3H3,(H,31,33)/t16-,21-/m1/s1 PQZKBUDIGDWISA-IIBYNOLFSA-N 320199 3-{[(2R)-4-methylmorpholin-2-yl]methoxyl}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}benzamide::US10174016, Example 366::US10202369, Example 366::US10472354, Example 366 P2X purinoceptor 2/3 Homo sapiens 977 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320199&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397655 384223472 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843172 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(Cl)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23ClF3N5O3S/c1-13(16-8-29-22(30-9-16)23(25,26)27)31-20(33)14-5-15(21-28-10-19(24)36-21)7-17(6-14)35-12-18-11-32(2)3-4-34-18/h5-10,13,18H,3-4,11-12H2,1-2H3,(H,31,33)/t13-,18-/m1/s1 AJIHXKQJGQMCEX-FZKQIMNGSA-N 320200 3-(5-chloro- 1,3-thiazol-2- yl)-5-{[(2R)-4- methylmorpholin- 2-yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 367::US10202369, Example 367::US10472354, Example 367 P2X purinoceptor 3 Homo sapiens 13.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320200&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397149 384223473 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843173 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(Cl)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23ClF3N5O3S/c1-13(16-8-29-22(30-9-16)23(25,26)27)31-20(33)14-5-15(21-28-10-19(24)36-21)7-17(6-14)35-12-18-11-32(2)3-4-34-18/h5-10,13,18H,3-4,11-12H2,1-2H3,(H,31,33)/t13-,18-/m1/s1 AJIHXKQJGQMCEX-FZKQIMNGSA-N 320200 3-(5-chloro- 1,3-thiazol-2- yl)-5-{[(2R)-4- methylmorpholin- 2-yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 367::US10202369, Example 367::US10472354, Example 367 P2X purinoceptor 2/3 Homo sapiens 506 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320200&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397149 384223473 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843174 CN1CCO[C@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)NCc2cnc(nc2)C(F)(F)F)C1 InChI=1S/C23H24F3N5O3S/c1-14-8-28-21(35-14)17-5-16(6-18(7-17)34-13-19-12-31(2)3-4-33-19)20(32)27-9-15-10-29-22(30-11-15)23(24,25)26/h5-8,10-11,19H,3-4,9,12-13H2,1-2H3,(H,27,32)/t19-/m0/s1 VTYFKUULJMRVCQ-IBGZPJMESA-N 320201 3-{[(2S)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{[2- (trifluoromethyl) pyrimidin-5-yl] methyl} benzamide::US10174016, Example 368::US10202369, Example 368::US10472354, Example 368 P2X purinoceptor 3 Homo sapiens 84.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320201&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397462 384223474 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843175 CN1CCO[C@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)NCc2cnc(nc2)C(F)(F)F)C1 InChI=1S/C23H24F3N5O3S/c1-14-8-28-21(35-14)17-5-16(6-18(7-17)34-13-19-12-31(2)3-4-33-19)20(32)27-9-15-10-29-22(30-11-15)23(24,25)26/h5-8,10-11,19H,3-4,9,12-13H2,1-2H3,(H,27,32)/t19-/m0/s1 VTYFKUULJMRVCQ-IBGZPJMESA-N 320201 3-{[(2S)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{[2- (trifluoromethyl) pyrimidin-5-yl] methyl} benzamide::US10174016, Example 368::US10202369, Example 368::US10472354, Example 368 P2X purinoceptor 2/3 Homo sapiens 1094 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320201&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397462 384223474 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843176 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)F InChI=1S/C25H28F2N4O3S/c1-15-11-29-25(35-15)19-8-18(9-20(10-19)34-14-21-13-31(3)6-7-33-21)24(32)30-16(2)17-4-5-22(23(26)27)28-12-17/h4-5,8-12,16,21,23H,6-7,13-14H2,1-3H3,(H,30,32)/t16-,21-/m1/s1 YEIOEBIHIRXRPN-IIBYNOLFSA-N 320202 N-{(1R)-1-[6- (difluoromethyl) pyridin-3- yl]ethyl}-3- {[(2R)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2- yl)benzamide::US10174016, Example 369::US10202369, Example 369::US10472354, Example 369 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320202&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397220 384223475 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843177 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)F InChI=1S/C25H28F2N4O3S/c1-15-11-29-25(35-15)19-8-18(9-20(10-19)34-14-21-13-31(3)6-7-33-21)24(32)30-16(2)17-4-5-22(23(26)27)28-12-17/h4-5,8-12,16,21,23H,6-7,13-14H2,1-3H3,(H,30,32)/t16-,21-/m1/s1 YEIOEBIHIRXRPN-IIBYNOLFSA-N 320202 N-{(1R)-1-[6- (difluoromethyl) pyridin-3- yl]ethyl}-3- {[(2R)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2- yl)benzamide::US10174016, Example 369::US10202369, Example 369::US10472354, Example 369 P2X purinoceptor 2/3 Homo sapiens 328 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320202&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397220 384223475 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843178 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-15-11-30-24(36-15)19-8-18(9-20(10-19)35-14-21-13-32(3)6-7-34-21)23(33)31-16(2)17-4-5-22(29-12-17)25(26,27)28/h4-5,8-12,16,21H,6-7,13-14H2,1-3H3,(H,31,33)/t16-,21+/m1/s1 PQZKBUDIGDWISA-IERDGZPVSA-N 320203 3-{[(2S)-4- methylmorpholin 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl} benzamide::US10174016, Example 370::US10202369, Example 370::US10472354, Example 370 P2X purinoceptor 3 Homo sapiens 41.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320203&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397778 384223476 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843179 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C25H27F3N4O3S/c1-15-11-30-24(36-15)19-8-18(9-20(10-19)35-14-21-13-32(3)6-7-34-21)23(33)31-16(2)17-4-5-22(29-12-17)25(26,27)28/h4-5,8-12,16,21H,6-7,13-14H2,1-3H3,(H,31,33)/t16-,21+/m1/s1 PQZKBUDIGDWISA-IERDGZPVSA-N 320203 3-{[(2S)-4- methylmorpholin 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[6- (trifluoromethyl) pyridin-3- yl]ethyl} benzamide::US10174016, Example 370::US10202369, Example 370::US10472354, Example 370 P2X purinoceptor 2/3 Homo sapiens 1007 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320203&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397778 384223476 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843180 C[C@@H](NC(=O)c1cc(OCC2(F)CN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F4N5O2S/c1-13-7-28-20(35-13)16-4-15(5-18(6-16)34-12-22(24)10-32(3)11-22)19(33)31-14(2)17-8-29-21(30-9-17)23(25,26)27/h4-9,14H,10-12H2,1-3H3,(H,31,33)/t14-/m1/s1 UHPSIXSPUGVYFA-CQSZACIVSA-N 320204 3-[(3-fluoro-1- methylazetidin-3- yl}methoxy]-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 371::US10202369, Example 371::US10472354, Example 371 P2X purinoceptor 3 Homo sapiens 24.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320204&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397234 384223477 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843181 C[C@@H](NC(=O)c1cc(OCC2(F)CN(C)C2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23F4N5O2S/c1-13-7-28-20(35-13)16-4-15(5-18(6-16)34-12-22(24)10-32(3)11-22)19(33)31-14(2)17-8-29-21(30-9-17)23(25,26)27/h4-9,14H,10-12H2,1-3H3,(H,31,33)/t14-/m1/s1 UHPSIXSPUGVYFA-CQSZACIVSA-N 320204 3-[(3-fluoro-1- methylazetidin-3- yl}methoxy]-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 371::US10202369, Example 371::US10472354, Example 371 P2X purinoceptor 2/3 Homo sapiens 1173 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320204&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397234 384223477 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843182 CN1CCO[C@@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)NCc2cnc(nc2)C(F)(F)F)C1 InChI=1S/C23H24F3N5O3S/c1-14-8-28-21(35-14)17-5-16(6-18(7-17)34-13-19-12-31(2)3-4-33-19)20(32)27-9-15-10-29-22(30-11-15)23(24,25)26/h5-8,10-11,19H,3-4,9,12-13H2,1-2H3,(H,27,32)/t19-/m1/s1 VTYFKUULJMRVCQ-LJQANCHMSA-N 320205 3-{[(2R)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{[2- (trifluoromethyl) pyrimidin-5-yl] methyl} benzamide::US10174016, Example 372::US10202369, Example 372::US10472354, Example 372 P2X purinoceptor 3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320205&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397797 384223478 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843183 CN1CCO[C@@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)NCc2cnc(nc2)C(F)(F)F)C1 InChI=1S/C23H24F3N5O3S/c1-14-8-28-21(35-14)17-5-16(6-18(7-17)34-13-19-12-31(2)3-4-33-19)20(32)27-9-15-10-29-22(30-11-15)23(24,25)26/h5-8,10-11,19H,3-4,9,12-13H2,1-2H3,(H,27,32)/t19-/m1/s1 VTYFKUULJMRVCQ-LJQANCHMSA-N 320205 3-{[(2R)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{[2- (trifluoromethyl) pyrimidin-5-yl] methyl} benzamide::US10174016, Example 372::US10202369, Example 372::US10472354, Example 372 P2X purinoceptor 2/3 Homo sapiens 1211 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320205&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397797 384223478 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843184 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-18(10-17)35-13-19-12-32(3)6-7-34-19)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,19H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,19-/m1/s1 IJFKDPNABTXGCF-DNVCBOLYSA-N 320206 3-{[(2R)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10174016, Example 373::US10202369, Example 373::US10472354, Example 373 P2X purinoceptor 3 Homo sapiens 21.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320206&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397505 384223479 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843185 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-18(10-17)35-13-19-12-32(3)6-7-34-19)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,19H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,19-/m1/s1 IJFKDPNABTXGCF-DNVCBOLYSA-N 320206 3-{[(2R)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10174016, Example 373::US10202369, Example 373::US10472354, Example 373 P2X purinoceptor 2/3 Homo sapiens 2827 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320206&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397505 384223479 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843186 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-18(10-17)35-13-19-12-32(3)6-7-34-19)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,19H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,19+/m1/s1 IJFKDPNABTXGCF-BEFAXECRSA-N 320207 3-{[(2S)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10174016, Example 374::US10202369, Example 374::US10472354, Example 374 P2X purinoceptor 3 Homo sapiens 55.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320207&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397406 384223480 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843187 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-18(10-17)35-13-19-12-32(3)6-7-34-19)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,19H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,19+/m1/s1 IJFKDPNABTXGCF-BEFAXECRSA-N 320207 3-{[(2S)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10174016, Example 374::US10202369, Example 374::US10472354, Example 374 P2X purinoceptor 2/3 Homo sapiens 2557 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320207&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397406 384223480 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843188 CCc1cnc(s1)-c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H28F3N5O3S/c1-4-21-12-29-23(37-21)17-7-16(8-19(9-17)36-14-20-13-33(3)5-6-35-20)22(34)32-15(2)18-10-30-24(31-11-18)25(26,27)28/h7-12,15,20H,4-6,13-14H2,1-3H3,(H,32,34)/t15-,20+/m1/s1 PEGAFCGSQABLTK-QRWLVFNGSA-N 320208 3-(5-ethyl-1,3- thiazol-2-yl)-5- {[(2S)-4- methylmorpholin- 2- yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 375::US10202369, Example 375::US10472354, Example 375 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320208&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397736 384223481 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843189 CCc1cnc(s1)-c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H28F3N5O3S/c1-4-21-12-29-23(37-21)17-7-16(8-19(9-17)36-14-20-13-33(3)5-6-35-20)22(34)32-15(2)18-10-30-24(31-11-18)25(26,27)28/h7-12,15,20H,4-6,13-14H2,1-3H3,(H,32,34)/t15-,20+/m1/s1 PEGAFCGSQABLTK-QRWLVFNGSA-N 320208 3-(5-ethyl-1,3- thiazol-2-yl)-5- {[(2S)-4- methylmorpholin- 2- yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 375::US10202369, Example 375::US10472354, Example 375 P2X purinoceptor 2/3 Homo sapiens 185 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320208&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397736 384223481 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843190 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)-c1ncc(Cl)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23ClF3N5O3S/c1-13(16-8-29-22(30-9-16)23(25,26)27)31-20(33)14-5-15(21-28-10-19(24)36-21)7-17(6-14)35-12-18-11-32(2)3-4-34-18/h5-10,13,18H,3-4,11-12H2,1-2H3,(H,31,33)/t13-,18+/m1/s1 AJIHXKQJGQMCEX-ACJLOTCBSA-N 320209 3-(5-chloro- 1,3-thiazol-2- yl)-5-{[(2S)-4- methylmorpholin- 2-yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 376::US10202369, Example 376::US10472354, Example 376 P2X purinoceptor 3 Homo sapiens 32.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320209&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397674 384223482 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843191 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)-c1ncc(Cl)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H23ClF3N5O3S/c1-13(16-8-29-22(30-9-16)23(25,26)27)31-20(33)14-5-15(21-28-10-19(24)36-21)7-17(6-14)35-12-18-11-32(2)3-4-34-18/h5-10,13,18H,3-4,11-12H2,1-2H3,(H,31,33)/t13-,18+/m1/s1 AJIHXKQJGQMCEX-ACJLOTCBSA-N 320209 3-(5-chloro- 1,3-thiazol-2- yl)-5-{[(2S)-4- methylmorpholin- 2-yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 376::US10202369, Example 376::US10472354, Example 376 P2X purinoceptor 2/3 Homo sapiens 898 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320209&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397674 384223482 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843192 CCc1cnc(s1)-c1cc(OC[C@H]2CN(C)CCO2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H28F3N5O3S/c1-4-21-12-29-23(37-21)17-7-16(8-19(9-17)36-14-20-13-33(3)5-6-35-20)22(34)32-15(2)18-10-30-24(31-11-18)25(26,27)28/h7-12,15,20H,4-6,13-14H2,1-3H3,(H,32,34)/t15-,20-/m1/s1 PEGAFCGSQABLTK-FOIQADDNSA-N 320210 3-(5-ethyl-1,3- thiazol-2-yl)-5- {[(2R)-4- methylmorpholin- 2-yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 377::US10202369, Example 377::US10472354, Example 377 P2X purinoceptor 3 Homo sapiens 5.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320210&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397144 384223483 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843193 CCc1cnc(s1)-c1cc(OC[C@H]2CN(C)CCO2)cc(c1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F InChI=1S/C25H28F3N5O3S/c1-4-21-12-29-23(37-21)17-7-16(8-19(9-17)36-14-20-13-33(3)5-6-35-20)22(34)32-15(2)18-10-30-24(31-11-18)25(26,27)28/h7-12,15,20H,4-6,13-14H2,1-3H3,(H,32,34)/t15-,20-/m1/s1 PEGAFCGSQABLTK-FOIQADDNSA-N 320210 3-(5-ethyl-1,3- thiazol-2-yl)-5- {[(2R)-4- methylmorpholin- 2-yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 377::US10202369, Example 377::US10472354, Example 377 P2X purinoceptor 2/3 Homo sapiens 273 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320210&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397144 384223483 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843194 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCN2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-13-19-5-4-6-32(19)3)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19+/m1/s1 TYUJHJGDOVFFQY-BEFAXECRSA-N 320211 3-{[(2S)-1- methylpyrrolidin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 378::US10202369, Example 378::US10472354, Example 378 P2X purinoceptor 3 Homo sapiens 60.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320211&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397183 384223484 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843195 C[C@@H](NC(=O)c1cc(OC[C@@H]2CCCN2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-13-19-5-4-6-32(19)3)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19+/m1/s1 TYUJHJGDOVFFQY-BEFAXECRSA-N 320211 3-{[(2S)-1- methylpyrrolidin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 378::US10202369, Example 378::US10472354, Example 378 P2X purinoceptor 2/3 Homo sapiens 3752 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320211&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397183 384223484 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843196 C[C@@H](NC(=O)c1cc(OC[C@H]2CCCN2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-13-19-5-4-6-32(19)3)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19-/m1/s1 TYUJHJGDOVFFQY-DNVCBOLYSA-N 320212 3-{[(2R)-1- methylpyrrolidin- 2-yl]methoxy}-5 (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 379::US10202369, Example 379::US10472354, Example 379 P2X purinoceptor 3 Homo sapiens 42.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320212&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397315 384223485 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843197 C[C@@H](NC(=O)c1cc(OC[C@H]2CCCN2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H26F3N5O2S/c1-14-10-28-22(35-14)17-7-16(8-20(9-17)34-13-19-5-4-6-32(19)3)21(33)31-15(2)18-11-29-23(30-12-18)24(25,26)27/h7-12,15,19H,4-6,13H2,1-3H3,(H,31,33)/t15-,19-/m1/s1 TYUJHJGDOVFFQY-DNVCBOLYSA-N 320212 3-{[(2R)-1- methylpyrrolidin- 2-yl]methoxy}-5 (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 379::US10202369, Example 379::US10472354, Example 379 P2X purinoceptor 2/3 Homo sapiens 2755 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320212&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397315 384223485 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843198 C[C@@H](NC(=O)c1cc(OCC2CCN(C)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H28F3N5O2S/c1-15-11-29-23(36-15)19-8-18(9-21(10-19)35-14-17-4-6-33(3)7-5-17)22(34)32-16(2)20-12-30-24(31-13-20)25(26,27)28/h8-13,16-17H,4-7,14H2,1-3H3,(H,32,34)/t16-/m1/s1 GQMGTASPVLCRIR-MRXNPFEDSA-N 320213 3-[(1- methylpiperidin- 4-yl)methoxy]-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 380::US10202369, Example 380::US10472354, Example 380 P2X purinoceptor 3 Homo sapiens 32.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320213&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397264 384223486 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843199 C[C@@H](NC(=O)c1cc(OCC2CCN(C)CC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H28F3N5O2S/c1-15-11-29-23(36-15)19-8-18(9-21(10-19)35-14-17-4-6-33(3)7-5-17)22(34)32-16(2)20-12-30-24(31-13-20)25(26,27)28/h8-13,16-17H,4-7,14H2,1-3H3,(H,32,34)/t16-/m1/s1 GQMGTASPVLCRIR-MRXNPFEDSA-N 320213 3-[(1- methylpiperidin- 4-yl)methoxy]-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 380::US10202369, Example 380::US10472354, Example 380 P2X purinoceptor 2/3 Homo sapiens 2880 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320213&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397264 384223486 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843200 CC(C)N1CCO[C@@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C26H30F3N5O3S/c1-15(2)34-5-6-36-22(13-34)14-37-21-8-18(7-19(9-21)24-30-10-16(3)38-24)23(35)33-17(4)20-11-31-25(32-12-20)26(27,28)29/h7-12,15,17,22H,5-6,13-14H2,1-4H3,(H,33,35)/t17-,22-/m1/s1 AOHBYHNFISDLHQ-VGOFRKELSA-N 320214 3-(5-methyl- 1,3-thiazol-2- yl)-5-{[(2R)-4- (propan-2- yl)morpholin- 2-yl]methoxy}- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 381::US10202369, Example 381::US10472354, Example 381 P2X purinoceptor 3 Homo sapiens 16.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320214&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397576 384223487 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843201 CC(C)N1CCO[C@@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C26H30F3N5O3S/c1-15(2)34-5-6-36-22(13-34)14-37-21-8-18(7-19(9-21)24-30-10-16(3)38-24)23(35)33-17(4)20-11-31-25(32-12-20)26(27,28)29/h7-12,15,17,22H,5-6,13-14H2,1-4H3,(H,33,35)/t17-,22-/m1/s1 AOHBYHNFISDLHQ-VGOFRKELSA-N 320214 3-(5-methyl- 1,3-thiazol-2- yl)-5-{[(2R)-4- (propan-2- yl)morpholin- 2-yl]methoxy}- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 381::US10202369, Example 381::US10472354, Example 381 P2X purinoceptor 2/3 Homo sapiens 954 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320214&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397576 384223487 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843202 CC(C)N1CCO[C@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C26H30F3N5O3S/c1-15(2)34-5-6-36-22(13-34)14-37-21-8-18(7-19(9-21)24-30-10-16(3)38-24)23(35)33-17(4)20-11-31-25(32-12-20)26(27,28)29/h7-12,15,17,22H,5-6,13-14H2,1-4H3,(H,33,35)/t17-,22+/m1/s1 AOHBYHNFISDLHQ-VGSWGCGISA-N 320215 3-(5-methyl- 1,3-thiazol-2- yl)-5-{[(2R)-4- (propan-2- yl)morpholin- 2-yl]methoxy}- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 382::US10202369, Example 382::US10472354, Example 382 P2X purinoceptor 3 Homo sapiens 13.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320215&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397421 384223488 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843203 CC(C)N1CCO[C@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C26H30F3N5O3S/c1-15(2)34-5-6-36-22(13-34)14-37-21-8-18(7-19(9-21)24-30-10-16(3)38-24)23(35)33-17(4)20-11-31-25(32-12-20)26(27,28)29/h7-12,15,17,22H,5-6,13-14H2,1-4H3,(H,33,35)/t17-,22+/m1/s1 AOHBYHNFISDLHQ-VGSWGCGISA-N 320215 3-(5-methyl- 1,3-thiazol-2- yl)-5-{[(2R)-4- (propan-2- yl)morpholin- 2-yl]methoxy}- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10174016, Example 382::US10202369, Example 382::US10472354, Example 382 P2X purinoceptor 2/3 Homo sapiens 432 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320215&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397421 384223488 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843204 C[C@@H](NC(=O)c1cc(OCC2CN(C)CCC2(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O2S/c1-14-9-31-22(38-14)17-6-16(7-20(8-17)37-13-19-12-35(3)5-4-24(19,26)27)21(36)34-15(2)18-10-32-23(33-11-18)25(28,29)30/h6-11,15,19H,4-5,12-13H2,1-3H3,(H,34,36)/t15-,19?/m1/s1 LGPVNMAGAZJDEW-NYRJJRHWSA-N 320216 3-{[4,4- difluoro-1- methylpiperidin- 3-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide, as a mixture of 2 diastereoisomers::US10174016, Example 383::US10202369, Example 384::US10472354, Example 383 P2X purinoceptor 3 Homo sapiens 2.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320216&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397497 384223489 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843205 C[C@@H](NC(=O)c1cc(OCC2CN(C)CCC2(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O2S/c1-14-9-31-22(38-14)17-6-16(7-20(8-17)37-13-19-12-35(3)5-4-24(19,26)27)21(36)34-15(2)18-10-32-23(33-11-18)25(28,29)30/h6-11,15,19H,4-5,12-13H2,1-3H3,(H,34,36)/t15-,19?/m1/s1 LGPVNMAGAZJDEW-NYRJJRHWSA-N 320216 3-{[4,4- difluoro-1- methylpiperidin- 3-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide, as a mixture of 2 diastereoisomers::US10174016, Example 383::US10202369, Example 384::US10472354, Example 383 P2X purinoceptor 2/3 Homo sapiens 35.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320216&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397497 384223489 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843206 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCC2(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O2S/c1-14-9-31-22(38-14)17-6-16(7-20(8-17)37-13-19-12-35(3)5-4-24(19,26)27)21(36)34-15(2)18-10-32-23(33-11-18)25(28,29)30/h6-11,15,19H,4-5,12-13H2,1-3H3,(H,34,36)/t15-,19-/m1/s1 LGPVNMAGAZJDEW-DNVCBOLYSA-N 420323 US10472354, Example 384 P2X purinoceptor 3 Homo sapiens 3.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420323&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843207 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)CCC2(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O2S/c1-14-9-31-22(38-14)17-6-16(7-20(8-17)37-13-19-12-35(3)5-4-24(19,26)27)21(36)34-15(2)18-10-32-23(33-11-18)25(28,29)30/h6-11,15,19H,4-5,12-13H2,1-3H3,(H,34,36)/t15-,19-/m1/s1 LGPVNMAGAZJDEW-DNVCBOLYSA-N 420323 US10472354, Example 384 P2X purinoceptor 2/3 Homo sapiens 75.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420323&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843208 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCC2(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O2S/c1-14-9-31-22(38-14)17-6-16(7-20(8-17)37-13-19-12-35(3)5-4-24(19,26)27)21(36)34-15(2)18-10-32-23(33-11-18)25(28,29)30/h6-11,15,19H,4-5,12-13H2,1-3H3,(H,34,36)/t15-,19+/m1/s1 LGPVNMAGAZJDEW-BEFAXECRSA-N 320217 3-{[4,4-difluoro-1-methylpiperidin-3-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 384::US10174016, Example 385::US10472354, Example 385 P2X purinoceptor 3 Homo sapiens 3.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320217&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 138374922 384223490 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843209 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCC2(F)F)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O2S/c1-14-9-31-22(38-14)17-6-16(7-20(8-17)37-13-19-12-35(3)5-4-24(19,26)27)21(36)34-15(2)18-10-32-23(33-11-18)25(28,29)30/h6-11,15,19H,4-5,12-13H2,1-3H3,(H,34,36)/t15-,19+/m1/s1 LGPVNMAGAZJDEW-BEFAXECRSA-N 320217 3-{[4,4-difluoro-1-methylpiperidin-3-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 384::US10174016, Example 385::US10472354, Example 385 P2X purinoceptor 2/3 Homo sapiens 28.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320217&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 138374922 384223490 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843210 C[C@@H](NC(=O)c1cc(OCC2(F)CN(C)C2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C24H24F4N4O2S/c1-14-9-30-22(35-14)18-6-17(7-19(8-18)34-13-23(25)11-32(3)12-23)21(33)31-15(2)16-4-5-20(29-10-16)24(26,27)28/h4-10,15H,11-13H2,1-3H3,(H,31,33)/t15-/m1/s1 YWRAMSXXAJRPGK-OAHLLOKOSA-N 320219 3-[(3-fluoro-1- methylazetidin-3- yl)methoxy]-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[6- (trifluoromethyl) pyridin-3-yl] ethyl}benzamide::US10174016, Example 386::US10202369, Example 386::US10472354, Example 386 P2X purinoceptor 3 Homo sapiens 24.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320219&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397321 384223491 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843211 C[C@@H](NC(=O)c1cc(OCC2(F)CN(C)C2)cc(c1)-c1ncc(C)s1)c1ccc(nc1)C(F)(F)F InChI=1S/C24H24F4N4O2S/c1-14-9-30-22(35-14)18-6-17(7-19(8-18)34-13-23(25)11-32(3)12-23)21(33)31-15(2)16-4-5-20(29-10-16)24(26,27)28/h4-10,15H,11-13H2,1-3H3,(H,31,33)/t15-/m1/s1 YWRAMSXXAJRPGK-OAHLLOKOSA-N 320219 3-[(3-fluoro-1- methylazetidin-3- yl)methoxy]-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[6- (trifluoromethyl) pyridin-3-yl] ethyl}benzamide::US10174016, Example 386::US10202369, Example 386::US10472354, Example 386 P2X purinoceptor 2/3 Homo sapiens 811 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320219&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397321 384223491 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843212 CCc1cnc(s1)-c1cc(OCC2(F)CN(C)C2)cc(c1)C(=O)N[C@H](C)c1ccc(nc1)C(F)(F)F InChI=1S/C25H26F4N4O2S/c1-4-20-11-31-23(36-20)18-7-17(8-19(9-18)35-14-24(26)12-33(3)13-24)22(34)32-15(2)16-5-6-21(30-10-16)25(27,28)29/h5-11,15H,4,12-14H2,1-3H3,(H,32,34)/t15-/m1/s1 HCTVCZSENAWJEB-OAHLLOKOSA-N 320220 3-(5-ethyl-1,3- thiazol-2-yl)-5-[(3- fluoro-1- methylazetidin-3- yl)methoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3-yl] ethyl}benzamide::US10174016, Example 387::US10202369, Example 387::US10472354, Example 387 P2X purinoceptor 3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320220&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397751 384223492 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843213 CCc1cnc(s1)-c1cc(OCC2(F)CN(C)C2)cc(c1)C(=O)N[C@H](C)c1ccc(nc1)C(F)(F)F InChI=1S/C25H26F4N4O2S/c1-4-20-11-31-23(36-20)18-7-17(8-19(9-18)35-14-24(26)12-33(3)13-24)22(34)32-15(2)16-5-6-21(30-10-16)25(27,28)29/h5-11,15H,4,12-14H2,1-3H3,(H,32,34)/t15-/m1/s1 HCTVCZSENAWJEB-OAHLLOKOSA-N 320220 3-(5-ethyl-1,3- thiazol-2-yl)-5-[(3- fluoro-1- methylazetidin-3- yl)methoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridin-3-yl] ethyl}benzamide::US10174016, Example 387::US10202369, Example 387::US10472354, Example 387 P2X purinoceptor 2/3 Homo sapiens 461 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320220&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397751 384223492 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843214 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-19(10-17)35-13-18-12-34-7-6-32(18)3)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,18H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,18-/m1/s1 SOWWCICJAYGBSY-CRAIPNDOSA-N 320221 3-{[(3R)-4- methylmorpholin-3- yl]methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3-yl] ethyl}benzamide::US10174016, Example 388::US10202369, Example 388::US10472354, Example 388 P2X purinoceptor 3 Homo sapiens 18.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320221&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397768 384223493 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843215 C[C@@H](NC(=O)c1cc(OC[C@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-19(10-17)35-13-18-12-34-7-6-32(18)3)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,18H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,18-/m1/s1 SOWWCICJAYGBSY-CRAIPNDOSA-N 320221 3-{[(3R)-4- methylmorpholin-3- yl]methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3-yl] ethyl}benzamide::US10174016, Example 388::US10202369, Example 388::US10472354, Example 388 P2X purinoceptor 2/3 Homo sapiens 1353 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320221&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397768 384223493 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843216 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-19(10-17)35-13-18-12-34-7-6-32(18)3)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,18H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,18+/m1/s1 SOWWCICJAYGBSY-QAPCUYQASA-N 320222 3-{[(3S)-4- methylmorpholin-3- yl]methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3-yl] ethyl}benzamide::US10174016, Example 389::US10202369, Example 389::US10472354, Example 389 P2X purinoceptor 3 Homo sapiens 18.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320222&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397449 384223494 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843217 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCCN2C)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-19(10-17)35-13-18-12-34-7-6-32(18)3)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,18H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,18+/m1/s1 SOWWCICJAYGBSY-QAPCUYQASA-N 320222 3-{[(3S)-4- methylmorpholin-3- yl]methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[6- (trifluoromethyl) pyridazin-3-yl] ethyl}benzamide::US10174016, Example 389::US10202369, Example 389::US10472354, Example 389 P2X purinoceptor 2/3 Homo sapiens 1614 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320222&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397449 384223494 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843218 CCN1CCO[C@@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C25H28F3N5O3S/c1-4-33-5-6-35-21(13-33)14-36-20-8-17(7-18(9-20)23-29-10-15(2)37-23)22(34)32-16(3)19-11-30-24(31-12-19)25(26,27)28/h7-12,16,21H,4-6,13-14H2,1-3H3,(H,32,34)/t16-,21-/m1/s1 IJXNJADLTIUKEL-IIBYNOLFSA-N 320223 3-{[(2R)-4-ethylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 390::US10202369, Example 390::US10472354, Example 390 P2X purinoceptor 3 Homo sapiens 17.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320223&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397822 384223495 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843219 CCN1CCO[C@@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C25H28F3N5O3S/c1-4-33-5-6-35-21(13-33)14-36-20-8-17(7-18(9-20)23-29-10-15(2)37-23)22(34)32-16(3)19-11-30-24(31-12-19)25(26,27)28/h7-12,16,21H,4-6,13-14H2,1-3H3,(H,32,34)/t16-,21-/m1/s1 IJXNJADLTIUKEL-IIBYNOLFSA-N 320223 3-{[(2R)-4-ethylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 390::US10202369, Example 390::US10472354, Example 390 P2X purinoceptor 2/3 Homo sapiens 804 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320223&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397822 384223495 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843220 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(CC(F)F)CCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O3S/c1-14-8-31-23(39-14)17-5-16(22(36)34-15(2)18-9-32-24(33-10-18)25(28,29)30)6-19(7-17)38-13-20-11-35(3-4-37-20)12-21(26)27/h5-10,15,20-21H,3-4,11-13H2,1-2H3,(H,34,36)/t15-,20-/m1/s1 LANXVVYUHZPONS-FOIQADDNSA-N 320224 3-{[(2R)-4-(2,2-difluoroethyl)morpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 391::US10202369, Example 391::US10472354, Example 391 P2X purinoceptor 3 Homo sapiens 19.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320224&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397746 384223496 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843221 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(CC(F)F)CCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F5N5O3S/c1-14-8-31-23(39-14)17-5-16(22(36)34-15(2)18-9-32-24(33-10-18)25(28,29)30)6-19(7-17)38-13-20-11-35(3-4-37-20)12-21(26)27/h5-10,15,20-21H,3-4,11-13H2,1-2H3,(H,34,36)/t15-,20-/m1/s1 LANXVVYUHZPONS-FOIQADDNSA-N 320224 3-{[(2R)-4-(2,2-difluoroethyl)morpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 391::US10202369, Example 391::US10472354, Example 391 P2X purinoceptor 2/3 Homo sapiens 840 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320224&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397746 384223496 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843222 COC(=O)N1CCO[C@@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C25H26F3N5O5S/c1-14-9-29-22(39-14)17-6-16(21(34)32-15(2)18-10-30-23(31-11-18)25(26,27)28)7-19(8-17)38-13-20-12-33(4-5-37-20)24(35)36-3/h6-11,15,20H,4-5,12-13H2,1-3H3,(H,32,34)/t15-,20-/m1/s1 AMNDVZJYNBRGRX-FOIQADDNSA-N 320225 Methyl (2R)-2-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}morpholine-4-carboxylate::US10174016, Example 392::US10202369, Example 392::US10472354, Example 392 P2X purinoceptor 3 Homo sapiens 11.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320225&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 134338451 384223497 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843223 COC(=O)N1CCO[C@@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C25H26F3N5O5S/c1-14-9-29-22(39-14)17-6-16(21(34)32-15(2)18-10-30-23(31-11-18)25(26,27)28)7-19(8-17)38-13-20-12-33(4-5-37-20)24(35)36-3/h6-11,15,20H,4-5,12-13H2,1-3H3,(H,32,34)/t15-,20-/m1/s1 AMNDVZJYNBRGRX-FOIQADDNSA-N 320225 Methyl (2R)-2-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}morpholine-4-carboxylate::US10174016, Example 392::US10202369, Example 392::US10472354, Example 392 P2X purinoceptor 2/3 Homo sapiens 411 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320225&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 134338451 384223497 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843224 COC(=O)N1CCO[C@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C25H26F3N5O5S/c1-14-9-29-22(39-14)17-6-16(21(34)32-15(2)18-10-30-23(31-11-18)25(26,27)28)7-19(8-17)38-13-20-12-33(4-5-37-20)24(35)36-3/h6-11,15,20H,4-5,12-13H2,1-3H3,(H,32,34)/t15-,20+/m1/s1 AMNDVZJYNBRGRX-QRWLVFNGSA-N 320226 Methyl (2S)-2- {[3-(5-methyl- 1,3-thiazol-2- yl)-5-({(1R)-1- [2- (trifluoromethyl) pyrimidin-5-yl] ethyl}carbamoyl) phenoxy]methyl} morpholine-4- carboxylate::US10174016, Example 393::US10202369, Example 393::US10472354, Example 393 P2X purinoceptor 3 Homo sapiens 24.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320226&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 134338452 384223498 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843225 COC(=O)N1CCO[C@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C25H26F3N5O5S/c1-14-9-29-22(39-14)17-6-16(21(34)32-15(2)18-10-30-23(31-11-18)25(26,27)28)7-19(8-17)38-13-20-12-33(4-5-37-20)24(35)36-3/h6-11,15,20H,4-5,12-13H2,1-3H3,(H,32,34)/t15-,20+/m1/s1 AMNDVZJYNBRGRX-QRWLVFNGSA-N 320226 Methyl (2S)-2- {[3-(5-methyl- 1,3-thiazol-2- yl)-5-({(1R)-1- [2- (trifluoromethyl) pyrimidin-5-yl] ethyl}carbamoyl) phenoxy]methyl} morpholine-4- carboxylate::US10174016, Example 393::US10202369, Example 393::US10472354, Example 393 P2X purinoceptor 2/3 Homo sapiens 1033 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320226&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 134338452 384223498 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843226 C[C@@H](NC(=O)c1cc(OCC2CNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H22F3N5O2S/c1-12-6-27-20(33-12)16-3-15(4-18(5-16)32-11-14-7-26-8-14)19(31)30-13(2)17-9-28-21(29-10-17)22(23,24)25/h3-6,9-10,13-14,26H,7-8,11H2,1-2H3,(H,30,31)/t13-/m1/s1 MHYFOJHMKOGSKR-CYBMUJFWSA-N 320227 3-(Azetidin-3-ylmethoxy)-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 394::US10202369, Example 394::US10472354, Example 394 P2X purinoceptor 3 Homo sapiens 82.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320227&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397376 384223499 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843227 C[C@@H](NC(=O)c1cc(OCC2CNC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C22H22F3N5O2S/c1-12-6-27-20(33-12)16-3-15(4-18(5-16)32-11-14-7-26-8-14)19(31)30-13(2)17-9-28-21(29-10-17)22(23,24)25/h3-6,9-10,13-14,26H,7-8,11H2,1-2H3,(H,30,31)/t13-/m1/s1 MHYFOJHMKOGSKR-CYBMUJFWSA-N 320227 3-(Azetidin-3-ylmethoxy)-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 394::US10202369, Example 394::US10472354, Example 394 P2X purinoceptor 2/3 Homo sapiens 3983 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320227&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397376 384223499 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843228 C[C@@H](NC(=O)c1cc(OC[C@H]2COCC(=O)N2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O4S/c1-13-7-28-22(37-13)16-4-15(5-19(6-16)36-11-18-10-35-12-20(33)32(18)3)21(34)31-14(2)17-8-29-23(30-9-17)24(25,26)27/h4-9,14,18H,10-12H2,1-3H3,(H,31,34)/t14-,18-/m1/s1 SDFLFPYVVNTAIN-RDTXWAMCSA-N 320228 3-{[(3R)-4-methyl-5-oxomorpholin-3-yl]methoxyl}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 395::US10202369, Example 395::US10472354, Example 395 P2X purinoceptor 3 Homo sapiens 30.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320228&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397767 384223500 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843229 C[C@@H](NC(=O)c1cc(OC[C@H]2COCC(=O)N2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O4S/c1-13-7-28-22(37-13)16-4-15(5-19(6-16)36-11-18-10-35-12-20(33)32(18)3)21(34)31-14(2)17-8-29-23(30-9-17)24(25,26)27/h4-9,14,18H,10-12H2,1-3H3,(H,31,34)/t14-,18-/m1/s1 SDFLFPYVVNTAIN-RDTXWAMCSA-N 320228 3-{[(3R)-4-methyl-5-oxomorpholin-3-yl]methoxyl}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 395::US10202369, Example 395::US10472354, Example 395 P2X purinoceptor 2/3 Homo sapiens 1312 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320228&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397767 384223500 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843230 C[C@@H](NC(=O)c1cc(OC[C@H]2COCC(=O)N2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H22F3N5O4S/c1-12-6-27-21(36-12)15-3-14(4-18(5-15)35-10-17-9-34-11-19(32)31-17)20(33)30-13(2)16-7-28-22(29-8-16)23(24,25)26/h3-8,13,17H,9-11H2,1-2H3,(H,30,33)(H,31,32)/t13-,17-/m1/s1 QBCIMXIDQXCQLC-CXAGYDPISA-N 320229 3-(5-methyl-1,3- thiazol-2-yl)-5- {[(3R)-5- oxomorpholin-3- yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 396::US10202369, Example 396::US10472354, Example 396 P2X purinoceptor 3 Homo sapiens 22.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320229&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397733 384223501 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843231 C[C@@H](NC(=O)c1cc(OC[C@H]2COCC(=O)N2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H22F3N5O4S/c1-12-6-27-21(36-12)15-3-14(4-18(5-15)35-10-17-9-34-11-19(32)31-17)20(33)30-13(2)16-7-28-22(29-8-16)23(24,25)26/h3-8,13,17H,9-11H2,1-2H3,(H,30,33)(H,31,32)/t13-,17-/m1/s1 QBCIMXIDQXCQLC-CXAGYDPISA-N 320229 3-(5-methyl-1,3- thiazol-2-yl)-5- {[(3R)-5- oxomorpholin-3- yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 396::US10202369, Example 396::US10472354, Example 396 P2X purinoceptor 2/3 Homo sapiens 1803 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320229&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397733 384223501 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843232 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)C(=O)O2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H22F3N5O4S/c1-12-7-27-20(36-12)15-4-14(5-17(6-15)34-11-18-10-31(3)22(33)35-18)19(32)30-13(2)16-8-28-21(29-9-16)23(24,25)26/h4-9,13,18H,10-11H2,1-3H3,(H,30,32)/t13-,18+/m1/s1 OAEQMLBAMDEFGR-ACJLOTCBSA-N 320230 3-{[(5S)-3-methyl-2- oxo-1,3-oxazolidin- 5-yl]methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 397::US10202369, Example 397::US10472354, Example 397 P2X purinoceptor 3 Homo sapiens 15.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320230&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397304 384223502 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843233 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)C(=O)O2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H22F3N5O4S/c1-12-7-27-20(36-12)15-4-14(5-17(6-15)34-11-18-10-31(3)22(33)35-18)19(32)30-13(2)16-8-28-21(29-9-16)23(24,25)26/h4-9,13,18H,10-11H2,1-3H3,(H,30,32)/t13-,18+/m1/s1 OAEQMLBAMDEFGR-ACJLOTCBSA-N 320230 3-{[(5S)-3-methyl-2- oxo-1,3-oxazolidin- 5-yl]methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 397::US10202369, Example 397::US10472354, Example 397 P2X purinoceptor 2/3 Homo sapiens 1362 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320230&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397304 384223502 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843234 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)C(=O)O2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H22F3N5O4S/c1-12-7-27-20(36-12)15-4-14(5-17(6-15)34-11-18-10-31(3)22(33)35-18)19(32)30-13(2)16-8-28-21(29-9-16)23(24,25)26/h4-9,13,18H,10-11H2,1-3H3,(H,30,32)/t13-,18-/m1/s1 OAEQMLBAMDEFGR-FZKQIMNGSA-N 320231 3-{[(5R)-3-methyl-2- oxo-1,3-oxazolidin- 5-yl]methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 398::US10202369, Example 398::US10472354, Example 398 P2X purinoceptor 3 Homo sapiens 17.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320231&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397297 384223503 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843235 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)C(=O)O2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H22F3N5O4S/c1-12-7-27-20(36-12)15-4-14(5-17(6-15)34-11-18-10-31(3)22(33)35-18)19(32)30-13(2)16-8-28-21(29-9-16)23(24,25)26/h4-9,13,18H,10-11H2,1-3H3,(H,30,32)/t13-,18-/m1/s1 OAEQMLBAMDEFGR-FZKQIMNGSA-N 320231 3-{[(5R)-3-methyl-2- oxo-1,3-oxazolidin- 5-yl]methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 398::US10202369, Example 398::US10472354, Example 398 P2X purinoceptor 2/3 Homo sapiens 1795 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320231&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397297 384223503 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843236 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)C(=O)CO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O4S/c1-13-7-28-22(37-13)16-4-15(5-18(6-16)35-11-19-10-32(3)20(33)12-36-19)21(34)31-14(2)17-8-29-23(30-9-17)24(25,26)27/h4-9,14,19H,10-12H2,1-3H3,(H,31,34)/t14-,19-/m1/s1 UCMZCPXWJACEJN-AUUYWEPGSA-N 320232 3-{[(2R)-4-methyl-5- oxomorpholin-2-yl] methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 399::US10202369, Example 399::US10472354, Example 399 P2X purinoceptor 3 Homo sapiens 69.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320232&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397565 384223504 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843237 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(C)C(=O)CO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O4S/c1-13-7-28-22(37-13)16-4-15(5-18(6-16)35-11-19-10-32(3)20(33)12-36-19)21(34)31-14(2)17-8-29-23(30-9-17)24(25,26)27/h4-9,14,19H,10-12H2,1-3H3,(H,31,34)/t14-,19-/m1/s1 UCMZCPXWJACEJN-AUUYWEPGSA-N 320232 3-{[(2R)-4-methyl-5- oxomorpholin-2-yl] methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 399::US10202369, Example 399::US10472354, Example 399 P2X purinoceptor 2/3 Homo sapiens 1722 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320232&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397565 384223504 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843238 C[C@@H](NC(=O)c1cc(OC[C@@H]2CNC(=O)CO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H22F3N5O4S/c1-12-6-28-21(36-12)15-3-14(4-17(5-15)34-10-18-9-27-19(32)11-35-18)20(33)31-13(2)16-7-29-22(30-8-16)23(24,25)26/h3-8,13,18H,9-11H2,1-2H3,(H,27,32)(H,31,33)/t13-,18+/m1/s1 SQKDWNUUISQXQF-ACJLOTCBSA-N 320233 3-(5-methyl-1,3- thiazol-2-yl)-5- {[(2S)-5- oxomorpholin-2- yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 400::US10202369, Example 400::US10472354, Example 400 P2X purinoceptor 3 Homo sapiens 59.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320233&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397173 384223505 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843239 C[C@@H](NC(=O)c1cc(OC[C@@H]2CNC(=O)CO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H22F3N5O4S/c1-12-6-28-21(36-12)15-3-14(4-17(5-15)34-10-18-9-27-19(32)11-35-18)20(33)31-13(2)16-7-29-22(30-8-16)23(24,25)26/h3-8,13,18H,9-11H2,1-2H3,(H,27,32)(H,31,33)/t13-,18+/m1/s1 SQKDWNUUISQXQF-ACJLOTCBSA-N 320233 3-(5-methyl-1,3- thiazol-2-yl)-5- {[(2S)-5- oxomorpholin-2- yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 400::US10202369, Example 400::US10472354, Example 400 P2X purinoceptor 2/3 Homo sapiens 1477 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320233&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397173 384223505 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843240 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)C(=O)CO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O4S/c1-13-7-28-22(37-13)16-4-15(5-18(6-16)35-11-19-10-32(3)20(33)12-36-19)21(34)31-14(2)17-8-29-23(30-9-17)24(25,26)27/h4-9,14,19H,10-12H2,1-3H3,(H,31,34)/t14-,19+/m1/s1 UCMZCPXWJACEJN-KUHUBIRLSA-N 320234 3-{[(2S)-4-methyl-5- oxomorpholin-2-yl] methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 401::US10202369, Example 401::US10472354, Example 401 P2X purinoceptor 3 Homo sapiens 30.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320234&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397710 384223506 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843241 C[C@@H](NC(=O)c1cc(OC[C@@H]2CN(C)C(=O)CO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O4S/c1-13-7-28-22(37-13)16-4-15(5-18(6-16)35-11-19-10-32(3)20(33)12-36-19)21(34)31-14(2)17-8-29-23(30-9-17)24(25,26)27/h4-9,14,19H,10-12H2,1-3H3,(H,31,34)/t14-,19+/m1/s1 UCMZCPXWJACEJN-KUHUBIRLSA-N 320234 3-{[(2S)-4-methyl-5- oxomorpholin-2-yl] methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 401::US10202369, Example 401::US10472354, Example 401 P2X purinoceptor 2/3 Homo sapiens 1466 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320234&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397710 384223506 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843242 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCC(=O)N2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O4S/c1-13-7-28-22(37-13)16-4-15(5-19(6-16)36-11-18-10-35-12-20(33)32(18)3)21(34)31-14(2)17-8-29-23(30-9-17)24(25,26)27/h4-9,14,18H,10-12H2,1-3H3,(H,31,34)/t14-,18+/m1/s1 SDFLFPYVVNTAIN-KDOFPFPSSA-N 320235 3-{[(3S)-4-methyl-5- oxomorpholin-3-yl] methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 402::US10472354, Example 402 P2X purinoceptor 3 Homo sapiens 21.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320235&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397212 384223507 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843243 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCC(=O)N2C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O4S/c1-13-7-28-22(37-13)16-4-15(5-19(6-16)36-11-18-10-35-12-20(33)32(18)3)21(34)31-14(2)17-8-29-23(30-9-17)24(25,26)27/h4-9,14,18H,10-12H2,1-3H3,(H,31,34)/t14-,18+/m1/s1 SDFLFPYVVNTAIN-KDOFPFPSSA-N 320235 3-{[(3S)-4-methyl-5- oxomorpholin-3-yl] methoxy}-5-(5- methyl-1,3-thiazol- 2-yl)-N-{(1R)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 402::US10472354, Example 402 P2X purinoceptor 2/3 Homo sapiens 1251 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320235&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397212 384223507 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843244 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCC(=O)N2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H22F3N5O4S/c1-12-6-27-21(36-12)15-3-14(4-18(5-15)35-10-17-9-34-11-19(32)31-17)20(33)30-13(2)16-7-28-22(29-8-16)23(24,25)26/h3-8,13,17H,9-11H2,1-2H3,(H,30,33)(H,31,32)/t13-,17+/m1/s1 QBCIMXIDQXCQLC-DYVFJYSZSA-N 320236 3-(5-methyl-1,3- thiazol-2-yl)-5- {[(3S)-5- oxomorpholin-3- yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 403::US10472354, Example 403 P2X purinoceptor 3 Homo sapiens 56.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320236&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397456 384223508 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843245 C[C@@H](NC(=O)c1cc(OC[C@@H]2COCC(=O)N2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H22F3N5O4S/c1-12-6-27-21(36-12)15-3-14(4-18(5-15)35-10-17-9-34-11-19(32)31-17)20(33)30-13(2)16-7-28-22(29-8-16)23(24,25)26/h3-8,13,17H,9-11H2,1-2H3,(H,30,33)(H,31,32)/t13-,17+/m1/s1 QBCIMXIDQXCQLC-DYVFJYSZSA-N 320236 3-(5-methyl-1,3- thiazol-2-yl)-5- {[(3S)-5- oxomorpholin-3- yl]methoxy}-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide::US10174016, Example 403::US10472354, Example 403 P2X purinoceptor 2/3 Homo sapiens 2108 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320236&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397456 384223508 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843246 C[C@@H](NC(=O)c1cc(OCC23CC(CO2)N(C3)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C29H32F3N5O5S/c1-16-10-33-24(43-16)19-6-18(23(38)36-17(2)20-11-34-25(35-12-20)29(30,31)32)7-22(8-19)40-15-28-9-21(13-41-28)37(14-28)26(39)42-27(3,4)5/h6-8,10-12,17,21H,9,13-15H2,1-5H3,(H,36,38)/t17-,21?,28?/m1/s1 FPSSQFUABOQNNZ-RWNQLPSJSA-N 320237 US10174016, Example 404::US10202369, Example 404::US10472354, Example 404::tert-butyl 1-{[3-(5- methyl-1,3-thiazol- 2-yl)-5-({(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}carbamoyl) phenoxy]methyl}-2- oxa-5- azabicyclo[2.2.1] heptane-5- carboxylate, as a mixture of 2 diastereoisomers P2X purinoceptor 3 Homo sapiens 44.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320237&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397508 384223509 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843247 C[C@@H](NC(=O)c1cc(OCC23CC(CO2)N(C3)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C29H32F3N5O5S/c1-16-10-33-24(43-16)19-6-18(23(38)36-17(2)20-11-34-25(35-12-20)29(30,31)32)7-22(8-19)40-15-28-9-21(13-41-28)37(14-28)26(39)42-27(3,4)5/h6-8,10-12,17,21H,9,13-15H2,1-5H3,(H,36,38)/t17-,21?,28?/m1/s1 FPSSQFUABOQNNZ-RWNQLPSJSA-N 320237 US10174016, Example 404::US10202369, Example 404::US10472354, Example 404::tert-butyl 1-{[3-(5- methyl-1,3-thiazol- 2-yl)-5-({(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}carbamoyl) phenoxy]methyl}-2- oxa-5- azabicyclo[2.2.1] heptane-5- carboxylate, as a mixture of 2 diastereoisomers P2X purinoceptor 2/3 Homo sapiens 533 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320237&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397508 384223509 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843248 CC(C)N1CC2(COc3cc(cc(c3)-c3ncc(C)s3)C(=O)N[C@H](C)c3cnc(nc3)C(F)(F)F)CC1CO2 InChI=1S/C27H30F3N5O3S/c1-15(2)35-13-26(8-21(35)12-38-26)14-37-22-6-18(5-19(7-22)24-31-9-16(3)39-24)23(36)34-17(4)20-10-32-25(33-11-20)27(28,29)30/h5-7,9-11,15,17,21H,8,12-14H2,1-4H3,(H,34,36)/t17-,21?,26?/m1/s1 YPUYZHJKGABFEF-XJNIYMOYSA-N 320238 3-[(5-isopropyl-2- oxa-5-azabicyclo [2.2.1]hept-1-yl) methoxy]-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide, as a mixture of 2 diastereoisomers::US10174016, Example 405::US10202369, Example 405::US10472354, Example 405 P2X purinoceptor 3 Homo sapiens 17.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320238&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397496 384223510 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843249 CC(C)N1CC2(COc3cc(cc(c3)-c3ncc(C)s3)C(=O)N[C@H](C)c3cnc(nc3)C(F)(F)F)CC1CO2 InChI=1S/C27H30F3N5O3S/c1-15(2)35-13-26(8-21(35)12-38-26)14-37-22-6-18(5-19(7-22)24-31-9-16(3)39-24)23(36)34-17(4)20-10-32-25(33-11-20)27(28,29)30/h5-7,9-11,15,17,21H,8,12-14H2,1-4H3,(H,34,36)/t17-,21?,26?/m1/s1 YPUYZHJKGABFEF-XJNIYMOYSA-N 320238 3-[(5-isopropyl-2- oxa-5-azabicyclo [2.2.1]hept-1-yl) methoxy]-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide, as a mixture of 2 diastereoisomers::US10174016, Example 405::US10202369, Example 405::US10472354, Example 405 P2X purinoceptor 2/3 Homo sapiens 1558 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320238&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397496 384223510 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843250 C[C@@H](NC(=O)c1cc(OCC23CC(CO2)N(C)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O3S/c1-14-8-29-22(37-14)17-4-16(5-20(6-17)35-13-24-7-19(11-36-24)33(3)12-24)21(34)32-15(2)18-9-30-23(31-10-18)25(26,27)28/h4-6,8-10,15,19H,7,11-13H2,1-3H3,(H,32,34)/t15-,19?,24?/m1/s1 QZIIXNSQPLEQAW-QOFOLWBBSA-N 320239 3-[(5-methyl-2- oxa-5-azabicyclo [2.2.1]hept-1-yl) methoxy]-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide, as a mixture of 2 diastereoisomers::US10174016, Example 406::US10202369, Example 406::US10472354, Example 406 P2X purinoceptor 3 Homo sapiens 26.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320239&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397318 384223511 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843251 C[C@@H](NC(=O)c1cc(OCC23CC(CO2)N(C)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C25H26F3N5O3S/c1-14-8-29-22(37-14)17-4-16(5-20(6-17)35-13-24-7-19(11-36-24)33(3)12-24)21(34)32-15(2)18-9-30-23(31-10-18)25(26,27)28/h4-6,8-10,15,19H,7,11-13H2,1-3H3,(H,32,34)/t15-,19?,24?/m1/s1 QZIIXNSQPLEQAW-QOFOLWBBSA-N 320239 3-[(5-methyl-2- oxa-5-azabicyclo [2.2.1]hept-1-yl) methoxy]-5- (5-methyl-1,3- thiazol-2-yl)-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide, as a mixture of 2 diastereoisomers::US10174016, Example 406::US10202369, Example 406::US10472354, Example 406 P2X purinoceptor 2/3 Homo sapiens 2026 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320239&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397318 384223511 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843252 C[C@@H](NC(=O)c1cc(OCC23CNC(CO2)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O3S/c1-13-7-28-21(36-13)16-3-15(4-19(5-16)34-12-23-6-18(10-35-23)31-11-23)20(33)32-14(2)17-8-29-22(30-9-17)24(25,26)27/h3-5,7-9,14,18,31H,6,10-12H2,1-2H3,(H,32,33)/t14-,18?,23?/m1/s1 NAZJZFLNXXGFCR-IHDUPTFDSA-N 320240 3-(5-Methyl-1,3-thiazol-2-yl)-5-[2-oxa-5-azabicyclo[2.2.1]hept-1-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a Mixture of 2 Diastereoisomers::US10174016, Example 407::US10202369, Example 407::US10472354, Example 407 P2X purinoceptor 3 Homo sapiens 15.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320240&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397648 384223512 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843253 C[C@@H](NC(=O)c1cc(OCC23CNC(CO2)C3)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C24H24F3N5O3S/c1-13-7-28-21(36-13)16-3-15(4-19(5-16)34-12-23-6-18(10-35-23)31-11-23)20(33)32-14(2)17-8-29-22(30-9-17)24(25,26)27/h3-5,7-9,14,18,31H,6,10-12H2,1-2H3,(H,32,33)/t14-,18?,23?/m1/s1 NAZJZFLNXXGFCR-IHDUPTFDSA-N 320240 3-(5-Methyl-1,3-thiazol-2-yl)-5-[2-oxa-5-azabicyclo[2.2.1]hept-1-ylmethoxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide, as a Mixture of 2 Diastereoisomers::US10174016, Example 407::US10202369, Example 407::US10472354, Example 407 P2X purinoceptor 2/3 Homo sapiens 1681 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320240&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397648 384223512 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843254 CCCN1CC2(COc3cc(cc(c3)-c3ncc(C)s3)C(=O)N[C@H](C)c3cnc(nc3)C(F)(F)F)CC1CO2 InChI=1S/C27H30F3N5O3S/c1-4-5-35-14-26(9-21(35)13-38-26)15-37-22-7-18(6-19(8-22)24-31-10-16(2)39-24)23(36)34-17(3)20-11-32-25(33-12-20)27(28,29)30/h6-8,10-12,17,21H,4-5,9,13-15H2,1-3H3,(H,34,36)/t17-,21?,26?/m1/s1 AAPJJGZIWGLKBD-XJNIYMOYSA-N 320241 3-(5-methyl-1,3- thiazol-2-yl)-5-[(5- propyl-2- oxa-5-azabicyclo [2.2.1]hept-1-yl) methoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide, as a mixture of 2 diastereoisomers::US10174016, Example 408::US10202369, Example 408::US10472354, Example 408 P2X purinoceptor 3 Homo sapiens 32.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320241&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397789 384223513 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843255 CCCN1CC2(COc3cc(cc(c3)-c3ncc(C)s3)C(=O)N[C@H](C)c3cnc(nc3)C(F)(F)F)CC1CO2 InChI=1S/C27H30F3N5O3S/c1-4-5-35-14-26(9-21(35)13-38-26)15-37-22-7-18(6-19(8-22)24-31-10-16(2)39-24)23(36)34-17(3)20-11-32-25(33-12-20)27(28,29)30/h6-8,10-12,17,21H,4-5,9,13-15H2,1-3H3,(H,34,36)/t17-,21?,26?/m1/s1 AAPJJGZIWGLKBD-XJNIYMOYSA-N 320241 3-(5-methyl-1,3- thiazol-2-yl)-5-[(5- propyl-2- oxa-5-azabicyclo [2.2.1]hept-1-yl) methoxy]-N- {(1R)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl}benzamide, as a mixture of 2 diastereoisomers::US10174016, Example 408::US10202369, Example 408::US10472354, Example 408 P2X purinoceptor 2/3 Homo sapiens 1710 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320241&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397789 384223513 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843256 COC(=O)N1CC2(COc3cc(cc(c3)-c3ncc(C)s3)C(=O)N[C@H](C)c3cnc(nc3)C(F)(F)F)CC1CO2 InChI=1S/C26H26F3N5O5S/c1-14-8-30-22(40-14)17-4-16(21(35)33-15(2)18-9-31-23(32-10-18)26(27,28)29)5-20(6-17)38-13-25-7-19(11-39-25)34(12-25)24(36)37-3/h4-6,8-10,15,19H,7,11-13H2,1-3H3,(H,33,35)/t15-,19?,25?/m1/s1 ACUSXDHHFJWBEG-QYRGRQSGSA-N 320242 Methyl 1-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate, as a mixture of 2 diastereoisomers::US10174016, Example 409::US10202369, Example 409::US10472354, Example 409 P2X purinoceptor 3 Homo sapiens 22.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320242&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397200 384223514 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843257 COC(=O)N1CC2(COc3cc(cc(c3)-c3ncc(C)s3)C(=O)N[C@H](C)c3cnc(nc3)C(F)(F)F)CC1CO2 InChI=1S/C26H26F3N5O5S/c1-14-8-30-22(40-14)17-4-16(21(35)33-15(2)18-9-31-23(32-10-18)26(27,28)29)5-20(6-17)38-13-25-7-19(11-39-25)34(12-25)24(36)37-3/h4-6,8-10,15,19H,7,11-13H2,1-3H3,(H,33,35)/t15-,19?,25?/m1/s1 ACUSXDHHFJWBEG-QYRGRQSGSA-N 320242 Methyl 1-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate, as a mixture of 2 diastereoisomers::US10174016, Example 409::US10202369, Example 409::US10472354, Example 409 P2X purinoceptor 2/3 Homo sapiens 976 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320242&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397200 384223514 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843258 CCOC(=O)N1CC2(COc3cc(cc(c3)-c3ncc(C)s3)C(=O)N[C@H](C)c3cnc(nc3)C(F)(F)F)CC1CO2 InChI=1S/C27H28F3N5O5S/c1-4-38-25(37)35-13-26(8-20(35)12-40-26)14-39-21-6-17(5-18(7-21)23-31-9-15(2)41-23)22(36)34-16(3)19-10-32-24(33-11-19)27(28,29)30/h5-7,9-11,16,20H,4,8,12-14H2,1-3H3,(H,34,36)/t16-,20?,26?/m1/s1 MVNNYWBQRAUUBD-ORALUJHKSA-N 320243 Ethyl 1-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate, as a Mixture of 2 Diastereoisomers::US10174016, Example 410::US10202369, Example 410::US10472354, Example 410 P2X purinoceptor 3 Homo sapiens 22.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320243&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397180 384223515 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843259 CCOC(=O)N1CC2(COc3cc(cc(c3)-c3ncc(C)s3)C(=O)N[C@H](C)c3cnc(nc3)C(F)(F)F)CC1CO2 InChI=1S/C27H28F3N5O5S/c1-4-38-25(37)35-13-26(8-20(35)12-40-26)14-39-21-6-17(5-18(7-21)23-31-9-15(2)41-23)22(36)34-16(3)19-10-32-24(33-11-19)27(28,29)30/h5-7,9-11,16,20H,4,8,12-14H2,1-3H3,(H,34,36)/t16-,20?,26?/m1/s1 MVNNYWBQRAUUBD-ORALUJHKSA-N 320243 Ethyl 1-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate, as a Mixture of 2 Diastereoisomers::US10174016, Example 410::US10202369, Example 410::US10472354, Example 410 P2X purinoceptor 2/3 Homo sapiens 906 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320243&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397180 384223515 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843260 CCN1CCO[C@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C25H28F3N5O3S/c1-4-33-5-6-35-21(13-33)14-36-20-8-17(7-18(9-20)23-29-10-15(2)37-23)22(34)32-16(3)19-11-30-24(31-12-19)25(26,27)28/h7-12,16,21H,4-6,13-14H2,1-3H3,(H,32,34)/t16-,21+/m1/s1 IJXNJADLTIUKEL-IERDGZPVSA-N 320244 3-{[(2S)-4-ethylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 411::US10202369, Example 411::US10472354, Example 411 P2X purinoceptor 3 Homo sapiens 20.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320244&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397533 384223516 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843261 CCN1CCO[C@H](COc2cc(cc(c2)-c2ncc(C)s2)C(=O)N[C@H](C)c2cnc(nc2)C(F)(F)F)C1 InChI=1S/C25H28F3N5O3S/c1-4-33-5-6-35-21(13-33)14-36-20-8-17(7-18(9-20)23-29-10-15(2)37-23)22(34)32-16(3)19-11-30-24(31-12-19)25(26,27)28/h7-12,16,21H,4-6,13-14H2,1-3H3,(H,32,34)/t16-,21+/m1/s1 IJXNJADLTIUKEL-IERDGZPVSA-N 320244 3-{[(2S)-4-ethylmorpholin-2-yl]methoxy}-5-(5-methyl-1,3-thiazol-2-yl)-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 411::US10202369, Example 411::US10472354, Example 411 P2X purinoceptor 2/3 Homo sapiens 697 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320244&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397533 384223516 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843262 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(CCO2)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O5S/c1-16-11-32-24(42-16)19-8-18(23(37)35-17(2)20-12-33-25(34-13-20)28(29,30)31)9-21(10-19)40-15-22-14-36(6-7-39-22)26(38)41-27(3,4)5/h8-13,17,22H,6-7,14-15H2,1-5H3,(H,35,37)/t17-,22-/m1/s1 OEKUZTDVCYAZBS-VGOFRKELSA-N 320179 Tert-butyl (2R)-2-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}morpholine-4-carboxylate::US10174016, Example 346::US10202369, Example 346::US10472354, Example 346 P2X purinoceptor 3 Homo sapiens 687 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320179&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 134338449 384223452 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843263 C[C@@H](NC(=O)c1cc(OC[C@H]2CN(CCO2)C(=O)OC(C)(C)C)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C28H32F3N5O5S/c1-16-11-32-24(42-16)19-8-18(23(37)35-17(2)20-12-33-25(34-13-20)28(29,30)31)9-21(10-19)40-15-22-14-36(6-7-39-22)26(38)41-27(3,4)5/h8-13,17,22H,6-7,14-15H2,1-5H3,(H,35,37)/t17-,22-/m1/s1 OEKUZTDVCYAZBS-VGOFRKELSA-N 320179 Tert-butyl (2R)-2-{[3-(5-methyl-1,3-thiazol-2-yl)-5-({(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}carbamoyl)phenoxy]methyl}morpholine-4-carboxylate::US10174016, Example 346::US10202369, Example 346::US10472354, Example 346 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320179&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 134338449 384223452 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843264 C[C@H](NC(=O)c1cc(OC[C@H]2CNCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O3S/c1-13-8-28-21(35-13)16-5-15(6-18(7-16)34-12-19-11-27-3-4-33-19)20(32)31-14(2)17-9-29-22(30-10-17)23(24,25)26/h5-10,14,19,27H,3-4,11-12H2,1-2H3,(H,31,32)/t14-,19+/m0/s1 HRVUBTPQOQIHTK-IFXJQAMLSA-N 320246 3-(5-methyl- 1,3-thiazol-2- yl)-5-[(2R)- morpholin-2- ylmethoxy]-N- {(1S)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 413::US10202369, Example 413::US10472354, Example 413 P2X purinoceptor 3 Homo sapiens 597 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320246&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397518 384223518 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843265 C[C@H](NC(=O)c1cc(OC[C@H]2CNCCO2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F InChI=1S/C23H24F3N5O3S/c1-13-8-28-21(35-13)16-5-15(6-18(7-16)34-12-19-11-27-3-4-33-19)20(32)31-14(2)17-9-29-22(30-10-17)23(24,25)26/h5-10,14,19,27H,3-4,11-12H2,1-2H3,(H,31,32)/t14-,19+/m0/s1 HRVUBTPQOQIHTK-IFXJQAMLSA-N 320246 3-(5-methyl- 1,3-thiazol-2- yl)-5-[(2R)- morpholin-2- ylmethoxy]-N- {(1S)-1-[2- (trifluoromethyl) pyrimidin-5-yl] ethyl}benzamide::US10174016, Example 413::US10202369, Example 413::US10472354, Example 413 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320246&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397518 384223518 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843266 CCc1cnc(s1)-c1cc(OC[C@@H]2CNCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-3-19-12-29-23(36-19)16-8-15(9-17(10-16)35-13-18-11-28-6-7-34-18)22(33)30-14(2)20-4-5-21(32-31-20)24(25,26)27/h4-5,8-10,12,14,18,28H,3,6-7,11,13H2,1-2H3,(H,30,33)/t14-,18+/m1/s1 PAVCMPZQEBSSQV-KDOFPFPSSA-N 320247 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(2S)- morpholin-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3-yl] ethyl}benzamide::US10174016, Example 414::US10202369, Example 414::US10472354, Example 414 P2X purinoceptor 3 Homo sapiens 29.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320247&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397150 384223519 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843267 CCc1cnc(s1)-c1cc(OC[C@@H]2CNCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-3-19-12-29-23(36-19)16-8-15(9-17(10-16)35-13-18-11-28-6-7-34-18)22(33)30-14(2)20-4-5-21(32-31-20)24(25,26)27/h4-5,8-10,12,14,18,28H,3,6-7,11,13H2,1-2H3,(H,30,33)/t14-,18+/m1/s1 PAVCMPZQEBSSQV-KDOFPFPSSA-N 320247 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(2S)- morpholin-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3-yl] ethyl}benzamide::US10174016, Example 414::US10202369, Example 414::US10472354, Example 414 P2X purinoceptor 2/3 Homo sapiens 2272 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320247&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397150 384223519 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843268 CCc1cnc(s1)-c1cc(OC[C@H]2CNCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-3-19-12-29-23(36-19)16-8-15(9-17(10-16)35-13-18-11-28-6-7-34-18)22(33)30-14(2)20-4-5-21(32-31-20)24(25,26)27/h4-5,8-10,12,14,18,28H,3,6-7,11,13H2,1-2H3,(H,30,33)/t14-,18-/m1/s1 PAVCMPZQEBSSQV-RDTXWAMCSA-N 320248 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(2R)- morpholin-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3-yl] ethyl}benzamide::US10174016, Example 415::US10202369, Example 415::US10472354, Example 415 P2X purinoceptor 3 Homo sapiens 10.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320248&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397550 384223520 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843269 CCc1cnc(s1)-c1cc(OC[C@H]2CNCCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-3-19-12-29-23(36-19)16-8-15(9-17(10-16)35-13-18-11-28-6-7-34-18)22(33)30-14(2)20-4-5-21(32-31-20)24(25,26)27/h4-5,8-10,12,14,18,28H,3,6-7,11,13H2,1-2H3,(H,30,33)/t14-,18-/m1/s1 PAVCMPZQEBSSQV-RDTXWAMCSA-N 320248 3-(5-ethyl-1,3- thiazol-2-yl)-5- [(2R)- morpholin-2- ylmethoxy]-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3-yl] ethyl}benzamide::US10174016, Example 415::US10202369, Example 415::US10472354, Example 415 P2X purinoceptor 2/3 Homo sapiens 2177 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=320248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=320248&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397550 384223520 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843270 C[C@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-18(10-17)35-13-19-12-32(3)6-7-34-19)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,19H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,19+/m0/s1 IJFKDPNABTXGCF-HNAYVOBHSA-N 420355 3-{[(2R)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1S)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10472354, Example 416 P2X purinoceptor 3 Homo sapiens 227 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420355&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843271 C[C@H](NC(=O)c1cc(OC[C@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-18(10-17)35-13-19-12-32(3)6-7-34-19)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,19H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,19+/m0/s1 IJFKDPNABTXGCF-HNAYVOBHSA-N 420355 3-{[(2R)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1S)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10472354, Example 416 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420355&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843272 C[C@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-18(10-17)35-13-19-12-32(3)6-7-34-19)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,19H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,19-/m0/s1 IJFKDPNABTXGCF-KXBFYZLASA-N 420356 3-{[(2S)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1S)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10472354, Example 417 P2X purinoceptor 3 Homo sapiens 434 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420356&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843273 C[C@H](NC(=O)c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)-c1ncc(C)s1)c1ccc(nn1)C(F)(F)F InChI=1S/C24H26F3N5O3S/c1-14-11-28-23(36-14)17-8-16(9-18(10-17)35-13-19-12-32(3)6-7-34-19)22(33)29-15(2)20-4-5-21(31-30-20)24(25,26)27/h4-5,8-11,15,19H,6-7,12-13H2,1-3H3,(H,29,33)/t15-,19-/m0/s1 IJFKDPNABTXGCF-KXBFYZLASA-N 420356 3-{[(2S)-4- methylmorpholin- 2-yl]methoxy}-5- (5-methyl-1,3- thiazol-2-yl)- N-{(1S)-1-[2- (trifluoromethyl) pyrimidin-5- yl]ethyl} benzamide::US10472354, Example 417 P2X purinoceptor 2/3 Homo sapiens 10000 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=420356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=420356&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843274 CCc1cnc(s1)-c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H28F3N5O3S/c1-4-20-12-29-24(37-20)17-9-16(10-18(11-17)36-14-19-13-33(3)7-8-35-19)23(34)30-15(2)21-5-6-22(32-31-21)25(26,27)28/h5-6,9-12,15,19H,4,7-8,13-14H2,1-3H3,(H,30,34)/t15-,19+/m1/s1 SIFMRPZFMXLARV-BEFAXECRSA-N 322607 3-(5-Ethyl-1,3- thiazol-2-yl)-5- {[(2S)-4- methyl- morpholin-2- yl]methoxy}-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10183937, Example 418::US10202369, Example 418::US10472354, Example 418 P2X purinoceptor 3 Homo sapiens 23.0 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322607&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397330 384225667 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843275 CCc1cnc(s1)-c1cc(OC[C@@H]2CN(C)CCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H28F3N5O3S/c1-4-20-12-29-24(37-20)17-9-16(10-18(11-17)36-14-19-13-33(3)7-8-35-19)23(34)30-15(2)21-5-6-22(32-31-21)25(26,27)28/h5-6,9-12,15,19H,4,7-8,13-14H2,1-3H3,(H,30,34)/t15-,19+/m1/s1 SIFMRPZFMXLARV-BEFAXECRSA-N 322607 3-(5-Ethyl-1,3- thiazol-2-yl)-5- {[(2S)-4- methyl- morpholin-2- yl]methoxy}-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10183937, Example 418::US10202369, Example 418::US10472354, Example 418 P2X purinoceptor 2/3 Homo sapiens 1556 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322607&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397330 384225667 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638 843276 CCc1cnc(s1)-c1cc(OC[C@H]2CN(C)CCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H28F3N5O3S/c1-4-20-12-29-24(37-20)17-9-16(10-18(11-17)36-14-19-13-33(3)7-8-35-19)23(34)30-15(2)21-5-6-22(32-31-21)25(26,27)28/h5-6,9-12,15,19H,4,7-8,13-14H2,1-3H3,(H,30,34)/t15-,19-/m1/s1 SIFMRPZFMXLARV-DNVCBOLYSA-N 322608 3-(5-ethyl-1,3- thiazol-2-yl)-5- {[(2R)-4- methyl- morpholin-2- yl]methoxy}-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10183937, Example 419::US10202369, Example 419::US10472354, Example 419 P2X purinoceptor 3 Homo sapiens 9.00 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5767&target=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322608&enzyme=P2X+purinoceptor+3&column=ki&startPg=0&Increment=50&submit=Search 121397262 384225668 1 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 843277 CCc1cnc(s1)-c1cc(OC[C@H]2CN(C)CCO2)cc(c1)C(=O)N[C@H](C)c1ccc(nn1)C(F)(F)F InChI=1S/C25H28F3N5O3S/c1-4-20-12-29-24(37-20)17-9-16(10-18(11-17)36-14-19-13-33(3)7-8-35-19)23(34)30-15(2)21-5-6-22(32-31-21)25(26,27)28/h5-6,9-12,15,19H,4,7-8,13-14H2,1-3H3,(H,30,34)/t15-,19-/m1/s1 SIFMRPZFMXLARV-DNVCBOLYSA-N 322608 3-(5-ethyl-1,3- thiazol-2-yl)-5- {[(2R)-4- methyl- morpholin-2- yl]methoxy}-N- {(1R)-1-[6- (trifluoromethyl) pyridazin-3- yl]ethyl} benzamide::US10183937, Example 419::US10202369, Example 419::US10472354, Example 419 P2X purinoceptor 2/3 Homo sapiens 1136 US Patent 10.7270/Q2KD2197 aid1803961 US10472354 Davenport, AJ; Brauer, N; Fischer, OM; Rotgeri, A; Rottmann, A; Neagoe, I; Nagel, J; Godinho-Coelho, A; Klar, J 11/12/2019 9/14/2020 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=322608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=284&target=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=322608&enzyme=P2X+purinoceptor+2%2F3&column=ki&startPg=0&Increment=50&submit=Search 121397262 384225668 2 MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNETTLKIAALTNPVYPSDQTTAEKQSTDSGAFSIGH P2X purinoceptor 3 P2RX3_HUMAN P56373 Q6DK37 Q9UQB6 MAAAQPKYPAGATARRLARGCWSALWDYETPKVIVVRNRRLGVLYRAVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVKGITTSEHKVWDVEEYVKPPEGGSVFSIITRVEATHSQTQGTCPESIRVHNATCLSDADCVAGELDMLGNGLRTGRCVPYYQGPSKTCEVFGWCPVEDGASVSQFLGTMAPNFTILIKNSIHYPKFHFSKGNIADRTDGYLKRCTFHEASDLYCPIFKLGFIVEKAGESFTELAHKGGVIGVIINWDCDLDLPASECNPKYSFRRLDPKHVPASSGYNFRFAKYYKINGTTTRTLIKAYGIRIDVIVHGQAGKFSLIPTIINLATALTSVGVGSFLCDWILLTFMNKNKVYSHKKFDKVCTPSHPSGSWPVTLARVLGQAPPEPGHRSEDQHPSPPSGQEGQQGAECGPAFPPLRPCPISAPSEQMVDTPASEPAQASTPTDPKGLAQL P2X purinoceptor 2 P2RX2_HUMAN Q9UBL9 A6NGB4 A6NH93 A6NHC2 A6NHU3 A6NIG9 Q6V9R6 Q9NR37 Q9NR38 Q9UHD5 Q9UHD6 Q9UHD7 Q9Y637 Q9Y638